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Inferring structures, free energy differences, and kinetic rates of biological 
macromolecular assemblies by integrative modeling 
Ilan Edmond Chemmama 
 
Abstract 
Biological macromolecular assemblies play crucial roles in most cellular processes. The 
determination of their structures, thermodynamics, and kinetics is essential to understand 
their function, evolution, modulation, and design. Determining such models, however, 
remains challenging. One particularly powerful approach to constructing models in 
general is integrative modeling. Integrative modeling aims to maximize the accuracy, 
precision, and completeness of models, by simultaneously utilizing all available 
information, including experimental data, physical principles, statistical analyses, and 
other prior models. The goal of this thesis is to expand the scope of integrative modeling 
to the inference of spatial, thermodynamic, and kinetic aspects of macromolecular 
assemblies.  
 In Chapter I, I introduce the integrative modeling framework for spatiotemporal 
modeling of biological macromolecular assemblies. In Chapter II, I demonstrate how the 
synergy between multi-chemistry cross-linking mass spectrometry and integrative 
modeling can map the structural dynamics of macromolecular assemblies, by application 
to the human Cop9 signalosome complex. In Chapter III, I present a method for 
determining structures, free energy differences, and kinetic rates of macromolecular 
assemblies along their functional cycle, mainly from negative stain electron microscopy 
(EM). We apply the method to the yeast Hsp90 to estimate the free energy differences 
x 
 
and kinetic parameters along its nucleotide hydrolysis cycle, which includes open and 
closed states of Hsp90. In Chapter IV, I describe a validation of stochastic sampling in 
integrative modeling. The remaining chapters describe applications of integrative 
modeling to assemblies of various sizes and scales, using various sources of information, 
thus illustrating the flexibility of the integrative modeling approach. Specifically, I apply 
integrative modeling to the human ECM29-Proteasome assembly under oxidative stress 
(Chapter V), the yeast nuclear pore complex (NPC) cytoplasmic mRNA export platform 
(Chapter VI), the major membrane ring component of the yeast NPC (Chapter VII), the 
entire yeast NPC (Chapter VIII), and the reconstruction of 3D structures of MET 
antibodies (Chapter IX). 
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Chapter I – Introduction 
 
Introduction 
Biological macromolecular assemblies play crucial roles in most cellular processes. 
These assemblies vary in size and composition, consisting of proteins and sometimes 
nucleic acids, other macromolecules, and small molecules. The determination of their 
structures, thermodynamics, and kinetics is thus essential to understand their function, 
evolution, modulation, and design (1). However, inferring structural, thermodynamic, and 
kinetics aspects of these assemblies remains challenging. One particularly powerful 
approach to constructing models in general is integrative modeling. Integrative modeling 
aims to maximize the accuracy, precision, and completeness of models, by 
simultaneously utilizing all available information, including experimental data, physical 
principles, statistical analyses, and other prior models. The goal of this thesis is to expand 
the scope of integrative modeling to the inference of spatial, thermodynamic, and kinetic 
aspects of macromolecular assemblies. 
 
Integrative modeling as an optimization problem 
Integrative structure modeling in principle relies on all available information about the 
modeled system (1, 2, 3). Thus, it can maximize the accuracy, precision, completeness, 
and efficiency of modeling (1, 2). Integrative modeling framework is best formulated as 
an optimization problem, thus requiring model representation, a scoring function, and a 
sampling scheme.  
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Representation 
Representation of a model specifies the variables whose values are modeled based on 
input information. The choice of representation must facilitate (1) answering biological 
questions of interest, (2) constructing an accurate and efficiently computed scoring 
function to quantify the consistency of a model with the input information, and (3) efficient 
sampling of alternative models. Examples of variables in integrative structure 
determination are atomic positions, the number of different states, and the population 
proportion of each state.  
Scoring 
The scoring function quantifies the degree of a match between a tested model and the 
input information. The most objective scoring function is a Bayesian posterior model 
probability density, based on information from one or more different experiments, physical 
theories, statistical analyses, and/or prior models. Bayes’ law provides a formula for the 
posterior probability density of a model M given the data D and prior information I, "($|&, () ∝ "(&|$, () ⋅ "($|(). 
The term "(&|$, (), called the likelihood function, is the probability of observing D given 
M and I. To define a likelihood for integrative modeling, we define a forward model and a 
noise model based on our belief about the family of processes that generated D given M 
and I. The forward model specifies a mapping of the model parameters to simulated 
measurements given the knowledge of the process of data generation in the absence of 
experimental noise. Thus, the forward model returns a simulated noiseless measurement 
given a realization of model M. The noise model specifies the distribution of the deviation 
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between the experimental measurement and the simulated measurement computed from 
the forward model.  
The term "($|() is the density of the prior probability distribution, that is the 
distribution of model M given I. The prior probability distribution expresses beliefs about 
model variables before any data is taken into consideration. Priors in integrative modeling 
are derived from physical principles, prior statistical analyses, and/or other models. 
Examples of such priors in integrative modeling are excluded volume restraints, sequence 
connectivity restraints, a molecular mechanics force field, statistical potentials, and 
previously determined structures (e.g., by using X-ray crystallography, electron 
microscopy, NMR spectroscopy, and comparative modeling).   
Finally, a Bayesian scoring function in integrative modeling is defined as the 
negative logarithm of the posterior probability density ,($) = −log	["($|&, ()]. 
Advantages of using the Bayesian formulation are as follows. First, the model M is a 
density of models described by the posterior probability density, not a single 
representative model, with possibly overfitted variables. Indeed, the distribution of models 
reflects the uncertainty in the experimental data as well as in the prior information. 
Second, the distribution of models derived by Bayesian modeling is in principle more 
accurate than the models derived by using traditional least-squares scoring functions, 
because model M (i.e., the model ensemble) was determined by objectively mixing 
different sources of information with their associated uncertainties (3). Third, we can 
objectively estimate the uncertainty associated with model M. Finally, multiple choices 
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about model representation and scoring functions can be quantified and compared via 
model selection criteria (4, 5). 
Sampling 
The sampling methods must efficiently and accurately sample the posterior probability 
density. Variables are often sampled stochastically (6, 7). For example, many Monte 
Carlo schemes have been developed to efficiently and accurately sample the posterior 
probability density, including simulated annealing, replica exchange, Gibbs sampling, and 
Hamiltonian Monte Carlo methods (8).  
 
The integrative modeling framework 
Integrative modeling iterates through four stages to transform input information into a 
model (1, 2, 9–14): (1) gathering all available experimental data and prior information; (2) 
translating information into representations of assembly components and a scoring 
function for ranking alternative assembly structures; (3) sampling structural models; and 
(4) validating the model. 
Stage 1: Gather information 
In the first stage of modeling, we gather all information available about a system needed 
to solve the spatial and temporal arrangements of assemblies at the highest precision 
(i.e., smallest uncertainty). First, information can be experimental data, such as 
observations by mass spectrometry (e.g., stoichiometry (13), list of cross-links (13–17)), 
spectroscopy (e.g., Förster resonance energy transfer [FRET] (18) and nuclear magnetic 
resonance [NMR] (19)), and microscopy (e.g., electron microscopy images (13, 16, 20, 
21) and electron microscopy density maps (13, 22, 23)). Second, information can be 
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physical principles and statistical analyses, such as a molecular mechanics force field, 
statistical potentials, excluded volume, and connectivity between contiguous beads. 
Finally, information can be prior structural models determined by integrative modeling, X-
ray crystallography, NMR spectroscopy, electron microscopy, and comparative protein 
structure modeling. 
Stage 2: Translate information into representations of assembly components and a 
scoring function 
Information gathered in the first stage can then be used to inform the priors and 
likelihoods, effectively resulting in defining the representation of the system, the scoring 
function, and the sampling space. Information gathered in the first stage can also be used 
for filtering and validation whether or not it is used for representation, scoring, and 
sampling.  
First, information can be used to define the representation by specifying the 
variables whose values will be determined by modeling. These variables determine the 
components of the system (identity, copy numbers, granularity, and number of states), 
the coordinates of these components (position, orientation, and conformations). They also 
include auxiliary variables that are fit to input information. For example, previously 
obtained component structures can be used to specify rigid bodies, thus reducing the 
number of sampled variables from three per atom to six per rigid body. 
Second, information can be used to construct and compute the scoring function. 
As described before, the most objective scoring function to assess the match between a 
tested model and the input information is the Bayesian posterior model probability density. 
Information can specify the likelihood function (i.e., the forward model and the noise 
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model), and the prior probability density. For example, experiments (e.g., chemical cross-
linking), physical principles and statistical analyses (e.g., excluded volume, connectivity 
restraints) can be used to inform part of the model’s spatial arrangements (e.g., positions, 
orientations, and conformations) and their associated uncertainty. Consequently, these 
prior probability densities can constrain and limits the model search space. For example, 
physical principles dictate that a kinetic rate is a real non-negative scalar, and thus we 
can constrain the sampling of a kinetic rate value to positive real numbers.  
Third, information can be used to filter the sample models after they are produced 
by the sampling scheme. Such filtering is especially useful for information that is 
computationally expensive to evaluate many times as part of the scoring function used 
for sampling. For example, experimental data (e.g., a set of electron microscopy 2D 
images) can be used only to filter a small subset of models that already satisfy other 
information. 
Finally, any subset of information can be set aside to be used only for validation of 
the good-scoring models, without changing or filtering them.  
Stage 3: Sample structural models 
The purpose of the third stage is to find a sample of all models that are sufficiently 
consistent with input information, as quantified by the scoring function; the goal of 
sampling methods is to accurately and efficiently sample the posterior model density. This 
search is often achieved by a stochastic sampling of alternative structures, avoiding the 
biases and limitations intrinsic to searches by humans. The sampling must be done at a 
precision that is higher than needed for interpreting the models and higher than the 
precision of the scoring function landscape. 
7 
 
Stage 4: Validate the model 
Validation is essential for avoiding overinterpretation of any model of any type. For 
integrative structures, we currently perform validation in these five steps: (1) select the 
models for validation; (2) estimate sampling precision; (3) estimate model precision; (4) 
quantify the degree to which a model satisfies the information used to compute it; and (5) 
quantify the degree to which a model satisfies relevant information not used to compute 
it.  
First, we need to select all models that represent the posterior model probability 
density (i.e., the ensemble). Due to the nature of stochastic sampling, the model is often 
sampled independently multiple times, each time starting from a different initial random 
configuration. Models generated in the early equilibration burn-in phase of each sampling 
are discarded, resulting in an equilibrated sample that maximizes the number of 
uncorrelated samples (24).  
Second, the sampling precision can be estimated for stochastic sampling methods 
by splitting the ensemble of models into two independent sets, followed by quantifying the 
difference between the two sets. It is important to properly estimate the sampling 
precision (uncertainty) because only the features of the model larger than the sampling 
precision are well estimated (3, 25). When using stochastic sampling methods, sampling 
precision can be increased simply by increasing the number of independently computed 
models. High sampling precision is necessary but not sufficient for exhaustive sampling 
(25, 26).  
In the third step, model uncertainty (precision) is estimated. The most explicit 
description of model uncertainty is provided by the set of all models that are sufficiently 
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consistent with the input information (i.e., the ensemble). Model precision can be 
quantified by the variability among the models in the ensemble; in the end, the ensemble 
can be described by one or more representative models and their uncertainties. The 
uncertainty is often not distributed evenly across the ensemble; thus, computing local 
estimates of precision can help improving the modeling and the inference of the biology. 
For example, model representation can be optimized such that sampling is exhaustive at 
a precision commensurate with the precision of the representation (4). 
It is often convenient for model interpretation if the ensemble structures are first 
clustered on the basis of their structural similarity. As a result, only a structure 
representative of each major cluster can potentially be used for interpretation. Many 
clustering methods exist. They vary in terms of the criterion used to quantify a similarity 
between two structures, such as the distance root-mean-square deviation between 
structure coordinates that avoids the need for structure superposition (27). They also vary 
in the method for converting pairwise similarities into clusters (28). Clustering generally 
depends on an arbitrary threshold parameter that determines how many clusters are 
produced. Minor clusters containing few structures might be ignored, especially if the 
scoring function approximates a Bayesian posterior model density where minor clusters 
represent unlikely solutions. However, discarding these minor clusters may result in an 
underestimation of uncertainty and overestimation of the confidence in the models. The 
clustering threshold is selected such that the following three criteria are satisfied: first, the 
number of major clusters is minimized for parsimony; second, the precision of these 
clusters is worse than the sampling precision; and finally, the cluster precision is high 
enough for interpreting the models.  
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Model uncertainty results from insufficient input information and sample 
heterogeneity (3). It is difficult to deconvolve the impact of these two sources of model 
uncertainty. In general, only the total model uncertainty is reported. In addition, model 
uncertainty can also result from uncertain model representation, uncertainty in the scoring 
function, and insufficient sampling. This uncertainty in particular is often not considered 
but can be large. For example, a mistake in representation is not recoverable in the 
current modeling schemes, because they assume that the representation is correct and 
so do not even attempt to generate the correct representation (e.g., when a protein 
subunit structure is incorrect, incorrectly assumed to be rigid, or incorrect stoichiometry is 
enforced during modeling a structure of a complex).  
Fourth, the model is assessed by quantifying the degree to which it satisfies the 
information used to compute it. This data satisfaction is considered on the scale of the 
uncertainty of the corresponding information. When data used to construct the model are 
insufficiently satisfied, the model is not validated. Such violations can occur when the data 
are more uncertain than assumed, the representation is incorrect, and/or the sampling is 
not sufficient. 
Finally, a model is tested against information that was not used to compute it. For 
example, one can perform a jackknifing test consisting of repetitively omitting a random 
subset of chemical cross-links, recomputing the model, and comparing these models 
against the omitted cross-links, to validate both the model and the cross-links, similarly to 
Rfree in X-ray crystallography (29).  
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Thesis summary 
In Chapter II, I demonstrate how the synergy between multi-chemistry cross-linking mass 
spectrometry and integrative modeling can map the structural dynamics of 
macromolecular assemblies, by application to the human Cop9 signalosome complex. In 
Chapter III, I present a method for determining structures, free energy differences, and 
kinetic rates of macromolecular assemblies along their functional cycle, mainly from 
negative stain electron microscopy (EM). We apply the method to the yeast Hsp90 to 
estimate the free energy differences and kinetic parameters along its nucleotide 
hydrolysis cycle, which includes open and closed states of Hsp90. In Chapter IV, I 
describe a validation of stochastic sampling in integrative modeling. The remaining 
chapters describe applications of integrative modeling to assemblies of various sizes and 
scales, using various sources of information, thus illustrating the flexibility of the 
integrative modeling approach. Specifically, I apply integrative modeling to the human 
ECM29-Proteasome assembly under oxidative stress (Chapter V), the yeast nuclear pore 
complex (NPC) cytoplasmic mRNA export platform (Chapter VI), the major membrane 
ring component of the yeast NPC (Chapter VII), the entire yeast NPC (Chapter VIII), and 
the reconstruction of 3D structures of MET antibodies (Chapter IX).  
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Abstract 
The COP9 signalosome (CSN) is an evolutionarily conserved eight subunit (CSN1–8) 
protein complex that controls protein ubiquitination by deneddylating Cullin-RING E3 
ligases (CRLs). The activation and function of CSN hinges on its structural dynamics, 
which has been challenging to decipher by conventional tools. Here, we have developed 
15 
 
a multichemistry cross-linking mass spectrometry approach enabled by three mass 
spectrometry-cleavable crosslinkers to generate highly reliable cross-link data. We 
applied this approach with integrative structure modeling to determine the interaction and 
structural dynamics of CSN with the recently discovered ninth subunit, CSN9, in solution. 
Our results determined the localization of CSN9 binding sites and revealed CSN9- 
dependent structural changes of CSN. Together with biochemical analysis, we propose 
a structural model in which CSN9 binding triggers CSN to adopt a configuration that 
facilitates CSN–CRL interactions, thereby augmenting CSN deneddylase activity. Our 
integrative structure analysis workflow can be generalized to define in-solution 
architectures of dynamic protein complexes that remain inaccessible to other approaches. 
 
Significance 
Structural plasticity is a critical property of many protein complexes that has been 
challenging to study using conventional structural biology tools. Cross-linking mass 
spectrometry (XL-MS) has become an emergent technology for elucidating architectures 
of large protein complexes. While effective, current XL-MS methods mostly rely on lysine 
reactive cross-linking chemistry and have limited capacity in fully defining dynamic 
structures of protein complexes. Here, we have developed an integrated structural 
approach based on three MS-cleavable cross-linkers with distinct chemistries. This 
approach enabled us to obtain highly reliable and comprehensive cross-link data that 
significantly facilitate integrative structural modeling of dynamic protein complexes. In 
addition, it has been successfully applied to the COP9 signalosome to determine its 
structural dynamics associated with its function. 
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Introduction 
The COP9 signalosome (CSN) is an evolutionarily conserved and essential multisubunit 
protein complex involved in diverse cellular and developmental processes in animals and 
plants (1–3). The CSN functions as a deneddylase, specific for cleaving Nedd8 
modification from cullin proteins, the key components of Cullin–RING ubiquitin E3 ligases 
(CRLs) (4–8). CRLs represent the largest evolutionarily conserved superfamily of 
multisubunit E3s (5, 6), which embody ∼30% of all human E3 proteins and coordinate 
degradation of ∼20% of the proteins processed by the proteasome. The dynamic cycle 
of neddylation and deneddylation of cullins is a critical step in regulating the assembly 
and activity of CRLs (6, 9, 10). In addition to enzymatic regulation of CRLs, the CSN can 
inactivate CRLs noncatalytically by direct binding, preventing their association with E2 
enzymes and ubiquitination substrates (11–14). While abnormal CRL activity is frequently 
associated with various human diseases, multiple studies have also identified the CSN 
as a positive regulator of oncogenes and negative regulator of tumor suppressors (15–
19). Moreover, elevated expression of CSN subunits has been found in a number of 
human tumors, often with poor prognosis (20, 21). Therefore, better understanding of the 
CSN structure would provide new insights on their function and the regulation of CRLs 
associated with human pathology.  
The canonical CSN complex (hereafter referred to as CSN) typically consists of 
eight subunits (CSN1–8) (1, 3), including six different PCI (proteasome lid-CSN-initiation 
factor 3) domain-containing subunits (CSN1 to CSN4, CSN7, and CSN8) and two MPN 
(MPR1/PAD1 amino-terminal) domain-containing proteins (CSN5 and CSN6). Among 
them, CSN5 is the catalytic subunit directly responsible for CSN deneddylase activity (4). 
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The CSN complex shares sequence similarities to the 19S proteasome lid subcomplex 
and the eukaryotic translation initiation complex eIF3, which also contain PCI and MPN 
domains (1, 3). The X-ray structure of recombinant human CSN has revealed that CSN5 
and CSN6 MPN domains form a heterodimer, while the six remaining PCI subunits 
assemble into a horseshoe-shaped ring from which their arm-like α-helical domains 
project (22). The PCI subunits provide a scaffold, primarily through CSN2 and CSN4, 
which facilitates the recruitment of neddylated CRLs. Meanwhile, the two MPN subunits 
are slightly juxtaposed, exposing the active MPN catalytic core in CSN5 (12, 23–25). All 
eight subunits are united in a helical bundle formed by their C-terminal carboxyl α-helices, 
which are stacked between the CSN5–CSN6 dimer and PCI ring. Interestingly, substrate-
free CSN exists in an inactive, autoinhibited state (23). Structural and biochemical 
characterization of CSN–CRL complexes have revealed substrate-induced structural 
dynamics associated with CSN activation (12, 23–26). Binding of neddylated CRLs to 
CSN triggers substantial remodeling and extensive conformational changes of the 
complex, activating the isopeptidase activity of CSN5. Although the structural plasticity of 
the CSN is important for CSN activation and function in regulating CRL activities in cells, 
it has not been well characterized due to limitations in existing technologies.  
Recently, the ninth CSN subunit, CSN9 (also known as CSNAP [CSN acidic 
protein]), has been discovered to complex with CSN1–8 stoichiometrically to form a nine-
membered noncanonical CSN complex (also known as CSN9-bound CSN, hereafter 
referred to as CSNn) (27). As canonical CSN subunits (CSN1–8) have a one-to-one 
correspondence to the subunits of the 19S proteasome lid subcomplex (3, 28), CSN9 is 
homologous to DSS1, the smallest component of the 19S lid. While CSN9 is not essential 
18 
 
for the assembly and catalytic activity of CSN (27), a recent study has suggested that 
CSN9 reduces the affinity of CSN–CRL interactions, contributing to steric regulation of 
CRLs (14). The depletion of CSN9 appears to have a global impact on CRL-associated 
activities, leading to altered reproductive capacity, suppressed DNA damage response, 
decreased viability, and delayed cell cycle progression (14). It has also been suggested 
that the C terminus of CSN9 is important in its incorporation within the CSN complex, 
likely through interactions with CSN3, CSN5, and CSN6 (27). However, due to its small 
size and highly disordered structure, it remains challenging to accurately determine 
interaction interfaces between CSN9 and CSN. As a result, no high-resolution structures 
are available for the CSN9-bound CSN complex. Thus, alternative strategies to dissect 
the architecture of the noncanonical CSN complex and determine how CSN9 interacts 
with CSN1–8 are needed to help us uncover structural details underlying the functional 
importance of CSN9 in cells.  
In recent years, cross-linking mass spectrometry (XL-MS) has become a powerful 
strategy for probing protein–protein interactions (PPIs) (29–31). While effective, XL-MS 
possesses several inherent challenges, including unambiguous identification of cross-
linked peptides due to their complex fragmentation when conventional (i.e., non-
cleavable) cross-linkers are used. To facilitate MS identification, we have developed a 
suite of sulfoxide-containing MS-cleavable cross-linkers (e.g., disuccinimidyl sulfoxide 
[DSSO]) (32–36). These MS-cleavable reagents contain symmetric MS-labile C-S bonds 
(adjacent to the sulfoxide group) that are selectively and preferentially fragmented prior 
to peptide backbone cleavage during collision-induced dissociation (CID) (31–36). Such 
fragmentation has proven robust, thus enabling simplified and accurate identification of 
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cross-linked peptides by MSn analysis. Among them, DSSO is an amine-reactive 
sulfoxide-containing MS-cleavable cross-linker that has been successfully applied for in 
vitro studies of purified protein complexes (32, 37, 38) and cell lysates (39, 40). Although 
lysine-reactive reagents are most popular, they alone cannot provide a full PPI mapping 
as some interaction interfaces do not contain proximal lysines for cross-linking (31). 
Therefore, we have developed dihydrazide sulfoxide (DHSO) for acidic residues (35) and 
bismaleimide sulfoxide (BMSO) for cysteine cross-linking (36), complementing the lysine-
reactive DSSO and expanding PPI coverage on residue-specific protein interconnectivity. 
In addition to PPI mapping, XL-MS data has been successfully used for integrative 
structure modeling of protein complexes as observed cross-links impose upper distance 
bounds on pairs of cross-linked residues (41–44). Coupling cross-link data with other 
biophysical data (43, 44) and utilizing cross-linkers with different reactive chemistries (43) 
can significantly increase the accuracy of the resulting structures by integrative modeling. 
In comparison to conventional structural tools, XL-MS approaches can uniquely 
characterize large, heterogeneous, and dynamic protein assemblies in solution (31).  
In this work, we developed and employed a multichemistry XL-MS approach 
enabled by three MS-cleavable cross-linkers to obtain comprehensive PPI maps of the 
CSN (CSN9-free) and CSNn (CSN9-bound) complexes to significantly improve precision 
and accuracy of their models. Based on our cross-link data, X-ray structures, and 
comparative models of CSN subunits, we computed the complete integrative structures 
of CSN and CSNn at 16- and 22-Å precisions, respectively. The integrative structures 
have maintained the core architecture of the known X-ray structure of CSN (PDB ID code 
4D10), but importantly revealed additional conformations and configurations of CSN in 
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solution that were absent in the static structure. The integrative structure of CSNn has 
defined the CSN9 binding site in a cleft formed among CSN1, CSN3, and CSN8, resulting 
in local subunit reorientations that more likely contribute to CSN9-dependent increase of 
CSN deneddylase activity in vitro. Collectively, this work not only provides molecular 
features for us to better determine the structure dynamics of the CSN complex, but also 
reveals the structural basis underlying the role of CSN9 in CSN-mediated activities. 
Moreover, the integrated structural approach presented here is effective and can be 
generalized to define in-solution structures of dynamic protein complexes that remain 
inaccessible to other approaches. 
 
Results  
Multichemistry XL-MS Strategy for CSN Complexes 
To define the architectures of CSN and CSNn complexes, we aimed to perform a 
comprehensive XL-MS analysis to maximize PPI mapping and to facilitate integrative 
structure modeling. To this end, we developed a combinatory XL-MS approach based on 
multiple MS-cleavable cross-linkers that carry specific but complementary cross-linking 
chemistries. Specifically, we selected three sulfoxide-containing MS-cleavable cross-
linkers that target lysines (DSSO) (32), acidic residues (DHSO) (35), and cysteines 
(BMSO) (36). This combination is based on the critical roles of the selected reactive 
residues in protein structures, and the complementarity of the resulting cross-links for 
mapping PPIs. Both lysines and acidic residues are highly prevalent and often enriched 
at protein interaction interfaces, whereas cysteines are less abundant but can be more 
selective for targeting specific regions. In addition, no disulfide bonds have been reported 
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for CSN subunits, indicating that cysteine cross-linking would be suited for structural 
analysis of CSN. Importantly, the usage of these reagents has shown to significantly 
improve the coverage of PPI mapping even for simple proteins (35, 36). The general 
workflow of our multichemistry XL-MS strategy is illustrated in SI Appendix, Fig. S1. CSN 
complexes were purified under reducing condition after coexpression in Escherichia coli 
(Datasets S1 and S2), which were catalytically active and used for all XL-MS experiments. 
It is noted that CSN7 exists as two functionally redundant homologs in mammalian cells, 
CSN7a and CSN7b (45). Here, CSN7b was expressed and incorporated into CSN 
complexes for structural analysis. Each purified complex was first subjected to DSSO, 
DHSO, and BMSO cross-linking separately (SI Appendix, Fig. S1). The resulting cross-
linked complexes were then enzymatically digested and separated to enrich cross-linked 
peptides by peptide size-exclusion chromatography (SEC) (46). The cross-links identified 
by liquid chromatography (LC)-MSn analysis were then used for generating 2D cross-link 
maps to describe intersubunit interactions and for integrative structure modeling.  
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Figure 2.1 | PPI maps of the CSN complexes based on cross-link data from all 
three linkers (DSSO, DHSO, BMSO) 
(A) CSN (CSN1–8). (B) CSNn (CSN1–9). Each CSN subunit is represented by colored 
nodes. The edges between two connected nodes are color-coded to describe PPIs 
resulted from individual or combinations of cross-linkers: That is, blue, DSSO; red, DHSO; 
purple, BMSO; lime, DSSO+BMSO; magenta, DHSO+BMSO; gold, DSSO+DHSO; black, 
DSSO+DHSO+BMSO. Edge thickness was determined by the total number of unique 
cross-links identified between the interactors. 
 
Identification of CSN Cross-Linked Peptides 
To illustrate cross-link identification, representative MSn spectra of DSSO, DHSO, and 
BMSO cross-linked peptides of CSN are displayed in SI Appendix, Fig. S2. As DSSO, 
DHSO, and BMSO cross-linked peptides all carry two symmetric MS-cleavable bonds 
adjacent to the central sulfoxide in linker regions, cleavage of either one during MS2 
analysis physically separates cross-linked peptide constituents (α and β), resulting in the 
detection of two characteristic fragment ion pairs modified with complementary cross-
linker remnants (αA/βT and αT/βA), regardless of linker chemistries (SI Appendix, Fig. S2 
A–C). MS3 analyses of these characteristic MS2 fragment ion pairs enabled accurate 
identification of their sequences (SI Appendix, Fig. S2 D–I). In combination with MS1 and 
MS2 data, DSSO, DHSO, and BMSO cross-linked peptides were identified 
unambiguously. In this work, we have performed at least four biological replicates for each 
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XL-MS experiment. As a result, from all of XL-MS experiments, we identified a total of 
682 DSSO, 275 DHSO, and 456 BMSO unique cross-linked peptides of CSN (Datasets 
S3–S5), and a total of 856 DSSO, 723 DHSO, and 576 BMSO unique cross-linked 
peptides of CSNn (Datasets S6–S9). Based on the identified cross-linked peptides, 
residue-to-residue linkages were determined (SI Appendix, Fig. S3). To ensure the 
validity of subsequent analyses, we decided to only use highly reproducible residue-to-
residue linkages that have ≥ 60% occurrence among all biological replicates of each 
experiment. Thus, we obtained a total of 452 highly reproducible cross-links for CSN, 
including 214 K-K, 169 D/E-D/E, and 69 C-C linkages, describing 205 intersubunit (74 
DSSO, 91 DHSO, and 40 BMSO) and 247 intrasubunit interactions (140 DSSO, 78 
DHSO, 29 BMSO) (Datasets S10–S12). For CSNn, a total of 544 highly reproducible 
cross-links were acquired with 269 K-K, 167 D/E-D/E, and 108 C-C linkages, representing 
244 intersubunit (86 DSSO, 83 DHSO, and 75 BMSO) and 300 intrasubunit interactions 
(183 DSSO, 84 DHSO, 33 BMSO) (Datasets S13– S15). These high-confidence cross-
links were used for subsequent analyses (SI Appendix, Fig. S3).  
The CSN Interaction Topology 
To define intersubunit physical contacts, we generated experimentally derived interaction 
topology maps of CSN complexes based on the highly reproducible cross-link data (Fig. 
2.1 and Datasets S10–S15). As a result, extensive interaction networks were formulated 
comprising a total of 26 and 24 unique pairwise interactions for CSN and CSNn, 
respectively (Datasets S16 and S17). Among the three linkers, DSSO yielded the most 
connectivity within CSN, indicating lysine reactive reagents best-suited for general 
assessment of PPIs within CSN. While DHSO and BMSO identified less overall, they did 
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yield additional subunit contacts. Specifically, DSSO alone identified five unique PPIs; in 
comparison, DHSO and BMSO yielded a total of seven unique PPIs (Dataset S16). To 
better assess linker-dependent interactions, we constructed DSSO, DHSO, and BMSO 
PPI maps separately for each CSN complex (SI Appendix, Fig. S4 A–F). Since the 
majority of CSN subunits possess similar percentages of K, D/E, and C residues in their 
primary sequences, the number of cross-links representing each intersubunit interaction 
is more likely dependent on the number of cross-linkable residues at their interaction 
interfaces, as well as the detectability of resulting cross-linked peptides. This is further 
illustrated by 2D cross-link maps (SI Appendix, Fig. S4 G–L). For example, for the two 
smallest subunits of CSN, CSN7b has a relatively high percentage of acidic residues and 
its interactions were mostly revealed by DHSO, whereas CSN8 interactions were better 
described by DSSO due to its relatively high percentage of lysines (Fig. 2.1A and SI 
Appendix, Fig. S4 A–C).  
Similar to the CSN complex, all three linkers have yielded extensive and 
complementary cross-links to represent subunit interconnectivities of CSNn (Dataset 
S17). Importantly, 16 CSN9-containing cross-links have been identified (Dataset S14), 
demonstrating its physical interactions within CSN at the residue level. Specifically, the 
C-terminal tail of CSN1 and several regions across CSN3 have been found to interact 
with CSN9. Since CSN9 is highly acidic with few lysine and no cysteine residues, only 
DHSO was able to capture CSN9 interactions within the CSNn complex. With the addition 
of CSN9, it appears that CSNn presented unique characteristics in its cross-link maps in 
comparison to those of CSN (Fig. 2.1B and SI Appendix, Fig. S4 D–F). This suggests 
that CSN9 may induce local changes in the CSNn complex that impact cross-link 
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formation. Collectively, our results have demonstrated the effectiveness and 
complementarity of our combinatory XL-MS strategy in mapping PPIs within CSN 
complexes. Integration of multichemistry cross-linking not only enabled cross-validation 
of intersubunit interactions, but also expanded interaction coverage due to the distinct 
capabilities of uncovering interactions at specific protein regions.  
Mapping of CSN Cross-Links to the X-Ray Structure 
To assess whether the cross-links agreed with the X-ray structure, we first mapped the 
identified K-K, D/E-D/E, and C-C linkages of CSN complexes to the existing CSN X-ray 
structure (3.8 Å, PDB ID code 4D10) by determining their Cα-Cα spatial distances 
(Datasets S10–S15). Considering linker spacer arm lengths (i.e., DSSO [10.1 Å], DHSO 
[12.4 Å], and BMSO [24.2 Å]), side-chain lengths of targeted amino acids (i.e., K [5.4 Å], 
D/E [2.5/3.7 Å], and C [2.8 Å]), as well as side-chain flexibility and dynamics, we have 
estimated the maximum Cα-Cα distances spanned by each linker: DSSO at 30 Å, DHSO 
at 30 Å, and BMSO at 45 Å. Thus, cross-links with distances above these thresholds were 
considered nonsatisfying or violating. For intersubunit interactions, 60% of DSSO cross-
links of CSN were considered violating (SI Appendix, Fig. S5A). This is surprising as 
usually less than 20% of lysine-reactive cross-links are violated when mapped onto 
existing high-resolution structures (30, 38, 40). Similar discrepancies with the X-ray 
structure were observed for DHSO and BMSO data as 55% DHSO and 87% of BMSO 
intersubunit cross-links were beyond the expected thresholds (SI Appendix, Fig. S5 B 
and C). In contrast, most intrasubunit cross-links of CSN were satisfied in the Xray 
structure, with only 12% of DSSO, 15% of DHSO, and 21% BMSO violating intrasubunit 
cross-links (SI Appendix, Fig. S5 A–C). Since the high-resolution structure of CSNn has 
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not been resolved, we also mapped CSNn cross-links onto the same CSN structure. 
Similarly, a significant portion of intersubunit cross-links of CSNn from all three linkers 
(i.e., 57% of DSSO, 52% of DHSO, and 84% BMSO) were nonsatisfying (SI Appendix, 
Fig. S5 D–F), whereas for the intrasubunit cross-links, only 10% of DSSO, 10% of DHSO, 
and 23% BMSO were nonsatisfying (SI Appendix, Fig. S5 D–F). The high proportion of 
violating intersubunit crosslinks is more likely due to the additional conformations that 
CSN complexes may adopt in solution beyond the one observed in the X-ray structure.  
Integrative Structure Modeling of the CSN Complex 
To determine CSN structure in solution, we performed integrative structure modeling 
using the previously described four-stage workflow (SI Appendix, Supplemental Method 
and Fig. S6 and Dataset S18) (38, 43, 44, 47–50). The input information included the 
highly reproducible cross-link datasets (Datasets S10–S15), the X-ray structure of CSN 
(PDB ID code 4D10), and two comparative models of CSN7b subunit domains based on 
the structure of the CSN7a subunit in the X-ray structure of CSN. The representation of 
the system used for modeling of CSN was chosen as follows. First, the helical bundle 
comprising segments from each of the eight subunits was constrained based on the X-
ray structure. Second, the remaining structures of subunits CSN1–8 were represented by 
15 rigid bodies, corresponding to different domains of the proteins (SI Appendix, 
Supplemental Method and Fig. S7H and Dataset S18). Finally, short (4 to 13 residues) 
segments linking rigid bodies and regions missing in the X-ray structure (2 to 52 residues 
long) were modeled as flexible strings of 2 to 10 residue beads each. Next, we 
exhaustively sampled configurations of the 16 rigid bodies (i.e., the helical bundle and the 
15 rigid bodies) that satisfy the cross-links as well as sequence connectivity and excluded 
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volume restraints, using a Monte Carlo method that started with a random initial structure. 
The modeling did not rely on any knowledge of the X-ray structure except for the shapes 
of the 16 rigid bodies. The sampling yielded 71,350 representative models that sufficiently 
satisfied the input restraints. The clustering of the ensemble identified a single distinct 
cluster containing the majority (76%) of the individual models (SI Appendix, Fig. S7 A–
D), corresponding to the complete integrative structure of CSN in solution. The precision 
of the cluster corresponds to the variability among the clustered ensemble and defines 
the overall precision (uncertainty) of the integrative CSN structure (Fig. 2.2A and SI 
Appendix, Fig. S7), which was quantified by the average RMSD with respect to the 
centroid of 16 Å (SI Appendix, Supplemental Method). The centroid structure is the most 
similar structure to all of the other structures in the cluster.  
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Figure 2.2 | Integrative structures of CSN 
(A) The integrative structure of CSN determined at 16-Å precision when all three cross-
link datasets (DSSO+DHSO+BMSO) were used for modeling. For each subunit, the 
localization probability density of the ensemble of models is shown with a representative 
structure (the centroid) from the ensemble embedded within it. (B) Integrative modeling 
of CSN determined using DHSO or DHSO+DSSO datasets yielded models determined 
at 29- and 24-Å precision, respectively. (C) Graphical representation of determined model 
precisions with seven combinations of our three cross-link datasets, illustrating that 
increasing the number of cross-linking chemistries (abscissa axis) for integrative structure 
modeling leads to increased model precision (ordinate axis). CSN subunit was color-
coded as illustrated. 
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Validation of the Integrative Structure of the CSN Complex 
To validate the integrative structure of CSN, we first assessed how well it satisfied the 
input cross-links used to compute it. The integrative structure of CSN satisfied 98% of the 
cross-links. The remaining 2% of the cross-links would be satisfied if the threshold was 
increased by 10 Å (SI Appendix, Fig. S7F). These violations can be rationalized by 
experimental uncertainty, coarse-grained representation of the complex, and finite 
structural sampling. Next, we evaluated the integrative structure of CSN by cross-
validation against different input cross-link datasets. Namely, we independently repeated 
integrative modeling described above with six different subsets of CSN cross-links 
(Datasets S10–S12), including: 1) DSSO only, 2) DHSO only, 3) BMSO only, 4) DSSO 
and DHSO, 5) DSSO and BMSO, and 6) DHSO and BMSO. The results were examined 
in three ways as follows. First, we gauged how well each of the six CSN model ensembles 
satisfied different subsets of the cross-links. All six models satisfied more than 95% of all 
cross-links, whether or not they were used for modeling, thus increasing our confidence 
in modeling. Second, we showed that increasing the amount of input information 
improved the precision of the output model when sampling was exhaustive. This result is 
expected when the choice of model representation (here, the 16 rigid bodies) is 
appropriate for input information (here, mainly the cross-links) as encoded in the scoring 
function. In addition to validating the model and the data, the improved precision of the 
model resulting from increasing the number of cross-linking chemistries demonstrate the 
complementarity of the three cross-linking datasets (Fig. 2.2B and C). Specifically, the 
model precision increased from 37 Å for BMSO cross-links only to 16 Å for all three types 
of cross-links (i.e., DSSO+DHSO+BMSO). Third, we calculated the overlaps between the 
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integrative structure ensemble using all cross-links and each of the six model ensembles 
based on a subset of crosslinks. The overlap was quantified by the ratio of the distance 
between ensemble centroids to three times the sum of the ensemble precisions (SI 
Appendix, Supplemental Method). The distance between two ensemble centroids is 
defined by their RMSD. The ensemble precision is defined by the RMSD from the centroid 
averaged over all models in the ensemble. In particular, two structural aspects were 
evaluated, including the tertiary structure of each individual subunit (a total of 8 subunits) 
as described by the intramolecular distances as well as the relative positions and 
orientations of all pairs of subunits (a total of 28 pairs) in the complex as described by the 
intermolecular distances. For each of the 8 subunits and each of the 28 pairs of subunits, 
the integrative structure based on all cross-links overlapped with the integrative structures 
based on each of the 6 cross-link subsets (SI Appendix, Fig. S8). Therefore, these cross-
validations further increased our confidence in the integrative structure of CSN.  
Comparison of Integrative and X-Ray Structures of CSN 
To compare the integrative and X-ray structures of CSN, we first examined how well both 
structures satisfied our cross-link datasets and determined that the integrative structure 
did much better than the X-ray structure, for both intrasubunit (98% vs. 85%) and 
intersubunit (99% vs. 39%) cross-links (SI Appendix, Fig. S7F and Datasets S19–S21). 
These results indicate that the integrative structure ensemble is a better representation 
of CSN conformations in solution than the X-ray structure.  
Next, we inspected whether or not the integrative model preserved the core of the 
previously determined CSN structures, which contains three main features: 1) The PCI 
ring (in the order of CSN7-CSN4-CSN2-CSN1-CSN3-CSN8), 2) the CSN5–CSN6 dimer, 
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and 3) a helical bundle consisting of a helix from each of the eight subunits (23, 45, 51). 
During our modeling, while the helical bundle was constrained as a rigid body (Figs. 2A 
and 3 A and D), the order of the PCI ring and CSN5–CSN6 dimer were not enforced. 
However, the latter two features emerged from our simulation and resemble those in the 
X-ray structure (Figs. 2A and 3B and SI Appendix, Fig. S7G). This preservation is 
important especially for the CSN5–CSN6 dimer, as it is crucial for keeping CSN5 inactive 
in the absence of a substrate, and releasing CSN5 for activation upon substrate binding 
(12, 23, 24, 52). The CSN5–CSN6 dimer was well-represented by our crosslink data, 
resulting in the highest precisions among the 28 pairs of subunits in the integrative 
structure of CSN (16 Å) (Figs. 2A and 3 B and D and SI Appendix, Fig. S7). Moreover, 
subunits CSN3 and CSN8 also adopted similar positions and orientations relative to other 
subunits in both the integrative and X-ray structures (Figs. 2A and 3A and SI Appendix, 
Fig. S7G), albeit the precision of the CSN3–CSN8 pair in the integrative structure was 
relatively low (25 Å). In summary, the core of CSN integrative structure in solution is 
similar to previous X-ray and electron microscopy (EM) structures (23, 45, 51).  
Finally, we computed the RMSD between the CSN X-ray and integrative structure 
centroids to assess whether the RMSD was larger than three times the precision of the 
integrative structure, as the resolution of the X-ray structure is much higher than that of 
the integrative structure. The crystallographic structures of three subunits (i.e., CSN2, 
CSN4, and CSN5) and four pairs of subunits (i.e., CSN2–CSN4, CSN2–CSN5, CSN4–
CSN5, and CSN4–CSN6) were found to lie further than three times the integrative 
structure precision from the ensemble centroid (Fig. 2.3D), indicating significant 
differences in these regions between the two compared structures. The observed 
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differences were further supported by the largest RMSDs measured in these regions 
between the X-ray and integrative structure centroid of CSN (SI Appendix, Fig. S9A). The 
detected discrepancies are unlikely the result of integrative modeling uncertainty; instead, 
they likely reflect different functional states in solution or differences between the solution 
and X-ray structures. Specifically, the C terminus of CSN4 interacts tightly with the C 
terminus of CSN6 (precision of 20 Å) (Fig. 2.3D and SI Appendix, Fig. S7G), opposite 
from CSN5 in the integrative structure (Figs. 2.2A and 2.3A). In contrast, CSN4 does not 
interact with CSN6 in the X-ray structure (Fig. 2.3D). The relative positions and 
orientations of CSN2, CSN4, CSN5, and CSN6 in the integrative structure were 
determined by satisfying all but 1 of the 47 intersubunit crosslinks. In contrast, the X-ray 
structure only satisfied 30 of these cross-links.  
Although the arrangement order of CSN1, CSN2, and CSN3 remained unchanged, 
the N terminus of CSN2 was found to wrap around CSN1 toward CSN3 in the integrative 
structure (Figs. 2.2A and 2.3 A and C), whereas it projected outwards without contacting 
either CSN1 or CSN3 in the X-ray structure. The relative positions and orientations of 
CSN1, CSN2, CSN3, and CSN4 in the integrative structure were determined by satisfying 
all but 1 of the 98 intersubunit cross-links. In contrast, the X-ray structure only satisfied 
28 of these cross-links and none of the 16 crosslinks between CSN2 and CSN3. Taken 
together, the results demonstrate that integrative structure modeling of CSN based on 
our comprehensive cross-link data were able to not only recapitulate the core architecture 
common to all known CSN structures, but also uncover significant quaternary differences 
relative to the X-ray structure.  
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Figure 2.3 | Comparison of integrative and X-ray structures of the CSN 
complexes.  
(A) Overall architectures of CSN: X-ray structure (PBD ID code 4D10) (Top), CSN 
integrative structure (Middle), and CSNn integrative structure (Bottom). For each subunit 
in the integrative structures, the localization probability density of the ensemble of models 
is shown with a representative structure (the centroid) from the ensemble embedded 
within it. The CSN and CSNn structures show that the models adopt a more condensed 
state as compared to the X-ray structure, but they generally retain the overall architecture 
with only the helical bundle being constrained during modeling. (B) The arrangement of 
the CSN5–CSN6 (MPN domain containing subunits) dimer was an emerging feature in 
integrative structures; however, a slight shift in the interface was observed in the CSNn 
model.  (C) Models indicate that the arrangement of CSN1, CSN2, and CSN3 was altered 
in the presence of CSN9; CSN2 moved from a state interacting with CSN3 in CSN to an 
opened state in the CSNn model, resembling the overall architecture of the CSN X-ray 
structure. (D) Respective binary subunit–subunit comparison of the CSN integrative 
structure with the CSN X-ray structure (Upper) and the CSNn integrative structure 
(Lower), respectively. The structures were compared by calculating their ensemble 
overlap; the overlap was quantified by the ratio of the distance between ensemble 
centroids to three times the sum of the ensemble precisions. Differences are shown in 
red. The CSN subunit was color-coded as illustrated. 
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Integrative Structure Modeling of the CSNn Complex  
To localize the CSN9 subunit and map its interactions with the CSN complex, we also 
performed integrative structure modeling of CSNn (CSN9-bound CSN), based primarily 
on 619 highly reproducible cross-links for CSNn from all three cross-linkers (SI Appendix, 
Supplementary Method and Fig. S10 and Dataset S22). Integrative structure modeling of 
CSNn was performed the same way as described above for CSN. The structure of CSN9, 
a 57 amino acid-long acidic protein, is unknown and cannot be modeled. Therefore, it 
was represented as a string of flexible beads corresponding to two residues each. The 
sampling of the CSNn complex yielded 125,750 representative models that sufficiently 
satisfied the input restraints. The clustering of the ensemble identified a single distinct 
cluster containing the majority (79%) of the individual models (SI Appendix, Fig. S10), 
corresponding to the complete integrative structure of CSNn in solution. The precision of 
the cluster is 22 Å (SI Appendix, Fig. S10 A–D), which is sufficient to map all positions 
and relative orientations of CSN1–9 subunits (Figs. 3A and 4A and SI Appendix, Fig. 
S10E). Moreover, the integrative structure of CSNn satisfied 99% of the input cross-links 
(intersubunit and intrasubunit) (Datasets S23–S25). Importantly, the resulting structure of 
CSNn has precisely localized CSN9 at a cavity formed by the C terminus of CSN1, all of 
CSN3, and CSN8 (Fig. 2.4A). The position of amino acid residues 20 to 57 of CSN9 was 
specified by satisfying all of the 16 CSN9-containing intersubunit cross-links (Fig. 2.4 A 
and B). It is noted that the exact position of the first 19 amino acid residues of CSN9 could 
not be accurately determined since cross-linked peptides involving this region were not 
identified. Regardless, we were able to determine the interactions of CSN9 with CSN1–8 
in the integrative structure. We consider a contact between CSN9 and any of the CSN1–
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8 subunit if the two subunits are within 12 Å from each other; a contact is defined as an 
interaction if the contact frequency across the ensemble is at least 75% (SI Appendix, 
Fig. S10G). As a result, CSN1 and CSN3 were found in the closest proximity to CSN9 
across the ensemble and thus were identified as CSN9 interactors, corroborating well 
with our cross-link data. Therefore, the CSN9–CSN interactions have been precisely 
determined by integrative structure modeling (Fig. 2.4 and SI Appendix, Fig. S10G), 
providing CSN9’s binding cavity and its interactors.  
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Figure 2.4 | Binding of CSN9 in the CSNn integrative structure.  
(A) The integrative structure of CSNn determined at 22-Å precision using all three cross-
link datasets (DSSO+DHSO+BMSO). For each subunit, the localization probability 
density of the ensemble of models is shown with a representative structure (the centroid) 
from the ensemble embedded within it. The higher probable localization of CSN9, 
corresponding to its C terminal, on the CSNn model is represented by the orange 
localization probability density, and a representative structure from the ensemble is 
shown with spheres corresponding to two residues per beads connected by an 
extrapolated trace of the backbone. CSN9 primarily interacts with the main body of CSN3 
(red) while its C-terminal tail also falls into the cavity between CSN1 (purple), CSN3 (red), 
and CSN8 (green). The Inset displays a closer view of CSN9 interaction. Green lines 
represent CSN9-containing DHSO cross-links. (B) Two-dimensional DHSO cross-link 
map linking CSN9 to CSN1 and CSN3 at specific residues. 
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Comparison of Integrative Structures of the Canonical and Noncanonical CSNs  
To compare the two CSN complexes in light of their precisions, we then examined their 
structural differences among the conformations of single subunits and configurations of 
pairs of subunits by assessing whether the differences are larger than the sum of their 
precisions (Fig. 2.3D) and by computing the RMSD between their respective centroid (SI 
Appendix, Fig. S9B). While a large portion of the two compared structures was similar, 
the conformation of 3 of the 8 subunits (i.e., CSN2, CSN5, and CSN7) and 3 of the 28 
pairs of subunits (i.e., CSN2–CSN3, CSN2–CSN5, and CSN2–CSN7) had notable 
differences in these regions (Fig. 2.3D and SI Appendix, Fig. S9B). Both the integrative 
structures of CSN and CSNn maintained similar core structures (i.e., ordering of the PCI 
ring, the CSN5–CSN6 dimer, and the helical bundle) (Fig. 2.3B). However, CSN2 
changed its conformation and position relative to its neighbors (i.e., CSN3, CSN5, and 
CSN7) (Fig. 2.3 A, C, and D and SI Appendix, Fig. S9B). Specifically, in the integrative 
structure of CSNn, CSN2, and CSN4 localize adjacent to one another, allowing the 
formation of the CSN9-binding cavity (Figs. 2.3D and 2.4). The conformation and relative 
position of the CSN2 subunit in the integrative structure of CSNn were determined by 
satisfying all 74 intersubunit cross-links obtained for CSNn. Therefore, our results suggest 
that CSN2 possesses structural plasticity, enabling its interaction with CSN1 and CSN3 
to yield a more open configuration in CSN9-bound CSN than in CSN9-free CSN.  
To explore the potential role of CSN9-mediated structural changes, we compared 
the integrative structures of CSN and CSNn to the cryo-EM structure of the CRL4A-bound 
CSN complex (at resolution of 6.4 Å) (24). Specifically, we assessed whether the structure 
of the CSN complexed with neddylated CRL4A overlapped with the two integrative 
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structures. The structure of CRL4A-bound CSN differs from the integrative structure of 
CSN for one subunit (i.e., CSN2) and two pairs of subunits (i.e., CSN2–CSN4 and CSN2–
CSN5) (SI Appendix, Fig. S9C). In contrast, the structure of CRL4A-bound CSN has no 
significant differences with the integrative structure of CSNn (SI Appendix, Fig. S9D). 
Similar comparisons were performed with the structure of CRL1-bound CSN (at resolution 
of 7.2 Å) (25). While the structure of CSN bound to neddylated CRL1 differs from the 
integrative structure of CSN for two subunits (i.e., CSN2 and CSN5) and three pairs of 
subunits (i.e., CSN2–CSN4, CSN2–CSN5, and CSN2–CSN6) (SI Appendix, Fig. S9E), it 
has no significant differences with the integrative structure of CSNn (SI Appendix, Fig. 
S9D). Collectively, these assessments suggest that CSN9-bound CSN is structurally 
similar to CRL-bound CSN (24, 25). Upon CSN9 binding, the integrative structure of 
CSNn displays local structural changes, mainly on the conformation and position of 
CSN2. Specifically, CSN2 moves closer to CSN4, causing CSN9-bound CSN to adopt a 
configuration resembling CRL-bound CSN (24, 25).  
Biochemical Validation of CSN9 Binding 
In order to validate the interactions of CSN9 with the CSN complex revealed by XL-MS 
and structural modeling, we performed in vitro binding assays using purified CSN 
subunits. CSN9 only interacts with CSN1-2-3 and CSN1-2-3-8 subcomplexes, whereas 
no binding was detected with CSN4-6-7, CSN4-6-7-5, or CSN4-6-7-5-8 subcomplexes 
(SI Appendix, Fig. S11). These results confirm that CSN1 and CSN3 are present in the 
subcomplex required for CSN9 binding onto CSN. To understand the importance of 
CSN9, we have compared in vitro deneddylase activities of CSN and CSNn with 
neddylated Cullin 1 as the substrate. Similar results were obtained for the same assay 
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performed at different time scales (SI Appendix, Fig. S12), demonstrating that CSNn 
displayed markedly increased activity over CSN and CSN9 can enhance CSN activity in 
vitro.  
Quantitative Validation of the Structural Dynamics of the CSN Complexes  
To validate the observed structural differences between CSN models with and without 
CSN9, parallel reaction monitoring (PRM)-based targeted quantitation of CSN crosslinks 
was utilized (53). Since DHSO cross-linking yielded the most intersubunit linkages best 
describing CSN9-induced structural changes, we individually cross-linked CSN and 
CSNn with DHSO for PRM experiments. To perform unbiased quantitative analysis, we 
generated a total of 341 PRM targets based on highly reproducible DHSO cross-linked 
peptides previously obtained from CSN and CSNn complexes (Datasets S11 and S14). 
Peptide quantitation was derived from the summation of peak areas of all transitions 
through Skyline software. As exemplified in Fig. 2.5A, an intra-CSN4 cross-link (E306–
E345) from both CSN and CSNn samples displayed similar abundance, indicating that 
this interaction is independent of CSN9. In contrast, a CSN2–CSN3 cross-link 
(CSN2:E63–CSN3:E333) was only observed in CSNn and not in CSN, suggesting a 
CSN9-induced conformational change. In total, 229 DHSO cross-linked peptides were 
quantified, which represent 18 intersubunit interactions (Dataset S26). As shown in Fig. 
2.5B, the vast majority of quantified cross-links remained unchanged between CSN and 
CSNn, confirming that CSN9 does not trigger major organizational changes within the 
CSN complex during its binding. This corroborates well with the modeling results as both 
of our CSN models satisfied 99% of DHSO cross-links from both complexes. Apart from 
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unchanged interactions, a total of 22 cross-linked peptides were found with significant 
changes (>2.5-fold, greater than 3σ) between the two compared complexes (Fig. 2.5B).  
Besides cross-links involving CSN9, two additional crosslinked peptides 
corresponding to two intersubunit interactions (i.e., CSN4–CSN6 and CSN6–CSN7) have 
decreased CSN/CSNn ratios, suggesting that these cross-links are favored in CSNn. In 
contrast, 18 cross-linked peptides describing 7 intersubunit interactions (CSN1–CSN2, 
CSN1–CSN3, CSN1–CSN5, CSN2– CSN3, CSN2–CSN7, CSN4–CSN5, and CSN6–
CSN7) and 1 intra-CSN1 interaction have increased CSN/CSNn ratios, implying that 
these cross-links are preferably formed in CSN. Apart from CSN9-containing interactions, 
five quantifiable CSN2– CSN3 cross-links exhibited the most significant changes between 
the two compared complexes with CSN/CSNn ratios all greater than 10.2 (Fig. 2.5C), 
indicating that CSN2–CSN3 interactions were severely disrupted upon CSN9 binding. 
This is consistent with the structural differences between CSN and CSNn revealed by 
integrative modeling as these linkages were only satisfied by the CSN models (Fig. 2.5D). 
Since CSN1 closely interacts with CSN2, CSN3, and CSN9, the decreased abundance 
of CSN1– CSN2 and CSN1–CSN3 cross-links in CSNn supports the CSNn model, 
suggesting that the main body of CSN2 swings away from CSN1 and CSN3 into a more 
open state. Collectively, PRM based targeted quantitation of CSN cross-links strongly 
supports structural similarities and differences between the integrative models of the two 
CSN complexes.   
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Figure 2.5 | PRM-based targeted quantitation of DHSO cross-linked peptides to 
validate CSN9-induced structural changes in CSN.  
(A) Skyline outputs for PRM quantitation of a representative DHSO intrasubunit 
(CSN4:E306–CSN4:E345) (Upper) and an intersubunit (CSN2:E63–CSN3:E333) (Lower) 
cross-linked peptides to compare their relative abundance in the CSN and CSNn 
complexes. Based on peak areas, the relative abundance ratio (CSN/CSNn) of the 
intrasubunit cross-link was determined as 1.11 (Upper), indicating no significant change. 
In contrast, the relative abundance of the intersubunit cross-link (CSN/CSNn) was 
determined as 30.15 (Lower), suggesting a significant change. (B) The distribution of 
cross-link ratios (CSN/CSNn) of 229 DHSO cross-linked peptides (represented as 
log2 values) determined by PRM quantitation, in which only 22 cross-linked peptides 
displayed significant changes (>2.5-fold, greater than 3σ), including 4 with decreased 
ratios (red dots) and 18 with increased ratios (blue dots). The cross-link ratios 
(CSN/CSNn) describe the relative abundance of cross-linked peptides in the two 
compared complexes. (C) Abundance of five quantifiable CSN2–CSN3 cross-links 
(CSN2:D45–CSN3:E333, CSN2:E59–CSN3:E284, CSN2E59–CSN3:E333, CSN2:E63–
CSN3:E333, and CSN2:E161–CSN3:E284) detected in the CSN and CSNn complexes. 
The underlined numbers shown represent relative abundance ratios (CSN/CSNn) of the 
selected cross-linked peptides between the two complexes, indicating that these 
interactions are favored in CSN. (D) The five cross-links shown in (C) were mapped on 
CSN and CSNn integrative structures. The linkages in the CSN model (green) are 
satisfied within the expected distance (<30 Å), which are not satisfied in the CSNn model 
(magenta). Details on PRM quantitation of the cross-linked peptides are listed in Dataset 
S26. 
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Discussion  
In this work, we have developed a multichemistry XL-MS approach based on three distinct 
MS-cleavable cross-linkers (i.e., DSSO, DHSO, and BMSO) to comprehensively map 
PPIs and facilitate integrative structure modeling of CSN complexes. The large number 
of cross-links identified in this work is highly complementary, allowing expanding PPI 
coverage and cross-validating results. This approach enables us to obtain the most 
extensive intrasubunit and intersubunit interaction maps of CSN (CSN9-free) and CSNn 
(CSN9-bound) complexes. It is noted that CSN9-containing interactions were only 
identified through DHSO cross-linking, not by DSSO and BMSO, signifying the need of 
multichemistry XL-MS to fully characterize PPIs of CSN complexes. Importantly, the 
combinatory XL-MS data enabled structural characterization of the CSN complexes with 
complete sequences and significantly enhanced the precision of integrative structure 
modeling, resulting in the precisions of 16 and 22 Å for CSN and CSNn, respectively. 
These are considerably higher than the precision of models from single and dual cross-
linking chemistries (24 to 37 Å). While lysine-to-lysine and acidic-to-acidic residue cross-
links have been successfully applied for structural mapping and modeling (31, 35, 38, 46, 
54, 55), we demonstrate here that cysteine-to-cysteine cross-links are as effective for 
structure determination of protein complexes. This is illustrated by the fact that a single 
integrative structure (i.e., a single cluster of models) satisfies most of the BMSO cross-
links, similarly to DSSO and DHSO cross-links (Fig. 2.2 and SI Appendix, Fig. S7). In 
addition, we obtained highly overlapping model ensembles based on seven different 
combinations of the three types of cross-link data (i.e., DSSO, DHSO, and BMSO 
crosslinks) (Fig. 2.2C and SI Appendix, Fig. S8), confirming the validity and coherence of 
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our cross-link data. Therefore, coupling combinatory XL-MS based on multiple cross-
linking chemistries with integrative structure modeling facilitates the determination of the 
interaction and structure dynamics of CSN complexes. The same strategy can be directly 
adopted for characterizing architectures of other dynamic protein complexes in solution.  
During XL-MS analyses, we have found that although the majority of intrasubunit 
cross-links of CSN from all three linkers were satisfied by the known X-ray structure (PDB 
ID code 4D10), most of intersubunit cross-links were classified as violating. This implies 
that CSN has much more flexible intersubunit than intrasubunit interactions. Since X-ray 
crystallography only reveals static structures with a single conformation, distance violation 
of cross-links suggests the presence of multiple conformations and configurations of CSN 
in solution. Similar results have been obtained for the CSNn complex, further confirming 
the interaction and structural plasticity of CSN complexes. While CSN is known to carry 
structural flexibility to allow its interaction with a diverse array of CRLs to regulate their 
activities (12, 23–25), our XL-MS results provide additional evidence to support CSN 
structural heterogeneity in solution. Because of this, our cross-link dataset generated here 
is comprised of a wide range of possible conformations of CSN complexes. Therefore, to 
minimize complexity, only highly reproducible cross-link data were used to derive 
structural ensembles that represent major conformations of CSN complexes in solution. 
The integrative structures of CSN complexes have satisfied 98% of all of the cross-links 
obtained in this work, considerably better than the X-ray structure. This result further 
indicates that CSN contains additional accessible states other than the one determined 
by X-ray crystallography. In contrast to the observed conformational and configurational 
differences in intersubunit interactions, the core structure of CSN is preserved. Indeed, 
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we have found that the CSN model maintains overall configuration with the presence of 
the PCI ring and the positioning of CSN5–CSN6 dimer, apart from a rearrangement of 
CSN2 with respect to CSN1, CSN3, and CSN4 positioning in the complex. The core 
structure of CSN has also been detected in the CSNn model, which was derived from a 
completely different set of cross-link data used for CSN modeling. As these core modules 
are crucial for the CSN assembly, structure, and function (12, 23–25, 45, 51), their 
determination by integrative modeling based primarily on cross-links further demonstrates 
the effectiveness of our approach and the validity of the determined integrative structures.  
Here, we have determined that CSN9 predominantly interacts with CSN3 and 
CSN1, and is localized in a cavity formed by CSN1-3-8 in the CSNn structure. Although 
CSN3–CSN9 interaction has previously been shown biochemically (27), our results have 
identified interaction contacts between the two interactors. Importantly, we have identified 
CSN1 as an additional CSN9 interactor and determined CSN9 binding sites within the 
CSN complex. While it has been suggested that CSN9 may bind to CSN5 and CSN6 (27), 
no cross-links between CSN9 and CSN5 or CSN6 were identified and the integrative 
structure of CSNn shows that both subunits are much farther away from CSN9 than CSN1 
and CSN3. Interestingly, CSN1, CSN3, and CSN8 form a connected submodule in the 
integrative and X-ray structures of CSN (23), and the assembled CSN1–3-8 subcomplex 
can be isolated in mammalian cells (56). It is known that each CSN subunit has a 
corresponding homolog in the nine-subunit 19S lid complex (27, 57). Recently, the 
proteasome subunit DSS1/ Rpn15, the homolog of CSN9, has been determined to 
interact with Rpn3 (homolog of CSN3) and Rpn7 (homolog of CSN1), which forms a 
subcomplex prior to the 19S lid assembly (58), corroborating well with the close 
45 
 
interactions of CSN9 with CSN3 and CSN1. These results further indicate interaction 
similarities between the CSN and the 19S lid complexes.  
Apart from similarities in organizational architectures in the CSN integrative and X-
ray structures, we have observed structural differences between the integrative structures 
of CSN and CSNn that may contribute to CSN dynamics. One notable difference is the 
CSN2–CSN3 interaction and its relative location to CSN1 subunit. Specifically, in the CSN 
integrative structure, the CSN2 N terminus wraps around CSN1 toward CSN3 and away 
from CSN4, whereby CSN2 is not readily available to interact with Cullin and Rbx1. This 
is of importance because CSN2 plays a major role along with CSN4 in stabilizing the 
CSN–CRL interaction when CSN binds to CRLs (12, 23–25). CSN1 has been shown to 
bind to the CRL4A adaptor DDB1, which is important in stabilizing Cul4A and required for 
efficient deneddylation (24). However, CSN1 involvement appears to be specific for CRL4 
and not CRL2 and CRL3 complexes (24, 26). While CSN3 has not been shown to directly 
contact CRL components, overexpression of CSN3 leads to increased amounts of CSN 
in cells and downregulation of CSN3 causes the destruction of CSN and cell death (59). 
Thus, we speculate that the observed changes of interactions among CSN1, CSN2, and 
CSN3 may represent one of the major conformations of CSN that is needed to interact 
with specific subsets of CRLs in cells.  
While the integrative structures of CSN and CSNn have both maintained the core 
structure of CSN, CSN9 binding causes a major shift in CSN2 and its interactions with 
neighboring subunits that have been confirmed by quantitative XL-MS analysis. Given the 
critical importance of CSN2 in CSN–CRL interactions (12, 24, 25), we suspect that CSN9-
induced structural changes may be associated with the augmented CSN in vitro 
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deneddylase activity observed in this work. Comparative analysis has revealed that the 
major differences between canonical CSN (CSN9-free) and CRL-bound CSN lie in the 
relative position of CSN2 and its interaction with CSN5 (SI Appendix, Fig. S9 C and E), 
indicating that CSN2 has to undergo conformational changes to fulfill its role in facilitating 
CSN binding to CRLs (24, 25). Therefore, the observed structural alterations at CSN2 
would be important for the formation of the CSN–CRL complex, the prerequisite for 
subsequent deneddylation. The structure similarity between CSN9-bound CSN and CRL-
bound CSN (SI Appendix, Fig. S9D) strongly supports the biological relevance of CSN9-
induced structural changes. Thus, these results prompt us to propose a structural model 
in which CSN9 causes the canonical CSN to adopt a configuration favorable for 
interacting with CRLs (Fig. 2.6). In the absence of CSN9, binding of neddylated CRL to 
CSN results in a series of conformational changes, among which the initial important 
steps involve the movement of N-terminal domains of CSN2 and CSN4 toward cullin (12, 
24, 25). These rearrangements occur prior to the release and activation of CSN5.  
In contrast, the addition of CSN9 triggers CSN to undergo conformational changes 
by repositioning the N terminus of CSN2 away from CSN3 but closer to CSN4 (Fig. 2.6). 
As the resulting conformation and configuration of CSN9-bound CSN are highly similar to 
those of CRL-bound CSN, we suspect that CSN9 may enhance the affinity (or 
recognition) between CSN and its substrate, neddylated CRLs, thus facilitating the 
assembly of CSNneddylated CRL complex to enhance CSN activation and deneddylation 
of CRLs. In addition, the conformation of CSNn may also enable its faster release from 
deneddylated CRLs as reported (14). In the absence of CSN9, the assembly/disassembly 
of the CSN–CRL complex would more likely be much slower due to substantial 
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conformational changes required for the activation of CSN upon binding to CRLs, thus 
leading to slower deneddylation rate. Therefore, the differences in the 
assembly/disassembly of CSN–CRL complexes more likely contribute to their interaction 
affinity, and slower disassembly of the CSN–CRL complex could imply tighter interaction.  
In summary, CSN9-induced conformational changes related to CSN2, are 
biologically relevant, especially in preparing CSN for associating with neddylated CRLs, 
thereby contributing to augmenting deneddylation activity of CSN. The integrative 
structures of CSN complexes determined in this work have established a structural basis 
for us to further dissect condition-induced structural dynamics of CSN in the future, 
unraveling molecular insights into its activation, function, and regulation under different 
physiological and pathological conditions.  
 
 
Figure 2.6 | The proposed structural model of CSN9 binding to facilitate CSN 
interaction with neddylated CRLs.  
CSN and neddylated CRL subunits were color-coded as illustrated. (I) CSN9-free CSN 
needs to undergo substantial conformational changes upon binding to a neddylated CRL. 
In comparison, (II) CSN9-bound CSN adopts a configuration better suited for CRL 
binding. 
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Methods  
Expression and Purification of CSN Complexes 
Eight of total nine subunits of the human CSN complex, except CSN5, were 
overexpressed and purified from E. coli. Two three-subunit subcomplexes, CSN1-2-3 and 
CSN4-6-7, were prepared through coexpression. Briefly, CSN2 was subcloned into a 
modified pGEX4T1 (Amersham Biosciences) vector containing a GST tag followed by a 
tobacco etch virus (TEV) protease cleavage site, while both CSN1 and CSN3 were 
subcloned into a modified pET15b (Novagen) vector containing a chloramphenicol 
resistance cassette. After coexpression in BL21(DE3) (Novagen), the CSN1-2-3 formed 
a complex and was purified by glutathione-affinity chromatography. Following TEV 
cleavage, the CSN1-2-3 subcomplex was further purified by anion exchange and gel-
filtration chromatography. CSN4-6-7 was prepared in the same way. CSN8 and CSN9 
were subcloned into the pGEX4T1 vector individually and subjected to the same 
purification procedure. Recombinant full-length CSN5 inserted into a modified GTE vector 
(Invitrogen). It has a GST tag that was removed during purification and was prepared from 
insect cells using a baculovirus expression system. Two CSN complexes, with or without 
CSN9, were reconstituted by incubating the purified subcomplexes and individual 
subunits in equimolar ratio and polished by SEC. Neddylated Cul1–Rbx1 complex was 
prepared as described previously (60).  
XL-MS Analysis of CSN Complexes 
Affinity-purified human CSN complex with or without CSN9 were cross-linked with DSSO, 
DHSO, or BMSO, respectively. Each CSN complex was reacted with a selected cross-
linker at their optimized molar ratios (protein to linker) respectively: DSSO (1:250), BMSO 
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(1:400), and DHSO (1:30) (32, 35, 36). DMTMM was used to activate acidic residues for 
DHSO cross-linking (35). All reactions were performed for 1 h at room temperature. The 
resulting cross-linked proteins were digested by lys-C and trypsin. Cross-linked peptides 
were enriched by peptide SEC, analyzed by LC MSn , and identified through database 
searching, as previously described (SI Appendix, Supplemental Method) (35, 36).  
PRM Targeted Quantitation of Cross-Linked Peptides 
The 341 PRM targets were obtained based on highly reproducible DHSO cross-linked 
peptides of CSN and CSNn complexes, as summarized in Datasets S11 and S14. For 
targeted analysis, the mass spectrometer was operated with the following settings: No 
survey scan collected, tMS2 resolving power 30,000, AGC target 5e4, maximum injection 
time 54 ms, isolation window 1 m/z, and CID normalized collision energy of 23%. A total 
of 341 cross-links were monitored over 3 separate targeted analyses for each sample, 
along with a set of 16 heavy-labeled AQUA peptides. Targeted analysis of AQUA peptides 
used the same settings as cross-link ions except were subjected to higher-energy 
collision dissociation with normalized collision energy of 30%. Transition lists based on 
expected cross-link fragmentation ions were generated and quantified using Skyline 
v.4.2.0.19072. Once exported, extracted intensities were normalized within sample sets 
using relative intensities of AQUA peptides based on quantified b and y ions.  
In Vitro Deneddylation Assay 
A mixture containing 5 μM Nedd8-Cul1-Rbx1 and 20 nM CSN was incubated in reaction 
buffer of 50 mM Hepes (pH 7.5), 150 mM NaCl, and 1 mM TCEP. The reactions were 
carried out at room temperature and stopped by adding SDS/PAGE sample buffer at 
indicated time points, then analyzed by 9% SDS/PAGE and stained with Coomassie blue.  
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Biochemical Validation of the CSN9 Interactors 
Purified components of CSN, including CSN5, CSN8, and subcomplex CSN1-2-3 and 
CSN4-6-7, were used for pull-down assay. His-GB1 fused CSN9 served as the bait 
protein. The prey samples (different combinations of CSN subunits) were mixed with His-
GB1- CSN9 at molar ratio 2:1. After 10-min incubation, His Mag Sepharose Ni beads (GE 
Healthcare) were added into the samples and suspended by gently tapping the sample 
tubes for 5 min to immobilize His-GB1-CSN9 and its binding partners. Then the beads 
were washed with 20 mM Tris·HCl (pH 8.0), 300 mM NaCl, 20 mM imidazole five times. 
The beads were further eluted with 200 mM imidazole and the elution was analyzed on a 
4 to 15% MiniPROTEAN TGX Gel (Bio-Rad). To identify the binding partners of CSN9, 
all of the purified CSN components were loaded on the same gel.  
Integrative Structure Modeling 
Integrative structure modeling was carried out to determine the structures of the human 
canonical and noncanonical CSN complexes (SI Appendix, Supplemental Method and 
Datasets S18 and S22). Mass spectrometry raw data have been deposited at the PRIDE 
Archive proteomics data repository site (dataset identifier PXD014673). All of the relevant 
scripts, data, and results are available at GitHub, https://salilab.org/ CSN2019. The 
integrative structures of CSN and CSNn are deposited at PDB-Dev (https://pdb-
dev.wwpdb.org/), with ID codes PDBDEV_00000037 and PDBDEV_00000038, 
respectively.  
Data deposition  
Mass spectrometry raw data have been deposited at the PRIDE Archive proteomics data 
repository site (dataset identifier PXD014673). All the relevant scripts, data, and results 
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are available at GitHub, https://salilab.org/CSN2019. The integrative structures of CSN 
and CSNn are deposited at PDB-Dev, https://pdb-dev.wwpdb.org/ (PDB ID codes 
PDBDEV_00000037 and PDBDEV_00000038). 
Supplemental Information 
This article contains supporting information online at https://www.pnas.org/lookup/suppl/ 
doi:10.1073/pnas.1915542117/-/DCSupplemental. 
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Abstract 
Mapping the functional cycle of a biomolecular machine requires determining the 
structures of key states, their stabilities and the kinetics of their interconversions under 
native conditions. Here, we describe a method that outputs these free energy differences 
and kinetic rates based on time-dependent negative-stain electron microscopy particle 
images for a given set of structural states and transitions between them. First, proportions 
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of these states in micrographs prepared at different lag times after triggering a process of 
interest are estimated by assigning each particle image to one of the states. Second, the 
free energy difference between each pair of connected states is estimated from the 
corresponding proportion and the rates of conversion between all pairs of connected 
states are estimated by fitting the time-dependent proportions to the system of first order 
reaction rate equations. In principle, different sets of transitions and reaction rate 
equations can be explored using model selection criteria. The accuracy of the estimates 
is limited by the uniformity of sampling structural states during particle picking and by the 
accuracy of assigning particle images to the structural states. The uncertainty of the 
estimates is determined by the numbers of particle images and is estimated by 
bootstrapping. We illustrate our method by applying it to the yeast Hsp90 chaperone 
engaged in its ATPase cycle in the presence of two ATP analogs, the non-hydrolysable 
AMP·PNP or the slowly hydrolysable ATPγS. The resulting estimates of the 
thermodynamic and kinetic parameters are in agreement with previous experiments. The 
proposed method is applicable to a large number of systems, including to those mapped 
by cryo-electron microscopy.  
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Introduction 
Biological macromolecular assemblies play crucial roles in most cellular processes. 
Spatiotemporal models of these assemblies facilitate the understanding of their function, 
evolution, and modulation (1–3). Traditional structure determination methods, such as X-
ray crystallography, provide mostly static structural models of these assemblies, but they 
are largely uninformative about thermodynamics and kinetics of transitions between 
states. Other methods can provide some dynamic information. For example, Förster 
resonance energy transfer (FRET) spectroscopy can probe the distance between dyes, 
with a spatial resolution of ~5 Å and temporal resolution of ~5 ms. However, numerous 
FRET measurements with dyes engineered at different locations on an assembly are 
required to infer global structural features along a functional cycle. To fully describe these 
assemblies, it is thus necessary to have a method for accurately, precisely, and 
completely determining the key states in the functional cycle, their structures and 
stabilities, as well as the kinetics of their interconversions under native conditions.  
Single particle electron microscopy (EM) allows for imaging of non-crystalline 
specimens (single particles) of assemblies. EM has recently undergone a “resolution 
revolution” (4). The number of high-resolution EM structures has greatly increased due to 
improvements in sample preparation, electron microscopes, image sensors, image 
processing software, and molecular modeling software (5, 6). For example, direct electron 
detectors have replaced film and charge-coupled device (CCD) cameras due to their 
improved quantum efficiency (i.e., a better conversion of incident radiation to photons) (5, 
7, 8). Image processing improvements are mostly due to the introduction of statistical 
treatment of the sample heterogeneity and experimental uncertainty (9–13). Thus, it is 
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now possible to image assemblies in solution at high resolution (14–18). As a result, EM 
has a unique opportunity to image assemblies along their functional cycle. An important 
role for modeling will include interpreting the single particle images in terms of time-
dependent populations of multiple states along the functional cycle in solution.  
Multiple structures of assemblies can be observed by EM if the differences 
between the structures are larger than the resolution of the images. Different multiple 
structures can be imaged in a sample by coupling structural changes to a process of 
interest, e.g. by modulation of a physical state variables (e.g., temperature) (19) or 
chemical composition (e.g., addition of a ligand) (20, 21). Furthermore, time-resolved EM 
aims at determining structures along the functional cycle (22). Time-resolved EM has 
been successfully used to describe (i) slow-processes such as the biogenesis of 
ribosomes (23) and the coupling between ribosome dynamics and tRNA movement (19) 
as well as (ii) sub-second processes such as the molecular mechanism of the bacterial 
translation initiation (24). In these experiments, both structures and population sizes 
agreed with prior experiments (21, 24).  
Here, we show that using time-resolved EM enables determining structures of 
states, free energy differences between pairs of states, and kinetic rate parameters for 
interconversions between them. We illustrate our method by applying it to the yeast 
Hsp90 chaperone engaged in its ATPase cycle in the presence of two ATP analogs, the 
non-hydrolysable AMP·PNP or the slowly hydrolysable ATPγS. We determined the 
structures of the open and closed states by negative stain EM, both in agreement with 
previously determined structures. Then, we estimated population fractions of these two 
states in micrographs prepared at different lag times, from which we estimated free 
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energy differences and kinetic rates, which agreed with previous estimates of these 
parameters. We discuss the limitations of the approach as well as potential future 
developments, including the possibility to determine even more state variables, such as 
entropy differences. The approach may contribute towards accurate, precise, and 
complete descriptions of macromolecular free energy landscapes. 
 
Methods 
Negative stain EM sample preparation, data acquisition, and analysis 
Purified S. cerevisae Hsp90 was mixed with either AMP·PNP or ATPγS, resulting in the 
final concentration of 110 nm for the Hsp90 dimer 5 mM for the nucleotide, in a buffer 
consisting of 20 mM HEPES pH 7.5, 150 mM KCl, and 5 mM MgCl2. Samples were 
incubated at room temperature (~20 °C) and aliquots were taken from a common stock 
at the specified time points for negative staining. For the 0 second time point, no 
nucleotide was added. Negative staining was performed following published protocols 
(25). Briefly, 2.5 μL of sample was applied to glow-discharged carbon-coated copper grids 
and stained with 0.75% (w/v) uranyl formate. Negatively stained samples were imaged 
on a Tecnai T20 electron microscope (FEI Company) equipped with a LaB6 filament 
operating at a 200kV acceleration voltage. Images were recorded at a nominal 
magnification of 50,000× using a TemF816 8K × 8K CMOS camera (TVIPS GmbH) with 
a calibrated pixel size of 1.57 Å. Images were 2 × 2 binned yielding a final pixel size of 
3.14 Å. Particles were picked and processed by cryoSPARC (26).  
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Determination of the estimate of free energy and kinetic parameters.  
To estimate the free energy differences and kinetic parameters, we formulate a model 
based on rate theory. For an N-species reversible reaction:  ,! ⇌ ," (for i,j = 1, …, N) ∧ (i≠j). 
We describe the chemical process by a master equation: 8[,!]89 =:;"!<,"= −"#! :;!"[,!]!#"  
with its matrix representation: 
>[,$]⋮̇[,%]̇ A = >
−∑ ;$""#$ ⋯ ;%$⋮ ⋱ ⋮;$% ⋯ −∑ ;%""#% AE[,$]⋮[,%]F. 
The system is thus described by a system of ordinary differential equations (ODE), with 
the solution of  <,⃗= = :H!I&'!(J)KKK⃗!  
where L!, J)KKK⃗ , and ci are the ith eigenvalue, eigenvector, and integration constant, 
respectively. We simultaneously fit these parameters to the population fractions for each 
state i normalized for each time point, as determined from EM images. In addition, from 
the obvious constraint ∑ M!! = 1: 
[+!]∑ .+"/" = #$%&'($&'(∑ %"%" = %!%∑ %"%" = M!, 
where [,!] is the concentration of state i at some time t, M!0	is the particle count observed 
by EM, V is the volume of the solution, and O1 is the Avogadro’s number. 
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Results  
The open and closed conformations of the yeast Hsp90 
We selected single particle images for the open conformation of the yeast Hsp90 and 
refined a single class using cryoSPARC (26) without enforcing the C2 symmetry. The 
resulting negative stain EM density map was determined at a nominal resolution of ~15Å 
(Fig. 3.1C). We also refined these particle images enforcing a C2 symmetry. The resulting 
negative stain EM density map was determined to a nominal resolution of ~15Å. We then 
assessed the overlap between the two maps by computing the cross-correlation 
coefficient between them. The overlap between the two maps had a cross-correlation 
coefficient of 0.99. The negative stain EM density maps were of sufficient quality to 
confidently dock the rigid extended conformation of Hsp90 previously determined by 
fitting a molecular model to a SAXS profile (27). We assessed the overlap between the 
model and the EM density map of the open conformation by computing the cross-
correlation between them. The model-map overlap had a cross-correlation coefficient of 
0.90.  
Similarly, we reconstructed a closed state of the yeast Hsp90 determined by 
negative stain EM. The resulting negative stain EM density map was determined at a 
nominal resolution of ~15Å (Fig. 3.1D). We assessed the model-map overlap between 
the yeast Hsp90 closed conformation (PDB code: 2CG9 (28)) by computing a cross-
correlation between them. The model-map overlap had a cross-correlation coefficient of 
0.82. We conclude that both conformations observed by negative stain EM agree with 
previously observed structures.  
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Figure 3.1 | Structure of the open and closed conformations of the yeast Hsp90 
(A) Representative negative stain image of the yeast HSP90. (B) Example of particle 
images in an open (top) and closed (bottom) conformation used for analysis. (C) 3D 
reconstruction of the open conformation of the yeast Hsp90 determined by negative stain 
EM at a nominal resolution of ~15Å. (D) 3D reconstruction of the closed conformation of 
the yeast Hsp90 determined by negative stain EM at a nominal resolution of ~15Å. 
 
 
The rate of conversion from open to closed state of yeast Hsp90 with AMP·PNP 
In the presence of the non-hydrolysable ATP analog AMP·PNP, Hsp90 closure is an 
irreversible two-state process from the open to closed conformation, because negligible 
hydrolysis occurs on the time scale of the experiment (29). The solution of the two-state 
system of ODEs for an irreversible process is: 
P	M2(9) 	= 				 +H3I&4(		M5(9) 	= H$ −H3I&4(	,     (1) 
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where M2 and M5 are the fractions of observed populations for the open and closed 
conformation, respectively, H$ and H3	are integration constants and ; is the rate of closure 
of Hsp90 in the presence of AMP·PNP. Without loss of generality, we apply boundary 
conditions (limit as 9 goes to 0 and ∞) and the normalization constraint (Methods) to 
determine that H$ = 1. We note that H$ corresponds to the fraction of particles in a closed 
state at 9 → ∞ and H3 corresponds to the fraction of particles in the open state at time 9 =0. 
We imaged seven time points for a total of 297 micrographs and automatically 
picked 793,319 particles using a Gaussian sphere as a reference. We then used multiple 
rounds of classification (2D and 3D) to determine population sizes in the open and closed 
conformations (Fig. 3.2). We fitted simultaneously the parameters in Equation 1 to the 
evolution of the population fractions over time. We determined that H3 = (0.79 ± 0.02) and ; = (3.5 ± 0.3)·10-4 s-1. Free energy differences at temperature U = 20 °C between the 
open and closed conformations of Hsp90 in the absence of the nucleotide can be 
calculated using ΔW2→5 = −XU	ln Y%)%*Z = −XU	ln Y$&5+5+ Z, propagating uncertainty using 
8ΔW2→5 = [∑ \789*→)7: \: 3 8]3, where ] is one of U or H3. We measure the free energy 
difference to be (0.77 ± 0.05) kcal·mol-1, in agreement with the fraction of populations 
previously observed (21).  
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Figure 3.2 | Two-state model for the kinetics of closure of the yeast Hsp90 in the 
presence of AMP·PNP.  
Experimentally determined kinetic traces of the irreversible process between the open 
and closed states. Population fractions of the open state (red filled circles) and closed 
state (blue filled squares) are shown as a function of time. The lines show the least-
squares fit of the first order kinetics of closing to the data (opaque lines; the fitting 
parameters are c2 = (0.79 ± 0.02) and kc = (3.5 ± 0.3)·10-4s-1). 
 
 
  
0.00
0.25
0.50
0.75
1.00
0 1000 2000 3000 4000
N
or
m
al
iz
ed
po
pu
la
tio
n
Time t (s)
Open
Closed
69 
 
The kinetic rate parameter of closure of the yeast Hsp90 with ATPγS 
In the presence of the slowly hydrolysable ATP analog ATPγS, Hsp90 closure and 
opening is a reversible two-state process. The solution for the two-state system of ODEs 
for a reversible process is 
^	M2(9) 	= H$ ;2;5 +	H3I&(4*<4))(		M5(9) 	= H$									 −	H3I&(4-<4))(	, 
where 	M2 and 	M5 is the fraction of observed population for the open and closed 
conformations, respectively, H$ and H3 are integration constants, and ;2 and ;5 are the 
rates of opening and closure of Hsp90 in the presence of ATPγS, respectively. Without 
loss of generality, we apply boundary conditions and the normalization constraint 
(Methods) and determine that H$ = 4)4*<4).  The solution is 
^	M2(9) 	= 4*4*<4) +	H3I&(4*<4))(		M5(9) 	= 4)4*<4) −	H3I&(4-<4))(	.     (2) 
We imaged 13 time points, resulting in the total of 967 micrographs. We present 
here preliminary results for 8 of these time points. We picked 715,475 particles using a 
Gaussian sphere as a reference. We then used multiple rounds of classification (2D and 
3D) to determine population sizes in the open and closed conformations (Fig. 3.3). We 
fitted simultaneously the parameters in Equation 2 to the evolution of the population 
fractions over time. We determined that H3 = (0.34 ± 0.05), ;2  = (6 ± 2)·10-4 s-1, and ;5  = 
(9 ± 3)·10-4 s-1. The rate of closure is in agreement with the rate of closure observed by 
FRET spectroscopy (30). Similarly to above, the free energy difference at temperature U 
= 20 °C between the open and closed conformations of Hsp90 in the absence of ATPγS 
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is (0.6 ± 0.4) kcal·mol-1, in agreement with a previous estimate (21). At equilibrium in the 
presence of ATPγS, the free energy difference between the two states is (-0.2 ± 0.3) 
kcal·mol-1. As expected, the closed conformation is favored in the presence of the 
nucleotide, as previously observed (21, 29, 31, 32). 
 
 
 
Figure 3.3 | Two-state model for the kinetics of closure of the yeast Hsp90 in the 
presence of ATPγS.  
Experimentally determined kinetic traces of the reversible process between the open and 
closed states. Population fractions of the open state (red filled circles) and closed state 
(blue filled squares) are shown as a function of time. The lines show the least-squares fit 
of the first order kinetics of closing and opening to the data (opaque lines; the fitting 
parameters are c2 = (0.34 ± 0.05) and kc = (9 ± 3)·10-4 s-1, ko = (7 ± 2)·10-4 s-1).  
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Discussion 
Electron microscopy is able to determine the structures of biological macromolecular 
assemblies. In addition, because EM is a true single particle method, it is also possible to 
use it to map the kinetics and thermodynamics of a system that exists in multiple states. 
As an example, we used here a slow process of closing the open state of yeast Hsp90. 
In particular, we determined the structures of the two key states, the open and closed 
states, as well as the evolution of their populations as a function of time. The population 
sizes enabled us to compute free energy differences and kinetic parameters for the yeast 
Hsp90 along its functional cycle, in agreement with previous estimates (21, 29, 31, 32). 
The modeling of kinetic and thermodynamic parameters can also be applied to cryo-EM 
images, which could allow us to characterize processes involving more similar structures 
than possible for negative stain EM (20, 33–35). Moreover, temperature dependent 
experiments (19) as well as ligand-dependent experimental conditions (20, 21) can 
modulate the population sizes and enable, in principle, the determination of entropy 
differences and structures of on-pathway intermediates. 
The method suffers from experimental, computational, and statistical limitations. 
First, the kinetics of interconversion between different states needs to be slower than the 
experiment setup time (e.g., pipetting, staining, or the time of plunge freezing (~10-7 sec)). 
Second, the approach is limited by the ability to classify and count particle images into 
their correct states; the classification can be improved by using cryo-EM for leveraging 
higher-resolution information. Third, the least stable state still needs to be sufficiently 
frequent for accurate counting; in principle, increasing the number of images will 
ameliorate this shortcoming, although the population frequency is an exponentially 
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decreasing function of thermodynamic stability. Finally, the particles in the different states 
need to be counted with equal bias relative to the uncounted particles. In principle, the 
sensitivity of the population estimates as a function of the accuracy of assigning single 
particle images to different states can be tested by cross-validation (e.g., bootstrapping).  
The results presented here are preliminary. We are currently investigating 
robustness and further validation of the process model. First, we need to estimate the 
uncertainty of the population fractions. This estimation requires to perform bootstrapping 
on each of the datasets and compute expectations and deviations for each time point of 
each sample. Lastly, we need to test whether the representation of our process model is 
appropriate. For example, we need to assess whether or not the kinetic model of Hsp90 
in the presence of ATPγS is a two-state system; it is possible that the data suggest 
additional on-pathway intermediates that have not yet been accounted for. The on-
pathway intermediates may be classifiable using negative-stain EM or may require higher 
resolution information available by imaging Hsp90 by cryo-EM. 
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Abstract 
Modeling of macromolecular structures involves structural sampling guided by a scoring 
function, resulting in an ensemble of good-scoring models. By necessity, the sampling is 
often stochastic, and must be exhaustive at a precision sufficient for accurate modeling 
and assessment of model uncertainty. Therefore, the very first step in analyzing the 
ensemble is an estimation of the highest precision at which the sampling is exhaustive. 
Here, we present an objective and automated method for this task. As a proxy for 
sampling exhaustiveness, we evaluate whether two independently and stochastically 
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generated sets of models are sufficiently similar. The protocol includes testing 1) 
convergence of the model score, 2) whether model scores for the two samples were 
drawn from the same parent distribution, 3) whether each structural cluster includes 
models from each sample proportionally to its size, and 4) whether there is sufficient 
structural similarity between the two model samples in each cluster. The evaluation also 
provides the sampling precision, defined as the smallest clustering threshold that satisfies 
the third, most stringent test. We validate the protocol with the aid of enumerated good-
scoring models for five illustrative cases of binary protein complexes. Passing the 
proposed four tests is necessary, but not sufficient for thorough sampling. The protocol is 
general in nature and can be applied to the stochastic sampling of any set of models, not 
just structural models. In addition, the tests can be used to stop stochastic sampling as 
soon as exhaustiveness at desired precision is reached, thereby improving sampling 
efficiency; they may also help in selecting a model representation that is sufficiently 
detailed to be informative, yet also sufficiently coarse for sampling to be exhaustive. 
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Introduction 
Integrative structure determination is an approach for characterizing the structures of 
large macromolecular assemblies that relies on multiple types of input information, 
including from varied experiments, physical theories, and statistical analysis (1–4). 
Therefore, it maximizes the accuracy, precision, completeness, and efficiency of structure 
determination. Moreover, it can often produce a structure for systems that are refractive 
to traditional structure determination methods (5–11), such as x-ray crystallography, 
electron microscopy, and NMR spectroscopy. Integrative structure determination 
proceeds in four stages. First, all information that describes the system of interest, 
including data from wet lab experiments, statistical tendencies such as atomic statistical 
potentials (12–14), and physical laws such as molecular mechanics force fields (15, 16), 
is collected. Second, a suitable representation for the system is chosen depending on the 
quantity and resolution of the available information. The available information is then 
translated into a set of spatial restraints on the components of the system. The spatial 
restraints are combined into a single scoring function that ranks alternative models based 
on their agreement with input information. Third, the alternative models are sampled using 
a variety of techniques, such as conjugate gradients, molecular dynamics, Monte Carlo 
(17), and divide-and-conquer message passing methods (18). The sampling generates 
an ensemble of models that are as consistent with the input information as possible. 
Finally, input information and output structures need to be analyzed to estimate structure 
precision and accuracy, detect inconsistent and missing information, and suggest more 
informative future experiments. Assessment begins with structural clustering of the 
modeled structures produced by sampling, followed by assessment of the thoroughness 
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of structural sampling, estimating structure precision based on variability in the ensemble 
of good-scoring structures, quantification of the structure fit to the input in-formation, 
structure assessment by cross-validation, and structure assessment by data not used to 
compute it. Integrative modeling can iterate through these four stages until a satisfactory 
model is built.  
A key challenge in integrative modeling of biomolecular structures is to map the 
complete ensemble of models consistent with the input information (good-scoring models) 
(1, 2, 19, 20). The variation among the models in this ensemble quantifies the uncertainty 
of modeling (model precision). Because sampling large macromolecular systems is often 
necessarily stochastic, we can only aim to find representative good-scoring models. 
These representative models sample all good-scoring models at some precision, which 
we define as the sampling precision. Clearly, the sampling precision imposes a lower limit 
on the model precision. Therefore, exhaustive sampling of good-scoring models is a 
prerequisite for accurate modeling and assessment of model precision. Sampling is 
exhaustive at a certain precision when it generates all sufficiently good-scoring models at 
this precision. Importantly, sampling exhaustive-ness and sampling precision are 
invariably intertwined. There is always a precision at which any sampling is exhaustive; 
for example, even a single structure provides an exhaustive sample at a precision worse 
than the scale of the system. 
Accurate estimation of model precision is key in assessing an integrative structure. 
It is perhaps more important to assess the precision of a model than to compute a model 
in the first place. The reason is that the utility of a model is determined significantly by its 
precision. First, model precision provides an estimate of the aggregate uncertainty in the 
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input information; second, it likely provides the lower bound on model accuracy; finally, 
applications of models strongly depend on their accuracy, with different applications 
having varied requirements for accuracy and precision (20–22). Further, only when model 
precision is estimated accurately, can the model be used to inform future choices, such 
as whether to gather more data, change the system representation, scoring functions, or 
sampling algorithms. Commonly used structural features for estimating model precision 
include the particle positions, distances, and contacts (5, 6, 23, 24), although specific 
systems may benefit from the use of derived features, such as the distance to a 
membrane in a transmembrane assembly. Of particular interest are the features that have 
a single maximum in their probability distribution. The spread around the maximum 
describes how precisely the feature was determined by the input information.  
Sampling convergence in Monte Carlo simulations for protein and RNA structure 
prediction has been assessed by checking for abundance of structures close to the lowest 
energy structure(s) (25–32). Convergence in molecular dynamics (MD) simulations has 
been measured by counting the number of structural clusters (33–35) and their relative 
populations (36–40), cosine of the principal components (41), distance between the free 
energy surfaces of different parts of the simulation (42), and drift in the free energies (43). 
Some methods assess convergence in MD simulations by comparing different trajectories 
via a difference in populations for each cluster (36–40). For example, models from a 
‘‘reference’’ simulation are first clustered based on a predetermined cutoff (38), followed 
by assigning models from additional simulation to the nearest cluster in the reference 
simulation; thus, each simulation produces a histogram of populations of clusters that 
enables comparison of any two simulations.  
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As mentioned above, testing for sampling exhaustiveness is the first step of the 
analysis and validation stage of our four-stage integrative modeling process, immediately 
following the sampling stage (2, 4, 7–9, 44). Here, we present an objective and automated 
protocol that aims to estimate the precision at which sampling is exhaustive, thereby 
assessing sampling exhaustiveness for integrative structural modeling. As a proxy for 
assessing sampling exhaustive-ness, we evaluate whether or not two independently and 
stochastically generated sets of models (model samples) are sufficiently similar. Model 
samples for assessment can be obtained, for example, from two independent simulations 
using random starting models or different random number generator seeds. The protocol 
for evaluating exhaustiveness includes two tests that consider the model scores, followed 
by two tests that consider the model structures.  
There are at least two major limitations of our approach. First, sampling 
convergence is at best an approximation of sampling exhaustiveness. Although similarity 
between independent model samples does indicate sampling convergence, we can only 
hypothesize that the convergence of stochastic sampling at some precision also indicates 
sampling exhaustiveness at that precision, for scoring function landscapes like those 
used in integrative structure modeling (many dimensions, rugged, few major minima). 
This hypothesis is supported by all five examined cases of binary docking solutions 
enumerated at a specified precision. Accordingly, passing the proposed tests is a 
necessary, but not sufficient condition for exhaustive sampling; a positive outcome of the 
test may be misleading if, for example, the landscape contains only a narrow, and thus 
difficult to find, pathway to the pronounced minimum corresponding to the native state. 
Second, our tests are also not applicable to methods whose sampling is not stochastic 
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(e.g., a conjugate gradients minimization from a fixed unique starting point) or so 
expensive that they cannot generate a large enough sample of independent models. The 
rest of the article is organized as follows. In Methods, we describe the four-part protocol 
for estimating sampling precision and assessing sampling exhaustiveness, including its 
application to five illustrative cases of binary protein complexes. In Results, we 
demonstrate the protocol on the illustrative cases and validate it by comparing stochastic 
model samples with models from exhaustive enumeration using rigid docking (45, 46). 
Parameters of the protocol, its applicability and uses, its shortcomings, the relationship 
between various kinds of precision in integrative modeling, relation to prior work, and 
future work are addressed in Discussion. 
 
Methods 
The protocol for estimating sampling precision and assessing sampling exhaustiveness 
(Fig. 4.1) consists of four tests that are increasingly stringent; each test needs to be 
passed before it makes sense to proceed to the next test. Given two model samples and 
their scores as input, the tests check 1) convergence of the model score, 2) whether 
model scores for the two model samples were drawn from the same parent distribution, 
3) whether each structural cluster includes models from each sample proportionally to its 
size, and 4) whether there is sufficient structural similarity between the two model 
samples in each cluster. Next, each step in the flowchart (Fig. 4.1) is described in turn. 
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Figure 4.1 | Flowchart of the protocol for estimating sampling precision and 
assessing sampling exhaustiveness 
 
Generating inputs for the protocol 
The necessary input for the protocol is two model samples of approximately equal size 
and their scores. Each model sample consists of random, independently generated 
models. Both model samples must be generated using the same sampling method. In 
Input: Set of good-scoring models 
and their scores from two 
independent runs.
    1. Plot convergence of the best 
score in each run.
    2. Verify similarity of score 
distributions from the two runs, 
using the t-test.
3. Compute pairwise weighted 
RMSDs for models from both runs.
4. Cluster models from both runs, 
for a series of thresholds.
6. Compute the precision of the 
clusters using the weighted RMSF 
of final clusters.
5. Find the sampling precision using 
the chi-square contingency test.
7. Compare localization densities of 
final clusters between runs, using 
cross-correlation.
END
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integrative structure modeling, we are generally not interested in all sampled models, but 
only in models that are good-scoring (i.e., those that are sufficiently consistent with input 
information) (2, 4, 7–9, 44). 
The precise definition of good-scoring models is left to the user and can be 
application-dependent. Example choices include all models scoring better than a 
threshold on the total score (2, 4, 7–9, 44), or all models satisfying all types of input 
information within acceptable thresholds. For example, if a protein complex is modeled 
by fitting its components into an electron microscopy density map subject to cross-linking, 
excluded volume, and sequence connectivity, the corresponding scoring function can be 
a sum of the correlation coefficient between the EM map and a model as well as harmonic 
(Gaussian) restraints for chemical cross-links, pairs of overlapping atoms, and sequence 
connectivity; a good-scoring model can then be defined as a model that fits the EM density 
with a cross-correlation > 0.80 and violates (e.g., a restraint value > 2 SD from the mean) 
a smaller number of harmonic restraints than expected for the corresponding Gaussian 
distributions (e.g., 5%). 
The samples are usually generated by a stochastic sampling algorithm. One such 
algorithm is the Metropolis Monte Carlo scheme (47) that starts from a different 
configuration and/or random number seed for each run. For our purposes, a larger 
number of shorter runs is preferable over a smaller number of longer runs for two reasons. 
First, a larger number of runs benefits more easily from parallel execution than a smaller 
number of runs. Second, independent runs are guaranteed to result in uncorrelated 
models, whereas, additional care is needed to ensure the lack of correlation for models 
from a single run. 
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Convergence of the best score 
The first test assesses whether the best model score continues to improve as more 
models are sampled. This test operates on random subsets of the model scores of the 
two samples combined. Model score subsets of several sizes (e.g., 20, 40, 60, 80%, and 
the complete set) are each created several times (replicates). The best score in each 
subset is averaged across the replicates. Plotting the average best score for each model 
subset size shows whether the best score converges as the number of models is 
increased.  
Similarity of scores  
The second test confirms that good-scoring models in the two model samples have similar 
score distributions (i.e., satisfy the data equally well). Specifically, the nonparametric 
Kolmogorov-Smirnov two-sample test (48, 49) tests the null hypothesis that the 
distributions of model scores in the two model samples were drawn from the same parent 
distribution. The p value from the Kolmogorov-Smirnov two-sample test is a measure of 
the statistical significance of the difference between the two distributions. A p value lower 
than the cutoff of significance (usually 0.05) indicates that the difference in the two score 
distributions is statistically significant.  
Even a tiny difference between two distributions can be significant if the samples 
are large (50, 51). Therefore, we additionally use an effect size measure for the 
Kolmogorov-Smirnov two-sample test. Conveniently, the Kolmogorov-Smirnov two-
sample test statistic, D, is itself a proportion (48, 49). The proportion ranges from 0 to 1, 
where 0 represents no difference between the two samples and 1 no overlap between 
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the two samples. A value of 0.30 (medium effect size) or higher suggests that the two 
score distributions are different (48, 49).  
Finally, we conclude that the score distributions are similar if the difference is not 
statistically significant (p value > 0.05) or if the difference is significant (p value < 0.05) 
but its magnitude is small (D < 0.30).  
 
 
Figure 4.2 | Conceptual representation of the c2 test for sampling exhaustiveness, 
showing models in a 2D coordinate space.  
Two independent equal-sized random samples of good-scoring models are shown in red 
and blue. Models in the two samples are clustered together. The gray circles indicate 
cluster boundaries and the gray-scale indicates the density of models in the cluster. The 
size of the circles indicates the clustering threshold. The test assesses whether the 
proportion of models from the two samples (red and blue) is similar in each significant 
cluster. Note that some models are shown as open circles, indicating that these models 
belong to insignificant clusters (i.e., small clusters containing few models). 
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Computing pairwise root-mean-square deviations  
The third test assesses whether models from each sample are present in each structural 
cluster proportionally to the sample size; when the sample sizes are equal, each cluster 
should contain approximately the same number of models from each sample. The test 
requires clustering models from both samples combined. It may be necessary to select 
sufficiently small random subsets of the two model samples, to make clustering 
computationally feasible.  
The first step of clustering is to compute root-mean-square deviation (RMSD) 
values between all pairs of models from both samples combined (8): 
X$,&!," = `: a4bc⃗!,4 − c⃗",4d3/: a4@4A$ 	@4A$ f$3 
where c⃗!,4 is the Cartesian coordinate of the kth of b beads in model i, a4 is the number 
of residues in bead k, and n is the total number of models; other structural dissimilarity or 
similarity measure may be used.  
Finding the sampling precision  
A stochastic sampling method does not enumerate all good-scoring models, but 
generates only a sample of them. Here, the sampling precision is defined as the radius 
of the clusters in the finest clustering for which each sample contributes models 
proportionally to its size (considering both significance and magnitude of the difference) 
and for which a sufficient proportion of all models occur in sufficiently large clusters (Fig. 
4.2).  
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Clustering models using several thresholds  
To find the sampling precision, we evaluate increasingly coarser clusterings, obtained 
using the following threshold-based clustering method (33). For each model, we first find 
all neighboring models, defined as models whose RMSD distance (above) from the model 
is less than the input threshold. Initially all models are unclustered. The unclustered model 
with the maximum number of neighbors and its neighbors are added to form a new cluster, 
and the list of unclustered models is updated. The last step is repeated until no 
unclustered models remain. This clustering is performed for all thresholds sampling the 
interval between the minimum and maximum RMSDs in steps of 2.5 Å. The next three 
paragraphs describe the three criteria evaluated for each clustering. Significance. To 
assess the significance of the difference between the proportions of each sample in the 
clusters, we use the c2 test for homogeneity of proportions (52). This test evaluates the 
null hypothesis that the two model samples are distributed nearly equally (for equal-sized 
samples) or approximately in proportion to their sizes (for unequal sized samples) in all 
major clusters. The p value from the test is a measure of the statistical significance of 
proportionate contributions to clusters from both samples. A p value lower than the cutoff 
of significance (usually 0.05) indicates that the difference in the two distributions is 
statistically significant.  
Magnitude. To assess the magnitude of the difference between the proportions of each 
sample in the clusters, we use an effect size measure for the c2 test, Cramer’s V (53). 
This test measures the magnitude of the difference between the distributions of the two 
samples across clusters. Cramer’s V is defined as gh3/a, where c2 is the c2 test metric 
and n is the total number of models in both samples. A value of V of at least 0.1 suggests 
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that the difference between the two distributions is large; it corresponds approximately to 
a p value of 0.05 for the case of two clusters and 500 models per sample.  
Population. The calculation of the p value and Cramer’s V requires that each sample has 
at least 10 expected models per cluster (54). Therefore, we remove all clusters containing 
< 10 models from either sample. To allow us to proceed with the assessment, we also 
require that at least 80% of the models remain after this removal. 
Computing precision of clusters 
For defining clusters and visualization, any threshold equal to or worse than the sampling 
precision can be chosen. The sampling precision is the smallest clustering threshold at 
which sampling is exhaustive; choosing a larger threshold will result in fewer, larger 
clusters, and may be preferable for analysis and/or visualization. 
Although the sampling precision limits the maximum radius of a cluster (Fig. 4.2), models 
could be more tightly distributed inside a cluster. To quantify the actual spread of models 
in clusters, we define the cluster precision as the weighted root-mean-square fluctuation 
(RMSF) of all models in the cluster. Weighted RMSF accounts for differing sizes of beads 
often used to represent integrative structures (8, 55). It is computed using 
〈X$,j3〉$/3 =	 Yl∑ a4@CA$ ∑ bc⃗!,4 − 〈c⃗!,4〉d3C!A$ m /ab∑ a4@4A$ dZ$/3. 
The cluster precision is ~1.4 times the sampling precision, reflecting the general 
relationship between RMSD and RMSF (8, 55). 
Computing localization densities and their cross correlation  
The final test involves computing the cross correlation between the model densities from 
each sample, for each cluster. The density maps are created at a resolution equal to the 
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threshold used for defining clusters (above). The cross-correlation coefficients between 
the maps are calculated using the software UCSF Chimera (56).  
Validation of the protocol  
We illustrate our protocol by relying on five binary protein complexes of known structure 
from the ZDOCK Benchmark 4.0 (57), spanning a range of docking difficulty, and 5–7 
simulated distance restraints per complex. We modeled the structure of each complex by 
stochastic sampling as implemented in an integrative modeling platform (IMP; Supporting 
Material). We assessed the sampling exhaustiveness protocol based on a comparison of 
stochastic sampling with exhaustive enumeration, as follows.  
The quality of the sampling exhaustiveness protocol is quantified by the fraction of good-
scoring models from exhaustive enumeration (below) that are located within any 
sufficiently large cluster of the good-scoring models from the tested sampling, for the 
clustering threshold equal to the tested sampling precision; an enumerated model is 
located in a cluster, if its distance to the cluster center is within the tested sampling 
precision.  
Fast-Fourier transform-based protein docking algorithms (45, 58–60) efficiently 
construct models of binary protein complexes by enumerating all possible rigid rotations 
and translations on a uniform 3D grid. The set of all models (57) produced by 1.2 Å and 
6º uniform sampling on an FFT grid was used. Good-scoring models from enumeration 
were identified as in stochastic sampling (models for which at least 90% of cross-links 
span a Ca-Ca distance of < 12Å). For each good-scoring ZDOCK model, its distance to 
the nearest major cluster center from IMP was calculated.  
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The distribution of models from stochastic sampling in IMP cannot be compared 
directly to enumerated models computed by ZDOCK. The ZDOCK models are 
enumerated on a uniform grid, whereas IMP samples the posterior probability of models 
and therefore produces a nonuniform model distribution. In addition, ZDOCK and IMP 
use different representations (atomic and coarse-grained, respectively). 
 
Results 
We demonstrate the sampling exhaustiveness protocol on an example from the Protein 
Data Bank (PDB), 1AVX. The remaining four examples are described in Figs. S1–S5.  
There are 3369 good-scoring models for PDB: 1AVX (1896 in sample 1 and 1473 in 
sample 2). The score convergence test shows that the best score does not continue to 
improve significantly with an increase in the number of models sampled (Fig. 4.3A; to 
visualize the relatively rapid convergence in model scores, see Fig. S6). The two score 
distributions are similar to each other, as shown by the overlap in the score histograms 
and the insignificant p value and small D value from the Kolmogorov-Smirnov two-sample 
test (Fig. 4.3B). Next, exhaustiveness is examined at varying thresholds between the 
minimum and maximum RMSDs of 0.43 and 42.93 Å (Fig. 4.3C; Table 4.1). Based on 
the p value, Cramer’s V, and the population of models in the contingency table, the c2 
test is satisfied from the threshold of 12.93 Å onwards (Table 1). Hence, the sampling 
precision is 12.93 Å. In general, stricter (smaller) clustering thresholds result in many 
small clusters, which are ignored (Table 1, last column; Fig. 4.3C). In contrast, more 
lenient (larger) clustering thresholds result in fewer, larger clusters that are more likely to 
be retained in the analysis. For example, for the lowest clustering threshold of 0.43 Å, 
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each model is in its own cluster and hence all clusters are small and eliminated from the 
contingency table. In contrast, for thresholds > 25.43 Å (Fig. 4.3C), only one cluster 
containing all models remains. Finally, we chose the sampling precision as the clustering 
threshold for visualizing clusters. Inspection of the cluster populations (Fig. 4.3D) shows 
that they are similar for the two samples. The sampling precision is ~1.4 times the cluster 
precision, as expected from the general relationship between RMSD and RMSF 
(Methods; (55)). The agreement between the localization densities for samples 1 and 2 
(Fig. 4.3, E and F) is demonstrated by the high cross-correlation coefficient of 0.99 for 
each cluster. 
Validation by comparison to exhaustive enumeration  
The sampling exhaustiveness protocol was validated by showing that 99.2% of the good-
scoring ZDOCK models were within an IMP cluster for PDB: 1AVX (Fig. 4.4); the 
corresponding fraction was 100% for the other four examples (Fig. S5). For PDB: 1AVX, 
out of 510 good-scoring ZDOCK models, 506 were within the sampling precision of the 
center of a significant cluster and the distances for the other four models were less than 
one grid spacing further away (Fig. 4.4). Similarly, the largest distances between good-
scoring ZDOCK and IMP models were 1.52, 3.96, 1.56, and 0.96 Å short of their sampling 
precisions for PDB: 1I2M, 1SYX, 2IDO, and 7CEI, respectively (Fig. S5). In conclusion, 
the sampling exhaustiveness protocol neither overestimates nor underestimates the 
sampling precision, for the five examined cases.  
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Figure 4.3 | Results for sampling exhaustiveness protocol for PDB: 1AVX 
(A) Shown here are results of test 1, convergence of the model score, for the 3369 good-
scoring models; the scores do not continue to improve as more models are computed 
essentially independently. The error bar represents the SD of the best scores, estimated 
by repeating sampling of models 10 times. The red dotted line indicates a lower bound 
on the total score. (B) Shown here are results of test 2, testing similarity of model score 
distributions between samples 1 (red) and 2 (blue); the difference in distribution of scores 
is not significant (Kolmogorov-Smirnov two-sample test p value > 0.05)and the magnitude 
of the difference is small (the Kolmogorov-Smirnov two-sample test statistic D is 0.02); 
thus, the two score distributions are effectively equal. (C) Shown here are results of test 
3, containing three criteria for determining the sampling precision (y axis), evaluated as a 
function of the RMSD clustering threshold (33) (x axis). First, the p value is computed 
using thec2testfor homogeneity of proportions (52) (red dots). Second, an effect size for 
the c2 test is quantified by the Cramer’s V value (blue squares). Third, the population of 
models in sufficiently large clusters (containing at least 10 models from each sample) is 
shown as green triangles. The vertical dotted gray line indicates the RMSD clustering 
threshold at which three conditions are satisfied (p value > 0.05 (dotted red line), Cramer’s 
V < 0.10 (dotted blue line), and the population of clustered models > 0.80 (dotted green 
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line)),thus defining the sampling precision of 12.93 Å. (D) Populations of sample 1 and 2 
models in the clusters are obtained by threshold-based clustering using the RMSD 
threshold of 12.93 Å. Cluster precision is shown for each cluster. (E and F) Shown here 
are results of test 4: comparison of localization probability densities of models from 
sample 1 (red) and sample 2 (blue) in each cluster. The density map of the receptor, 
which is kept fixed through the simulation, is shown in gray. All densities were visualized 
at a threshold equal to one-third the maximum. The cross-correlation of the density maps 
of the two samples is 0.99 for each of the three clusters. 
 
Table 4.1 | Three criteria for determining the sampling precision for PDB: 1AVX, 
evaluated as a function of the clustering threshold 
The three criteria are 1) p values and 2) Cramer’s V, both from the c2 test; and 3) the 
population of models in the contingency table after eliminating small clusters. 
 
Threshold (in Å) p value Cramer’s V 
Population of models 
 in contingency table 
(%) 
0.4 0.0 1.0 0.0 
2.9 0.0 0.1 10.1 
5.4 0.0 0.2 82.7 
7.9 0.0 0.2 86.2 
10.4 0.0 0.1 98.7 
12.9 0.3 0.0 98.7 
15.4 0.5 0.0 98.7 
17.9 1.0 0.0 98.8 
20.4 1.0 0.0 99.8 
22.9 1.0 0.0 100.0 
25.4 1.0 0.0 100.0 
27.9 1.0 0.0 100.0 
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Threshold (in Å) p value Cramer’s V 
Population of models 
in contingency table 
(%) 
30.4 1.0 0.0 100.0 
32.9 1.0 0.0 100.0 
35.4 1.0 0.0 100.0 
37.9 1.0 0.0 100.0 
40.4 1.0 0.0 100.0 
42.9 1.0 0.0 100.0 
 
 
Discussion 
Summary of the protocol  
Accurate assessment of model uncertainty in integrative modeling necessitates that 
sampling is exhaustive at a precision sufficient for assessing model uncertainty. In this 
article, we introduce a protocol for determining the sampling precision of integrative 
structural models computed by a stochastic sampling algorithm. The protocol requires 
two samples of independently and stochastically generated sets of models and their 
scores. It includes two tests for convergence of the score and two tests for convergence 
of the structures. The tests for score convergence assess whether the scores in the two 
samples are from similar distributions. The tests for structural convergence rely on 
structural clustering of the models, followed by assessing whether the models in the two 
samples are distributed similarly across the clusters. The five illustrative cases 
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demonstrate the relative accuracy of the sampling exhaustiveness protocol (Figs. 3 and 
4; Figs. S1–S5). Below, we discuss the parameters used in the protocol, and its 
applicability, shortcomings, and relationship among various kinds of precision in 
integrative modeling; we then address overfitting in integrative modeling, relation to prior 
work, and future work.  
Parameters  
All parameters used in the protocol are listed next; their values are chosen based on 
rules-of-thumb in statistics literature. First, the significance cutoff for the KS test is 0.05 
and the magnitude cutoff for the KS statistic, D, is 0.3, the latter corresponding to medium 
effect size . Second, due to the inability of the c2 test to handle small expected cell counts, 
we eliminate clusters with 80%. Finally, the significance cutoff for the c2 test is 0.05 and 
the magnitude cutoff on Cramer’s V is 0.1, the latter corresponding approximately to a p 
value of 0.05 for the case of two clusters and 500 models per sample.  
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Figure 4.4 | Histogram showing the distribution of distance (measured 
by weighted ligand RMSD) of a good-scoring PDB: 1AVX model from enumeration 
(ZDOCK) to the nearest cluster centroid model from stochastic sampling (IMP)  
The dotted line indicates the sampling precision for the IMP model sample determined by 
the sampling exhaustiveness protocol. 
 
Applicability and uses  
The sampling exhaustiveness protocol is broadly applicable to a range of sampling 
methods, a range of clustering or binning methods, features of models other than model 
scores, and models other than macromolecular structures, and it can be used dynamically 
during sampling to stop as soon as desired sampling precision is reached, as follows.  
First, any stochastic sampling method that generates a large number of 
independent model samples is appropriate. Metropolis Monte Carlo sampling can satisfy 
this requirement of independence by 1) sampling models from multiple independent 
trajectories (e.g., starting from different random initial configurations) and 2) sampling 
models at sufficiently distant intervals on a single trajectory, such that samples are 
effectively uncorrelated with each other. The sampling exhaustiveness protocol can only 
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compare model samples produced by the same sampling algorithm (e.g., samples from 
uniform sampling and importance sampling are clearly not directly comparable).  
Second, any one of the variety of clustering or binning methods for grouping 
models based on their similarity could be used instead of the distance threshold-based 
clustering. In principle, even a uniform grid could be applied to bin the models. This 
clustering is used as a relatively rapid method to assign most models to a relatively small 
number of groups of similar precision. As a result, we can easily quantify the sampling 
precision across the entire space of models and convey the results in terms of a small 
number of model clusters. In contrast, for example, k-means clustering generally results 
in clusters of varying precision, thus obfuscating the relationship between the cluster 
precision and sampling precision.  
Third, any quantity of interest, such as radius of gyration and distance to a 
membrane, can be tested in the same manner as the model scores here.  
Fourth, the protocol is applicable to stochastic sampling of any kind of a model, not 
just a structural model.  
Fifth, and finally, the protocol can be applied to estimate sampling precision 
dynamically during a simulation, so that sampling is stopped as soon as desired sampling 
precision is reached, maximizing sampling efficiency. Assessment of exhaustiveness is 
particularly important for modeling large systems with many degrees of freedom, where 
exhaustive sampling of representative good-scoring solutions is particularly difficult.  
Critique  
In the absence of enumeration, exhaustiveness of stochastic sampling cannot be proved 
with complete certainty. Therefore, we suggest that even a statistical test such as the one 
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proposed here is better than no test. As a proxy for assessing exhaustiveness, our 
protocol evaluates whether two independent random model samples are similar to each 
other (Introduction). Our tests are not applicable to methods that do not generate 
independent random samples (e.g., a conjugate gradients minimization from a fixed 
unique starting point), or are so expensive that they cannot generate a large enough 
sample of independent models. Further, passing the proposed tests is a necessary, but 
not sufficient, condition for exhaustive sampling; a positive outcome of the test may be 
misleading if, for example, the landscape contains only a narrow, and thus difficult to find, 
pathway to the pronounced minimum corresponding to the native state. Nevertheless, 
based on the five examples, we argue that convergence of stochastic sampling at some 
precision often also indicates sampling exhaustiveness at that precision.  
Precision in integrative modeling  
In this article, we used the model (ensemble) precision, sampling precision, and cluster 
precision. In addition, the data precision (uncertainty) reflects the experimental noise 
(systematic and random error) (4); and the representation precision can be defined, for 
example, by the diameter of the largest primitive (Gaussian, bead) used to represent the 
system. We now discuss these five precisions in the context of each other.  
First, the sampling precision imposes a lower limit on the model precision. The 
shape of the scoring function landscape at precisions better than the sampling precision 
is not sampled accurately by definition; thus, any features of the model landscape more 
precise than the sampling precision are unlikely to be estimated accurately.  
Second, because the model ensemble is divided into one or more clusters, the 
model precision is always equal to or worse than any cluster precision.  
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Third, for the final description of the model ensemble, it only makes sense to cluster 
the models using a clustering threshold that is equal to or larger than the sampling 
precision (due to the first point above; see Fig. 4.4).  
Fourth, and lastly, the sampling precision is in turn limited by the representation 
precision and data precisions. Although the model, sampling, and cluster precisions, as 
defined here, are directly comparable to each other, the representation and data 
precisions are defined on different scales. Nevertheless, qualitatively speaking, the 
sampling precision cannot be significantly higher than the representation and data 
precisions; moreover, it is likely not beneficial to use a representation with a precision that 
is significantly higher than the data precision.  
Addressing overfitting in integrative structure modeling  
Overinterpretation of the data (overfitting) is a frequent concern in any modeling. For 
example, a single high-resolution atomic model may fit an EM density map at intermediate 
resolution well; proposing such a model as the solution is often a case of overfitting 
because there are likely many other atomic models that also fit the data equally well. Our 
sampling exhaustiveness test provides a potential insurance against overfitting. When a 
test is passed, overfitting is not a problem (at the sampling precision) because all models 
(at this precision) that are consistent with the data are provided in the output model 
ensemble.  
Relation to prior work  
The methods most related to that in this article, applied in the context of MD simulations, 
are those in (36–39) (also used in (40)). In (36, 37), models from multiple MD simulations 
are combined and compared in terms of their relative populations. In (38), a new 
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simulation is compared against a reference simulation, by clustering models from the 
reference simulation based on a predetermined cutoff. The models of the new simulation 
are then assigned to the nearest cluster from the reference simulation. Thus, each 
simulation produces a histogram of populations across clusters and any two simulations 
can be compared by the difference in their populations for each cluster. In (39), this 
method is expanded by computing the number of independent samples in an MD 
trajectory as a way of assessing the sampling quality. The number of independent 
samples in an MD simulation is determined by comparing the observed variance in the 
population of a cluster to the expected analytical variance from an independent and 
identically distributed sample, for various subsample sizes.  
Our protocol additionally determines the significance and magnitude of the 
difference in population distributions across clusters, using the c2 test. More importantly, 
our protocol also determines the sampling precision objectively, by applying the c2 test 
for a range of clustering thresholds (Figs. 3 and 4). Moreover, we test both score 
convergence and convergence of structural coordinates (Fig. 4.1). A few minor 
differences exist in our respective clustering methods as well: 1) similarly to (36, 37), we 
cluster models from all simulations, potentially producing a more comprehensive set of 
clusters, in contrast to clustering only models from the reference simulation (38, 39); and 
2) our cluster centers are chosen based on the density of models close to the cluster 
center, in contrast to choosing cluster centers randomly (38), choosing clusters of uniform 
probability (39), or choosing cluster centers based on average linkage with a similarity 
cutoff (36, 37). Finally, our statistical test applies to independent samples from a 
stochastic algorithm such as Monte Carlo sampling, whereas some other methods do not 
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require the samples to be independent (36–40). Preliminary versions of our sampling 
exhaustiveness protocol have been already used in several integrative modeling 
applications (9–11, 61–63). Earlier, sampling exhaustiveness for integrative modeling 
was estimated, at best, by manual visual inspection of localization densities of clusters 
(7, 8, 44).  
Future directions  
Future directions include expanding this protocol to establish more detailed tests for 
exhaustiveness. For instance, it will be useful to determine not just the sampling precision 
for the entire macromolecular system, but also the sampling precision for different 
components of the system (e.g., proteins, domains) separately. Such more detailed 
information would be useful in the analysis stage of the iterative four-stage integrative 
modeling process (2, 4) to determine, for instance, what representations to change and 
what input data to reexamine to improve the sampling precision for the entire system.  
Structures of macromolecular systems are increasingly computed by integrative 
modeling that relies on various types of experimental data and theoretical information 
(20). However, validation of integrative models and data is a major open research 
challenge. It is particularly timely because of the Worldwide Protein Data Bank effort to 
expand the scope of its archive to integrative structures (20). We suggest that a sampling 
exhaustiveness protocol, such as the one described here, is the first assessment applied 
to all integrative models.  
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Abstract 
Oxidative stress has been implicated in multiple human neurological and other disorders. 
Proteasomes are multi-subunit proteases critical for the removal of oxidatively damaged 
proteins. To understand stress-associated human pathologies, it is important to uncover 
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the molecular events underlying the regulation of proteasomes upon oxidative stress. To 
this end, we investigated H2O2 stress–induced molecular changes of the human 26S 
proteasome and determined that stress-induced 26S proteasome disassembly is 
conserved from yeast to human. Moreover, we developed and employed a new proteomic 
approach, XAP (in vivo cross-linking–assisted affinity purification), coupled with stable 
isotope labeling with amino acids in cell culture (SILAC)– based quantitative MS, to 
capture and quantify several weakly bound proteasome-interacting proteins and examine 
their roles in stress-mediated proteasomal remodeling. Our results indicate that the 
adapter protein Ecm29 is the main proteasome-interacting protein responsible for 
stresstriggered remodeling of the 26S proteasome in human cells. Importantly, using a 
disuccinimidyl sulfoxide– based crosslinking MS platform, we mapped the interactions of 
Ecm29 within itself and with proteasome subunits and determined the architecture of the 
Ecm29–proteasome complex with integrative structure modeling. These results enabled 
us to propose a structural model in which Ecm29 intrudes on the interaction between the 
20S core particle and the 19S regulatory particle in the 26S proteasome, disrupting the 
proteasome structure in response to oxidative stress.  
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Introduction 
Oxidative stress has been associated with the aging process and implicated in many 
human diseases, particularly neurodegenerative disorders (1). Protein oxidation can lead 
to unwanted changes in protein structure and function, resulting in the accumulation of 
severely oxidized proteins, subsequent cytotoxicity, and, ultimately, cell death. Therefore, 
oxidatively damaged proteins must be repaired or removed in a timely fashion to maintain 
cell homeostasis. Most oxidized proteins undergo selective proteolysis, and abundant 
evidence has indicated that proteasomes play a critically important role in the removal of 
oxidized proteins to preserve cell viability in response to oxidative stress (2–4). In 
addition, proteasomes are highly regulated during cellular responses to oxidative 
stresses. However, the molecular details underlying such modulation remain largely 
unexplored, particularly in human cells.  
The 26S proteasome is a macromolecular machine responsible for ubiquitin/ATP-
dependent protein degradation and comprises two subcomplexes: a 20S core particle 
(CP) and a 19S regulatory particle (RP) (5, 6). The 20S CP harbors various catalytic 
activities, including chymotrypsin-like, trypsin-like, and caspase-like peptidase activities. 
It is composed of seven and seven subunits in eukaryotes that form a conserved 
cylindrical structure of four heptameric stacked rings assembled in the order of abba. 
Activation of the 20S CP requires binding to proteasome activator proteins (5). The 19S 
RP is one of the major proteasome activators and consists of at least 19 distinct subunits 
that constitute the base and lid subcomplexes. The base is composed of six ATPases 
(Rpt1– 6) and four non ATPase subunits (Rpn1, 2, 10, and 13), whereas the remaining 
nine subunits (Rpn3, 5–9, 11, and 12 and Rpn15/Sem1) comprise the lid structure. The 
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19S RP carries multiple functions to facilitate substrate degradation, including substrate 
recognition, deubiquitination, protein unfolding, substrate translocation, and gating of the 
20S CP. In contrast to the highly ordered and stable structure of the 20S CP, the 19S RP 
appears to be much more flexible and dynamic. Nevertheless, the overall architectures 
of the 19S RP and the 26S holocomplex are highly conserved from yeast to human (7–
11).  
During oxidative stress, the proteasome system is highly regulated to fulfill its 
function in maintaining cell homeostasis (3, 4, 12). To facilitate the removal of oxidatively 
damaged proteins, ubiquitin/ATP-independent degradation by the 20S CP is significantly 
enhanced because of the increased amount of free 20S CP in cells, which is not the result 
of transcriptional control but, rather, of oxidative stress–triggered disassembly of the 26S 
proteasome (13–15). In yeast, such proteasome dissociation is dependent on the 
proteasome-interacting protein Ecm29 (13). However, it remains unclear whether human 
Ecm29 possesses a similar function because of low sequence similarity to its yeast 
ortholog (20%) and the relative complexity of human systems. In addition, Ecm29-
dependent regulation of the proteasome system can have a multifaceted effect on cell 
physiology (11, 13, 16–19) by inhibiting ubiquitin-dependent protein degradation (11, 19), 
stabilizing proteasomes (16, 17), and assisting membrane-associated localization of 
proteasomes (20, 21) and TLR3-dependent signaling (22). However, how Ecm29 
regulates the activity of the 26S proteasome in human cells, particularly in response to 
oxidative stress, is largely unknown. Therefore, further studies are needed to fully 
describe the molecular details underlying stress-mediated regulation of the 26S 
proteasome.  
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Here we quantitatively examined oxidative stress–mediated changes in the human 
26S proteasome by developing a new affinity purification-MS strategy. In addition, we 
investigated the recruitment of Ecm29 to the proteasome and its associated biological 
implications. Moreover, we employed cross-linking mass spectrometry to define 
interactions within the Ecm29– proteasome complex, which were used for integrative 
structure modeling. Together, the results allow us to propose a structural model in which 
Ecm29 intrudes on the interaction between the 20S CP and 19S RP, thus modulating the 
function of the proteasome in response to oxidative stress. 
 
Results  
H2O2-mediated molecular changes in the human 26S proteasome  
To evaluate the compositional changes of the human 26S proteasome under oxidative 
stress, we applied a single-step affinity purification procedure using an HTBH-tagged 
proteasome subunit (i.e. Rpn11-HTBH) as bait (23). This method has proven to be fast 
and effective to obtain functional human proteasome complexes and to identify 
proteasome-interacting proteins (23, 24). However, one of the key proteasome regulators, 
Ecm29, was not co-purified with human proteasomes. This is not surprising, as dynamic 
or transient interactions are often lost during conventional affinity purification (24, 25). To 
circumvent this problem, we developed a new strategy named in vivo cross-linking–
assisted affinity purification MS (XAPMS) (Fig. 5.1A). XAP-MS integrates mild in vivo 
formaldehyde (FA) cross-linking (0.1%) prior to cell lysis, which enables better 
preservation of 26S proteasome intactness and proteolytic activities during native lysis 
(26). To quantify H2O2-induced changes, we coupled XAP-MS with SILAC-based 
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quantitation, in which one population of 293Rpn11-HTBH cells was grown in light (L) medium 
and treated with H2O2, whereas the other population of the same cells was grown in heavy 
(H) medium as a control without treatment. The relative abundances of proteasome 
subunits between treated and untreated cells are represented by average peptide SILAC 
ratios (i.e. L/H) of the two compared samples (Fig. 5.1B and supplemental Table S2). As 
shown, all identified 19S RP subunits have SILAC ratios close to 1, indicating that the 
abundances of these subunits in the purified samples were unaffected by H2O2 stress 
(Fig. 5.1B). In contrast, the SILAC ratios of all 20S CP subunits decreased substantially 
with SILAC ratios of < 0.4, demonstrating that oxidative stress resulted in dissociation of 
the 20S CP from the 19S RP. These results were validated using quantitative immunoblot 
analysis (supplemental Fig. S1). Similarly, we carried out XAP-SILAC MS experiments 
using 293a7/Pre10-HTBH cells. As expected, 20S CP subunits remained unchanged, whereas 
copurified 19S RP subunits decreased substantially upon H2O2 stress (supplemental Fig. 
S2). Taken together, we confirmed that H2O2 stress–induced disassembly of the 26S 
proteasome is conserved in mammalian cells.  
 
 
 
 
 
 
 
 
118 
 
 
 
Figure 5.1 | Determination of 26S proteasome disassembly and enrichment of 
Ecm29 upon oxidative stress in human cells.  
A, the general workflow of the SILAC-based quantitative XAP-MS strategy. B, relative 
abundance changes (i.e. SILAC (L/H) ratios) of the human 26S subunits purified from 
293Rpn11-HTBH cells in the presence and absence of H2O2 treatment. L ([12C14N]Arg/Lys), 
treated cells; H ([13C15N]Arg/Lys), untreated control cells. C, MS spectrum of a 
representative Ecm29 tryptic peptide pair (m/z 763.3522+ versus 767.3522+) with the 
SILAC ratio (L/H) as 6.0 when comparing treated with untreated samples. ○, treated (L); 
●, untreated (H). D, immunoblot analysis of Ecm29 abundance in proteasomes purified 
from 293Rpn11-HTBH cells before and after H2O2 treatment. IP, immunoprecipitation. E, 
immunoblot analysis of protein complexes purified using FLAG–Ecm29 that was 
transiently transfected in 293Rpn11-HTBH cells. Specific antibodies against Rpt6 and 
a7/Pre10 were used to probe their abundance. Streptavidin–HRP was used to probe 
HTBH-tagged Rpn11. All of the treated cells were incubated with 2 mM H2O2 for 30 min; 
untreated cells served as controls. The numbers under the immunoblot bands represent 
quantitative measurements using a Fuji LAS4000 scanning system. 
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Ecm29-dependent regulation of the 26S proteasome upon oxidative stress  
Although it is known that Ecm29 can be recruited to the 19S proteasome during oxidative 
stress to regulate the proteasome composition in yeast (13), it remains unclear whether 
Ecm29 is a general player in modulating proteasome structure upon oxidative stress in 
eukaryotic systems. To this end, we first determined H2O2-triggered enrichment of human 
Ecm29 in the 19S RP using quantitative XAP-MS and immunoblotting analyses (Fig. 5.1, 
C and D). This was further validated by reciprocal affinity purification using FLAG-Ecm29 
and quantitative immunoblotting (Fig. 5.1E). As shown, increased amounts of the two 
selected 19S subunits (i.e. Rpn11 and Rpt6) were co-purified with Ecm29 upon H2O2 
treatment, whereas the amount of a 20S subunit, a7/Pre10, did not change in the purified 
Ecm29 complex. This result suggests that, although there is a dramatic increase in 
Ecm29 binding to the 19S upon oxidative stress, there is no change in Ecm29 binding to 
the 26S, thus implying two populations of Ecm29 detected here.  
To understand how human Ecm29 regulates the 26S proteasome, we generated 
two Ecm29 knockdown (KD) cells (i.e. 293Rpn11-TB_Ecm29KD#53 and 293Rpn11-TB_Ecm29KD#55) 
(Fig. 5.2A). Quantitative immunoblotting analysis of purified proteasomes revealed that 
the abundances of the selected proteasome subunits (i.e. Rpt6 and a7/Pre10) are similar 
in Ecm29 KD and control KD cells under unstressed conditions (Fig. 5.2B). In addition, 
the 26S proteasomal activities were comparable in the two knockdown cells (Fig. 5.2C). 
Together, these results show that human Ecm29 is not essential for the assembly and 
function of the 26S proteasome. However, when cells were treated with H2O2 to induce 
oxidative stress, the 26S proteasome was rapidly disassembled in control KD cells, but 
such dissociation was considerably reduced in 293Rpn11-TB_Ecm29KD#53 and 293Rpn11-
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TB_Ecm29KD#55 cells (Fig. 5.2B). As expected, H2O2 stress also significantly reduced 26S 
proteasomal activities in control KD cells but not in Ecm29 KD cells (Fig. 5.2C). The 
observed changes in proteasomal activities correlated well with the levels of ubiquitinated 
proteins detected in these cells in the presence and absence of H2O2 stress, respectively 
(Fig. 5.2D). Collectively, our data strongly suggests that Ecm29 regulates H2O2-induced 
26S proteasome disassembly in human cells.  
To further evaluate the function of Ecm29, we overexpressed human FLAG-Ecm29 
in 293Rpn11-HTBH cells. Quantitative immunoblotting analyses of the purified proteasomes 
revealed that overexpression of Ecm29 resulted in more proteasome bound Ecm29 and, 
concurrently, less 19S RP-associated 20S CP under normal conditions (Fig. 5.3A and 
supplemental Fig. S3). This suggests that increased abundance of Ecm29 under 
nonstress conditions can disrupt normal 26S proteasome integrity, albeit to a lesser 
extent compared with the impact of oxidative stress. Interestingly, upon H2O2 stress, an 
increased amount of Ecm29 was also detected at the 19S RP even in the presence of 
overexpressed Ecm29, similar to wild-type cells, resulting in increased separation of the 
20S CP from the 19S RP. These results were subsequently confirmed by the 
measurements of 26S proteasomal activities, as illustrated in Fig. 5.3B. Our data 
demonstrate that Ecm29 plays an evolutionarily conserved role in regulating the 26S 
proteasome, especially upon oxidative stress.   
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Figure 5.2 | The effect of human Ecm29 on H2O2-induced 26S proteasome 
disassembly.  
A, evaluation of Ecm29 KD efficiency. B, the 26S proteasome was affinity-purified with 
Rpn11-TB from 293Rpn11-TB_controlKD (control KD), 293Rpn11-TB_Ecm29KD#53 (KD #53), and 
293Rpn11-TB_ Ecm29KD#55 (KD #55) cells and analyzed by quantitative Western blotting with 
antibodies against Rpt6 (19S) and a7/Pre10 (20S). C, effect of Ecm29 knockdown on the 
activity of the 26S proteasome. The proteasomal proteolytic activities in 293Rpn11-
TB_controlKD (control KD), 293Rpn11-TB_ Ecm29KD#53 (KD #53), and 293Rpn11-TB_ Ecm29KD#55 (KD 
#55) cells (treated or untreated) were determined by in-solution peptidase activity assays. 
Three fluorogenic peptide substrates were used: SUC-LLVYAMC for chymotrypsin-like 
activity, SUC-LLE-AMC for peptide hydrolase activity, and SUC-ARR-AMC for trypsin-like 
activity. The activities were normalized to Rpn11 (a 19S subunit) in each sample. Data 
were obtained from three experiments. D, detection of total ubiquitin conjugates after 
H2O2-induced stress by Western blot analysis with an antibody against ubiquitin. 
Equivalent loading was determined by analysis of Western blots with an antibody against 
Rpn11 and by staining the membrane with Amido Black. The numbers under the 
immunoblot bands represent quantitative measurements using a Fuji LAS4000 scanning 
system. 
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Ecm29 is the main PIP responsible for stress-induced proteasome disassembly  
In addition to Ecm29, we identified 9 proteasome-interacting proteins (PIPs) that 
displayed H2O2-induced abundance changes alongside purified 19S RP (i.e. SILAC ratios 
≥ 2) using quantitative XAP-MS analysis of 293Rpn11-HTBH cells (supplemental Table S2). 
Among them, five have known functions in the proteasome system: 19S assembly 
chaperones (p27/Nas2 and Rpn14/Gankyrin), deubiquitinase (Usp15), ubiquitin ligase 
(Ube3A), and Hsp70. Hsp70 has been shown to be important for proteasome reassembly 
after H2O2 stress (14). Three of the four remaining PIPs (i.e. Bag6, Ubl4A, and Trc35) are 
components of a ubiquitin ligase–associated multiprotein transmembrane recognition 
complex (TRC), which is unique to mammalian systems. With the exception of Bag6 (27), 
the other factors have not been linked to regulation of proteasome function. To confirm 
the MS results, respective immunoblotting analyses of purified Rpn11-containing 
proteasomes and FLAG–Ubl4A complexes were performed (supplemental Fig. S4). Our 
results demonstrate that the TRC complex interacts with the 26S proteasome via the 19S 
complex and that their interactions can be modulated by H2O2 stress. Given the similarity 
in H2O2-induced enrichment of the TRC complex to that of Ecm29 at the 19S RP, we 
initially hypothesized that the TRC complex may regulate the 26S proteasome complex 
in the same manner as human Ecm29 during oxidative stress. However, CRISPR-
mediated knockout or siRNA-mediated silencing of Bag6 did not affect the interaction 
between 20S and 19S proteasomes in either normal or H2O2-treated cells (supplemental 
Fig. S5), suggesting that Bag6 is not required for H2O2-induced 26S proteasome 
disassembly. In addition, knockout of Bag6 did not interfere with H2O2-induced 
recruitment of Ecm29 to the 19S proteasome and vice versa. These results imply that 
123 
 
Bag6 is not associated with Ecm29-dependent regulation of the 26S proteasome complex 
despite its increased association with the 19S RP upon H2O2 treatment. Because the TRC 
complex is thought to chaperone polypeptides en route to the proteasome to facilitate the 
degradation of folding-defective proteins, which include retrotranslocation products from 
the endoplasmic reticulum and mislocalized membrane proteins (28, 29), the increased 
association of Bag6 with the 19S complex may result from the loss of communication 
between the 19S and the 20S proteasome, which presumably traps ubiquitinated proteins 
together with their chaperones on the 19S complex. From these results, we concluded 
that, although oxidative stress-induced changes in the proteasome interactome are not 
limited to Ecm29, proteasome disassembly is specifically regulated by the 19S-
associated Ecm29.  
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Figure 5.3 | Modulation of the human 26S proteasome by Ecm29 overexpression. 
A, effect of Ecm29 overexpression on 26S proteasome integrity. Shown are quantitative 
immunoblot analyses of purified proteasomes (left) and cell lysates (right) in the presence 
or absence of overexpressed Ecm29. 293Rpn11-HTBH cells were transiently transfected with 
FLAG–Ecm29 either treated with H2O2 or untreated as a control. Quantitative Western 
blotting was performed with antibodies against Ecm29, Rpt6 (19S), and a7/Pre10 (20S). 
B, effect of Ecm29 overexpression on 26S proteasome activities. The proteasomal 
proteolytic activities were determined by in-solution peptidase activity assays with three 
fluorogenic peptide substrates: SUC-LLVY-AMC (LLVY); SUC-LLE-AMC (LLE), and 
SUC-ARR-AMC (ARR). The activities were normalized to Rpn11 (a 19S subunit) in each 
sample. Data were from three experiments. The numbers under the immunoblot bands 
represent quantitative measurements using a Fuji LAS4000 scanning system. 
 
 
125 
 
Physical interactions of Ecm29 with the proteasome  
Because of the lack of structural details on Ecm29 alone and its complex with 
proteasomes, how Ecm29 is recruited to the 19S particle during oxidative stress is largely 
unknown. To understand how Ecm29 regulates the proteasome upon oxidative stress, 
we employed our previously developed XL-MS strategy to determine protein interaction 
contacts at specific residues (30). This XL-MS strategy enables simplified and accurate 
identification of cross-linked peptides by integrating an MS-cleavable homobifunctional 
amine-reactive NHS ester, disuccinimidyl sulfoxide (DSSO), with multistage tandem mass 
spectrometry (MSn) (30). To ensure the capture of a sufficient amount of Ecm29–
proteasome complexes, we co-expressed HTBH-Ecm29 in 293HTBH-Rpt6 cells and treated 
the cells with H2O2 stress prior to cell lysis. Single-step affinity purification by binding to 
streptavidin beads was carried out to isolate Ecm29–proteasome complexes for in vitro 
DSSO cross-linking, similar as described previously (11). The resulting DSSO cross-
linked peptides were analyzed by LC/MSn for identification (30). As an example, a 
representative MSn analysis of a DSSO interlinked peptide is illustrated in Fig. 5.4. As 
shown, the cleavage of either of the two symmetric MS-cleavable C–S bonds in the linker 
region of the DSSO interlinked peptide a-b (m/z 848.669744+) resulted in detection of two 
characteristic fragment pairs: aA/bT (m/z 762.4122+ and 925.9222+) and aT/bA (m/z 
778.3922+ and 909.9422+) during MS2 analysis (Fig. 5.4A). MS3 sequencing of the aT and 
bA fragment ion pair yielded series of b and y ions that unambiguously identified them as 
284HSVATAADLELKTSK287 of Ecm29 and 372KAMNVSPDVNYEELAR386 of Rpt5, 
respectively (Fig. 5.4B, left and right panels). Together, the MSn analysis determined a 
cross-link between Lys-285 of Ecm29 and Lys-372 of Rpt5 (Fig. 5.4). In total, LC/MSn 
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analysis identified 69 unique Lys–Lys linkages involving Ecm29, seven of which were 
interprotein and 62 intraprotein interactions (supplemental Tables S3 and S4). Ecm29 
was determined to interact with five 19S base subunits, Rpt1, Rpt4, Rpt5, Rpn1, and 
Rpn10, as illustrated in Fig. 5.5. Among them, Ecm29 has the most contacts with Rpt5, 
as their interactions are supported by multiple Lys–Lys linkages with the highest number 
of redundant counts. Based on the cross-link map (Fig. 5.5), we concluded that Ecm29 
interacts with the 19S base subunits through its multiple HEAT repeat domains. Although 
the N termini of Rpt4 and Rpt5 are both proximal to the N terminus of Ecm29, the C termini 
of Rpt5, Rpt1, and Rpn10 also have close contacts with Ecm29. In addition, Lys-397 in 
Rpn1 near its T2 site was cross-linked to Lys-694 of Ecm29. Our results suggest that 
Ecm29 most likely interacts with the proteasome through multiple contact sites, with Rpt5 
as the major docking point.  
To evaluate the cross-links identified between Ecm29 and 19S RP subunits, we 
first performed phylogenetic alignment analysis of Ecm29 derived from five selected 
organisms: Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila, mouse, and 
human. Despite a relatively low degree of sequence homology, six of the seven lysine 
residues of Ecm29 that crosslinked with 19S base subunits were located proximally to 
conserved sequence regions (i.e. within five amino acid residues); only Lys-852 of Ecm29 
was found to be relatively far from the nearest conserved site, 18 residues away 
(supplemental Table S5). When a similar phylogenetic alignment was performed for Rpt1, 
Rpt4, Rpt5, Rpn1, and Rpn10, the lysine residues on each respective subunit found to be 
cross-linked to Ecm29 were mostly located within or directly adjacent to highly conserved 
regions as well, with the exception of Lys-16 of Rpt5 (supplemental Table S5). Therefore, 
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almost all of the residues cross-linked between Ecm29 and 19S base subunits 
correspond to evolutionarily conserved regions, suggesting that these cross-links more 
likely represent the functional protein interaction interfaces between Ecm29 and the 
proteasome complex.  
 
 
Figure 5.4 | Representative MSn analysis of a selected DSSO cross-link between 
Ecm29 and Rpt5.  
A, collision-induced dissociation (CID) cleavage of the DSSO cross-linked peptide a-b 
(m/z 848.66974+) in MS2 resulted in the formation of two predicted fragment ion pairs: 
aA2+/bT2+ and aT2+/bA2+. B, respective MS3 spectra of the two selected MS2 fragment ions 
aT2+ (m/z 778.392+) and bA2+ (909.942+). A series of b and y ions unambiguously identified 
the peptides as 284HSVATAADLELKTSK287 of Ecm29 and 372KAMNVSPDVNYEELAR386 
of Rpt5, respectively. C, along with peptide mass matching at the MS1 level, three lines 
of evidence (including MS2 cross-linker fragmentation and individual MS3 peptide 
sequencing) confirm the identification of a DSSO cross-link between Lys-285 of Ecm29 
and Lys-372 of Rpt5. 
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Figure 5.5 | Cross-link map of Ecm29-proteasome interactions.  
Diagram of unique Lys–Lys linkages between Ecm29 and the 19S base subunits Rpn1, 
Rpn10, Rpt1, Rpt4, and Rpt5. The remaining members of the AAA-ATPase ring are also 
included for spatial context. Cross-linked Ecm29 residues are labeled in green, whereas 
the residues of the respective 19S RP subunits are shown in blue. Various functional 
domains of individual proteins are labeled according to SMART: coiled-coil domain, 
orange; AAA-ATPase, blue; von Willebrand factor (VWA), green; ubiquitin-interacting 
motif (UIM), magenta; HEAT repeats, brown. The T1 and T2 domains of Rpn1 are shown 
in yellow and orange, respectively. 
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Integrative modeling of the Ecm29–proteasome complex  
To understand how Ecm29 docks onto the proteasome, the architecture of the Ecm29–
proteasome complex was determined using the integrative structure modeling approach 
described previously (31–35). All available structural information on the Ecm29–
proteasome complex was used for computational analyses (supplemental Fig. S6 and 
Methods). The proteasome was represented by the high-resolution structure of the 
human 26S proteasome (PDB code 5GJR) (10), whereas Ecm29 was represented by two 
comparative models built with MODELLER 9.17 (36) based on known template structures 
detected by HHPred (37) (supplemental Methods). Regions with unknown structures 
were modeled as flexible strings of beads. Finally, the proximity between specific residue 
pairs was determined by DSSO XL-MS experiments, which identified a total of 69 unique 
Lys–Lys linkages (supplemental Tables S3 and S4) describing seven Ecm29-containing 
interprotein interactions and 62 Ecm29 intraprotein interactions. The maximum C–C 
distance between any two lysine residues cross-linked by DSSO was estimated to be 30 
Å, based on the spacer length of DSSO (10.1 Å), flexibility of lysine side chains, and 
backbone dynamics. Next, 3,750,000 Ecm29–proteasome models were computed by 
optimizing spatial proximities, as informed by cross-linking data, excluded volume, and 
sequence connectivity from 500 random initial models. This process yielded 109,951 
good-scoring models (i.e. the ensemble) that satisfy the cross-linking data, the excluded 
volume, and sequence connectivity restraints used in computing the models. The 
clustering of the good-scoring models identified two distinct clusters (Fig. 5.6A), including 
60% (89% of intersubunit cross-links satisfied; Fig. 5.6, B, left panel, and C) and 31% 
(100% of intersubunit crosslinks satisfied; Fig. 5.6, B, right panel, and C) of the models; 
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the precision of both clusters is 60 Å root mean square deviation for all Ecm29 Cs 
(supplemental Fig. S7). In general, an ensemble of good-scoring models can be 
visualized as a localization probability density map. The map specifies the probability of 
any volume element being occupied by a given bead in superposed good-scoring models. 
The probability localization density for the structured regions of Ecm29 is sufficiently 
precise to define the position, but not the orientation, of Ecm29 relative to the proteasome 
for each of the two clusters (Fig. 5.6A). The binding sites on the proteasome are different 
between the two clusters, indicating that Ecm29 may interact with the proteasome in two 
different states (although it is also conceivable that we simply do not have enough data 
to define a single state). In the first state (cluster 1), Ecm29 interacts with the 19S within 
10 Å of Rpn1, Rpt2, Rpt4, Rpt5, and Rpn10 (Fig. 5.6A, left panel). In this binding mode, 
Ecm29 does not overlap with the 20S particle and is proximal to the 1 subunit. In the 
second state (cluster 2), Ecm29 is similarly vicinal to the same partners in the 19S RP 
(Fig. 5.6A, right panel), although its relative position is different and inconsistent with the 
presence of 20S (Fig. 5.6A). 
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Figure 5.6 | Integrative structure modeling of the Ecm29–proteasome complex.  
A, localization probability density of the structured part of Ecm29 from cluster 1 (left panel) 
and 2 (right panel). The 19S structure is shown in dark gray, and the interacting partners 
of 19S with Ecm29 are colored. The 20S α ring is shown in light gray for reference. B, 
Euclidean Cα–Cα distance distributions of all measured cross-links in the ensemble of 
solutions for each cluster. The y axis provides the normalized number of cross-links that 
were mapped onto the model. The dashed red line denotes the expected maximum reach 
of a cross-link. C, Euclidean Cα–Cα distance statistics for each cross-link in both clusters 
(cluster 1 in green empty squares and cluster 2 in orange disks). The cross-links are 
sorted by average distance (ordinate axis); intra- and interprotein cross-links are 
separated (left and right, respectively). The error bars represent the standard deviation of 
the distance across all models in the clusters. 
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Discussion  
Here we developed and employed the XAP-MS strategy to dissect the H2O2-dependent 
compositional dynamics of the human 26S proteasome complex. The results confirmed 
that the 26S proteasome is highly regulated during oxidative stress and that its 
disassembly yields more free 20S CP for the removal of oxidatively damaged proteins, 
corroborating previous reports (13, 14). In addition, with the XAP-MS strategy, we were 
able to co-purify human Ecm29 with proteasomes reliably with and without H2O2 treatment 
for the first time. This is significant, as the interaction of human Ecm29 with proteasomes 
appears to be much weaker and/or more transient than yeast Ecm29–proteasome 
interaction, thus preventing its capture using conventional affinity purification–MS 
approaches. The reliability of co-purification of human Ecm29 with proteasomes enabled 
us to confirm H2O2-induced enrichment of Ecm29 onto the 19S RP in human cells, similar 
to its yeast ortholog (13). Our results further indicate that the mild in vivo FA cross-linking 
implemented in the XAP-MS strategy is indeed beneficial for preserving weak, transient, 
and/or dynamic interactors of protein complexes under native conditions, as described 
previously (26, 38). Thus, it helps to maintain the integrity of protein complexes as well 
as to prevent reorganization and loss of protein–protein interactions. Therefore, the XAP-
MS method can be applied to study the dynamic interactors of other protein complexes 
and identify their regulators through protein–protein interactions. 
Ecm29 has been shown to be critical in modulating proteasome structure and 
function (11, 13, 16–19). Interestingly, knockdown of human Ecm29 did not seem to have 
much impact on the structure and function of proteasomes, as the 26S holocomplex 
remained intact, and its proteolytic activities were not impaired. These observations are 
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consistent with those in yeast ECM29D cells (13) and Ecm29 (i.e. KIAA0368)-deficient 
mice (39). Collectively, our results suggest that Ecm29 is nonessential for the assembly, 
integrity, and function of proteasomes under unstressed conditions. However, the impact 
of Ecm29 on proteasomes becomes noticeably more apparent upon H2O2-induced stress. 
Here we demonstrated that Ecm29 has a conserved function in regulating oxidative 
stress-triggered 26S proteasome disassembly in eukaryotes, which has been shown to 
be important for cell survival, particularly for recovery from oxidative stress (13). In 
addition, we have shown that increased interaction between Ecm29 and the 19S RP is 
directly associated with remodeling of the 26S proteasome and that Ecm29–proteasome 
interaction is regulated by oxidative stress. These results indicate that the modes of 
Ecm29 function are diverse and depend on cellular conditions. Moreover, we found that 
overexpression of Ecm29 alone could not induce the same level of effects on the 26S 
proteasome as oxidative stress, suggesting that additional signal(s) would be needed for 
the recruitment of Ecm29 to dissociate the 20S CP from the 19S RP. It has been shown 
that oxidation of cysteine residues within proteasome subunits can activate 20S 
proteolytic activities by inducing gate opening (40) or modulate proteasome disassembly 
in yeast upon mitochondrial stress (15). Future studies are needed to determine whether 
protein oxidation and Ecm29 work hand in hand to reshape the structure of the 26S 
proteasome during oxidative stress.  
We combined XL-MS studies and integrative structural modeling to explore the 
action mechanisms of Ecm29. Our XL-MS studies provide the first physical evidence at 
peptide resolution to model the positions of Ecm29 on the proteasome structure. It is not 
surprising that Ecm29 can have multiple contact sites on the proteasome, as it contains 
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1845 amino acids in the form of HEAT-like repeats throughout its sequence (41). In 
addition, EM imaging at low resolution has indicated that Ecm29 has an elongated and 
curved structure (16). Among the five 19S base subunits, Rpt5 seems to be the one that 
interacts most intimately with Ecm29, based on the number of detected Ecm29–Rpt5 
cross-links. This is supported by previous studies showing that Ecm29 localizes in close 
proximity to Rpt5 in yeast (11, 25). We computed a structural model of the Ecm29– 
proteasome complex and show that either one of two similar states are consistent with 
the input cross-link data as well as atomic models of Ecm29 and the proteasome. The 
Ecm29–19S model shows an elongated structure for Ecm29, forming contacts with Rpt1, 
Rpt4, Rpt5, Rpn1, and Rpn10, with its C terminus reaching 20S, in agreement with an 
earlier EM study (16). 
Apart from Rpt5, the 20S subunit a7 has been shown to interact with Ecm29 in 
yeast, depending on the phosphorylation of the a7 tail (15). Interestingly, a7 
phosphorylation is constitutive and has been shown to be important for modulating the 
stability of the CP–RP interactions in a human system (42) but has not been associated 
with Ecm29 function. We found that phosphorylation of the a7 tail at Ser-250 did not 
change in response to oxidative stress (data not shown), suggesting that it might not be 
important for Ecm29 interaction during oxidative stress. In addition, integrative structure 
modeling has indicated that oxidative stress-mediated proteasome-bound Ecm29 is not 
in close proximity to a7. Indeed, either localization of Ecm29 on the 19S proteasome 
suggests that the closest distance between Ecm29 and the a7 subunit of 20S is more 
than 30 Å. However, this finding is not completely unexpected, as our XL-MS experiments 
were designed to localize Ecm29 on the 19S and not the 20S or 26S proteasomes.  
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XL-MS analysis of affinity-purified complexes often reveals multiple conformational states 
(11). The purified proteasome sample for DSSO cross-linking in this study is expected to 
contain two major populations of proteasomes: free 19S RP and the 26S proteasome. 
Each of the two good-scoring models of Ecm29–19S satisfies the input data equally well 
(Fig. 5.6), including six distinct interprotein cross-links (Fig. 5.6C, right panel). The major 
difference between the two clusters is that cluster 1 suggests a closer interaction between 
Ecm29 and Rpn1, whereas cluster 2 suggests a closer interaction with Rpt1. Although it 
is possible that we simply did not collected sufficient information to determine the Ecm29–
19S structure precisely, it is also conceivable that Ecm29 interacts with the proteasome 
in multiple (at least two) conformations to fulfill its role in modulating the disassembly of 
the 26S proteasome upon oxidative stress. The two localizations of Ecm29 on the 19S 
RP suggest a possible mechanism for the dissociative role of Ecm29 on the proteasome 
under oxidative stress: recognition of the 19S (cluster 1, state 1) and its inhibition of the 
20S–19S interaction (cluster 2, state 2) (Fig. 5.7). Thus, these binding modes imply two 
sequential events: the recruitment of Ecm29 to trigger the 26S proteasome disassembly 
and relocalization of Ecm29 on the 19S proteasome to block 26S proteasome 
reassembly. As shown, an increased amount of 19S-bound Ecm29 would lead to elevated 
competition between Ecm29 and 20S for the binding site on the 19S, thus keeping the 
20S and the 19S separated after Ecm29-mediated dissociation upon oxidative stress.  
In summary, we examined oxidative stress-triggered molecular changes in the 
human 26S proteasome using quantitative XAP-MS, biochemical methods, XL-MS, and 
integrative modeling. In addition, we were able to capture proteasome-bound Ecm29 and 
determined that Ecm29 binds to the 19S in response to H2O2 stress. Importantly, we 
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demonstrated the biological role of human Ecm29 in modulating 26S proteasome 
disassembly and mapped specific residue–residue interactions between Ecm29 and 
multiple 19S RP subunits. The molecular architecture of the Ecm29–proteasome complex 
allows us to propose a model of Ecm29-dependent regulation of the 26S proteasome 
during oxidative stress. This model provides a basis for further exploring the diverse roles 
of Ecm29 in the proteasome system.  
 
 
 
Figure 5.7 | The proposed model of Ecm29-mediated disassembly of the 26S 
proteasome upon H2O2 stress.  
The amount of Ecm29 at the 19S proteasome increases with oxidative stress, which is 
illustrated with increased intensity in red. 
 
Experimental procedures  
Materials  
Regular DMEM, SILAC DMEM (deficient in lysine and arginine), ImmunoPure 
streptavidin, horseradish peroxidase– conjugated antibody, Super Signal West Pico 
chemiluminescent substrate, and TurboFect transfection reagent were obtained from 
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Thermo Fisher Scientific. [13C6 15N4]arginine and [13C6 15N2]lysine were purchased from 
Cambridge Isotope Laboratories. [12C6 14N4]arginine, [12C6 14N2]lysine, anti-FLAG M2 
affinity gel, and Ecm29 (KIAA0368) MISSIONÒ shRNA bacterial glycerol stocks (catalog 
nos. TRCN0000263353 and TRCN0000263355) were obtained from Sigma. MISSIONÒ 
pLKO.1-puro non-target shRNA bacterial glycerol stocks (catalog no. SHC016-1EA) were 
a kind gift from Dr. Anand Ganesan at the University of California, Irvine. Antibodies 
against human Rpt6 and Pre10 were obtained from Biomol International. Initially, human 
Ecm29 antibody was a kind gift from Dr. Carlos Gorbea (University of Utah, School of 
Medicine); later on it was purchased from Thermo Fisher Scientific. Ubiquitin antibody 
was from Santa Cruz Biotechnology. Endoproteinase Lys-C was from Wako Chemicals. 
Sequencing-grade trypsin was purchased from Promega. The proteasome substrates 
SUC-LLVY-AMC, SUC-LLE-AMC, and SUC-ARR-AMC were purchased from Boston 
Biochem. All other general chemicals for buffers and culture media were purchased from 
Thermo Fisher Scientific or VWR International.  
Generation of Ecm29 knockdown cells and BAG6 knockdown cells  
Lentiviruses were produced and knockdown cells were generated as described previously 
(43). Briefly, lentiviruses were generated by transfecting HEK293 cells with the pLKO.1- 
Ecm29shRNA vectors together with the packaging vectors pMDG and pCMVDR8.91. 
Lentiviruses were collected 24 and 48 h post-transfection for target cell infection. 
293Rpn11-TB (Hygro) (26) cells were transduced with recombinant lentivirus and 
selected with 2.5 µg/ml puromycin 48 h after viral infection to produce the stable cell line 
expressing Ecm29shRNA (293Rpn11-TB_Ecm29KD). Bag6 knockout cells were generated by 
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using CRISPR technology (44) from 293Rpn11-TB(Hygro) cells to get 293Rpn11-TB_Bag6KO cell 
lines.  
Cloning of pQCXIP-HBTH-Ecm29  
Ecm29 was PCR-amplified using FLAG-Ecm29 as the template with the following 
primers: forward, TTAATTAACGCTGGAAAGGCCGGTGAAGGTG; reverse, 
GAATTCTCACATCCCTAACTCTCCTT-GAAAG. The CSN5 fragment in pQCXIP-HBTH-
CSN5 (45) was removed, and Ecm29 PCR fragment was inserted. Cell culture and 
purification of human 26S proteasomes Nine cell lines (293Rpn11-HTBH, 293Rpn11-TB, 293HBTH-
Rpt6, 293a7/Pre10-HTBH, 293HBTH-Ecm29, 293Rpn11-TB_controlKD, 293Rpn11-TB_Ecm29KD#53, 293Rpn11-
TB_Ecm29KD#53, and 293Rpn11-TB_Bag6KO) were used in this work as listed in supplemental 
Table S1. Cells were grown to (90%) confluence in DMEM and either treated with 2 mM 
H2O2 for 30 min or left untreated as a control. Prior to harvesting, cells were incubated 
with 0.05% FA for 10 min at 37 °C. The human 26S proteasome was purified by binding 
to streptavidin–agarose resin (23), which was on-bead digested for MS analysis or eluted 
with SDS loading buffer for Western blotting. For SILAC experiments, stable cell lines 
were grown in SILAC DMEM as described previously (24). A Mix-After-Purification SILAC 
strategy was used to compare proteasome compositions before and after treatment (24).  
Transient transfection and affinity purification of FLAG–Ecm29 and FLAG–Ubl4A  
293Rpn11-HTBH cells were transiently transfected with FLAG– Ecm29 or FLAG–Ubl4A using 
TurboFect transfection reagent as described in the protocol of the manufacturer (Thermo 
Fisher Scientific). After 24 h, cells were treated with 2 mM H2O2 at 37 °C for 30 min or left 
untreated as a control, followed by 0.05% FA incubation for 10 min at 37 °C in PBS before 
harvesting. The respective Ecm29 and Ubl4A complexes were affinitypurified by anti-
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FLAG M2 affinity gel and eluted with 0.1 M glycine following the protocol of the 
manufacturer (Sigma).  
Proteasome proteolytic activity assay  
In-solution proteolytic activity assays for human proteasomes in cell lysates were 
performed with the fluorogenic pep tide substrates SUC-LLVY-AMC, SUC-LLE-AMC, and 
SUCARR-AMC as described previously (23).  
Quantitative immunoblot analysis  
The purified proteasome complexes were analyzed by Western blotting as described 
previously (13). Primary antibodies against Rpt6, a6/MCP20, a7/Pre10, Ecm29, and 
Bag6 were utilized, followed by an HRP-conjugated mouse or rabbit secondary antibody 
against mouse IgG. Protein bands were detected and quantified using a Fuji LAS4000 
scanning system (Fujifilm Life Sciences).  
Protein identification and quantification by MS  
Purified proteasome complexes were digested in-solution with Lys-C/trypsin and 
analyzed by LC/MS-MS using an EasynLC 1000 coupled with a linear ion trap (LTQ) 
Orbitrap XL mass spectrometer (Thermo Fisher, San Jose, CA) as described previously 
(13). The LC/MS-MS data were searched using Batch-Tag within a developmental 
version (v. 5.17.0) of Protein Prospector at the University of California, San Francisco 
against a decoy database consisting of a normal SwissProt database concatenated with 
its randomized version (SwissProt.2013.06.17.random.concat with a total of 455,294 
protein entries) (13). Proteins were identified by at least two peptides with an FDR of ≤ 
0.5%.  
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For SILAC experiments, the Search Compare program within Protein Prospector was 
used to calculate the relative abundance ratios of Arg/Lys-containing peptides based on 
ion intensities of monoisotopic peaks observed in the LC/MS spectra when the peptides 
were sequenced and subsequently identified during database searching as described 
previously (13, 24).  
DSSO cross-linking of Ecm29–proteasome complexes  
293HBTH-Rpt6 cells were transiently transfected with HBTH–Ecm29. After 24 h, the cells 
were treated with 5 mM H2O2 at 37 °C for 30 min to maximize the interaction between 
Ecm29 and 19S RP, followed by 0.025% FA at 37 °C in PBS for 10 min. Single-step 
affinity purification of the human Ecm29–proteasome complexes was achieved by binding 
to streptavidin–agarose resin. The bound protein complexes were cross-linked on-bead 
in PBS buffer (pH 7.5) with 0.5 mM DSSO for 1 h at 37 °C and then quenched, 
reduced/alkylated, and digested as reported previously (11, 30). The resulting peptide 
mixture was extracted and desalted prior to LC/MSn analysis.  
LC/MSn analysis of DSSO cross-linked peptides  
LC MSn analysis was performed using a Thermo Scientificä EASY-nLCä 1200 ultrahigh 
pressure liquid chromatography (UPLC) system coupled with an Orbitrap Fusion Lumosä 
MS (46). Briefly, a 25 cm x 75 µm PepMap EASY-Spray column was used to separate 
peptides over acetonitrile gradients of 6% to 35% at a flow rate of 300 nl/min. Two different 
types of acquisition methods were utilized to maximize the identification of DSSO cross-
linked peptides: top four data-dependent MS3 and targeted MS3 acquisition (46). Two 
biological replicates were analyzed, and each of them was analyzed with at least two 
technical replicates.  
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Data analysis to identify DSSO cross-linked peptides  
MSn data were extracted, searched, and analyzed as described previously (11). Briefly, 
MS3 data were subjected to Batch-Tag against a decoy database consisting of a normal 
SwissProt database concatenated with its randomized version 
(SwissProt.2014.12.4.random.concat with a total of 20,194 protein entries). Peptides 
were identified from MS3 data with a FDR of 1.7%. MSn data and MS3 database search 
results were integrated in xl-Discoverer (an in-house script) to automatically generate, 
summarize, and validate identified cross-linked peptide pairs. The final FDR of identified 
interlinked peptides was determined to be 0.1%. The reduction in FDR for the 
identification of cross-linked peptides occurs as a result of MSn data integration, which 
improves identification accuracy.  
Integrative modeling of the Ecm29–proteasome complex  
Comparative and integrative modeling was carried out to elucidate the architecture of the 
human Ecm29–26S proteasome complex (11) (supplemental Methods).  
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Abstract 
The last steps in mRNA export and remodeling are performed by the Nup82 complex, a 
large conserved assembly at the cytoplasmic face of the nuclear pore complex (NPC). By 
integrating diverse structural data, we have determined the molecular architecture of the 
native Nup82 complex at subnanometer precision. The complex consists of two 
compositionally identical multiprotein subunits that adopt different configurations. The 
Nup82 complex fits into the NPC through the outer ring Nup84 complex. Our map shows 
that this entire 14-MDa Nup82- Nup84 complex assembly positions the cytoplasmic 
mRNA export factor docking sites and messenger ribonucleoprotein (mRNP) remodeling 
machinery right over the NPC’s central channel rather than on distal cytoplasmic 
filaments, as previously supposed. We suggest that this configuration efficiently captures 
and remodels exporting mRNP particles immediately upon reaching the cytoplasmic side 
of the NPC.  
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Introduction 
The nuclear pore complex (NPC) is a large cylindrical structure with eight symmetrically 
arranged spokes embedded in the nuclear envelope (NE) and is composed of multiple 
copies of ~30 different nucleoporins (Nups). Discrete Nup subcomplexes associate to 
form the different substructures of the NPC, consisting of coaxial outer, inner, and 
membrane rings surrounding a central channel and linked to peripheral components such 
as the nuclear basket. Approximately one-third of all Nups, termed FG Nups, contain 
intrinsically disordered domains comprising multiple Phe-Gly (FG) repeats between 
hydrophilic spacers. These FG repeat regions populate the NPC central channel and, 
through their specific interaction with cargo-carrying transport factors, mediate transport 
(1).  
Although much of transport across the NPC is mediated by the karyopherin family 
of transport factors, the export of mRNAs follows a different mechanism that requires a 
special platform located at the cytoplasmic face of the NPC, called the Nup82 complex in 
budding yeast (2), which in turn associates with Dyn2, Nup116, Gle2, and Gle1 (3). The 
central role of this complex is underscored by the fact that its mammalian homolog, the 
Nup88 complex, is a nexus for disease-associated mutations (4, 5). The Nup82 complex 
and its associated proteins have proven challenging for structural analyses due to their 
flexibility and the presence of intrinsically disordered domains. The core of the Nup82 
complex is composed of the proteins Nup82, Nup159, and Nsp1. Fragments of each have 
been solved crystallographically (6–8), and negative stain electron microscopy (EM) 
revealed this complex to have an overall ‘‘P’’-shaped morphology (9), but no structures 
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exist for either the whole complex or how it interacts with its associated proteins and the 
NPC.  
mRNA export is achieved in several stages. First, mRNAs, packaged into export-
competent messenger ribonucleoprotein (mRNP) particles, are docked into the nuclear 
basket; the mRNP particle then travels across the NPC through interaction of the non-
karyopherin transport factors Mex67-Mtr2 with FG repeats that fill the NPC’s central 
channel (2). Once the mRNP particle reaches the cytoplasmic face of the NPC, the 
coordinated action of the DEAD-box RNA helicase Dbp5, the nucleoporin Gle1, and the 
N-terminal b-propeller of Nup159 leads to active remodeling of the mRNP (3, 10). Mex67-
Mtr2 and other transport factors are removed during remodeling (11), preventing the 
mRNA from traveling back to the nucleus. In the final stage, the remodeled mRNA is 
released into the cytoplasm for translation.  
Unfortunately, the precise coordination of these processes at the molecular scale 
has not been elucidated, in large part due to the lack of sufficiently detailed information 
on the spatial arrangement of transport and remodeling components relative to each other 
and the NPC. Localization studies have led to the proposal that the Nup82 complex forms 
filaments that project orthogonally from the cytoplasmic face of the NPC; such a location 
would imply that exporting mRNPs must first transit the central channel of the NPC before 
being transferred out to these peripheral cytoplasmic filaments, where the final stages of 
mRNP remodeling and export would occur distally from the central channel of the NPC 
(reviewed in (1–3). However, exactly how this transfer would be accomplished, and how 
central channel transit and mRNP processing could be coordinated, remained unclear.  
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To understand these processes, we solved the structure of the endogenous Nup82 
complex by using an integrative approach that relies on multiple structural and proteomic 
data sources (12, 13). We also determined how the Nup82 complex is anchored to the 
cytoplasmic face of the NPC via the Nup84 complex, a seven-member assembly forming 
the outer rings. In addition, we used a combined structural and functional mapping 
analysis to elucidate the major mechanism responsible for mRNA export defects affecting 
Nup84 complex components. Finally, we integrate our data into a detailed map of the 
whole cytoplasmic mRNA export and remodeling machinery. We show that, surprisingly, 
the Nup82 complex positions the cytoplasmic FG repeats and mRNP remodeling 
machinery right over the NPC’s central channel rather than on distal cytoplasmic 
filaments, as previously supposed.  
 
Results 
Solving the Structure of the Endogenous Nup82 Holocomplex  
We solved the structure of the endogenous native Nup82 holocomplex (Fig. 6.1) using 
an integrative modeling approach that has previously allowed us and others to 
successfully determine the molecular architecture of numerous other large native 
assemblies (14). Such integrative strategies have proven to be suited for the structural 
analysis of large endogenous complexes that are by nature flexible, contain unstructured 
regions, and are conformationally heterogeneous (13, 15).  
We measured the native stoichiometry of the purified Nup82 holo-complex by a 
combination of QConCAT-MS (16) and classical Siegel and Monte biophysical 
measurements (Fig. S1; Methods). The consensus of our analyses results in a 
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stoichiometry of 2:2:2:2 (Nup159:Nup82:Nsp1:Dyn2), consistent with that previously 
measured (9) for a truncated overexpressed version of the complex, with the exception 
of the Dyn2 dimer, a labile component that, unless overexpressed (Fig. S1E), is present 
as a single dimer in the average native complex. The morphology and dimensions of the 
complex were determined by negative stain EM, where 4,266 particles were classified 
into 23 class averages (Fig. S2C); a majority of these (21) showed what appears to be a 
single dimer of Dyn2, in agreement with a previous study (9) and with our stoichiometry 
(see above), and were thus included in the calculation. Interestingly, two of the class 
averages seemingly presented two consecutive dimers of Dyn2 (Fig. S2C, arrowheads), 
underscoring the previously observed heterogeneity of the complex in vivo (9). Instead of 
using a highly uncertain 3D map computed via single-particle reconstruction based on a 
heterogenous set of images, we relied on much more robustly computed 2D class 
averages, following a previously demonstrated procedure (13). Only the structured 
portions of the complex were constrained by the EM data, because we showed that the 
unstructured FG repeats are not revealed by negative stain EM (Fig. S2D).  
All components of the complex were used in the final calculation, including FG 
repeats to account for their excluded volume and emanating points. Protein 
representations were derived from the atomic structures in the Protein Data Bank, where 
available, or comparative models were built with MODELER 9.13 (17) based on the 
closest homolog with a known structure detected by HHPred (18) (Fig. S3; Table S1); 
disordered FG-repeat-containing regions were modeled as flexible strings of beads, 
guided by our recent nuclear magnetic resonance (NMR) data (19). Finally, the residue-
specific spatial proximity and orientation of the different subunits were determined by a 
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comprehensive chemical crosslinking with mass spectrometry readout (CX-MS) method, 
using two complementary cross-linkers (Fig. 2A and S2A) (13). To reduce the intrinsic 
ambiguity of cross-link data arising from the presence of two copies of each protein, we 
also analyzed a strain expressing an exogenous homolog of Nup82 (skNup82) from the 
yeast Saccharomyces kudriavzevii (20) (Fig. S2A; Methods), whose distinct protein 
sequence allows crosslinks to it to be distinguished from the endogenous Nup82. We 
identified a total of 1,131 cross-links (Table S2) that include 662 unique disuccinimidyl 
suberate (DSS) and 126 unique 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC) cross-links from the wild-type yeast strain and 343 unique DSS 
cross-links from the skNup82-containing complex (Fig. S2A). The majority of the identified 
inter-molecular cross-links mapped to the coiled coil, C-terminal regions of Nup159 and 
Nsp1 and the whole Nup82 and Dyn2 proteins. Few inter-molecular cross-links were 
found to connect to the FG regions of Nup159 or Nsp1 and none connected to the b-
propeller domain of Nup159, strongly indicating that those domains are dynamic, 
peripheral, and not located in proximity to the core of the complex (9).  
We computed the structure of the Nup82 complex (Fig. 6.1) through our integrative 
modeling approach as implemented in the Integrative Modeling Platform (IMP) program 
(21) using the data described above. A detailed assessment of the input data and the 
resulting model are shown in Table 1 and Methods. In summary, the 463 best-scoring 
solutions satisfy within stringent tolerances the data used to compute them. The clustering 
analysis of the best-scoring solutions identified a single dominant cluster of 370 similar 
structures. The corresponding localization probability density map represents the 
probability of any volume element being occupied by a given protein (Fig. 6.1). The 9.0 
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Å precision of the core structured region is sufficiently high to pinpoint the locations and 
orientations of the constituent proteins and domains, demonstrating the quality of the 
input data, including the cross-links and EM 2D class averages (Fig. S4; Table 6.1).  
Our structure is validated by seven considerations as follows. First, the EDC and 
DSS cross-links are highly consistent with each other, despite different chemistries, and 
there is significant highly non-random clustering of both EDC and DSS cross-links into 
equivalent ‘‘cliques’’ (Fig. 6.2A). These represent immediately adjacent regions in the 
complex, as validated by those cliques that coincide with known crystallographic interface 
regions, such as Nup159:Dyn2 (PDB: 4DS1) (22) and Nup159:Nup82 (PDB: 3PBP) (8) 
(Fig. 6.2B); indeed, in our final calculated structure these cliques represent immediately 
adjacent regions in the complex. Second, those few cross-links in violation of strict 
distance limits in our structure are nevertheless right next to one of the cliques; they are 
thus consistent with the structure when locally limited flexibility is taken into account (Fig. 
6.2A and S4D). Third, mass tagging of our structure is consistent with the localization of 
GFP tags on both the Nup82 and Nup159 C termini (Fig. 6.2C). Fourth, our structure is 
consistent with the previously published data, including an independent negative stain 3D 
density map (Fig. S5A) (9). Fifth, the trimeric coiled-coil structure is recapitulated even 
when computed using the chemical cross-linking data alone (Fig. S5C). Sixth, our 
structure is in agreement with small angle X-ray scattering (SAXS) profiles and ab initio 
shapes of Nup82 constructs spanning residues 4–220, 4–452, and 572–690 (Fig. 6.2D 
and S5D–S5F; Table S4). Notably, the Nup82 coiled-coil (572–690) forms a kinked 
structure, and the corresponding SAXS profile shows a monotonous increase in the 
Kratky plot (Fig. 6.2D and S5F), indicating a high degree of flexibility between coiled-coil 
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segments in solution, as would be expected for coiled-coils that form two different 
conformers seen in the final structure. Finally, our structure is also validated by the non-
random and clustered distribution of cross-links connecting the Nup82 holo-complex to 
other parts of the NPC, revealing interaction sites, as described below.  
 
 
Figure 6.1 | Structure of the Core Nup82 Holo-Complex. 
(A) Three views of the localization probability density map corresponding to the Nup82 
holo-complex ensemble are shown (light gray), with a single representative ribbon 
structure embedded; the proteins, subunits, and different structural features of the 
complex are indicated. Subunit assignment is indicated with a superscript “s1” (subunit 1) 
or “s2” (subunit 2). In all views, the components of each subunit are colored in tones of 
red (subunit 1) or blue (subunit 2) (see also B). (B) Exploded view of the Nup82 holo-
complex subunits and protein components, with the whole complex shown in the center 
and the two subunits and the different components shown on the right (subunit 1, colored 
in red tones) or the left side (subunit 2, colored in blue tones). CCS, coiled-coil segment 
(as described in the main text). 
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Figure 6.2 | Nup82 Holo-complex Structure Validation. 
(A) Circos-XL plots showing the distribution of all DSS (top plot) or EDC (bottom 
plot) cross-links mapping within the core of the Nup82 holo-complex. Each protein is 
represented as a colored segment, with the amino acid residue indicated on the outside 
of the plot and relevant domains indicated inside each segment; regions without reliable 
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fold assignment are identified by lighter shading. Inter-molecular cross-links are depicted 
as purple lines and intra-molecular cross-links as gray lines. The internal circles include 
bars representing the density of cross-links per ten residues in DSS and EDC (blue and 
light blue color for inter-molecular cross-links and intra-molecular cross-links, 
respectively) and the density of lysines in DSS (orange and light orange bars for cross-
linked and uncross-linked residues, respectively) or the density of lysine/carboxylic acid 
in EDC (pink and light pink bars for cross-linked and uncross-linked residues, 
respectively). (B) Structure of the Nup82 holo-complex showing the cross-links falling 
within the expected Cα-Cα maximum distance threshold (blue) or outside of that threshold 
(orange). Below the structure, a bar graph shows the Cα-Cα distance distribution of all DSS 
or EDC cross-links in the structure. DSS threshold = 35 Å; EDC threshold = 30 Å. 
(C) GFP mass-tagging analysis of the Nup82 holo-complex. Analyses of a Nup82-GFP 
tagged version (top diagram) or a Nup159-GFP tagged version (bottom diagram) of the 
holo-complex are shown. For each diagram, a view of the native Nup82 holo-complex 
structure is shown (wild-type [WT]), and the tagged version of the structure shown on the 
right side. The top panels show a representative negative stain 2D class average of the 
native complex (left) and the tagged version (right; green arrowhead, GFP). The bottom 
panels show 2D projections of the native structure (left) and the calculated GFP-tagged 
version (right; green arrowhead, GFP). ccc, cross correlation coefficient. Scale bar, 
10 nm. (D) SAXS analysis of the Nup82 (572–690) fragment, showing two views of the 
computed ab initio shape (gray envelope), with ribbon representations of the equivalent 
Nup82 fragments in the conformation they adopt within the Nup82 holo-complex; subunits 
1 (red) and 2 (blue) are indicated. 
 
Features of the Nup82 Holo-complex  
The C termini of Nup82, Nup159, and Nsp1 share a common domain arrangement, 
formed by consecutive helical coiled-coil regions of different length, connected by flexible 
linkers. They assemble (together with Dyn2) to form the Nup82 holo-complex, a roughly 
‘‘D’’-shaped particle, which is formed by the asymmetric assembly of two compositionally 
identical subunits (termed subunit 1 [s1] and subunit 2 [s2] in Fig. 6.1). Each subunit 
consists mainly of parallel, three-stranded, hetero-trimeric coiled-coils connected by 
flexible linkers, consisting of a single copy of the C termini of Nup82, Nup159, and Nsp1. 
However, the two subunits adopt different configurations, mainly due to the different 
degree of flexion of the hinges between heterotrimeric coiled-coil segments (termed 
CCSs) and the relative position of the Nup82 b-propellers. Subunit 1 mainly forms the 
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‘‘rod,’’ while subunit 2 forms the ‘‘loop’’ of the holo-complex, with both subunits 
contributing to the spurs (Fig. 6.1). The CCS1s2 and CCS2s2 trimers constitute the 
extended loop that can be observed in certain orientations of the particle (Fig. 6.1A, left 
and center). The denser region of the complex is formed by trimeric parallel CCS domains 
that form the slightly bent, elongated central rod. Both Nup82 b-propellers are located 
side by side on top of the rod formed by subunit s1, with Nup82 b-propellers2 located in 
trans in a distal position from the CCS1-2s2 loop. The two ends of the central rod are each 
formed by the C-terminal (spur-1) and the N-terminal (spur-2) bundles of the CCS 
domains. Two copies of Dyn2 form a dimer that is perpendicular with spur-2 and seems 
to help lock the two subunits into their asymmetric arrangement. Dyn2 also helps to orient 
the two Nup159 copies, so that their FG regions emanate in parallel from that end of the 
complex. Interestingly, the FG regions of Nsp1 also project from spur-2, forming, together 
with the Nup159 FGs, an intrinsically disordered plume. In agreement with prior work, the 
hump formed by the Nup82 b-propellers helps to lock down the C termini of Nup159 and 
form the attachment site for two Nup116 copies (8) (see below).  
Structure of the Nup82-Nup84 Complex Assembly and the Cytoplasmic mRNA 
Export Platform  
To understand how the Nup82 holo-complex is associated with the whole NPC, we 
isolated it under conditions that preserved its interaction with other Nups (23). CX-MS 
was used to analyze those proteins proximally associated with each of the Nup82 holo-
complex’s components (Table S3). Notably, most of the identified cross-links connected 
the spur-1 region of the Nup82 holo-complex to components of the Nup84 complex hub 
(Fig. 6.3; Table S3) (13); indeed, a direct physical connection between the Nup82 and 
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Nup84 complexes was recently demonstrated in Chaetomium thermophilum (24). Our 
data, together with our prior map of the Nup84 complex (13), crystallographic data on the 
Nup84 complex (25, 26), and the previous map of the entire NPC (12), were sufficient to 
allow us to dock the two complexes together to generate a map of the entire ~1.3-MDa, 
15-protein, Nup82-Nup84 complex assembly (Fig. 6.3A). All our solutions were similar, 
differing only in the degree of rotation along the Nup82 complex long axis relative to the 
Nup84 complex (Fig. S6). The Nup82 holo-complex body associates through its spur-1 
region with the Nup85/Seh1 arm on the Y-complex hub and the N-terminal side of 
Nup145C (Fig. 6.3A), with the two complexes oriented orthogonally with respect to their 
long axis (Fig. 6.3A). Our arrangement is supported by the tight clustering of cross-links 
between the Nup82 and Nup84 complexes mainly to two discrete locations, one on spur-
1 and the other on a single region of the Nup85-Seh1 arm, respectively.  
It has been previously shown that the Nup84 complex long axis orientation is 
approximately parallel to the plane of the NE in the NPC’s outer ring (27, 28). 
Consequently, our structure reveals that the Nup82 holo-complex long axis is orthogonal 
to that of the Nup84 complex, forming a potential linker between the outer and inner ring. 
The coiled-coil bundles of the Nup82 holo-complex body form a scaffold, and their 
downward orientation makes it so that the FG plume in spur-2 projects from the bottom 
of the complex. The FG regions of Nsp1 and Nup159 would thus face the central transport 
channel and be adjacent to the Nsp1 FG regions emanating from the inner-ring Nic96 
complex (Fig. 6.3).  
Our CX-MS analysis of the higher-order assembly also identified cross-links 
connecting other known components of the mRNA export machinery (Gle1, Nup42, and 
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Nup116) to the Nup82 holo-complex (Fig. 6.3; Table S3). The identified crosslinks are 
fully consistent with previous work showing physical connections between some of these 
components, such as the C-termini of Gle1 and Nup42 (29) and the C terminus of Nup116 
to Nup82 (8), indicating that our CX-MS analysis is targeting bona fide physical 
connections within the mRNA export machinery. In combination with published crystal 
structures of labile components of this machinery (10, 30), our data allowed us to 
assemble a physical map of the whole cytoplasmic mRNA export platform comprising 16 
different proteins (some in multiple copies, so comprising 24 subunits) with a mass of 
~1.8 MDa (Fig. 6.3B). The organization of the assembly reveals that the components 
actively involved in the mRNP remodeling process (Dbp5, Gle1, and Nup159 N terminus) 
and associated FG regions (Nup42, Nup116, Nup159, and Nsp1) are localized around 
the Nup82 holo-complex and the short arms of the Nup84 complex. Remarkably, we 
identified ten cross-links connecting Gle1 to the Nup82 holo-complex, delineating for the 
first time the position and orientation of Gle1 in the NPC, adjacent to the Nup82 holo-
complex and oriented with its N terminus toward the holo-complex hump, its middle region 
running parallel to spur-2, and its C-terminal and the Dbp5-interacting domain facing 
downward toward the NPC central channel (Fig. 6.3). Through its interaction with Gle1, 
Nup42 is also seemingly localized toward the central channel, in agreement with a recent 
report that showed how the FG region of Nup42 is fully functional if fused to the Gle1 C 
terminus (31). Thus, in our map, both the core of the Nup82 holo-complex and the Nup84 
complex form a flexible scaffold, which organizes and properly orients the two functional 
ends (FG regions and enzymatic activities) of the cytoplasmic mRNA export machinery.  
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Functional Relationship between the Nup82 Holocomplex and the Nup84 Complex  
To functionally annotate our Nup82-Nup84 complex assembly structure, we sought to 
investigate its relationship to mRNA export. Mutations affecting both Nup84 and Nup82 
complex components have previously been shown to display characteristic mRNA export 
defects (33). Although the direct involvement of components of the Nup82 holo-complex 
in mRNA export has been long established (33), until now, the association of mRNA 
defects with the Nup84 complex has remained unclear. Thus, to identify regions of the 
Nup84 complex that are most relevant for mRNA export, we analyzed a collection of 
truncation mutants (23). The mRNA export defect of each mutant was quantified and 
heat-mapped into the Nup84 complex structure (Fig. 6.4 and S7). We detected a clear 
hotspot mapping to the Nup85/Seh1 arm (Fig. 6.4), different from those determined for 
other Nup84 complex phenotypes (23). Notably, this hotspot maps to where the Nup85-
Seh1 arm connects to the Nup82 holo-complex (Fig. 6.3). This significant structure-
function correlation supports the idea that the mRNA export phenotype, focused to this 
part of the Nup84 complex, is largely associated with a defective incorporation of the 
Nup82 complex into the NPC. To test this idea, we analyzed the in vivo localization of 
Nup82- GFP in several Nup84 complex truncation mutants affecting different parts of the 
Y-shaped complex. As shown in Fig. 6.4, the Nup82-GFP construct is indeed significantly 
mislocalized to the cytoplasm only in mutations affecting the Nup85/Seh1 arm, while a 
control Nup49-GFP reporter did not show similar behavior (23). Thus, we conclude that 
the mRNA export phenotype found in Nup84 complex mutants is mainly the consequence 
of a defective or weakened incorporation of the Nup82 holo-complex into the NPC.  
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Figure 6.3 | Molecular Architecture of the Cytoplasmic mRNA Export and 
Remodeling Platform. 
(A) Structure of the Nup82-Nup84 complex assembly. Three views of the structural 
arrangement formed by the Y-shaped Nup84 complex (light gray density) and the Nup82 
holo-complex (light blue density) calculated using CX-MS data. Each component and 
structural feature of the different complexes are labeled and shown as a density with fitted 
ribbon representations of their component Nups. A Circos plot shows the distribution 
of cross-links (dashed, light blue lines) identified between components of the Nup82 
complex, Nup84 complex, and mRNP export/remodeling machinery, used for the 
calculation of the assembly and the map described in (B). (B) Molecular architecture of 
the cytoplasmic mRNA export and remodeling platform. An exploded view of the different 
platform components is presented (solid blue lines, covalent attachment; dashed blue 
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lines, CX-MS-identified associations). When available, components are represented as 
crystal structures (Dbp5, Gle1, and Nup159 N termini; PDB: 3RRM (10); Gle2/RAE1; 
PDB: 3MMY (30); Nup116 C termini; PDB: 3PBP (8); and 3NF5 (32)). The Gle1 N 
terminus is represented with a homology model of its predicted coiled-coil region as a red 
ribbon inside a light gray density of the approximate expected size for the domain. 
 
 
 
Figure 6.4 | mRNA Export Phenotype in Nup84 Complex Mutants Is Associated 
with Defective Incorporation of the Nup82 Holo-complex into the NPC. 
(A) The mRNA export defect phenotype was quantified and plotted (mean value; n = 4) 
for each Nup84 complex component mutant in order of increasing level of nuclear poly(A) 
mRNA accumulation as observed by fluorescence in situ hybridization (FISH) (see 
Methods and Fig. S7 for details) and assigned to five divisions of increasing level of 
accumulation (white to dark purple) (23). Representative examples of strains included in 
each division are shown on the top. AU, arbitrary units. Error bars represent SEM. Scale 
bar, 5 μm. (B) Mapping of the color code described in (A) into the Nup84 complex 
components. Horizontal lines represent the amino acid residue length of each protein and 
truncated version; amino acid residue positions are shown on top of the lines. (C) The 
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severity of nuclear mRNA accumulation phenotype (detailed in A and B) for specific 
truncations of the Nup84 complex components are shown mapped into the Nup82-Nup84 
complex assembly. The color code is the same as the one described in (A). The Nup82 
holo-complex density is shown in light blue. (D) Subcellular localization of Nup82-GFP in 
Nup84 complex truncation mutants. Top: diagrams representing the Nup84 complex, with 
the corresponding truncated region of the complex shown. Middle: localization of the 
genomically tagged Nup82-GFP reporter as determined by fluorescence microscopy. 
Bottom: differential interference contrast (DIC) image of the same cells. Scale bar, 5 μm. 
 
Conservation of the Cytoplasmic mRNA Export Platform in Opisthokonts  
We tested whether our current structure was consistent with previous maps of the whole 
NPC. When the Nup82-Nup84 complex assembly is docked into our yeast NPC map (12), 
the arrangement of their common components is fully consistent, as shown in Fig. 6.5A. 
The Nup82 holo-complex overlaps with the localization density of Nup82, facing down 
into the central channel, and is in close proximity to the Nup85 arm of the Nup84 complex.  
Previous attempts to align a single EM envelope for the yeast Nup82 complex to a human 
cryo-EM NPC map (28) led to divergent and ambiguous results (9). However, we were 
able to unambiguously dock the yeast Nup82-Nup84 complex assembly into the available 
human cryo-EM maps (28, 34). When the Nup84 complex was aligned to the 
corresponding inner copy of its homolog (the Nup107-160 complex), the Nup82 holo-
complex aligned with a density projecting only from the cytoplasmic ring, pointing toward 
the central channel (Fig. 6.5B and 6.5C). It has been suggested that this protrusion might 
indeed represent some aspect of the Nup88-Nup214 complex, the vertebrate counterpart 
to the Nup82 holo-complex (28). The yeast and human alignments both support an overall 
conservation for certain major features of NPC architecture between fungi and metazoa 
and provide further independent validation of our Nup82-Nup84 complex assembly 
structure. Importantly, the position of the Nup82 holo-complex FG repeat regions with 
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respect to the whole NPC is suggestive of an organized arrangement of transport factor 
docking sites (see Discussion).  
 
Figure 6.5 | Position of the Nup82-Nup84 Complex Assembly within the NPC. 
(A) Fitting to the yeast NPC map. Two views of the optimized alignment of 
two S. cerevisiae Nup82-Nup84 complex assemblies into the S. cerevisiae NPC 
localization probability density map (transparent gray), together with a side view of the 
detailed alignment (12); Nup85 (green), Nup133 (red), and two Nup82 units (blue and 
orange) are indicated. Scale bars, 100 Å. (B) Comparison with the human NPC 
tomographic cryo-EM map (EMDB: 2444) (28). Two views of the optimized alignment of 
two S. cerevisiae Nup82-Nup84 complex assemblies (pink and blue) into the human NPC 
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map (CCC = 0.72). One suggested localization for the human Nup214/Nup88 complex is 
colored in yellow. (C) Comparison with the mutant human NPC tomographic cryo-EM 
map (EMDB: 3104) (34), lacking an outer cytoplasmic Y-complex ring (CCC = 0.81). 
 
Discussion 
Structure and Evolution of the Nup82 Holo-complex  
We present the structure of the Nup82 holo-complex and show how it assembles with the 
Nup84 complex and other proteins to form the 24-subunit, ~1.8- MDa cytoplasmic mRNA 
export platform in the NPC. Our structural analysis therefore covers close to one-third of 
the yeast NPC mass (12), which is now mapped in molecular detail. Unexpectedly, the 
Nup82 holo-complex and its associated machinery do not form any kind of cytoplasmic 
filament, in contrast to how it has been pictured in the literature. On the contrary, it forms 
a strut that faces the central channel. The Nup82 holo-complex exhibits an unusual 
architecture, with two compositionally identical trimers forming an asymmetric structure. 
Hinges in coiled-coils allow flexibility to convert two otherwise identically arranged 
subunits into two similar but morphologically distinct subunits. This structural 
arrangement, with flexibility in the subunits permitting alternate assemblies, is reminiscent 
of how vesicle-coating proteins form variable architectures within the same coat complex, 
such as the hexagonal versus pentagonal architectures observed in clathrin coated 
vesicles (35). Perhaps this variability is another echo of the evolutionary origin of the NPC 
in an ancient coating complex (36), and it may also contribute to the observed flexibility 
of the NPC as a whole. Another feature shared by the NPC and its related coating 
complexes is the presence of compositionally distinct but structurally and evolutionarily 
related modules within the entire assembly that arose from ancient duplication events (12, 
23, 36). Indeed, there is another NPC subcomplex that also uses a trimeric bundle and 
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appears to be homologous and evolutionarily related to the Nup82 holo-complex. We 
discovered this relationship through a homolog detection search using HHPred (18), 
aiming to find structures comparable to the coiled-coil regions of the three core Nup82 
complex components. Remarkably, the top and highly significant hit (HHpred p = 4.5E-
60, 3.3E-9, and 0.0053 for Nup82, Nsp1, and Nup159, respectively) was another complex 
from the NPC also containing a heterotrimer of coiled-coils: the Xenopus laevis 
Nup93:Nup62:Nup58:Nup54 complex (6) and its Chaetomium thermophilum 
Nic96:Nsp1:Nup57:Nup49 complex homolog (7) (Fig. S3). This similarity aided in 
generating high-confidence comparative models for our calculations (Methods). The C 
termini of both complexes share a common domain arrangement, formed by three 
consecutive helical coiled-coil regions of different lengths, connected by flexible linkers 
(Fig. 6.1), and both complexes share a common component, Nsp1. Collectively, these 
observations further support the idea that both complexes evolved from a single common 
precursor structure, providing yet another example of an ancient duplication now 
generating diverse modules within the NPC, as postulated by our original protocoatomer 
hypothesis (36).  
Spatial Organization of the FG Repeats  
A common architecture and evolutionary origin might also imply a degree of shared 
functionality. In the case of the Nup82 holocomplex, the coiled-coil region serves as a 
strut to position various transport factor docking sites out from the core scaffold and 
toward the central channel of the NPC, where nucleocytoplasmic exchange is mediated 
(Fig. 6.6). We therefore suggest that the coiled-coil trimeric region of the homologous 
Nic96:Nsp1:Nup57:Nup49 complex and that of the Nup82 holo-complex perform 
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analogous functions, namely to serve as struts for the correct positioning of transport 
factor docking sites along the nucleocytoplasmic axis of the central transport channel 
(Fig. 6.6). Being intrinsically disordered, the FG repeat regions themselves cannot form 
ordered structures to span the central channel. However, by providing a semi-rigid 
support, the coiled-coil regions of the two complexes may act as flexible struts, placing 
the FG Nup docking sites so that they efficiently occupy the central channel to form an 
effective selective barrier, perhaps such that the struts plus FG repeats together comprise 
the observed ‘‘central transporter’’ (37). Indeed, space-filling models based on size data 
for FG repeats (38) (Fig. 6.6) show that the FG regions would project from the Nup82 
holo-complex in such a manner as to essentially span the NPC’s central channel and 
essentially form the top, cytoplasmic part of the central transporter.  
The Nup82 Complex Projects into the NPC’s Central Channel to Coordinate 
Efficient Export and Remodeling of mRNPs  
The FG repeats associated with the Nup82 holo-complex project from the end of the 
complex adjacent to the Nic96 complex, toward the midplane of the central channel (Fig. 
6.6); there, they would neighbor the Nsp1, Nup57, and Nup49 FG repeats at the equator 
of the NPC (7, 39, 40). It is known that the relative position of FG repeats in the Nup82 
holo-complex are crucial (31) and that the Mex67/Mtr2 dimer mediating mRNA export 
directly engages the FG repeats associated with the Nup82 holo-complex (41, 42) (Fig. 
6.3). Collectively, these results suggest that the type and position of FG repeats in the 
Nup82 holo-complex are key for an efficient mRNA export mechanism.  
Surprisingly, we show that the Nup82 holo-complex does not project outward from 
the cytoplasmic face of the NPC, as previously assumed. Instead, it projects inward, both 
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radially and vertically. This arrangement has several important functional consequences. 
First, based on the organization of the Nup82 holo-complex, this places the associated 
cytoplasmically disposed FG repeat regions in intimate contact with the symmetrically 
positioned FG repeat regions in the central channel, forming a continuous conduit of 
transport factor docking sites from the nuclear to cytoplasmic sides of the NPC. Second, 
this arrangement also places the mRNP remodeling machineries at the immediate 
cytoplasmic end of this channel (Fig. 6.5 and 6.6). We suggest that the Nup82 holo-
complex and Nup84 complex position these cytoplasmic docking and remodeling sites 
right over the central channel to efficiently capture exporting mRNP particles immediately 
upon reaching the cytoplasmic end of the central channel; once captured, they can be 
directly processed by the proximally tethered Gle1/Dbp5/Nup159N remodeling machinery 
rather than requiring a transfer mechanism to previously supposed distal processing sites 
on cytoplasmic filaments. Third, the transport factors released during remodeling are also 
potentially well positioned to be recycled back into the nucleus, while the now 
translationally primed mRNP exits to the cytoplasm (Fig. 6.6). Our molecular architecture 
is fully consistent with proposed mRNP remodeling models (3, 10), as well as with the 
observation that cytoplasmic release, but not translocation, is a ratelimiting step during 
mRNA export (2). When translated into the overall NPC architecture, the presence of 
eight remodeling hubs surrounding the central channel ensures a highly efficient system 
consistent with the fast mRNA export rates observed in vivo (43–45). Other types of 
ribonucleoproteins are also actively exported through the NPC, using pathways and 
components that largely overlap with those of mRNA export (46). It is thus reasonable to 
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expect that our structural analysis would also serve as a framework for revealing the 
mechanisms governing their transit and maturation through the NPC.  
While the Nup82 holo-complex is a major nexus for RNA export and remodeling 
processes, its human homolog when altered is also a major nexus for numerous 
diseases, as underscored by the fact that the mammalian orthologs of Nup82 (Nup88), 
Nup159 (Nup214), and Nup116 (Nup98) represent the Nups most prevalent in cancer 
and developmental diseases (47). Hence, our structure may also help rationalize the 
modifications in this machinery that lead to severe human diseases. For example, 
mutations in the human homolog of Gle1 are associated with lethal congenital contracture 
syndrome 1, lethal arthrogryposis with anterior horn cell disease (5), and amyotrophic 
lateral sclerosis (4). We have been able to localize and orient Gle1 at the hump and spur-
2 region of the Nup82 holo-complex, facing the NPC central channel (Fig. 6.3). Our data 
(Table S3) also indicate that the C terminus of Nup42 is associated with the C terminus 
of Gle1 (29), where the Nup159 N-terminal b-propellers are dynamically associated, with 
the Nup159 FG regions oriented toward the arms of the Nup84 complex (Fig. 6.6) and 
Dbp5 physically associated with its ATPase cycle modulators Gle1 and the Nup159 b-
propeller (10, 48). Strikingly, the residues equivalent to those causing disease states in 
human Gle1 (49) all map to sites that anchor the yeast protein to either the Nup82 holo-
complex or to Nup42 and Dbp5-Nup159N (Fig. 6.6). These results, taken together with 
our structural and functional analyses, underscore the importance of the Nup82 complex 
as a hub for anchoring the mRNA transport and processing machineries into the heart of 
the NPC itself and help explain why this complex is a focus for so many developmental, 
oncogenic, and viral diseases. 
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Figure 6.6 | The Nup82-Nup84 Complex Assembly Acts as a Scaffold to Organize 
the FG Region and mRNP Remodeling Sites in the NPC. 
Top: model for the arrangement of the FG regions associated to the Nup82 holo-complex. 
FG regions were modeled using molecular dynamics. The position of the Nup116 FG 
regions is based on the position of their C termini (PDB: 3PBP (8)) but could vary 
significantly, depending on the orientation of the unstructured region connecting the FG 
domains (dotted blue line). N termini of Nup159 can interact with Dbp5 during mRNP 
remodeling, as indicated by the dashed blue line. Sequential mRNP export and 
remodeling steps associated with each region of the complex are shown on the left. 
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Bottom left: mapping of disease-associated Gle1 mutations into our model for the mRNA 
export platform. The yeast Gle1 region equivalent to where disease-related mutations 
have been found in human Gle1 were colored in purple (lethal congenital contracture 
syndrome 1 [LCCS-1]), gold (lethal arthrogryposis with anterior horn cell disease 
[LAAHD]), and cyan (amyotrophic lateral sclerosis [ALS]), based on data described 
previously (4, 49, 50). Proteins are represented as described in Fig. 6.3B. Dashed blue 
lines indicate identified protein-protein associations. Bottom right: schematic 
representation comparing the previous view (left) of the Nup82 complex as components 
of cytoplasmically oriented filaments, with the new view (right) of how it instead forms 
struts projecting toward the NPC central channel, positions the FG regions to fill the 
channel, and forms the top part of the central transporter region. 
 
Methods 
Yeast Strains  
All Saccharomyces cerevisiae strains used in this study are listed in the Table 2, with the 
exception of the Nup84 complex truncation mutants that were described in detail in (23). 
The Nup82 complex tagged strains were constructed in a W303 (Mata/alpha ade2-1 ura3-
1 his3-11,15 trp 1-1 leu2- 3,112 can1-100) background. Otherwise stated, strains were 
grown at 30ºC in YPD media (1% yeast extract, 2% bactopeptone, and 2% glucose). The 
Saccharomyces kudriavzevii strain was obtained from the American Type Culture 
Collection (ATCC 2601) and grown in the same conditions as referred above for S. 
cerevisiae.  
Affinity Purification of Protein Complexes  
To purify the native Nup82 complex, that we will call from now on Nup82 holo-complex 
(as it includes all its intact, full-length endogenous components), we constructed strains 
in which the NUP encoding gene was genomically tagged with a variant of the 
Staphylococcus aureus Protein-A, preceded by the human rhinovirus 3C protease (ppx) 
target sequence (GLEVLFQGPS). The sequence was introduced by PCR amplification 
of the transformation cassette from the plasmid pProtA/HIS5. Harvested yeast cells, 
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grown in YPD at 30ºC to mid-log phase were frozen in liquid nitrogen and cryogenically 
lysed in a Retsch PM100 planetary ball mill (http://lab. rockefeller.edu/rout/protocols). A 
total of 10-20 g of frozen cell powder were resuspended in 9 volumes of IP buffer (20mM 
HEPES pH 7.4, 300mM NaCl, 2mM MgCl2, 0.1% Tween 20, 1mM DTT). Cell lysate was 
clarified by centrifugation at 20,000 g for 10 min. IgG Ab conjugated magnetic beads 
(Invitrogen) at a concentration of 50 μL slurry/g of frozen powder were added to the 
clarified cell lysate and incubated for 30 min at 4ºC. Beads were washed three times with 
1 mL of IP buffer without protease inhibitors. The native complex was released from the 
affinity matrix by PreScission protease digestion in the same buffer. The recovered 
sample was then centrifuged at 20.000 g for 10 min. The supernatant (50-100 μl) was 
loaded on top of a 5%–20% sucrose gradient made in IP buffer without Tween 20 plus 
1/1000 of protease inhibitors. Gradients were ultracentrifuged on a SW55 Ti rotor 
(Beckman) at 42.000 rpm and 5ºC for 17 hr. Gradients were manually unloaded from the 
top in 12 fractions of 410 μl. Fractions were analyzed by SDS-PAGE and R250 
Coomassie or Sypro Ruby staining.  
A higher order complex, containing the Nup84 complex plus several other nups, 
including the Nup82 holo-complex components, was identified previously (23). The 
complex was affinity purified from a Nup84-ppx-PrA strain (Methods; Table 2) as 
described above using as IP buffer 20mM HEPES pH 7.4, 20mM NaCl, 150mM 
potassium acetate, 2mM MgCl2, 0.5% Triton X-100, 0.1% Tween 20, 1mM DTT, and 
processed for cross-linking and mass spectrometry analysis.  
Stoichiometry of the Nup82 Holo-complex  
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Diploid strains, carrying one wild-type and one Protein-A-tagged version of each of the 
major Nup82 holo-complex components were analyzed by affinity purification as 
described above and the identity of the bands verified by mass spectrometry (Fig. S1). 
To determine the Stokes radius (Rs) of the Nup82 holo-complex, the natively eluted 
complex was run through a calibrated Superose 6 GL 30/100 column in 20mM HEPES 
pH 7.4, 150mM NaCl, 0.1% Tween 20 buffer, and the results plotted against reference 
protein standards (Ovalbumin, Rs: 3.05; Aldolase, Rs: 4.81; Ferritin, Rs: 6.1; 
Thyroglobulin, Rs: 8.5). The sedimentation coefficient (S20,w) of the Nup82 holo-complex 
was estimated from the peak of the complex banded in sucrose gradients, run as 
described above, using the formula S20,w = ΔI/(ω2·t), where ΔI is the time integral, ω the 
angular velocity (seconds-1), and t is time (seconds) (see also (51)). The mass of the holo-
complex was then calculated using the Siegel-Monte equation (Fig. S1A and S1B) (52). 
Quantification of the relative amounts of each protein in the purified complex was 
performed using a synthetic concatamer of tryptic peptides or QconCAT (16) based on 
the Nup82 complex components (Fig. S1D). Quantotypic peptides for each of the four 
nucleoporins of the Nup82 complex were selected based on their mass spectrometric 
behavior (Nup82: 7-LSALPIFQASLSASQSPR-24, 636-NQILQFNSFVHSQK-649; 
Nup159: 301-TNAFDFGSSSFGSGFSK-717, 948-TSESAFDTTANEEIPK-963; Nsp1: 
779-TTNIDINNEDENIQLIK-795, 806-SLDDNSTSLEK-816; Dyn2: 64-NFGSYVTHEK-73, 
53- YGNTWHVIVGK-63). A synthetic gene (called Nup82 QconCAT) was designed by 
concatenation of the sequences encoding the referred peptides and addition of a 6xHis 
c-terminal tag: (MKEIRNQILQFNSFVHSQKTNAFDFGSSSFGSGFSKNFGSYV 
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THEKTTNIDINNEDENIQLIKLSALPIFQASLSASQSPRTSESAFDTTANEEIPKYGNTWH
VIVGKSLDDNSTSLEKQINSIKHHHHHH).  
The E. coli codon optimized sequence was cloned into plasmid pGEX6p-1, 
resulting in the expression of a protein with an n-terminal GST tag that was used both as 
a purification tag and sacrificial peptide (53). The Nup82-QconCAT protein was 
expressed by growing 300ml of BL21 E. coli cells at 37ºC to OD600 = 0.6 in minimal M9 
media (16) supplemented with heavy arginine and lysine (L-arginine:HCl 13C6; L-
lysine:2HCl 13C6, Cambridge Isotope Laboratories Inc.). IPTG (1mM) was used to induce 
expression of the construct for 3 hr at 37ºC. Harvested cells were processed using 
BugBuster Extraction Reagent (Novagen) as indicated by the manufacturer. The full-
length Nup82 QconCAT was then purified using a two-step method that ensures a final 
fulllength product by consecutive purification from the n and c-terminal tags: i) Clarified 
soluble material was incubated with 500 μL of gluthatione Sepharose 4b (GE Healthcare) 
at room temperature for 1 hr at 4ºC, and the retained proteins eluted using 2x 1ml of 
elution buffer (20mM HEPES pH 7.4, 150mM NaCl, 45mM imidazole, 6M guanidinium 
hydrochloride, 1mM TCEP, 1/500 protease inhibitor cocktail (PIC) (Sigma)). ii) The elution 
volume was then passed through an equilibrated His-Trap HP (GE Healthcare) at room 
temperature. The retained Nup82 QconCAT was then eluted in 20mM HEPES pH 7.4, 
500mM imidazole, 150mM NaCl, 6M guanidinium hychloride, 1mM TCEP, 1/500 PIC. The 
resulting elution was analyzed by SDS-PAGE to ensure the presence of a full-length, pure 
protein.  
For the MS analysis, the Nup82 holo-complex was purified as described above. 
The gradient fractions containing the complex were collected and concentrated by 
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centrifugation at 355,000 g for 6 hr in a TLA 120.1 rotor at 4ºC. The concentrated complex 
was then resuspended in a final 1x Nupage LDS Sample buffer (Thermo Fisher 
Scientific), 10mM TCEP (Thermo Fisher Scientific). The Nup82-QconCAT was ethanol 
precipitated and washed to eliminate the guanidinium chloride and resuspended in 1x 
Nupage LDS Sample buffer, 10mM TCEP. Approximately equimolar amounts of complex 
and Nup82-Qconcat were combined to give a final protein amount of 1 μg. The combined 
sample was heated at 72ºC for 10 min and then alkylated using a final concentration of 
30mM iodoacetamide (Sigma). The sample was then loaded into a 4% (37.5:1) in-house 
prepared stacking acrylamide SDS-PAGE gel. The resulting band, containing a mixture 
of Nup82 complex and stable-isotopically labeled Nup82 QconCAT proteins, was excised 
and sequentially digested by endoproteinase LysC (Roche) and trypsin (Roche) inside 
gel matrix, followed by LC-MS analyses to determine L/H ratio of standard peptides. LC-
MS analyses were performed on an Orbitrap Fusion Mass Spectrometer (Thermo 
Scientific), with an Easy-nLC 1000 HPLC (Thermo Scientific) and an Easy-Spray 
electrospray source (Thermo Scientific). L/H ratios of standard peptides were determined 
using the MaxQuant software (version 1.2.2.5) (54).  
Overexpression of Dyn2 was performed mimicking the conditions described in (9): 
the S. cerevisiae Dyn2 coding sequence was cloned into the 2-micron plasmid p424-
Gal1, under the control of the Gal-1 promoter. Overexpression was achieved by growing 
the transformed yeast cells in yeast synthetic minimal media supplemented with 2% 
glucose, 1% raffinose, harvesting the cells in mid-log phase, washing them with ddH2O 
and then transferring them to yeast synthetic minimal media supplemented with 2% 
galactose, 1% raffinose for 3 hr at 30ºC. Cells were then harvested and cryo-milled and 
178 
 
the endogenous Nup82 holo-complex was purified as described above using Nup82-PrA 
as the handle. Purified complexes were run in SDS-PAGE gels, stained with SyproRuby 
(Thermo Fisher Scientific) and the relative intensity of the different bands were quantified 
using ImageJ (http://imagej.net).  
Chemical Cross-linking and Mass Spectrometry  
The natively eluted complex (250 μl, in buffer 1- 20mM HEPES pH 7.4, 300mM NaCl, 
0.1% Tween, 2mM MgCl2, 1mM DTT) was crosslinked via the addition of DSS-H12/D12 
(DiSuccinimidylSuberate) cross-linker (Creative Molecules) to yield a final concentration 
of 0.25 mM and incubated for 45 min at 25ºC with gentle agitation in a shaker (900 rpm). 
The reaction was then quenched by 50 mM ammonium bicarbonate. In the case of cross-
linking using EDC reagent (Pierce), the sample was equilibrated and natively eluted in 
EDC cross-linking buffer (10mM BisTris pH 6.5, 100mM NaCl, 2mM MgCl2, 0.1% Tween, 
1mM DTT). EDC (20 mM) and N-hydroxysulfosuccinimide (0.4 mM) (i.e., 2% molar ratio 
with respect to EDC) were then added to cross-link the sample. The sample was 
incubated for 45 min at 25ºC with gentle agitation. After cross-linking, Tris-HCl pH 8.0 (50 
mM) and β-mercaptoethanol (20 mM) were added to the cross-linked sample to quench 
the reaction. After Cysteine reduction and alkylation, cross-linked samples were 
separated in a 4%–12% NuPage SDS-PAGE (Invitrogen). Gels were briefly stained by 
GelCode Blue Stain Reagent (Thermo Fisher Scientific) to enable the visualization of the 
cross-linked protein complexes. The cross-linked complexes were then digested in-gel 
with trypsin or chymotrypsin to generate cross-linked peptides as previously described 
(Shi et al., 2014). After in-gel digestion, the cross-linked peptide mixtures were 
fractionated by peptide SEC (Superdex Peptide PC 3.2/30, GE Healthcare) by an offline 
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HPLC (Agilent Technologies). Two or three SEC fractions covering the molecular mass 
range of ~2.5 kD to ~10 kD were subsequently collected and analyzed by LC/MS. For 
cross-link identifications, the purified peptides were dissolved in the sample loading buffer 
(5% MeOH, 0.2% FA) and analyzed by a LTQ Velos Orbitrap Pro mass spectrometer or 
an Orbitrap Q Exactive (QE) Plus mass spectrometer (Thermo Fisher). For the analysis 
by the Velos Orbitrap mass spectrometer, briefly, the dissolved peptides were pressure 
loaded onto a self-packed PicoFrit column with integrated electrospray ionization emitter 
tip (360 O.D, 75 I.D with 15 μm tip, New Objective). The column was packed with 10 cm 
reverse-phase C18 material (3 μm porous silica, 200 Å pore size, Dr. Maisch GmbH). 
Mobile phase A consisted of 0.5% acetic acid and mobile phase B of 70% ACN with 0.5% 
acetic acid. The peptides were eluted in a 120 or a 140 min LC gradient (8% B to 50% B, 
0-93 min, followed by 50% B to 100% B, 93-110 min and equilibrated with 100% A until 
120 or 140 min) using a HPLC system (Agilent), and analyzed with a LTQ Velos Orbitrap 
Pro mass spectrometer. The flow rate was ~200-250 nL/min. The spray voltage was set 
at 1.9-2.3 kV. The instrument was operated in the data-dependent mode, where the top 
eight-most abundant ions were fragmented by higher energy collisional dissociation 
(HCD) (normalized collisional energy 27-29) and analyzed in the Orbitrap mass analyzer. 
The target resolution for MS1 was 60,000 and 7,500 for MS2. The QE instrument was 
directly coupled to an EASY-nLC 1200 System (Thermo Fisher) and experimental 
parameters were similar to those of the Velos Orbitrap. The cross-linked peptides were 
loaded onto an Easy-Spray column heated at 35ºC (C18, 3mm particle size, 200 Å pore 
size, and 50 μm X 15cm, Thermo fisher). The top 8 or 10 most abundant ions (with charge 
stage of 3-7) were selected for fragmentation by HCD. The raw data were searched by 
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pLink (Yang et al., 2012a) using a FASTA database containing protein sequences of the 
complexes. An initial MS1 search window of 5 Da was allowed to cover all isotopic peaks 
of the cross-linked peptides. The data were automatically filtered using a mass accuracy 
of MS1 ≤ 10 ppm (parts per million) and MS2 ≤ 20 ppm of the theoretical monoisotopic 
(A0) and other isotopic masses (A+1, A+2, A+3, and A+4) as specified in the software. 
Other search parameters include cysteine carbamidomethyl as a fixed modification, and 
methionine oxidation as a variable modification. A maximum of two trypsin missed-
cleavage sites was allowed. The initial search results were obtained using a default 5% 
false discovery rate (FDR) – expected by target-decoy search strategy. All spectra were 
manually verified. ~94% of the cross-link identifications have a MS1 mass accuracy within 
6 ppm. The cross-link data was visualized and analyzed by the CX-Circos software 
(manuscript in preparation). 
Chemical Cross-linking and Mass Spectrometry Analysis of the S. cerevisiae/S. 
kudriavzevii Nup82 Holo-complex  
To define the relative orientation of the two copies of Nup82 present in the Nup82 holo-
complex we expressed an exogenous copy of Nup82 from the yeast Saccharomyces 
kudriavzevii (called from now on skNup82). We selected S. kudriavzevii because it is a 
closely related species that forms natural hybrids with S. cerevisiae, some of them used 
for wine fabrication (Borneman et al., 2012), and the level of conservation at the amino 
acid level between both species is particularly high, ensuring functionality of the skNup82 
version and enough sequence variation to identify the specific peptides from each species 
protein version. S. kudriavzevii strain was obtained from ATCC (ATCC 2601) and 
genomic DNA was prepared using standard methods. The 30 UTR and open reading 
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frame for skNup82 was amplified and sequenced to account for potential mutations 
detected in the sequence available in the public database (GenBank: EHN01740.1). The 
wild-type verified skNup82 sequence was found to encode a 716 amino acid protein with 
75% identity to the scNup82 primary sequence (alignment available upon request). The 
upstream 190 nucleotides (promoter) region and the gene sequence were amplified using 
primers skN82Prom-F(5´-CACCGAAAGTTTATAGATTCAT-3´) and skN82GTW_R2 (5´-
GCTGGGCCCCTGGAACAGAACTTCCAGGCCGTTTTTTGGCTGAGTATTAGTG-3´) 
that introduces an in-frame prescission protease cleavage site at the end of the skNup82 
coding sequence. The PCR product was cloned using the pENTR/D-TOPO Cloning Kit 
(Thermo Fisher Scientific) and then transferred to a modified pAG305GPD-ccdb-EGFP 
plasmid (Addgene), where the GPD promoter had been eliminated through a SacI-XbaI 
(New England Biolabs) cleavage and refill. The resulting integrative plasmid, pAG305- 
skNup82ppx-EGFP, was linearized using ClaI (New England Biolabs) and transformed 
into a diploid w303 S. cerevisiae strain. Successful integrations were assessed by PCR; 
correct expression and localization of the skNup82-EGFP construct were confirmed by 
western-blot and fluorescence microscopy, that showed the characteristic nuclear rim 
staining of a properly localized nucleoporin. Affinity purification of the Nup82 complex 
using skNup82-EGFP as a handle showed all the components of the native Nup82 
complex, including a substoichiometric amount of scNup82, showing correct 
incorporation of the construct into the native Nup82 complex. The isolated, purified 
complex (see above for details on purification) was analyzed by CX-MS (see above).  
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Negative Stain Electron Microscopy  
Purified endogenous Nup82 complex samples were applied to glow-discharged carbon-
coated copper grids and stained with 1% uranyl formate. Images were collected on a 
Tecnai F20 (FEI Inc., USA) transmission electron microscope operating at an acceleration 
voltage of 80 kV at 50,000x magnification and underfocus ~1.5 μm. Images were 
recorded on a Tietz F224 4096x4096 CCD camera (15 μm pixels) at 2x binning. The pixel 
size at the specimen level was 3.23 Å. Particles were selected using Boxer from EMAN 
(Ludtke et al., 1999). The contrast transfer function (CTF) of the normalized images was 
determined using ctfit from EMAN and the phases were flipped accordingly. After that, 
the particles were subjected to Iterative Stable Alignment and Clustering (ISAC; (55)) 
technique. A pixel error of 2√3 was used for the stability threshold. For comparison, the 
Nup82 holo-complex class averages were aligned and paired with Nsp1-FGD class 
averages or with GFP-tagged Nup82 complex class averages using the modified Spider 
‘AP SH’ operation. Then the Nsp1-FGD class averages were subtracted from the Nup82 
holo-complex class averages and the Nup82 holo-complex class averages were 
subtracted from the GFP-tagged Nup82 complex class averages and difference maps 
generated.  
Fluorescence In Situ Hybridization  
FISH on wild-type and Nup84 complex truncation mutant strains was performed in 96-
well plates. A 35 nucleotide long oligo dT probe (synthetized by Exiqon) and labeled post-
synthesis with cy5 was used to detect poly A+ RNA [TT+TTT+TTTT+TTT+TTT+TT.  
TT+TTT+TTT+TTT+TTT+TTTT, T+ represents locked nucleic acids (LNA). Cells were 
grown in SD complete at 25ºC to OD 600 = 0.5-0.6 and fixed by the addition of para-
183 
 
formaldehyde at a final concentration of 4% for 45min at room temperature. Cells were 
washed 3x with buffer B (1.2M Sorbitol, 100mM KHPO4 pH7.5), suspended in 
spheroplast buffer [1.2M Sorbitol, 100mM KHPO4 pH7.5, 20mM Ribonucleoside-vanadyl 
complex (NEB #S1402S), 20mM β-mercaptoethanol, 25U lyticase / 1OD600 of cells 
(Sigma cat # L2524)] and incubated at 37ºC until cell walls were digested. Digested cells 
were washed 2x with cold buffer B, attached to polyA lysine (0.01%) treated 96 glass 
bottom MicroWell plate (MGB096-1-2-LG-L #0325289L2L) and stored in 70% ethanol at 
-20ºC. For hybridization cells were washed twice with 2 3 saline sodium citrate (SSC) and 
1x 35% formamide/2 3 SSC. 20ng of labeled dT LNA probe was resuspended in 35% 
(v/v) formamide, 2 3 SSC, 1 mg·ml-1 BSA, 10 mM ribonucleoside vanadyl complex (NEB 
#S1402S), 5 mM NaHPO4, pH 7.5, 0.5 mg·ml-1 Escherichia coli tRNA and 0.5 mg·ml-1 
single-stranded DNA and denatured at 95ºC for 3 min and cells hybridized overnight in 
the dark at 37ºC. Cells were then washed in 35% formamide/2 3 SSC at 37ºC 2x 30 min, 
followed by a 1 min wash in 1 3 PBS at room temperature followed by the addition of 
DAPI containing mounting medium to each well (Prolong Gold - Invitrogen #P36935). 
Images were acquired using a Zeiss Z1 inverted microscope, a 100x 1.43 NA oil objective 
and a AxioCam mRm CCD camera and the following filter sets: Zeiss 488050-9901-000 
(Cy5), Zeiss 488049-9901-000 (DAPI). Three-dimensional datasets were generated by 
acquiring multiple 200 nm z stacks spanning the entire volume of cells, 3D datasets 
reduced to 2D datasets by applying a maximum projection function in FiJi. The polyA 
accumulation phenotype was quantified by determining the fraction of cells showing 
strong nuclear polyA accumulation. For each strain, at least 200 cells from at least 3 
different fields were quantified. 
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Fluorescence Microscopy  
Nup82 was genomically tagged with GFP on selected Nup84 complex truncation yeast 
mutant strains using standard techniques. Cells were grown in YPD media at 30C and 
visualized with a 63x 1.4 numerical aperture plan-apochromat objective using a Carl Zeiss 
Axioplan 2 microscope equipped with a Hamamatsu Orca ER-cooled CCD camera. The 
system was controlled with Openlab imaging software (Perkin Elmer). Images were 
treated with ImageJ (http://imagej.net/Welcome) and Adobe Photoshop (Adobe) 
softwares.  
Integrative Structure Determination  
Our integrative structure determination of the Nup82 holo-complex proceeded through 
four stages (Fig. S3D) (12, 27): (1) gathering of data, (2) representation of subunits and 
translation of the data into spatial restraints, (3) configurational sampling to produce an 
ensemble of structures that satisfies the restraints, and (4) analysis and validation of the 
ensemble structures. The modeling protocol (i.e., stages 2, 3, and 4) was scripted using 
the Python Modeling Interface (PMI), version c7411c3, a library for modeling 
macromolecular complexes based on our open-source Integrative Modeling Platform 
(IMP) package, version 2.5 (https://integrativemodeling.org) (21). Further details of the 
integrative modeling procedures are provided in Table 1, as well as previous publications 
(13). Files containing the input data, scripts, and output structures are available online 
(https://salilab.org/nup82; https://github.com/salilab/nup82).  
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Table 6.1. Summary of Integrative Structure Determination of the Nup82 Complex 
Modeling Programs 
Python Modeling Interface (PMI), version 
c7411c3; Integrative Modeling Platform (IMP), 
version 2.5; MODELER 9.13 
Homology Detection and 
Structure Prediction 
HHPred, PSIPRED, DISOPRED, DomPred, 
COILS/PCOILS, and Multicoil2 (see also Figure 
S3 and Table S1) 
Spatial Restraints 
Chemical cross-links, electron microscopy 2D, 
excluded volume, sequence connectivity, and 
five homo-dimer cross-links restraints (see also 
Methods) 
Sampling Method 
Replica exchange Gibbs sampling, based on the 
Metropolis Monte Carlo algorithm; 8–16 replicas 
were used through 270 (initial step) and 80 
(refinement step) independent runs, at the 
temperature range of 1.0–2.5 
Monte Carlo Moves 
Random translation and rotation of rigid bodies 
(up to 2 Å and 0.04 radians, respectively) 
Random translation of individual beads in the 
flexible segments (up to 3 Å) 
Number of Structures 
Generated 
1,350,000 (initial step) and 10,000 (refinement 
step) structures 
463 top-scoring structures were subjected to the 
clustering analysis 
Clustering Analysis 2 clusters of 370 (80%) and 93 (20%) structures (see also Figures S4 and S5) 
Sampling Exhaustiveness p = 0.972 
Precision of the Clusters 9.0 Å (cluster 1: 370 structures) / 16.3 Å (cluster 2: 93 structures) 
Stoichiometry 2:2:2:2 (Nup82:Nup159:Nsp1:Dyn2; see also Figure 6.1) 
Chemical Cross-links Satisfied 
in the Cluster 
88.5% combined (93.3% DSS and 74.1% EDC 
within 35 and 30 Å distances, respectively; see 
also Figures 6.2B and S4D) 
EM 2D Class Averages Average ccc for 21 class averages is 0.931. See also Figures 6.2C and S2C. 
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GFP Mass-Tagging EM 2D 
Class Averages 
ccc = 0.932 (GFP mass-tagging at the Nup159 C 
termini); ccc = 0.953 (GFP mass-tagging at the 
Nup82 C termini) (see also Figure 6.2C) 
Small Angle X-Ray Scattering 
(SAXS) 
χ = 1.66 (Nup824–220), 2.55 (Nup824–452), and 
6.47 (Nup82572–690) (see also Figures 6.2D 
and S5D–S5F and Table S4) 
Human NPC cryo-EM Map ccc = 0.72 (wild-type) and 0.81 (mutant) (see also Figure 6.5 and S6) 
Visualization and Plotting UCSF Chimera 1.10, CX-Circos, matplotLib, and GNUPLOT 
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Stage 1: Gathering of Data  
The stoichiometry was determined via biochemical quantitation of the density-gradient 
purified Nup82 complex (Fig. S1). 1,131 cross-links were identified via mass spectrometry 
(Fig. 6.2A; Table S2). The atomic structures for some of the yeast Nup82 complex 
components had been previously determined via X-ray crystallography (Table S1) (8, 22, 
32, 56). Their close homologs were identified by HHPred (Table S1) (18). Secondary 
structure and disordered regions were predicted by PSIPRED (57) and DISOPRED (58), 
respectively (Table S1). Coiled-coil regions of Nup82, Nsp1, and Nup159 were predicted 
by COILS/PCOILS (59) and Multicoil2 (60) (Table S1). 21 EM class averages (Fig. S2C) 
and 3 SAXS profiles (Fig. S5D–S5F) were obtained as described in Methods and Table 
S4.  
Stage 2: Representation of Subunits and Translation of the Data into Spatial Restraints  
The domains of the Nup82 complex subunits were coarse-grained using beads of varying 
sizes representing either a rigid body or a flexible string, based on the available 
crystallographic structures and comparative models (Table S1). In a rigid body, the beads 
have their relative distances constrained during configurational sampling, whereas in a 
flexible string the beads are restrained by the sequence connectivity (13). The residues 
in the rigid bodies and flexible strings corresponded to 37.3% and 62.7% of the Nup82 
complex, respectively. To maximize computational efficiency while avoiding using too 
coarse a representation, we represented the Nup82 complex in a multi-scale fashion, as 
follows.  
First, the crystallographic structures of each Nup82 complex domain were coarse-
grained using two categories of resolution, where beads represented either individual 
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residues or segments of up to 10 residues. For the one-residue bead representation, the 
coordinates of a bead were those of the corresponding Ca atoms. For the 10-residue 
bead representation, the coordinates of a bead were the center of mass of all atoms in 
the corresponding consecutive residues (each residue was in one bead only). The 
crystallographic structures covered 25.6% of the residues in the Nup82 complex.  
Second, for predicted non-disordered domains of the remaining sequences, 
comparative models were built with MODELER 9.13 (17) based on the closest known 
structure detected by HHPred (18) and the literature (Table S1) (6, 7). Notably, 
structurally defined remote homologs (PDB: 5C3L and 5CWS) (6, 7) were detected for 
the C-terminal coiled-coil regions of Nup82, Nup159, and Nsp1 (Fig. S3; Table S1). 
Similarly to the X-ray structures, the modeled regions were also coarse-grained using two 
categories of resolution, resulting in the 1-residue and 10-residue bead representations. 
The comparative models covered 11.7% of the residues in the Nup82 complex.  
Finally, the remaining regions without a crystallographic structure or a comparative 
model (i.e., regions predicted to be disordered without a known homolog) were 
represented by a flexible string of beads corresponding to up to 100 residues each. We 
used the low-resolution representation (100 residues per bead) only for the unstructured 
FG repeats, whose structure is ‘‘decoupled’’ from the configurations of the core of the 
Nup82 holo-complex (27). The residues in these beads corresponded to 62.7% of the 
Nup82 complex.  
To improve the accuracy and precision of the structure ensemble obtained through 
the satisfaction of spatial restraints (below), we also imposed constraints based on 
crystallographically defined interfaces: Dyn27-92-Nup1591117-1126 (PDB: 4DS1) (22) and 
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Nup827-452-Nup1591429-1456-Nup116966-1111 (PDB: 3PBP) (8). The latter interface of 
ScNup116966-1111 was compared with the structure of CgNup116882–1034 (PDB: 3NF5) (32), 
leading to the conclusion that the Nup116 interfaces are consistent among different 
species. Subcomplexes including these interfaces were simply represented as rigid 
bodies.  
With this representation in hand, we next encoded the spatial restraints into a 
Bayesian scoring function (13) based on the information gathered in Stage 1, as follows.  
First, the collected DSS and EDC cross-links were used to construct the Bayesian scoring 
function that restrained the distances spanned by the cross-linked residues (13), taking 
into account the ambiguity due to multiple copies of identical subunits; the ambiguous 
cross-link restraint considers all possible pairwise assignments in multiple copies of 
identical subunits, weighting more the least violated distance(s).  
Second, the excluded volume restraints were applied to each bead in 10-residue (or the 
closest) bead representations, using the statistical relationship between the volume and 
the number of residues that it covered (27).  
Third, we applied the sequence connectivity restraint, using a harmonic upper 
bound on the distance between consecutive beads in a subunit, with a threshold distance 
equal to four times the sum of the radii of the two connected beads. The bead radius was 
calculated from the excluded volume of the corresponding bead, assuming standard 
protein density (13, 27).  
Fourth, 5 homo-dimer DSS cross-links between Nup159 residues of 1384-1384, 
1387-1387, 1414-1414, 1417-1417, and 1432- 1432 as well as one homo-dimer DSS 
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cross-link between Nup82 residues of 517-517 were transformed to upper-harmonic 
distance restraints (up to 30 Å), enforcing the homo-dimer formation of the helices.  
Finally, the EM 2D restraint (13) was imposed on the highest resolution representation of 
each subunit, using a negative logarithm of the cross-correlation coefficient between the 
EM class average density and the best-matching density projection of the structure as the 
em2D score (Stage 3). For sufficient precision, 100 projections were generated by 
uniform sampling of the unit sphere (13). The pixel size of the resulting projection image 
was equal to the pixel size of the class average (3.23Å). The relative weight of the final 
EM 2D restraint in the total score of a structure was set to 104, so that the scale of the 
em2D score matched those of the other restraint types.  
Most of the remaining information (stoichiometry, crystallographic structures of the 
subunits, their homologs, and the two crystallographic interfaces) is included in the 
representation, whereas the SAXS profiles, immuno-EM class averages, and the density 
map from single-particle EM reconstruction (9) were used only for validating our final 
structures. See the IMP scripts for details (https://salilab.org/nup82; 
https://github.com/salilab/nup82).  
Stage 3: Conformational Sampling  
Structural models of the Nup82 complex were computed using Replica Exchange Gibbs 
sampling, based on the Metropolis Monte Carlo algorithm (13). The Monte Carlo moves 
included random translation and rotation of rigid bodies (up to 2 Å and 0.04 radians, 
respectively) and random translation of individual beads in the flexible segments (up to 3 
Å). 8 to 16 replicas were used for each run, with temperatures ranging between 1.0 and 
2.5 (Table 1). A structure model was saved every 10 Gibbs sampling steps, each 
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consisting of a cycle of Monte Carlo steps that moved every rigid body and flexible bead 
once. The entire sampling procedure (Steps 1 to 3) took ~4 weeks on a cluster of ~5,000 
cores.  
Step 1—Initial modeling against each corresponding EM 2D class  
21 subsets of independent sampling runs were performed, each sampling run starting 
with a random initial configuration and sampled against the EM 2D restraint of the 
corresponding class. The calculations were repeated 10 to 20 times per subset, producing 
a total of ~1,350,000 structures through the 270 independent runs.  
Step 2—Application of the EM 2D filter  
From the ~1,350,000 structures from Step 1, we selected 650 structures whose em2D 
cross-correlation coefficient was at least 0.89 for at least 10 of the 21 class averages (Fig. 
S4B).  
Step 3—Refinement against all 21 EM 2D class averages  
80 independent refinement runs were performed, each one starting with one of the 650 
structures from Step 2. The scoring function included em2D scores for all 21 class 
averages as well as other restraints listed above. The sampling produced a total of 
~10,000 structures. 463 top-scoring structures from Step 3 were subjected to the 
subsequent analysis in Stage 4.  
Stage 4: Analysis and Validation of the Ensemble Structures  
Input information and output structures need to be analyzed to estimate structure 
precision and accuracy, detect inconsistent and missing information, and to suggest more 
informative future experiments. Assessment begins with structural clustering of the 
modeled structures produced by sampling, followed by assessment of the thoroughness 
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of structural sampling, estimating structure precision based on variability in the ensemble 
of good-scoring structures, quantification of the structure fit to the input information, 
structure assessment by cross-validation, and structure assessment by data not used to 
compute it. These validations are based on the nascent wwPDB effort on archival, 
validation, and dissemination of integrative structure models, which we lead (14). We now 
discuss each one of these points in turn.  
Clustering  
A prerequisite for structure analysis is the clustering of the structures generated by 
satisfying the input data (12, 13). We used Cα root-mean-square deviation (RMSD) 
quality-threshold clustering (13). In general, there are three possible modeling outcomes, 
based on the number of clusters of models and consistency between the models and 
information (13). First, if only a single model (or a cluster of similar models) satisfies all 
restraints and all input information, there is likely sufficient information for determining the 
structure (with the precision corresponding to the variability within the cluster). Second, if 
two or more different models are consistent with the input restraints, the information is 
insufficient to define the single state or there are multiple significantly populated states. If 
the number of distinct models is small, structural differences between models may 
suggest additional experiments to narrow down the number of possible solutions. Third, 
if no model satisfies all input information, the information or its interpretation in terms of 
the inferred spatial restraints is incorrect, in which case the representation needs to be 
modified to include additional degrees of freedom, and/or sampling needs to be improved.  
In the case of the Nup82 complex, the clustering analysis identified a single dominant 
cluster of 370 similar structures (Fig. S4A and S5B), corresponding to the most favorable 
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outcome of the three possibilities described above. The average RMSD between the 
major (370 structures) and minor clusters (93 structures) is relatively low at approximately 
20 Å, considering the resolution of the data, the resolution of the coarse-grained 
molecular representation, and the variation within each cluster (13) (Fig. S4A). As a result, 
localization of all components is effectively identical between the major and minor 
clusters, differing only in the orientation of the Nup82 β-propeller (Fig. S5B). Most 
importantly, our functional interpretation of the structure is completely robust with regard 
to the differences between the means of the two clusters.  
Convergence of Sampling  
Any structure determination or computational modeling exercise can be described as a 
structural sampling process, guided by a scoring function (27). Generally, good-scoring 
structures need to be found by a sampling, optimization, or enumeration scheme. Unless 
structures are enumerated, the very first test needs to estimate the thoroughness of 
structural sampling or optimization (13), which is often stochastic (e.g., Monte Carlo and 
Molecular Dynamics simulations). For stochastic methods, thoroughness of sampling can 
be assessed by showing that two independent runs (e.g., using random starting 
configurations or different random number generator seeds) do not result in significantly 
different solutions (13, 23, 27). Given two or more sets of structures from independent 
runs, we first cluster structures from all sets together, followed by assessing whether or 
not the runs contribute evenly to the population of each cluster, using the p value from 
the χ2 contingency test for homogeneity of proportions (61).  
For the Nup82 complex, the highly significant p value of 0.972 (Table 1) indicated 
that our Monte Carlo algorithm sampled all top scoring solutions at the resolution better 
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than the precision of the dominant cluster. The caveat is that passing this sampling test 
is not absolute evidence of thorough sampling; a positive outcome of the test may be 
misleading if, for example, the landscape contains only a narrow, and thus difficult to find, 
pathway to the pronounced minimum corresponding to the correct structure.  
Estimating Structure Precision Based on Variability in the Ensemble of Good-Scoring 
Structures  
The ensemble of the top-scoring structures is analyzed in terms of the precision of its 
structural features (12, 27). In general, commonly-used features include particle positions, 
distances, and contacts. Precision is defined by the feature variability in the ensemble 
with a measure similar to the crystallographic isotropic temperature factor (Biso) (Fig. 
S4C), and likely provides the lower bound on its accuracy. Of particular interest are 
features present in most configurations in the ensemble that have a single maximum in 
their probability distribution. The spread around the maximum describes how precisely 
the feature is determined from the input information. The precision of component position 
is quantified as the average root-mean-square fluctuation (RMSF) across all pairs of 
structures in the cluster, after least-squares superposition onto the centroid structure (13).  
For the Nup82 complex, the 9.0 Å precision of the core structured region in the dominant 
cluster was sufficiently high to pinpoint the locations and orientations of the constituent 
proteins and domains (Fig. 6.1 and S4C; Table 1), demonstrating the quality of the data 
including the cross-links and EM 2D class averages. The localization probability density 
maps of every Nup82 subunit as well as the whole complex were computed from the 
dominant cluster of the 370 solutions (Fig. 6.1 and S4A).  
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Fit to Input Information  
An accurate structure needs to satisfy the input information used to compute it. The 
ensemble of solutions was assessed in terms of how well they satisfied information from 
which they were computed, including the cross-links, the excluded volume, sequence 
connectivity, and the EM two-dimensional restraints.  
First, the dominant cluster satisfied 88.5% of all combined cross-links (93.3% and 
74.1% of the DSS and EDC cross-links, respectively) (Fig. 6.2B and S4D; Table 1); a 
cross-link restraint was satisfied by the cluster ensemble if the median Cα-Cα distance of 
the corresponding residue pairs (considering restraint ambiguity) was < 35 Å and 30 Å for 
the DSS and the EDC cross-links, respectively. Our cross-link data (10 DSS and 1 EDC 
cross-links) is in complete agreement with the crystal structure of Nup827-452-Nup1591429-
1456-Nup116966-1111 (PDB: 3PBP) (Fig. 6.3).  
Second, the EDC and DSS cross-links are highly consistent with each other, 
despite different chemistries, and there is significant highly non-random clustering of both 
EDC and DSS cross-links into equivalent ‘‘cliques’’ (Fig. 6.2A). These represent 
adjacencies, as validated by those cliques that coincide with known crystallographic 
interface regions, such as Nup159:Dyn2 (PDB: 4DS1) (22) and Nup159:Nup82 (PDB: 
3PBP) (8); indeed, in our final calculated structure these cliques represent immediately 
adjacent regions in the complex (Fig. 6.2B).  
Third, considering the more abundant DSS cross-links, as can be seen from Fig. 
S4D (left), relatively few cross-links (< 7%) remain unsatisfied by our structures. Of those 
that are not satisfied, most involve relatively modest distance violations that can clearly 
be rationalized by locally limited flexibility of the proteins, as shown in Fig. 6.2B (cross-
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link distance distributions). Moreover, those few cross-links in violation of strict distance 
limits in our structure are nevertheless right next to one of the cliques; they are thus 
consistent with the structure when locally limited flexibility is taken into account (Fig. 6.2A 
and S4D) (13).  
Fourth, the solutions also fit the EM class averages, with an average cross-
correlation coefficient of 0.931 (Fig. 6.2C; Table 1). Finally, 99% of the top 463 solutions 
satisfied the excluded volume and sequence connectivity restraints under the combined 
score threshold of 500.  
Satisfaction of Data that Were Not Used to Compute Structures  
In principle, our Bayesian modeling already effectively includes cross-validation via its 
Bayesian scoring function and sampling (13). However, the most direct test of a modeled 
structure is by comparing it to the data that were not used to compute it (a generalization 
of cross-validation). A structure can be validated directly against experimental data 
deliberately omitted from the structural model calculation (62). This goal is achieved by 
excluding a subset of the experimental data from structure calculation, followed by 
evaluation of the resulting structures against the omitted subset of data. This procedure 
is analogous to the one used for calculating the crystallographic Rfree parameter and can 
be used to assess both the structure and the input data.  
First, mass tagging of our structure is consistent with the localization of GFP tags 
on both the Nup82 and Nup159 C-termini (See ‘‘GFP mass-tagging analysis of the Nup82 
holo-complex by immuno-EM’’ below and Fig. 6.2C).  
Second, our structure is consistent with the previously published data, including 
an independent negative stain 3D density map (Fig. S5A) (9). Our asymmetric ~19 nm 
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long structure bears a general resemblance to the Nup82 complex class averages by 
Gaik et al., except for having mostly one Dyn2 dimer at its end instead of five dimers (9). 
Third, the trimeric coiled-coil structure between the helical Nup82-Nup159-Nsp1 
regions is recapitulated even when computed using the chemical cross-linking data alone, 
without using the EM class averages (Fig. S5C). We modeled the trimer using the 
available crystallographic structures, the helical regions predicted by PSIPRED (57), and 
the cross-links. All crystallographic structures and predicted helical regions were kept 
rigid. We used an ideal helix template to construct the coordinates of the predicted helical 
regions. We adopted the same multi-scale approach used to represent the entire Nup82 
complex described above. The 500 best-scoring solutions satisfied all cross-links. The 
structural clustering of the 500 best-scoring solutions revealed that regions Nup82522-612-
Nup1591211-1321-Nsp1637-727 were consistently arranged into a trimeric helical bundle.  
Fourth, our structure is in agreement with SAXS profiles and ab initio shapes of 
Nup82 constructs spanning residues 4-220, 4-452, and 572-690 (Fig. 6.2D and S5D–
S5F; Table S4). Notably, the Nup82 coiled-coil (572-690) forms a kinked structure and 
the corresponding SAXS profile shows a tendency of monotonous increase in the Kratky 
plot (Fig. S5F), indicating a high degree of flexibility between coiled-coil segments in 
solution, as would be expected for coiled-coils that form two different conformers as seen 
in the final structure.  
Finally, our structure is also validated by the non-random and clustered distribution 
of cross-links connecting the Nup82 holo-complex to other parts of the NPC, revealing 
interaction sites, as described in ‘‘Docking of the Nup82 holo-complex and the Y-shape 
Nup84 complex’’ below.  
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GFP Mass-Tagging Electron Microscopy  
Two different types of GFP-tagged structures of the Nup82 holo-complex were generated 
by attaching a rigid-body GFP structure (PDB: 1GFL) to either the Nup82 or Nup159 C-
termini via the 14 linker residues of DPLALPVATPGIPM. For the Nup82 complex, the 
best-scoring structure was used. The configuration of the GFP tags was optimized using 
the replica exchange Gibbs sampling as described above using IMP. In summary, 10 
independent sampling runs were performed, each run starting with a random initial 
configuration of the GFP tags. 4 replicas were used for each run, with temperatures 
ranging between 1.0 and 2.5. We produced a total of 50,000 structures each for the 
Nup82 and Nup159 GFP tags, using the EM 2D restraint of the corresponding immuno-
EM class average. As a result, the best-scoring model structures are consistent with the 
localization of the GFP tags on both the Nup82 (ccc = 0.953) and Nup159 (ccc = 0.932) 
C-termini (Fig. 6.2C).  
Docking of the Nup82 Holo-complex and the Y-Shape Nup84 Complex  
A structure of the Nup82 holo-complex interacting with the Y-shape Nup84 complex was 
obtained by rigid-body docking restrained by 9 chemical cross-links identified at the 
interface (Table S3), using the replica exchange Gibbs sampling using IMP, as described 
above. For the Nup82 complex, the best-scoring structure was used. For the Nup84 
complex, our previous structure (Shi et al., 2014) was refined by using new 
crystallographic structures of the complex subunits (PDB: 4XMM and 4YCZ) (25, 26). 
Next, 20 independent sampling runs were performed, each run starting with a random 
initial configuration. 6 replicas were used for each run, with temperatures ranging between 
1.0 and 2.5. We produced a total of 100,000 structures using the crosslink restraints 
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spanning the interface between the Nup82 holo-complex and the Nup84 complex. 
Subsequently, 200 top-scoring structures were subjected to the clustering analysis, 
identifying 3 clusters (clusters A, B, and C; 86, 70, and 44 structures, respectively) of 
solution structures (Fig. S6A). At least 7 out of the 9 chemical cross-links were satisfied 
by the 200 top-scoring structures, within the distance threshold of 35 Å. All our solutions 
were similar, differing only in the degree of the Nup82 complex rotation along its long axis, 
relative to the Nup84 complex (Fig. S6B). Precisions of the Nup82 holo-complex in the 3 
clusters were 30.2, 11.0, and 39.0 Å, respectively. Among the three clusters, only cluster 
C satisfied the cross-links used to compute them (Table S3) and the S. cerevisiae NPC 
localization probability density map (fit score by overlapping volume = 0.46, Fig. 5A and 
S6C) (12). Notably, this cluster of solutions is also the only one that aligns with the wild-
type human NPC tomographic cryo-EM map (Fig. 6.5B and S6D, EMDB 2444) (28) and 
the mutant one lacking an outer cytoplasmic Y-complex ring (Fig. 6.5C, EMDB 3104) 
(34). The cross-correlation coefficients between the Nup82 holo-complex structure and 
the human NPC tomographic cryo-EM maps are 0.72 (wild-type, Fig. 6.5B and S6D) and 
0.81 (mutant, Fig. 6.5C) in cluster C (Table 1). The cross-correlation coefficients were 
calculated using the measure correlation command in the UCSF Chimera software 
(https://www.cgl.ucsf.edu/chimera/).  
Data and software availability 
Software  
The modeling protocol (i.e., stages 2, 3, and 4) was scripted using the Python Modeling 
Interface (PMI), version c7411c3, a library for modeling macromolecular complexes 
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based on our open-source Integrative Modeling Platform (IMP) package, version 2.5 
(https:// integrativemodeling.org) (21). 
To display the CX-MS data we used the software CX-Circos (http://cx-circos.net).  
Data Resources  
The chemical cross-linking with mass spectrometric readout data used in this study was 
deposited in the Chorus database (https:// chorusproject.org/pages/index.html).  
Files containing the input data, modeling scripts, and output structures are available 
online (https://salilab.org/nup82; https:// github.com/salilab/nup82). 
Supplemental Information 
Supplemental Information includes seven figures, four tables, and two movies and can 
be found with this article online at http://dx.doi.org/10.1016/j.cell.2016.10.028.  
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Abstract 
The membrane ring that equatorially circumscribes the nuclear pore complex (NPC) in 
the perinuclear lumen of the nuclear envelope is composed largely of Pom152 in yeast 
and its ortholog Nup210 (or Gp210) in vertebrates. Here, we have used a combination of 
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negative-stain electron microscopy, nuclear magnetic resonance, and small-angle X-ray 
scattering methods to determine an integrative structure of the ~120 kDa luminal domain 
of Pom152. Our structural analysis reveals that the luminal domain is formed by a flexible 
string-of-pearls arrangement of nine repetitive cadherin-like Ig-like domains, indicating an 
evolutionary connection between NPCs and the cell adhesion machinery. The 16 copies 
of Pom152 known to be present in the yeast NPC are long enough to form the observed 
membrane ring, suggesting how interactions between Pom152 molecules help establish 
and maintain the NPC architecture.  
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Introduction 
The eukaryotic nucleus is delimited by the nuclear envelope (NE), composed of two 
distinct membranes, the inner and the outer nuclear membranes, that enclose the 
perinuclear lumen. The outer and inner nuclear membranes join to form specialized 
circular apertures (nuclear pores), containing large proteinaceous assemblies termed 
nuclear pore complexes (NPCs) (1). The yeast NPC is a large (~50 MDa) cylindrical 
assembly composed of multiple copies of ~30 different proteins, termed nucleoporins or 
Nups, arranged to form eight symmetrically arranged spokes linked by coaxial outer, 
inner, and membrane rings (2, 3). NPCs facilitate the active transport of macromolecules 
between the nucleoplasm and cytoplasm and are involved in other multiple essential 
roles, including controlling genome organization and expression (4). As a consequence, 
disruptions of the NPC can lead to human disease (5). 
It has been shown that the NPC has at its heart a cage-like core scaffold consisting 
of Nups composed entirely of either a b-propeller fold, an a-solenoid fold, or a distinctive 
arrangement of both folds, a combination otherwise unique to vesicle-coating complexes 
(6). These similarities suggest a common evolutionary origin for NPCs and coated 
vesicles in an early membrane-curving module or ‘‘protocoatomer’’ that led to the 
formation of the internal membrane systems defining the features of modern eukaryotes 
(6, 7). This coatomer-like core scaffold is anchored to the pore membrane through two 
different mechanisms. First, ALPS (amphipathic lipid packing sensor) motifs, membrane-
binding a-helical ‘‘fingers,’’ are found on the membrane-facing surface of the NPC core 
scaffold (8–10). Second, several Nups, termed pore membrane proteins or Poms, carry 
trans-membranous a-helices (11–13). Curiously, none of these transmembrane domains 
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or ALPS motifs seem individually essential for NPC assembly or membrane anchoring, 
suggesting functional redundancy (14). One particular Pom stands out by virtue of its size 
and its apparent homo-oligomerization (15, 16) to form the membrane ring that 
equatorially circumscribes the NPC in the perinuclear lumen of the NE (1). In yeast, this 
protein is termed Pom152 (17), a type II integral membrane protein (15) that has an N-
terminal NPC-associating region followed by a single transmembrane domain, whereas 
its presumed vertebrate homolog Nup210 (also known as Gp210) has its transmembrane 
domain near the C terminus followed by the NPC-associating region (13, 18). Both 
homologs have a large luminal domain that was previously suggested to be formed by 
repeated domains (17) of an Ig or cadherin-like fold (19). However, there is no available 
experimental evidence defining the precise number and structure of these domains or for 
the protein as a whole. Although Pom152 is non-essential in yeast, its overexpression 
significantly inhibits cell growth (17), and it has been implicated in helping to form an early 
intermediate structure during NPC assembly (20). In vertebrates, Nup210 is a key 
regulator of cell-fate adaptation (21, 22). Mutation and mis-regulation of Nup210 have 
been related to severe human diseases, including numerous cancers (23, 24). Here, we 
have used a combination of negative-stain electron microscopy (EM), nuclear magnetic 
resonance (NMR), and small-angle X-ray scattering (SAXS) methods to determine an 
integrative structure of the ~120 kDa luminal domain of Pom152.  
 
 
 
 
213 
 
Results 
Negative-Stain Electron Microscopy Analysis of Pom152 
To determine the overall shape and dimensions of the native full-length Pom152 
(Pom152FL; Fig. 7.1A), we purified the endogenous protein as a monomer using affinity 
purification, native elution, and sucrose density gradients (25) (Fig. 7.1 and S1A). The 
samples were visualized by negative-stain EM. The individual particle images display 
varying degrees of curvature, although the dominant form was elongated with a 
pronounced curvature, convex on the side adjacent to the head (Fig. 7.1). The particle 
images were analyzed using an iterative stable alignment and clustering (ISAC) method 
to generate class averages that were reproducible in multiple classification trials (26). All 
35 resulting class averages showed a thin elongated shape for the isolated monomeric 
protein molecule (Fig. 7.1B). The average end-to-end distance of Pom152FL class 
averages is 38.7 nm (±1.5 nm; 30 class averages) (Fig. 7.1G).  
To further assess the structural features of Pom152FL, we relied on the random 
conical tilt method (27) to compute an initial 3D map (Fig. 7.1C) and then used the Relion 
program to compute the final 3D map at 25 Å resolution (28) (Fig. 7.1D). The resolution 
is limited by incomplete angular coverage of particle views and conformational 
heterogeneity (Fig. S1D and S1E). Nevertheless, the map faithfully recapitulates the 
major features seen in the 2D class averages. Pom152FL has a prominent head that is 
attached to a long tail resembling a string-of-pearls (Fig. 7.1B). This tail is apparently 
formed by nine consecutive globular domains (Fig. 7.1D) and exhibits heterogeneity in 
the observed conformational states, probably due to changes in the relative orientations 
of the globular domains with respect to each other (Fig. 7.1B and 7.1C). The arrangement 
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of the first three domains (the neck) is relatively linear, while domains 3–9 form a curved 
shape in all observed classes. The estimated inter-domain angle between the latter 
globular domains (3–9) in most particle images ranges from -10º to +5º, with an average 
of -4.1º (Fig. 7.1E, 7.1B, and S1C). Some curvature is retained even as the domains are 
sequentially removed, supporting the idea that the curvature is an intrinsic property of the 
tail (Fig. 7.1F; below). 
To define which of the morphological features correspond to the N- and C-terminal 
domains of Pom152, we used negative-stain EM to analyze two C-terminally truncated 
versions of the protein. All resulting class averages for the C-terminal truncations 
Pom1521-1,135 and Pom1521-936 showed an intact head, but were missing a number of 
globular domains proportional to the size of the deletion, as reflected by their average 
end-to-end distance of 28.9 nm (±1.6 nm; 28 class averages) for Pom1521-1,135 and 24.4 
nm (±1.0 nm; 33 class averages) for Pom1521-936 (Fig. 7.1A, 7.1F, and 7.1G). This finding 
indicated that the tail corresponds to the C-terminal luminal domain of Pom152 
(Pom152LD) and that the head contains the N-terminal NPC-associating region and the 
transmembrane domain. The truncated Pom152 particles showed a degree of 
heterogeneity similar to that of Pom152FL. The difference between the end-to-end 
distances of Pom152FL and the truncated forms (Pom1521-1,135 and Pom1521-936) 
suggested an average size of 4.0 nm (±2.4 nm; 20 class averages) for each globular 
domain. The average width of the domains is 2.9 nm (±1.6 nm; 37 class averages).  
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Figure 7.1 | Negative-Stain EM Analysis Shows that Pom152 has an Extended, 
String-of-Pearls-Shaped Luminal Domain.  
(A) Domain organization of Pom152FL and four truncations drawn to scale. 
Pom152FL exhibits a three-domain organization with the NPC-associating domain 
(NPC), the transmembrane segment (TM), and the domain inside the perinuclear lumen 
of the nuclear envelope (luminal domain). The numbers indicate amino acid residue 
positions. Horizontal gray lines for the truncations represent the number of amino acid 
residues in each segment. (B) Thirty-five representative negative-stain EM class 
averages of Pom152FL. The number of particles in each class is shown. Bar, 10 nm. (C) 
Representative random conical tilt 3D maps (right) are aligned to each of the 
corresponding class averages (left). The number of particles in each class is shown. Bar, 
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10 nm. (D) Negative-stain EM density map of Pom152FL. The nine globular domains in 
the C-terminal lumen (1–9) and the N-terminal head region containing the NPC-
associating and TM domains are indicated. Bar, 50 Å. (E) The average inter-domain angle 
for the last seven repetitive regions was estimated in 37 representative Pom152FL class 
averages using the ImageJ angle tool. One angle was measured between domains 3 and 
9, its difference from 180° was determined, and the resulting value divided between the 
seven globular domains involved in the estimation. Distribution of the resulting inter-
domain angles is shown in a Kernel density plot with a peak of −4.1°, indicating a small 
negative curvature for the particles. (F) Representative negative-stain EM class averages 
of three assigned views of Pom152FL, Pom1521−1,135, and Pom1521−936. The number 
of particles in each class is shown. Bar, 10 nm. (G) End-to-end distances of Pom152FL, 
Pom1521−1,135, and Pom1521−936 in samples of 30, 28, and 33 class averages, 
respectively. The lines on the data points indicate the mean and SD: 38.7 ± 1.5 nm, 28.9 ± 
1.6 nm and 24.4 ± 1.0 nm for the samples, respectively. 
 
 
The Luminal Domain of Pom152 Stabilizes the NPC’s Association with the Pore 
Membrane 
Complete deletions of Pom152 have not been observed to change the fitness phenotype 
(17) but have been shown to cause synthetic defects when combined with mutations 
affecting inner-ring nucleoporins (15) or other integral membrane proteins involved in 
NPC biogenesis, such as Heh1 (16) or Apq12 (29). Pom152 is a part of the NPC 
membrane ring and has been suggested to be involved in shaping and stabilizing the 
NPC’s pore membrane (1, 16, 30). Indeed, Nups with ALPS-motif associated with the 
pore membrane also appear to help stabilize the membrane (8, 20, 31), as is exemplified 
by sensitivity to growth in the membrane-destabilizing reagent benzyl-alcohol (25). We 
thus decided to test the phenotype of Pom152LD truncation mutants in the presence of 
benzyl-alcohol.  
Addition of benzyl-alcohol caused especially clear growth defects in the luminal 
domain mutants (Fig. 7.2A). Complete deletion of Pom152 does not show such obvious 
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defects, suggesting that the observed phenotype is mainly related to the functional role 
of the luminal domain. When the same mutants were tested for thermosensitivity, no 
growth defect was observed (Fig. 7.2A), showing that the benzyl-alcohol phenotype is a 
specific and not a general response to stress; also, addition of the chemical chaperone 
tauroursodeoxycholic acid (TUDCA) did not compensate for the benzyl-alcohol growth 
defect (not shown), suggesting that the phenotype is not associated with the ER stress 
response pathway, as shown for hNup210 (22). To control for the possibility of subcellular 
mislocalization causing the Pom152 truncation mutant phenotypes, we used fluorescently 
tagged reporters to observe the localization of the Pom152 truncations in relation to other 
NPC markers. As shown in Fig. 7.2B, the truncated form of Pom152 shows the nuclear 
rim staining characteristic of a nucleoporin; the localization and distribution of NPCs, 
revealed by co-localization of the inner-ring component Nup188, appears normal. 
However, upon treatment with benzyl-alcohol, both Nup188 and the truncated Pom152 
start to co-accumulate at cytoplasmic foci. Our results thus show that the luminal domain 
of Pom152 is functionally relevant and suggest that it plays key roles in shaping and 
stabilizing the NPC structure.  
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Figure 7.2 | Functional Analysis of Truncations Affecting the Pom152 Luminal 
Domain.  
(A) Growth phenotypes of Pom152FL tagged with Protein A or 
Prescission protease cleavage site (PPX)-Protein A and related truncation mutants 
(see Fig. 1A). Serial 10-fold dilutions of cells were spotted on YPD plates in the absence 
or presence of 0.3% and 0.4% benzyl-OH at 30°C or on YPD plates and grown at the 
indicated temperatures for 1–3 days. (B) Subcellular localization of benzyl-OH treated 
Pom152-GFP constructs. Panels show the localization of the indicated genomically 
tagged Pom152-GFP or Nup188-mCherry (used as NPC localization control) constructs 
as determined by fluorescence microscopy. Cells were grown on liquid yeast minimal 
medium supplemented with 2% glucose at 30°C (untreated) or with an additional 0.1% 
benzyl-OH for 3 hr at 30°C (benzyl-OH). Differential interference contrast (DIC). Bar, 
5 μm. 
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Structure Determination of Pom152718–820, the Luminal Ig-like Domain, Using NMR 
Spectroscopy 
Negative-stain EM revealed that Pom152LD is formed by nine globular domains whose 
arrangement displays a significant but limited degree of heterogeneity and/or flexibility 
(Fig. 7.1), making this domain challenging for structure determination. However, their 
small size made individual domains suitable for structure determination by solution NMR 
spectroscopy. Two segments (Pom152603-820 corresponding to domains 3–4 and 
Pom152718-820 corresponding to domain 4) were evaluated by recording their 2D 1H-15N 
HSQC (heteronuclear single-quantum coherence) spectra (Fig. S2). The line shapes and 
intensities of the peaks seen for Pom152603-820 were non-uniform, making this segment 
intractable by NMR spectroscopy, whereas Pom152718-820 HSQC spectra showed well-
dispersed peaks with uniform line shapes and intensities. Pom152718-820 was thus chosen 
for full structure characterization due to its apparently higher conformational homogeneity.  
The backbone and side-chain resonances as well as distance restraints were 
determined for a [U-13C, 15N] Pom152718-820 sample. The 20 best-scoring structures in the 
ensemble superimpose well on each other, with root-mean-square deviation (RMSD) of 
0.60 ± 0.11 Å over N, Ca, and C backbone atoms; they also have good stereochemistry 
(Fig. 7.3A and Table 1). The solution structure of Pom152718-820 revealed an Ig-like fold 
(Fig. 7.3C and 7.3D) containing nine b strands that form two b sheets with a typical b-
sandwich topology (Fig. 7.3B). The two b sheets are made of the ABE and C´CFGG´A´ 
b strands (using the standard Ig-like domain annotation) (Fig. 7.3B). The fold does not 
contain any inter-sheet disulfide bonds, resulting in a less compact b sandwich with a 
distance between the two sheets of 11.4 Å (between B3 [Ser739] and F3 [Ile792] Ca 
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atoms) that is larger than that in related Ig-like fold structures, such as cadherins (e.g., 
9.4 Å between I33 and V79 in the neural cell adhesion molecule [NCAM]; PDB: 1EPF; 
(32)). Accordingly, we consider the Ig-like domain of Pom152718-820 to be a variant of the 
C3-subtype Ig-like fold family (Table 2 in (33)). Structural mapping of sequence 
conservation of Pom152718-820 among 37 fungal species reveals a conserved surface 
region lined by residues from the F, G, and G´ b strands and the FG loop, as well as 
highly conserved cysteine residues at the termini of the Ig domains (Fig. 7.3E, 7.3F, and 
S6). The former region has a net negative electrostatic potential in its center, partly 
bounded by patches with a net positive potential (Fig. 7.3G and 7.3H). We tested the 
possibility that this region is a binding site for calcium ions, as is the case for many 
cadherin-like proteins. However, addition of EDTA or calcium chloride did not significantly 
alter chemical shifts of Pom152718-820 or the negative-stain EM images (not shown), 
suggesting that Pom152 does not bind calcium ions, unlike many other cadherin-like 
proteins.  
Pom152 Luminal Domain Is Formed by an Array of Ig-like Domains 
We predicted that the remaining eight domains in the luminal domain of Pom152 are also 
Ig-like domains, as was already revealed by NMR spectroscopy for Pom152718-820. This 
prediction was based on the following four considerations. First, sequence-based 
predictions of secondary structure, disordered regions, and domain boundaries are 
consistent with an Ig-like fold (Fig. S3A–S3C). Second, the eight domains share 
statistically significant sequence alignments to Pom152718-820 (E-values ranging from 3.3 
x 10-49 to 6.8 x 10-39) (Fig. 7.4B, 7.4C, and S3D). Third, comparative models of these 
domains, constructed with MODELLER (34) using the NMR structure of Pom152718-820 as 
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a template (Fig. 7.4B and 7.4C), have reasonable stereochemistry, indicating all nine 
domains might assume the same fold. Finally, the cysteine residues in Pom152718-820 that 
we identified as conserved across different species (above) are also conserved in the 
remaining eight domains (Fig. 7.3E, 7.3F, and S6). As an aside, it is conceivable that 
putative disulfide bridges involving these cysteine residues help stabilize interfaces 
between the Ig-like domains of Pom152, intra- and/or inter-molecularly.  
 
Figure 7.3 | NMR Structure Determination of Pom152718-820 Reveals a Conserved 
Ig-like Fold Domain 
(A) Superimposition of the 20 lowest-energy structures of Pom152718-820 that satisfy the 
NMR restraints best. The two b sheets are made of the ABE (blue) and C´CFGG´A b 
strands (cyan). Scale bar, 5 Å. (B) Topology of the Pom152 fold. b strands are 
represented as thick arrows and the linkers connecting them as lines. Each strand is 
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named following the standard Ig-like domain annotation (Halaby et al., 1999). (C and D) 
Two views of the best-scoring structure, showing the arrangement of b strands and 
features labeled as in (B). (E and F) Sequence conservation of Pom152718-820 among 37 
fungal homologs (Figure S6), plotted on the surface of the Pom152718-820 structure; low 
conservation in white, high conservation in red. (G and H) Electrostatic potential on the 
surface of the Pom152718-820 structure, calculated using the PyMOL tool APBS; negative 
(2 kT/e) and positive (+2 kT/e) potentials are shown in red and blue, respectively. See 
also Figure S2 and Table 1. 
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Table 7.1 | NMR Restraints and Structural Statistics for the 20 Lowest-Energy 
Structures of Pom152718−820 
aHydrogen-bond restraints were an HN-O distance of 1.8–2.3 Å and an N-O distance of 
2.8–3.3 Å. bStructural characteristics for the final ensemble of 20 water-refined 
structures. cRMSD of the mean structure from individual structures in the ensemble. 
dRMSD for residues 718–820 shown. eRamachandran plot data shown for residues 718–
820 (in bracket structured region: 722–725; 731–733; 737–746; 751–759; 766–773; 778–
785; 789–800; 804–807; 813–817). See also Fig. 3 and S2.  
 
Restraints and Statistics Wild-Type 
Total number of restraints 2,590 
NOE restraints 2,346 
Unambiguous 2,086 
Intra-residue 863 
Sequential 478 
Short-range 115 
Medium-range 27 
Long-range 603 
Ambiguous 260 
Inter-molecular  
Dihedral angle restraints 176 
Hydrogen-bond restraintsa 68 
Structure statisticsb 
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Restraints and Statistics Wild-Type 
NOE violations >0.5 Å 0% 
Dihedral violations >5° 0% 
RMSD from average structurec,d 
All residues (236–298)  
Backbone (N, Cα, C) (Å) 0.60 ± 0.11 
Heavy atoms (Å) 1.20 ± 0.10 
Ramachandran statisticse 
Most favored region (%) 78.9 (89.7) 
Additionally allowed (%) 18.4 (8.9) 
Generously allowed (%) 2.6 (1.4) 
Disallowed (%) 0.0 (0.0) 
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A Structural Model of a Luminal Ig-like Domain in Human Nup210 
Nup210 is the human ortholog of Pom152. Its luminal domain is a key regulator of cell 
differentiation (21, 22). The two orthologs share domain composition, although the order 
of the domains is swapped, with the luminal domain located at the N terminus of Nup210, 
while the transmembrane and NPC-associating domains are at its C terminus (Fig. 7.4D). 
The low sequence identity between the yeast and human luminal domains (~20%) 
prevented us from unambiguously defining the number and boundaries of the Nup210 Ig-
like domains. Nevertheless, we were able to construct a comparative model of 
Nup2101,079-1,152 by relying on our structure of Pom152718-820 as a template (Fig. 7.4E and 
Supplemental Experimental Procedures). The NCBI Conserved Domain (35) server 
predicts that Nup2101,079-1,152 is an Ig-like fold domain, based on an alignment (E-value 
1.02 x 10-16) to the Pfam family PF02368 (a bacterial Ig-like domain family), suggesting 
that the luminal domain of Nup210 is organized similarly to that of Pom152.  
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Figure 7.4 | Comparative Models of Eight Ig-like Domains and Comparison with an 
Ig-like Domain in Human Nup210 
(A) Domain organization of Pom152FL and its domains drawn to scale. The head region 
contains the domain that faces the NPC inner ring (NPC) and the transmembrane 
segment (TM), followed by the luminal domain composed of nine Ig-like repeats. The 
amino acid boundaries for each Ig-like repeat are indicated below them. The repeat 
analyzed by NMR (Ig-4, Pom152718-820) is highlighted in light blue. (B) Comparative 
models of the remaining eight Ig-like domains were built using the Pom152718-820 NMR 
structure as the template, followed by superposing them on the Pom152718-820 structure. 
The eight domains share statistically significant sequence alignments to Pom152718-
820 (E-values ranging from 3.3 x 10-49 to 6.8 x 10-39). (C) Sequence conservation among 
the nine Ig-like domains was mapped on the structure of Pom152718-820 using ConSurf 
(36). Low conservation, white; high conservation, orange. (D) Domain organization of 
human Nup210. See legend of Fig. 1A. (E) Superposition of comparative models for 
yeast Pom152718-820 (orange) and human Nup2101,079-1,152 (blue). See also Fig. S3.  
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Integrative Structure Determination of Pom152FL  
We determined the structure of Pom152FL through an integrative modeling approach (Fig. 
7.5) that has proven useful for structural analysis of flexible and thus conformationally 
heterogeneous proteins, such as Pom152 (9, 37). We represented Pom152FL in a coarse-
grained fashion to reflect the relatively low resolution of structural information about it, as 
follows. Each of the nine Ig-like domains was represented as a rigid body at the resolution 
of 1 residue per bead, computed from the atomic NMR structure (Fig. 7.3C) or a 
comparative model (Fig. 7.4B and 7.4C). In addition to these nine domains connected by 
flexible linkers (from 4 to 10 residues per bead), a Pom152FL model also included a 
flexible string of beads (from 20 to 100 residues per bead) corresponding to the N-terminal 
NPC-associating domain (residues 1–100), the transmembrane domain (residues 101–
200), and the linker domain (residues 201–374). Next, 100,000 Pom152FL models were 
computed by flexibly fitting random initial models into the negative-stain EM density map 
while avoiding steric clashes and retaining sequence connectivity.  
The 500 best-scoring models (i.e., the ensemble) fit the EM map as well as satisfy 
the excluded volume and sequence connectivity restraints used to compute the models. 
The structures also fit the EM class averages, with cross-correlation coefficients ranging 
from 0.84 to 0.87 for representative class averages (Fig. S4C).  
In addition to satisfying information used to compute them, the models are also similar to 
each other. The clustering of the best-scoring models identified a single dominant cluster 
of 364 similar structures, with a precision (Supplemental Experimental Procedures) of 7.0 
Å for the luminal domain (Fig. S4A).  
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In general, an ensemble of good-scoring models can be visualized as a localization 
probability density map. The map gives the probability of any volume element being 
occupied by a certain bead in superposed good-scoring models. Fig. 7.6A shows the 
localization density for each of the nine Ig-like domains, as sampled by the 364 good-
scoring models in the dominant cluster. The 7.0 Å precision of this cluster is sufficiently 
high to pinpoint the locations, but not the orientations, of the constituent Ig-like domains 
(Fig. S4B). The integrative structure further supports the similarity between the molecular 
architectures of Pom152LD and cadherins (Fig. 7.6A) (19).  
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Figure 7.5 | Four-Stage Scheme for Integrative Structure Determination of 
Pom152FL 
The integrative structure determination of Pom152FL proceeds through four stages: (1) 
gathering data, (2) representing and translating data into spatial restraints, (3) 
conformational sampling to produce an ensemble of structures that satisfies the 
restraints, and (4) analyzing, assessing, and validating the ensemble structures. The 
modeling protocol (i.e., stages 2, 3, and 4) was scripted using the Python Modeling 
Interface (PMI), version 4d97507, a library for modeling macromolecular complexes 
based on our open-source Integrative Modeling Platform (IMP) package, version 2.6 
(http://integrativemodeling.org) (38). 
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Validation of the Pom152LD Structure Using SAXS Data  
We validated our integrative structure of Pom152LD by SAXS data. Specifically, the 
computed SAXS profiles match measured SAXS profiles for all five experimentally 
characterized segments, spanning residues 718–820 (Ig-4), 718–920 (Ig-4,5), 603–820 
(Ig-3,4), 919–1020 (Ig-6), and 718–1148 (Ig-4,5,6,7) (Fig. S5 and Table S1). In addition, 
the shapes of these segments in our mode also match the envelopes (ab initio shapes) 
computed from the corresponding SAXS profiles (Fig. 7.6 and S5). The linearity of the 
Guinier plots confirms a high degree of homogeneity for each of the five Pom152 SAXS 
samples. Each radius of gyration (Rg) and maximum particle size (Dmax) are consistent 
with those of the corresponding Pom152 segments (Table S1). Notably, all five SAXS 
profiles show well-defined bell-shaped curves in Kratky plots (Fig. S5, middle), indicating 
relatively rigid conformations of the individual Ig-like domains. In addition, plateaus at the 
high q region (0.2–0.3 Å-1) in the Kratky plots indicate some flexibility between Ig-like 
domains in solution, consistent with the heterogeneity inferred from the negative-stain EM 
class averages (Fig. 7.1B).  
Position of Pom152LD within the NPC 
Pom152 is the main component of the membrane ring of the NPC (1, 15, 17). To 
determine whether or not the shape and length of our integrative structure of Pom152 
account for the formation of the membrane ring, we fitted the luminal domains of 16 copies 
of Pom152 into our previously published yeast NPC map (1) (Fig. 6B and S7). A good fit 
positions two copies of the extended Pom152LD molecule in an antiparallel fashion on top 
of each other, forming a homodimer; it is ambiguous whether the tail-to-head direction is 
clockwise or counter-clockwise. The length of the elongated Pom152LD (~38.7 nm) is 
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sufficient to span the spoke width. The arrangement suggests that the membrane ring is 
made possible by tight interactions between the Ig-like domains in the two antiparallel 
luminal domains, in agreement with the observed homo-dimerization of Pom152 in vivo 
(1, 15).  
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Figure 7.6 | Integrative Structure of Pom152FL Based on NMR Spectroscopy, 
Negative-Stain EM, and SAXS 
(A) (Left) The localization probability density map computed from 364 superposed 
structures that satisfy the input spatial restraints shows the location of each of the nine Ig-
like domains (ranging from blue to red). The negative-stain EM density map is 
superposed in gray. A representative molecular model of Pom152LD (ribbon plot) was 
obtained by adjusting the relative orientations of adjacent Ig-like domains to resemble 
those in known cadherin structures (PDB: 1L3W, 1EPF, 1NCI, 4ZI9, 5K8R) (32, 39–42). 
(Right) Validation of the integrative structure of Pom152LD by SAXS data for five Pom152 
segments spanning residues 718-820 (Ig-4), 718-920 (Ig-4,5), 603-820 (Ig-3,4), 919-1020 
(Ig-6), and 718-1148 (Ig-4,5,6,7). The shapes of these segments in our integrative 
structure match the envelopes (ab initio shapes) computed from the corresponding SAXS 
profiles. (B) Fit of 16 copies of Pom152LD into the yeast NPC map (1). A good fit positions 
two copies of the extended Pom152LD molecular in an anti-parallel fashion on top of each 
other, forming a homodimer; we only show the potential arrangement of the anti-parallel 
homodimer, which is implied by the C2 symmetry of the NPC (1, 43, 44). See also Fig. 5, 
S4-S7, and Table S1. 
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Discussion  
Since the first high-resolution structure of a nucleoporin domain was solved in 2002 (45), 
the combined efforts of many groups have provided a detailed structural picture for most 
of the major components of the NPC (46). However, conspicuously absent was any such 
information for the NPC membrane ring. Our structure of Pom152FL is thus the first 
detailed view of the molecular architecture of the NPC’s transmembrane components. 
The structure confirmed our previous suggestion (19) that the domain arrangement in 
Pom152, with repeated Ig-like b-sandwich folds forming an extended luminal module, 
most strongly resembles the organization of another conserved eukaryotic family of 
proteins, classical (type I) cadherins (47). The similarities between these two types of 
proteins extend beyond each repetitive unit, including: (1) they share an overall arch 
shape (Fig. 7.1 and (48)); (2) they are both able to dimerize (15, 16, 48); and (3) they 
share a similar domain organization, with a segment of repetitive Ig-like domains 
connected through a single-pass transmembrane region to a short protein-protein 
interaction domain (although in cadherins the orientation of the domains is equivalent to 
that in Nup210; see Fig. 7.1 and 7.4 and(48)). In the case of cadherins, their cytoplasmic 
short region is extended and largely unstructured (49) and has been shown to interact 
with the arm-repeat a-solenoid proteins p120 catenin (50) and b-catenin (49). The NPC-
associating domains of Pom152 and Nup210 are of similar size (~150 amino acid 
residues) and both are predicted to be largely disordered, although the orientation of this 
domain in Nup210 is at the C-terminus while that of Pom152 is at the N-terminus (13, 17). 
Variability in the position and type of the membrane domain between potential Nup 
homologs has previously been seen in the Trypanosome NPC (51); interestingly, Pom152 
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localizes to the NPC when expressed in mammalian cells (17), suggesting conservation 
in assembly mechanism and even function between vertebrates and fungi.  
The N-terminal Pom152 NPC-associating domain is positioned close to the NPC 
inner ring (1). Indeed, genetic interactions with inner-ring components (Nic96, Nup59, 
Nup170, and Nup188) that require the presence of the Pom152 N terminus have been 
described (15); moreover, Pom152 appears to physically interact with several inner-ring 
proteins (1). It is thus reasonable to suggest that, similar to the cadherin-catenin 
interactions, the disordered N-terminus of Pom152 connects to the a-solenoids of the 
NPC inner-ring components (1, 43, 44), just as cadherins use a largely unstructured linker 
to interact with the a-solenoid catenin proteins.  
Despite their common organization, some clear differences are also observed 
between Pom152 and cadherins. First, Pom152 lacks the conserved tryptophans that 
mediate the ‘‘strand-swap’’ mechanism of dimerization in cadherins (48). Not a single Trp 
residue is present at the C-terminus of Pom152 (Fig. S6), and our fitting into the whole 
NPC suggests that Pom152 molecules likely dimerize through more extensive contacts 
(Fig. 7.6B and S7). The distribution of electrostatic potential and sequence conservation 
on the structure of Pom152718-820 (Fig. 7.3E–7.3H and S6) indicates a mechanism where 
facing Ig-like domains from opposite strands generate complementary interaction 
surfaces. Second, unlike cadherins, Pom152 does not seem to be able to bind calcium. 
Cadherin Ig-like domains coordinate calcium through highly conserved residues, 
stiffening the connections between successive domains and imparting a strong curvature 
to the full-length ectodomain (39, 52). Removal of calcium leads to a disordering of inter-
domain orientations that can be observed by negative-stain EM (53). However, we were 
236 
 
not able to detect calcium binding or any obvious calcium-dependent Pom152 shape 
changes (data not shown). Perhaps this observation is unsurprising in proteins that 
diverged more than a billion years ago.  
Pom152 and Nup210 homologs exist beyond the opisthokonts (Fungi and 
Metazoa). Clear homologs are found in Amoebozoa and in plants, although all these are 
more similar to Nup210, the closer homologs of Pom152 being restricted to the Fungi. 
Although clearly structurally and functionally similar, the precise nature of the evolutionary 
relationship between the Pom152-like and Nup210-like homologs therefore remains 
somewhat unclear. Even so, cadherin-like proteins predate the eukaryota, being found in 
bacteria where they may mediate cell-cell contact (54), consistent with an ancient 
evolutionary origin for Pom152 and Nup210, and the entire NPC (1, 6, 19, 55). 
 
Experimental Procedures 
Affinity Purification of Endogenous Pom152 and Truncation Mutants  
Native Pom152 and the truncation mutants Pom1521-1,135 and Pom1521-936 were affinity 
purified, natively eluted, and further purified in 5%–20% sucrose gradients as previously 
described (7).  
Yeast Strains  
Yeast strains (Table S2) were constructed in a W303 (MATa/alpha ade2-1 ura3-1 his3-
11, 15 trp 1-1 leu2-3,112 can1-100) background using standard techniques (25). Unless 
otherwise stated, strains were grown at 30ºC in YPD medium (1% yeast extract, 2% 
bactopeptone, and 2% glucose).  
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Electron Microscopy Analyses and 3D Reconstruction of Pom152  
Purified Pom152FL and the truncated versions Pom1521-1,135 and Pom1521-936 were 
applied to glow-discharged carbon-coated copper grids and stained with 1% uranyl 
formate. Images were collected on a JEOL JEM-2100F transmission electron microscope 
(JEOL USA) or a Philips CM200 transmission electron microscope (FEI) and analyzed 
using ISAC (26). The 3D density map of Pom152FL was generated through the random 
conical tilt reconstruction method and Relion (28). Angles were measured with the ImageJ 
angle tool. Further details are provided in the Supplemental Experimental Procedures.  
Phenotypic Assays  
To analyze the growth phenotype, 10-fold dilutions of yeast cultures were spotted on 
YEPD plates in the presence or absence of 0.3% or 0.4% benzyl-alcohol and incubated 
at the indicated temperatures (25). Indicated fluorescently tagged proteins were 
visualized, in the presence of absence of 0.1% benzyl-alcohol, using a 63x 1.4 NA Plan-
Apochromat objective using a microscope (Axioplan 2, Zeiss) equipped with a cooled 
charge-coupled device camera (ORCA-ER, Hamamatsu) (25).  
Expression and Purification of Pom152 Constructs  
Pom152 constructs used for SAXS studies were expressed as SeMET labeled proteins 
and purified following a standard procedure (9, 56). Pom152 constructs used for the NMR 
studies were expressed in minimal medium following a standard protocol (57) with minor 
modifications. See Supplemental Experimental Procedures for details. 
NMR Resonances Assignments and Structure Calculation of Pom152718–820  
The [U-13C,15N] Pom152718-820 samples were used for backbone and side-chain 
resonance assignments using multidimensional NMR experiments (58). All NMR data 
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were acquired at 25ºC using either Varian 600 MHz or Bruker 600 and 900 MHz 
spectrometers equipped with cryogenic probes capable of applying pulse-field gradients 
along the z axis. Structure calculations were carried out using distance, dihedral, and 
hydrogen-bond restraints using the ARIA/CNS program (59). A total of 2,095 restraints 
were used to solve the structure of Pom152718-820 (Fig. 7.3A). Twenty best-scoring 
structures with no distance restraint violations larger than 0.5 Å and no dihedral restraint 
violations larger than 5º were chosen to represent the structural ensemble consistent with 
the NMR data. Further details are provided in the Supplemental Experimental 
Procedures.  
Small-Angle X-Ray Scattering Experiments  
SAXS measurements for five Pom152 segments were carried out at the SSRL Beamline 
4-2 in the SLAC National Accelerator Laboratory (Menlo Park, CA) (Fig. 7.6A and S5; 
Table S1). Further details of SAXS analysis are provided in Supplemental Experimental 
Procedures and our previous publications (9, 56).  
Comparative Modeling of Luminal Ig-like Domains in Pom152 and Human Nup210 
Comparative models of eight luminal Ig-like domains of Pom152 (Fig. 7.4B) and a single 
luminal Ig-like domain of human Nup2101,079-1,152 (Fig. 7.4E) were computed with 
MODELLER (34), using the NMR structure of Pom152718-820 as the template. Further 
details are provided in Supplemental Experimental Procedures.  
Integrative Structure Determination of Pom152FL  
The integrative structure determination of Pom152FL proceeded through four stages (Fig. 
7.5) (1, 2, 25, 60, 61): (1) gathering data, (2) representing and translating data into spatial 
restraints, (3) conformational sampling to produce an ensemble of structures that satisfies 
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the restraints, and (4) analyzing, assessing, and validating the ensemble structures. The 
modeling protocol (i.e., stages 2, 3, and 4) was scripted using the Python Modeling 
Interface (PMI), version 4d97507, a library for modeling macromolecular complexes 
based on our open-source Integrative Modeling Platform (IMP) package, version 2.6 
(http://integrativemodeling.org) (38). Further details are provided in Supplemental 
Experimental Procedures and our previous publications (9, 37, 62).  
Accession Numbers 
The coordinates and spatial restraints for NMR structure determination have been 
deposited in the PDB (PDB: 5TVZ). NMR resonance assignments have been deposited 
in the Biological Magnetic Resonance Bank (BMRB: 30201). 3D negative-stain EM 
reconstruction of Pom152 has been deposited in the Electron Microscopy Data Bank 
(EMD: EMD-8543). The accession numbers for the SAXS profiles for five Pom152 
segments have been deposited in the Small Angle Scattering Biological Data Bank 
(SASDB: SASDBV9, SASDBW9, SASDBX9, SASDBY9, SASDBZ9). Files containing the 
input data, scripts, and output structures are available online (https://salilab.org/pom152; 
https:// github.com/salilab/pom152).  
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Abstract 
Nuclear pore complexes play central roles as gatekeepers of RNA and protein transport 
between the cytoplasm and nucleoplasm. However, their large size and dynamic nature 
have impeded a full structural and functional elucidation. Here we determined the 
structure of the entire 552-protein nuclear pore complex of the yeast Saccharomyces 
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cerevisiae at sub-nanometre precision by satisfying a wide range of data relating to the 
molecular arrangement of its constituents. The nuclear pore complex incorporates sturdy 
diagonal columns and connector cables attached to these columns, imbuing the structure 
with strength and flexibility. These cables also tie together all other elements of the 
nuclear pore complex, including membrane-interacting regions, outer rings and RNA-
processing platforms. Inwardly directed anchors create a high density of transport factor-
docking Phe-Gly repeats in the central channel, organized into distinct functional units. 
This integrative structure enables us to rationalize the architecture, transport mechanism 
and evolutionary origins of the nuclear pore complex. 
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Introduction 
Nuclear pore complexes (NPCs) are large proteinaceous assemblies studded through the 
nuclear envelope, the double-membraned barrier that surrounds the nucleus; NPCs are 
the sole mediators of macromolecular transport between the nucleus and the cytoplasm, 
and carry key regulatory platforms for numerous nuclear processes (1). NPCs are also 
major targets for viral manipulation and defects in this transport machine are directly 
linked to human diseases, including cancers (2). Each NPC is an eight-fold symmetric, 
cylindrical assembly consisting of approximately 550 copies of about 30 different proteins 
of the nucleoporin family (Nups). These Nups assemble into sub-complexes that form 
higher-order structures called spokes. Eight spokes assemble into even larger modules: 
coaxial outer and inner rings form a symmetric core scaffold, which is connected to a 
membrane ring, a nuclear basket and cytoplasmic RNA export complexes (3). The 
scaffold surrounds a central channel that is formed in part by multiple intrinsically 
disordered Phe-Gly (FG) repeat motifs that extend from nucleoporins termed FG Nups. 
These FG motifs mediate selective nucleocytoplasmic transport through specific 
interactions with nuclear transport factors (NTFs), which carry their cognate 
macromolecular cargoes (4). It has also previously been suggested that the central 
channel contains a feature called the central transporter (5). Although partial structures 
have previously been described (3, 6, 7), a complete, high-resolution structure for the 
entire NPC in any organism has hitherto been lacking, leaving open key questions as to 
how the NPC is organized and functions, and how it evolved. To address these questions, 
we have determined an integrative structure of the yeast NPC at sub-nanometre 
precision. 
252 
 
Results  
Solving the structure of the S. cerevisiae NPC 
We developed a method to rapidly and gently isolate native yeast NPCs, enabling us to 
determine the type and amount of each Nup in the NPC, the proximities between Nups 
resolved to the amino acid residue level, and the mass and detailed morphology of the 
entire NPC. These data were then used to solve the structure using an integrative 
modelling approach (8, 9) (Extended Data Fig. 1, Supplementary Results and Discussion, 
and Methods).  
We determined the mass of the entire NPC and a definitive stoichiometry for every 
Nup and associated molecules using mass spectrometric and in vivo imaging methods. 
The native NPC has a mass of 52 MDa, or about 87 MDa when including the membrane, 
cargo and NTFs (Fig. 8.1 and Extended Data Figs 2, 3c). To inform the proximities, 
orientations and conformations of the Nups, isolated NPCs were subjected to cross-
linking with mass spectrometric readout (9, 10). This approach identified 3,077 unique 
cross-linked pairs of residues, and provided the distance restraints between them, both 
within and between Nups (Fig. 8.2, Supplementary Table 1 and Methods). The 
morphology of the NPC was determined using cryo-electron tomography (cryo-ET) and 
sub-tomogram averaging (11) (Methods). This approach provided a final 3D map at 
approximately 28Å resolution, with a local resolution of 20–25Å for the inner ring, which 
has approximate C2 symmetry (Fig. 3 and Extended Data Figs 4–6). The NPCs retained 
a considerable amount of nuclear envelope membrane, which forms a continuous belt 
around the midline of the structure (Fig. 8.3a, b, d, e). We found that a membrane protein 
ring interconnects adjacent spokes within the nuclear envelope lumen (Fig. 8.3a, e), a 
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feature largely absent from recent electron microscopy maps. A cylindrically averaged, 
bi-lobed density fills the central channel (the ‘central transporter’, Fig. 8.3a, b). Individual 
Nups and their domains, as well as the subcomplexes of the NPC, were represented on 
the basis of published crystallographic structures, integrative structures and comparative 
models (9, 10, 12) (Supplementary Table 2 and Methods), and validated by small-angle 
X-ray scattering profiles for 18 Nups (147 constructs; Supplementary Table 6 and 
Methods). An ensemble of structural solutions for the NPC that sufficiently satisfied all 
experimental data was calculated by extensive configurational sampling (8, 9) 
(Supplementary Table 3 and Methods). Variability among these solutions defines the 
precision of our structure, as quantified by the average root-mean square deviation 
between solutions in the final ensemble (9). Our final structure defines the positions of 
552 Nups (Fig. 8.4 and Supplementary Videos 1–3), with an overall precision of about 9Å 
(Extended Data Fig. 1e, f). The centroid solution is used as the representative structure. 
The structure was validated by numerous independent tests (Extended Data Figs 1, 7, 8, 
Supplementary Tables 3, 4 and Methods).  
The multiple functionalities and enormous size of the NPC present unique and 
substantial structural challenges: it must form a stable passageway with a fixed inner 
diameter; it must be anchored to the nuclear envelope and stabilize the pore membrane 
within which it resides, with a height appropriate for the thickness of the nuclear envelope; 
it must correctly position the transport machinery; and it must resist stresses that might 
lead to disassembly or malfunction. Our structure suggests how each of these challenges 
is met and — by comparison with the vertebrate scaffold (6) — how different organisms 
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may meet these challenges (see the section ‘Evolutionary origin and diversity of the 
NPC’).  
 
Figure 8.1 | Defining the mass, composition and stoichiometry of the native NPC.  
a, Stoichiometry of the entire complement of NPC components determined by quantitative 
mass spectrometry (bar plot) and by in vivo calibrated imaging of Nup–GFP reporters 
(dots) (Extended Data Fig. 3a, b). Darker and lighter color bars (average ± s.d.) represent 
measurements from a diploid non-tagged S. uvarum strain (n=2 or 3 technical and 2 
biological replicas) and haploid tagged S. cerevisiae strains (n=1–3 technical and 4 
biological replicas), respectively. Each Nup is colored on the basis of its localization, as 
depicted in the cartoon. FG-repeat-containing Nups are labelled in green. b, Affinity 
captured whole NPCs were analysed intact by charge detection mass spectrometry, and 
a representative mass spectrum is shown. n=2 biological replicas; more than 3 runs with 
over 1,500 individual NPCs per run. c, Dissection of the mass and composition of an 
NPC. 
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Forming a stable and defined passageway  
The fitness defects of strains containing Nup truncations provide an estimate of the 
structural importance of the truncated regions (9, 13). We quantified the fitness defect of 
strains containing systematic truncations of every major symmetric Nup using ODELAY 
(14) (an automated phenotypic analysis platform; Extended Data Fig. 9). Results were 
heat mapped onto the NPC structure to reveal critical elements of NPC stability (Fig. 
8.5a). The inner ring of the NPC contains crucial stabilizing elements, including Nic96, 
which forms the heart of a diagonally oriented column within each spoke (Fig. 8.5b) and 
interacts with every other protein in the inner ring (Fig. 8.4d–f). This high connectivity 
explains why Nic96 is an essential keystone, holding in place much of the scaffold of the 
NPC. The remainder of each diagonal column is made of Nup157 and Nup170, which 
flank Nic96 (Fig. 8.5b); Nup157 and Nup170 are functionally redundant but are 
synthetically lethal (15) and together form another essential element of the diagonal 
column. Inter-spoke connections represent a second crucial stabilizing element. Nup192 
probably serves as a cross-brace between adjacent spokes (Fig. 8.5a, c). The N termini 
of Nup170 and disordered regions of Nup53 and Nup59 also form key connections 
between adjacent spokes (16) (Figs. 8.4d, 8.5c). The inter-spoke connections are 
established largely through small, hinge-like contacts that may confer flexibility to the 
interface between adjacent spokes; the diagonal arrangement of the central columns may 
also enable rotation or local flexing (Fig. 8.5ba), by accommodating compression and 
expansion forces from nuclear envelope distortions and from the central transporter and 
the transit of cargoes. Nup188 and Nup192 act as radial separators between the Nic96 
column and the triple coiled-coil domains of Nsp1, Nup57 and Nup49, which form a 
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discontinuous ring that defines the narrowest part of the passageway and may allow some 
dilation of the NPC (Fig. 8.4d–f). This architecture sets a soft upper limit of about 40nm 
for the size of cargoes that can transit the NPC (4).  
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Figure 8.2 | Chemical cross-linking and mass spectrometry reveals nucleoporin 
connectivity in the NPC. 
Circular plot showing the distribution of chemical crosslinks (Supplementary Table 1), 
mapped to each nucleoporin represented as a coloured segment and with the amino acid 
residues indicated. The identity of each module and Nup is shown in the periphery of the 
plot. Key in top left gives the types of cross-links; diagram in top right illustrates the relative 
positions of modules in the NPC. 
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How the NPC shapes the nuclear envelope  
The pore membrane, where the inner and outer membranes of the nuclear envelope join, 
defines the inner surface of a torus and therefore has both concave and convex 
curvatures (Fig. 8.5d). The inner ring is anchored to the pore membrane through 
membrane-binding motifs (MBMs) on the β-propellers at the N termini of Nup157 and 
Nup170, and on the C termini of Nup53 and Nup59 (refs. (17–19)). These proteins also 
interact with the scaffold-facing regions of the transmembrane domain (TMD) carrying 
Nups, such as Pom152, Ndc1 and Pom34 (Fig. 8.4d). Together, these MBMs and TMDs 
form an NPC-anchoring girdle of membrane-associated motifs around the scaffold 
equator, defining the concave curve of the pore membrane. The convex curvature is 
defined by both outer and inner rings (Figs 8.4a, e, 8.5d). Each outer ring is formed by 
eight Y-shaped Nup84 complexes arranged head-totail and joined by an interaction 
between the N termini of Nup120 and Nup133 (20), creating another hinged spoke-to-
spoke interface and a minor fitness hotspot (Fig. 8.5a, c). The outer rings also help define 
the overall height of the NPC such that it is appropriate for the width of the nuclear 
envelope. Each Nup84 complex is anchored to the pore membrane by MBMs situated 
within the N-terminal β-propellers of Nup133 and Nup120 (10, 12, 21) (Fig. 8.5d). The 
convex curvature of the pore membrane is thus defined and stabilized by a ring of MBMs 
underneath the outer rings and by the thick girdle of MBMs and TMDs around the NPC 
equator. On the nuclear side, MBMs from Nup1 and Nup60 help anchor the basket to the 
nuclear envelope (22) (Fig. 8.5d, e).  
In the membrane ring, the luminal domain of Pom152 is composed of nine 
immunoglobulin-like fold repeats (23) that oligomerize in an anti-parallel fashion to form 
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eight circumferential arches within the nuclear envelope lumen, producing additional 
connections between adjacent spokes. Pom152 appears to be pre-stressed by assembly 
into these arches (Fig. 8.4e); the resulting tension may minimize elliptical distortion of the 
NPC (23). Each arch also delimits a channel (300×120Å wide) between itself and the 
underlying pore membrane (Figs 8.3e, 8.4e). The outer rings form a series of 
circumferential arches that align with the Pom152 luminal arches (Fig. 8.4b, e). These 
arches align with hinges in the inner ring (Fig. 8.5c) that could flex to form lateral openings 
between spokes. This juxtaposition of arches and transient openings may delineate 
conduits for nucleocytoplasmic transport of transmembrane proteins (24), potentially 
resolving the issue of how membrane proteins transit the NPC (25).  
Positioning the RNA processing platforms  
Whereas the core scaffold is symmetric about the plane of the nuclear envelope, two 
machineries associated with RNA processing and transport—the basket and export 
platform— are located at the nuclear and cytoplasmic faces of the NPC, respectively (Fig. 
8.4d–f). At the core of the export platform is the Nup82 complex, which has a coiled-coil 
bundle that is attached to the Nup85–Seh1 arm and hub region of the Nup84 complex in 
the cytoplasmic outer ring (Fig. 8.4f). Together, they form a lateral platform that faces the 
central channel. An α-helical rod that extends from the Nup82 complex holds Gle1, the 
RNA helicase Dbp5 and the FG-repeat-carrying Nup42 over the middle of the central 
channel (9, 25, 26). As a result, numerous transport-factor-docking sites and ATP-
dependent RNA remodeling proteins are aligned above the cytoplasmic exit of the NPC 
to efficiently receive exporting RNAs, to remodel and then release them into the 
cytoplasm. Likewise, Mlp1 and Mlp2 in the nuclear basket are anchored to the core 
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scaffold mainly by the Nup85–Seh1 arm, similar to the Nup82 complex (Figs 8.4d, e, 
8.5e). The nuclear basket serves as a platform for the first stages of RNA processing and 
export (27), and the export platform organizes the last stages of export (26). Similarities 
between the export platform and basket suggest that these structures are ancient 
homologues (Extended Data Fig. 10); their asymmetric localization directs unidirectional 
export of transcripts out of the nucleus.  
Flexible connectors tie the NPC together  
Certain disordered connectors have recently been shown to be important for holding parts 
of the scaffold together (6, 7, 16); the complete structure presented here highlights the 
extent to which such connectors are critical to NPC integrity. Remarkably, flexible 
connectors run the entire length of each spoke, tying together every major element in the 
NPC (Fig. 8.5c, e). They link the periphery and outer rings to the inner rings, both inner 
rings to the pore membrane and adjacent spokes to one another. We identified two types 
of connectors (Supplementary Results and Discussion). First, there are vertical 
connections, aligned parallel to the cylindrical axis of the NPC and constituting the main 
anchor points between the export platform and the inner ring. On the nuclear side, similar 
connections are present between the nuclear basket and the inner ring, with an additional 
connection between the basket and outer ring (Figs 8.4d, 8.5e). Second, there are 
horizontal flexible connectors that link the central channel to the pore membrane between 
adjacent spokes (Fig. 8.5e). Collectively, these flexible connectors may serve to allow 
limited movement of the more rigid modules with respect to one another, thereby 
providing the NPC with another degree of flexibility in response to deformation (28).  
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Figure 8.3 | Morphology of the NPC.  
a, b. Cryo-ET map of the NPC: core scaffold, blue; membrane region, grey; central 
transporter, pink. MR: membrane ring. In a, cytoplasmic top view (left); cross-section side 
view (middle); and central cross-section top view (right). b, Cryo-ET map from a presented 
at a higher threshold. Top view (left); 60°-tilted view of the inner ring (middle); and side 
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(right, top) and cross-section views (right, bottom) of the inner ring. Scale bar, 200Å. c–f, 
Cross-section views show a representative structure embedded within the cryo-ET 
density (grey), presented with different filtering and thresholding to show the good fit to 
the cryo-ET map in the inner ring (c, d), the membrane ring (e) and the cytoplasmic outer 
ring and mRNA export platform (f). Nups indicated as in Fig. 8.4. Scale bars, 50Å (c, d) 
and 100Å (e, f). 
 
Organization of the transport machinery  
Despite its critical function, the central gating machinery has largely been excluded from 
recent NPC maps (6, 7, 29) and its properties have remained controversial (4). Here we 
confirm the existence of a large central transporter with two high-density ‘lobes’ 
connected by a narrower ‘waist’ of lower density (5) (Figs 8.3, 8.6 and Extended Data 
Figs 4–6). This central transporter comprises multiple FG repeats that account for about 
9 MDa, together with approximately 26 MDa of NTFs and their cargoes caught in transit 
(though they may be somewhat averaged out in our map) (Fig. 8.1b, c and Extended 
Data Fig. 3c). Indeed, even after isolation, each NPC carried 10–80 copies of each of the 
observed NTFs (30), reflecting the huge and varied transport flux through NPCs.  
The localization of FG-repeat anchor points reveals three patterns. First, a vertical 
path is formed along each spoke by a continuous array of FG repeats (Fig. 8.6a, c and 
Extended Data Fig. 11b–d). By binding to these repeats, NTFs may follow these paths 
across the entire NPC. Second, the FG anchor points of Nsp1–Nup57–Nup49 form a 
central ring on the equator of the NPC (Fig. 8.6b). Thin bridges in our cryo-ET map 
coincide with the location of these FG anchor points, which indicates that these bridges 
comprise the FG repeats themselves, emanating from their anchor points (Fig. 8.6b). 
Third, the structured regions of the NPC largely direct the FG-repeat regions inwards 
toward the axis of the central channel (Fig. 8.6a), instead of projecting from the NPC 
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towards the cytoplasm and nucleoplasm as they are often represented (9). This geometry 
generates a highly concentrated (25–150 mM) and dynamic FG-repeat phase through 
which cargo-carrying NTFs readily pass, facilitated by their specific FG interactions, 
whereas nonspecific macromolecular diffusion is hindered by this same dense phase 
(31).  
It has previously been suggested that the two main types of FG repeat (‘Phe-X-Phe-
Gly/Phe-Gly’ (FXFG/FG) and ‘Gly-Leu-Phe-Gly’ (GLFG)) are segregated in the NPC to 
define functionally distinct zones of the gating machinery (32). Consistent with this, and 
with the known role of FXFG/FG-type repeats in docking RNAs during export (33), we 
find that FXFG/FG-type repeats are enriched in the nuclear and cytoplasmic peripheries 
of the NPC, where the RNA-associating export platform and basket reside (Fig. 8.6d and 
Extended Data Fig. 11c). By contrast, the GLFG-type repeats are enriched in regions 
adjacent to the inner ring and near the cytoplasmic entrance to the central channel. This 
cytoplasmic localization coincides with the position of FG repeats that are most important 
for limiting the passage of nonspecific macromolecules (Fig. 8.6e and Extended Data Fig. 
11d), and is consistent with the known role of GLFG-type repeats in maintaining the 
passive permeability barrier (34, 35).  
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Figure 8.4 | Structural dissection of the NPC. 
Complete structure of the NPC and its components shown in different orientations, with 
a model of the pore membrane region shown in grey (Supplementary Videos 1, 2, 3). For 
each Nup, the localization probability density of the ensemble of structures is shown with 
a representative structure from the ensemble embedded within it (Supplementary Table 
2). a, Two views of three consecutive NPC spokes (C8-symmetry units), showing how the 
coaxial outer, inner and membrane rings run continuously between spokes. b, 
Cytoplasmic top view of the complete NPC structure with modelled FG-repeat regions 
(green). c, Side view of a single NPC spoke. d, Relative position of major NPC 
components and connections both within and between spokes. Top (left) and side (right) 
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views are shown. The membrane ring (beige) is included for reference. Flexible 
connectors between outer and inner rings are shown in the top and bottom panels, with 
the inner and membrane rings shown as faded grey densities. e, Exploded view of three 
consecutive spokes, spanning from the cytoplasmic face (top) to the nuclear face 
(bottom), with dashed lines connecting neighboring rings. f, Cytoplasmic mRNA export 
complex (top), the Nup84 complex (center) and the inner ring complex, including the 
Nic96 complex (bottom), from a single spoke. The complexes are shown as an exploded 
diagram, with dashed lines connecting neighboring components. 
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Figure 8.5 | Key NPC architectural features and principles. 
a, Severity of fitness defects, indicated in increasing intensity of purple shades for specific 
truncations of nucleoporins (Extended Data Fig. 9), mapped onto three spokes of the 
NPC. b, c, Structures corresponding to the position of the most severe defects (dark 
blue). In top panels in b, diagonally oriented columns reinforcing the core scaffold may 
accommodate NPC compression and expansion (diagram to right). Bottom, molecular 
details of Nup arrangement (relevant residue numbers indicated). In middle panels in c, 
the position of hotspots coincides with spoke-to-spoke connections. Central spoke, grey; 
flanking spokes, white (schematic, middle right). Top and bottom, molecular details of 
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spoke-to-spoke connector hinges. d, Top left and centre left, three spokes shown as top 
and front views; centre right, one spoke in side view. Schematic indicates convex and 
concave pore membrane curvatures. Positions of TMDs and MBMs are depicted and their 
proteins are labelled in brown and orange, respectively. Top right, diagrammatic side view 
showing how the MBMs and TMDs curve the pore membrane. Bottom, molecular details 
of the Nups containing the TMDs and MBMs. e, Second row left, three spokes in front 
view, showing how vertical connector Nups (cyan) spanning from the cytoplasmic to 
nuclear sides of the NPC connect the rings. Second row right, one spoke in side view, 
showing how horizontal connector Nups (aquamarine) connect modules spanning from 
the pore membrane to the central channel. First row and bottom row left show molecular 
details of the connectors within the NPC. Bottom row centre and right, diagrammatic 
views of the connectors depicted as blue dotted lines; modules connected labelled in blue; 
major Nups being contacted by connectors listed in grey. 
 
Evolutionary origin and diversity of the NPC  
NPCs share architectural features with vesicle coating complexes (Extended Data Fig. 
10), which led us to hypothesize that they share a common evolutionary ancestor, the 
‘protocoatomer’ (36). Two major families of coating complexes exist: COPI/clathrin and 
COPII, each of which have discrete vesicle recognition and trafficking roles (37, 38). We 
find both COPI/clathrin-like and COPII-like features in the NPC, suggesting that ancestral 
COPI and COPII coating families evolved first and were followed by the NPC, which may 
have evolved through a partnership of COPI and COPII coats. This hypothesis implies 
that the nucleus was a later addition in the evolutionary path of the first eukaryotes 
(Supplementary Results and Discussion).  
Despite substantial conservation of some elements of NPC architecture, other elements 
can vary widely between species. Generally, the inner ring appears most conserved (39, 
40), as is seen in a comparison of our yeast structure with that of the human scaffold (6), 
although the latter is more expanded (Extended Data Fig. 12). By contrast, peripheral 
elements exhibit considerable lineage-specific losses and duplications (40, 41). In yeast, 
each outer ring is formed by 8 copies of the Nup84 complex (Figs 8.3f, 8.4), whereas in 
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vertebrates each outer ring contains 16 copies of the equivalent Y-shaped complex 
arranged in two interlocked rings (17, 42). Moreover, we see neither an additional copy 
of Nup157 or Nup170 connecting the outer and inner rings nor Nup188 or Nup192 in the 
outer rings, as indicated in humans (6) (Fig. 8.4d–f and Extended Data Fig. 12a). Another 
previous model assumed that fungal and human core scaffolds have essentially identical 
structures (7). Our data invalidate this assumption (Fig. 8.1, Supplementary Table 2a and 
Supplementary Results and Discussion), as well as an earlier ‘fencepost’ model (43). In 
summary, there is no single universal NPC structure; instead, similar structural elements 
are used in somewhat different arrangements to generate many lineage-specific 
adaptations.  
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Figure 8.6 | The distributions of FG repeats informs the NPC transport 
mechanism. 
a,  Central transporter density from the cryo-ET map (Fig. 8.3) is shown within the 
structure of the NPC scaffold (grey) (top). Features of the central transporter are 
indicated. Anchors (light green) in FG Nups largely direct the FG-repeat emanating points 
(dark green) towards the central channel (bottom). Scale bar, 100Å. b, Central cross-
section of the cryo-ET map (grey) with embedded representative NPC structure (Fig. 8.4), 
showing the central transporter and the bridges connecting it to the core scaffold in top 
view (scale bar, 100Å), with a magnified view of one spoke on the left (scale bar, 20Å). 
The anchor points for the FG repeats of Nup49, Nup57 and Nsp1 are depicted as green 
densities. c, Position of FG-repeat anchor points (green) within a side view of three 
spokes of the scaffold (grey). Scale bar, 100Å. d, Heat mapping of repeats of FXFG/FG 
type (red) and GLFG type (blue), from Brownian dynamics simulations (Methods), 
showing partitioning to different regions of the central channel. Scale bar, 100Å. e, Heat 
mapping of the effect of FG-repeat region truncations on NPC permeability; the severity 
of the permeability defect (34) (measured as permeability relative to permeability in wild 
type, (p/pWT)) is indicated in increasing shades from minor (light green) to severe (dark 
blue). Cyt, cytoplasm; nucl, nucleoplasm. Scale bar, 100Å. 
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Conclusions  
We have described the structure of the entire yeast NPC at sub-nanometre precision. At 
the heart of the inner ring, rigid diagonal columns reinforce the structural integrity of the 
NPC. Membrane-binding and transmembrane Nups are strategically placed throughout 
the core scaffold to stabilize pore membrane curvature and clamp the NPC to the nuclear 
envelope. Connectors run the length of each spoke, flexibly tying together all the major 
modules in the NPC. The architecture of the NPC is reminiscent of a suspension bridge, 
in which rigid supporting columns are firmly anchored to a substrate and flexible 
suspension cables connect the columns and roadway to provide a strong and resilient 
structure. We show that most FG Nup anchor points face inwards toward the NPC central 
channel to generate a highly concentrated milieu of FG repeats: FXFG/FG repeats form 
mRNA docking ‘traps’ at the entrance and exit of the channel, and GLFG repeats help 
form a cytoplasmically biased permeability barrier.  
Despite differences, yeast and human NPCs retain a notable degree of structural 
conservation (Extended Data Fig. 12a, b). As a result, many of the conclusions drawn 
here should be applicable to the human NPC. To illustrate this point, we mapped the 
positions of yeast homologues of the oncogenic hotspot human Nup214, Nup98 and Tpr 
(2) (Extended Data Fig. 12c). Rather than being randomly scattered, these positions 
coincide with RNA-binding platforms on the cytoplasmic and nucleoplasmic faces of the 
NPC as well as with several critical connectors and associated FG regions. This 
conservation suggests that alterations in RNA export, and changes in NPC architecture 
induced by defective connectors, may underlie the altered behaviour of NPCs in cancer 
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cells. Thus, our yeast structure provides a roadmap with the potential to advance our 
understanding of NPC physiology and nuclear transport in general.  
 
Methods  
Yeast strains and materials 
All S. cerevisiae strains used in this study are listed in Supplementary Table 5, with the 
exception of the Nup84 complex truncation mutants (13) and the Pom152 truncation 
mutants (23). Unless otherwise stated, strains were grown at 30°C in YPD medium (1% 
yeast extract, 2% bactopeptone and 2% glucose). The diploid S. uvarum strain (ATCC 
9080) was grown and processed for nuclear envelope purification as previously described 
(44). The following materials were used in this study: Dynabeads M-270 Epoxy (143.02D; 
Invitrogen); rabbit IgG (55944; MP Biomedicals); protease inhibitor cocktail (P-8340; 
Sigma-Aldrich); and Solution P (2mg Pepstatin A, 90mg PMSF, and 5ml of absolute 
ethanol).  
Immuno-purification of the endogenous S. cerevisiae NPC.  
An immunopurification protocol for the isolation of endogenous whole NPCs from S. 
cerevisiae was developed using previously published methodology (3, 45–49). S. 
cerevisiae Mlp1-, Nup84- or Nup82-encoding genes were genomically tagged with PrA 
preceded by the human rhinovirus 3C protease (PPX) target sequence (GLEVLFQGPS). 
Cells were grown in YPD medium at 30°C until early log phase (~2×107 cells/ml), 
collected, frozen in liquid nitrogen and cryogenically lysed in a planetary ball mill PM 100 
(Retsch) (http://lab.rockefeller.edu/rout/protocols). Frozen cell powder was resuspended 
in 9 volumes of resuspension buffer (20mM HEPES–KOH pH 7.4, 50 mM potassium 
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acetate, 20 mM NaCl, 2 mM MgCl2, 0.5% (w/v) Triton X-100, 0.1% (w/v) Tween-20, 1mM 
DTT, 10% (v/v) glycerol, 1/500 (v/v) protease inhibitor cocktail (Sigma)). Cell lysate was 
clarified by centrifugation at 2,500 RCF for 5min followed by filtration through 1.6-μm 
filters (Whatman glass microfibre syringe filters). Magnetic beads (Invitrogen) conjugated 
to rabbit IgG antibodies (http://lab.rockefeller.edu/rout/protocols) were added to the 
clarified cell lysate at a concentration of 50μl slurry per 1g of frozen cell powder and 
incubated for 30min at 4°C. Beads were washed once with 1ml of elution buffer without 
protease inhibitors (20mM HEPES–KOH pH 7.4, 50mM potassium acetate, 20mM NaCl, 
2mM MgCl2, 0.1% (w/v) Tween-20, 1mM DTT, 10% (v/v) glycerol). For native elution of 
the complex, the desired volume of elution buffer with PreScission protease (GE 
Healthcare) (1/15 (v/v)) was added to the beads and incubated for 45min at 4°C. A 
magnet was used to remove the beads and collect the supernatant. Beads were 
subsequently washed with the desired volume of elution buffer containing 1/500 (v/v) 
protease inhibitor cocktail (Sigma). The total elution volume was centrifuged at 20,000g 
for 5min to remove the residual magnetic beads. Typical yield of the immuno-purification 
is ~4μg of isolated NPCs per 1g frozen cell powder (see Extended Data Fig. 2b for SDS-
PAGE analysis; for gel source data, see Supplementary Fig. 1).  
Mass and stoichiometry of the native S. cerevisiae NPC.  
Quantification of the absolute stoichiometry of each nucleoporin in the native NPCs was 
performed using a strategy that combined several orthologous methods (Extended Data 
Fig. 2a): (1) use of synthetic concatemers of tryptic peptides or QconCATs (50) to define 
the relative stoichiometry of each component by quantitative mass spectrometry in 
affinity-captured NPCs; (2) in vivo calibrated imaging analysis of GFP-tagged Nups (51), 
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to quantify the absolute copy number per NPC of Nups selected to represent each major 
module of the NPC; and (3) charge detection mass spectrometry to measure the total 
mass of affinity-captured NPCs (52). For the calculation of the integrative NPC structure, 
the final copy numbers were rounded to fit the known NPC C8-symmetry and these values 
are indicated in Supplementary Table 2a.  
NPC QconCAT design and purification 
Mass spectrometry quantification of the relative amounts of each nucleoprotein in the 
purified NPC complex was performed using two specifically designed, heavy-labelled 
synthetic internal standards or QconCATs (50, 53) (Extended Data Fig. 2d, e) formed by 
concatenated quantotypic nucleoporin peptides. To minimize the potential effect of having 
different residues flanking the trypsin cleavage site on the cleavage efficiency, we 
included the native three-residue flanking sequences framing the trypsin cleavage site for 
each peptide (54). For QconCAT-A (Extended Data Fig. 2d), two peptides for each of the 
nucleoporins and one peptide for Staphylococcus aureus protein A and Aequorea victoria 
GFP proteins were selected (Supplementary Table 7) on the basis of their favourable 
signal responses in liquid chromatography–mass spectrometry analyses of NPC samples 
and by fitting to the following criteria (when possible): (1) the native three-residue flanking 
sequences at both sides of the trypsin cleavage sequence do not contain Lys or Arg; (2) 
avoid the presence of Cys or Met residues within the peptide; (3) avoid the presence of 
potential internal trypsin cleavage sites (Lys or Arg residues); (4) peptides should be less 
than 3,000 Da (small size); and (5) avoid peptides showing obvious interferences from 
co-eluting peptides during the liquid chromatography separation for mass spectrometry 
analyses. QconCAT-B included two quantotypic peptides for Nup159, Mlp2, Nup192, 
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Nup84, Nup85, Nup120, Nup49, Nup57, Pom152 and Nic96, and the same GFP peptide 
as in QconCAT-A (Supplementary Table 7). As an internal control, both QconCAT-A and 
-B included the same peptides for Nic96, Pom152 and GFP. Each synthetic gene was 
designed by concatenation of the sequences encoding the selected peptides and addition 
of a 6× His C-terminal tag (Extended Data Fig. 2d). A 3×FLAG peptide was also included 
at the N terminus of QconCAT-A, resulting in a protein of 148.2kDa. The Escherichia coli 
codon optimized sequences were cloned into: (1) plasmid pET15-b (as a NcoI–XhoI 
fragment) in the case of QconCAT-A; and (2) pGEX6p-1 (as a BamHI–XhoI fragment) in 
the case of QconCAT-B, resulting in the expression of a 68.1kDa protein with a N-terminal 
GST tag that was mainly used as a sacrificial peptide (55). The QconCAT proteins were 
expressed by growing 300ml of BL21 E. coli cells at 37°C to OD600=0.6 in minimal M9 
medium without ammonium chloride (50, 53) supplemented with light amino acids and 
0.5mg/ml of heavy arginine and lysine (l-arginine:HCl 13C6; l-lysine:2HCl 13C6, 
Cambridge Isotope Laboratories). IPTG (1mM) was used to induce expression of the 
constructs for 3h at 37°C. Collected cells were processed using BugBuster Extraction 
Reagent (Novagen), as indicated by the manufacturer, to isolate the inclusion bodies 
where the QconCAT protein is accumulated. The full-length QconCAT-A was then purified 
by resuspending the inclusion bodies pellet in binding buffer (20mM sodium phosphate 
pH 7.4, 45mM imidazole, 500mM NaCl, 6M guanidinium chloride, 10mM TCEP (0.5M 
Bond-Breaker TCEP solution, Thermo Fisher Scientific), 1/500 protease inhibitor cocktail 
(Roche)) and passed through an equilibrated His-Trap HP (GE Healthcare) at room 
temperature. The retained NPC QconCAT-A was then eluted in 20mM sodium phosphate 
pH 7.4, 500mM imidazole, 500mM NaCl, 6M guanidinium hydrochloride, 1mM TCEP, 
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1/500 protease inhibitor cocktail. One-hundred-microlitre aliquots of the resulting elution 
were precipitated to eliminate the guanidinium hydrochloride by adding ice-cold ethanol 
to a final concentration of 90% and incubating the samples at −20°C for 2h. Samples were 
then centrifuged for 10min at 14,000r.p.m. and 4°C to pellet the precipitated protein. The 
resulting pellet was washed with ice-cold 90% ethanol and allowed to air-dry until most of 
the liquid was evaporated, leaving a wet pellet. These pellets were solubilized with 5% 
SDS, 500mM Tris–HCl pH 8.0, 5mM TCEP buffer, by incubating for 5min at room 
temperature and 5min at 72°C and centrifuged for 10min at 14,000 r.p.m. at room 
temperature. The supernatants were recovered and two of them combined and injected 
into a TSKgel G4000SWxl size-exclusion column (TOSOH Bioscience) coupled to a 
TSKgel SWxl guard column (TOSOH Bioscience), pre-equilibrated in running buffer (40 
mM HEPES–KOH pH 7.0, 150 mM NaCl, 0.1% SDS, 5 mM TCEP, 1mM EDTA). Two-
hundred-microlitre fractions were collected and analysed by SDS-PAGE to detect the 
presence of the QconCAT-A peak. Fractions containing the full-length pure protein were 
supplemented with a final 20% glycerol (v/v), aliquoted, flash-frozen in liquid nitrogen and 
stored at −80 °C for further use. In the case of QconCAT-B, the protein was purified using 
His-Trap HP and the elution precipitated and prepared as described for QconCAT-A. The 
resulting sample was injected into a TSKgel Super SW3000 size-exclusion column 
(TOSOH Bioscience) pre-equilibrated in running buffer (40mM HEPES–KOH pH 7.0, 
150mM NaCl, 0.1% SDS, 5mM TCEP, 1mM EDTA). One-hundred-microlitre fractions 
were collected and analysed by SDS-PAGE to detect the presence of the QconCAT-B 
peak. Fractions containing the full-length pure protein were stored as indicated for 
QconCAT-A.  
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For the quantitative mass spectrometry analysis, the native NPCs from S. 
cerevisiae PPX–PrA-tagged haploid strains were affinity captured as described above, or 
purified as enriched NPCs from a diploid S. uvarum strain using a subfractionation 
method previously described in detail (44, 56–58) (http://lab.rockefeller.edu/ 
rout/protocols), using 0.035mg heparin per mg of fraction protein. For affinitycaptured 
NPCs, the natively eluted NPCs (5μg) were concentrated by pelleting at 40,000r.p.m. for 
20min at 4°C in a TLA 55 rotor (Beckman). In the case of subfractionation-enriched NPCs, 
a volume of the 1.45M:1.85M sucrose gradient fraction that contained an estimated 5μg 
of NPCs was diluted 1/5 (v/v) in bt-DMSO buffer (10mM bis-Tris-HCl pH 6.5, 0.1mM 
MgCl2, 20% DMSO) and pelleted at 15,000r.p.m. for 450min at 4°C in a TLA 55 rotor 
(Beckman). For in-solution mass spectrometry analysis of subfractionation-enriched 
NPCs, 0.1μg of QconCAT-A were immobilized on Dynabeads His-Tag Isolation and 
Pulldown resin (Thermo Fisher Scientific) pre-equilibrated in binding buffer (20mM 
HEPES, 150mM NaCl, 8M urea, 5mM TCEP). The purified protein sample was incubated 
with the resin for 20min at room temperature, and washed with binding buffer 5×200μl to 
eliminate residual SDS; in-solution and in-gel analyses showed consistent results (not 
shown), so most of the further analyses were performed in-gel to improve consistency, 
speed and throughput. For the solid-state in-gel mass spectrometry analyses, pelleted 
NPCs were solubilized in 10μl of 0.5M Tris-HCl pH 8.0, 5% SDS by incubating at 72 °C 
for 5min and then diluted 1:1 with 20% glycerol, 50mM TCEP, 0.5mM EDTA, 0.05% (w/v) 
bromophenol blue. Approximately equimolar amounts of 0.1μg of purified QconCAT-A or 
0.045μg of purified QconCAT-B were added to each 5-μg NPC sample. Samples were 
then incubated at 72°C for 10min, cooled to room temperature and treated with a final 
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30mM of iodoacetamide (Sigma), at room temperature in the dark for 30min. Samples 
was then loaded into a 4% (37.5:1) stacking acrylamide SDS-PAGE gel prepared in-
house. The resulting bands, containing a mixture of whole NPCs and QconCAT protein 
(labelled with a stable isotope), were excised and processed for quantitative mass 
spectrometry analyses.  
Mass spectrometry characterization of QconCAT labelled with a stable isotope 
The mass of purified intact QconCAT-A protein, labelled with a stable isotope, was 
analysed by matrix-assisted laser desorption/ionization (MALDI) (Extended Data Fig. 2e) 
on a JEOL JMS-S3000 SpiralTOF mass spectrometer using the ultra-thin-layer sample 
preparation method (59, 60) in which α-cyano-4- hydroxycinnamic acid (Sigma) was used 
as the matrix. The mass of QconCAT-A was internally calibrated with horse myoglobin. 
Mass calibration and background subtraction were carried out with the JEOL msTornado 
control software, and additional analyses were carried out with the MoverZ software (61). 
The QconCAT-A protein was also characterized by peptide mapping, in which tryptic 
peptides from in-gel digestion were loaded onto a PicoFrit column (New Objective) with 
an integrated emitter tip (360-mm O.D., 50-mm I.D., 10-mm tip) self-packed with 6cm of 
reverse-phase C18 material (ReproSil-Pur C18-AQ, 3-mm beads, Dr. Maisch GmbH), 
and analysed with a LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific), 
with a Agilent 1200 series HPLC system (Agilent) and a micro electrospray source built 
in-house. The purified QconCAT-B was characterized by peptide mapping on a Thermo 
Orbitrap Fusion mass spectrometer, with a Thermo Easy-nLC 1000 HPLC and a Thermo 
Easy-Spray electrospray source.  
Stoichiometry quantification of NPC using QconCAT and by mass spectrometry 
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Mixtures of yeast NPC proteins and QconCAT, labelled with a stable isotope, were 
enzymatically digested either in solution in the presence of urea or inside a SDS-PAGE 
gel matrix. For in-solution digestion, a mixture of the NPCs and immobilized QconCATs 
on His-Dynabeads were sequentially digested at room temperature by Endoproteinase 
Lys-C in 8M urea for 66h and by trypsin in 2M urea for 3h. For in-gel digestion, proteins 
in the gel matrix were digested in 100mM TrisHCl at room temperature either sequentially 
by 0.25–2μg Endoproteinase Lys-C for 66h and by 3–25μg trypsin for 3h, or—in later 
experiments—by 25μg trypsin alone for 3h. The resulting peptides were analysed in 
duplicate by liquid chromatography–mass spectrometry using a Thermo Fusion or a 
Thermo Q Exactive Plus mass spectrometer, with a Thermo Easy-nLC 1000 HPLC and 
a Thermo EasySpray electrospray source. The ratios of light nucleoporin (L) to heavy 
QconCAT proteins (H) for standard peptides were obtained using MaxQuant (62), 
complemented with manual determination.  
We incorporated two standard peptides from each nucleoporin into the QconCAT 
standard to enable us to check for internal consistency of the measured L/H ratios for 
each nucleoporin. Our check required that the relative standard deviations of L/H ratios 
for two standard peptides from two duplicate liquid chromatography–mass spectrometry 
runs—that is, for a total of four measurements per nucleoporin—be≤25%. When deriving 
relative stoichiometry for any given preparation of NPCs analysed in different replication 
experiments, we corrected for variations in the mixing ratio of light nucleoporins and 
heavy QconCAT proteins by scaling the measured L/H ratios to minimize the sum of the 
relative standard deviations of the L/H ratios over all nucleoporins. The resulting scaled 
L/H ratios from different experiments were used to derive the average L/H ratios and 
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standard deviations. To assay for potential nucleoporin stoichiometry bias arising from 
capture through particular affinity handles, we used stable isotope labelling with amino 
acids in cell culture followed by mass spectrometry (SILAC–MS) analysis of these 
preparations versus the nuclear envelope preparation. We performed n=2 or 3 technical 
and 2 biological replicas for NPCs purified by subfractionation procedures from a diploid, 
non-tagged S. uvarum strain, and n=1–3 technical and 4 biological replicas for the 
nuclear-envelope-corrected affinity-captured NPCs from haploid, tagged S. cerevisiae 
strains (Fig. 8.1a).  
The absolute stoichiometry (Fig. 8.1 and Supplementary Table 2a) was then determined 
by normalizing the summed copies of Nup188, Nup120 and Nic96 per NPC to 64 copies 
(that is, 16 for Nup188 and Nup120, and 32 for Nic96).  
SILAC-MS analyses of the NPC stoichiometry 
A preparation of yeast nuclear envelopes obtained by a previously established 
subfractionation method (44) does not involve disruption of the nuclear envelope 
membrane by detergents and generates sheets of nuclear envelope studded with intact 
NPCs. To assess the degree to which the affinity-captured NPCs were intact, we used 
SILAC-MS to compare the levels of each Nup in the affinity-captured preparation relative 
to those in the nuclear envelope preparation. To do this, the nuclear envelope sample 
labelled with light isotopes was mixed with Mlp1-PPX-PrA affinity-captured NPC sample 
labelled with a heavy isotope (l-lysine:2HCL 13C6) in a SILAC experiment. Mixtures of 
nuclear envelope proteins and NPCs labelled with stable isotopes, purified using the 
Mlp1–PPX-PrA handle, were digested sequentially in gel matrix by Endoproteinase LysC 
and by trypsin. Resulting peptides were analysed by liquid chromatography–mass 
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spectrometry on a Thermo Q Exactive Plus mass spectrometer, with a Thermo Easy-nLC 
1000 HPLC and a Thermo Easy-Spray electrospray source. H/L ratios for all peptides 
were obtained using MaxQuant (62), complemented with manual examinations. The H/L 
ratios of peptides were used to derive the H/L ratios of nucleoporins and standard 
deviations (data not shown). The result showed that the affinity-capture process does not 
affect the overall ratios of the major Nups and NPC modules relative to the nuclear 
envelope samples (data not shown), indicating that the affinity-capture procedure 
generates intact NPCs. We also used this comparison relative to nuclear envelopes to 
correct for the slight increases observed in the ratios of Nups closely associated with the 
Mlp1 handle in the affinity-captured NPCs (Fig. 8.1a).  
In vivo calibrated imaging analysis of GFP-tagged Nups 
Calibrated imaging data were acquired as previously described (51). Using the avalanche 
photodiode imaging module of a Zeiss confocor 3, confocal z-stacks of live yeast were 
acquired with a 40× 1.2 NA Plan-Apochromat water objective. The 488-nm laser line was 
used to excite GFP, with a 405/488/561 dichroic. Emission was reflected with a LP580 
emission dichroic and collected through a BP 505–540-nm emission filter. The pinhole 
was set to 1 Airy unit. The zoom was set to maintain a pixel size of 55nm, and a z-step 
size of 400nm was used. After acquisition, images were binned in XY by 2, resulting in 
an effective pixel size of 110nm, and anaphase cells were analysed for diffraction-limited 
Nup spots along the anaphase bridge. These spots, when present, were fit to a 2D 
Gaussian curve to obtain the amplitude of the signal. The z-slice with the maximum signal 
intensity of the spot was analysed. Fluorescence correlation spectroscopy was used to 
convert the amplitude of the Gaussian fit of the Nup spot number of molecules of GFP. In 
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brief, using a strain expressing only cytosolic GFP, fluorescence correlation spectroscopy 
determined the average number of molecules in the focal volume, as previously described 
(51). Then, the amplitude of the signal of the Nup spot was compared to the intensity of 
cytosolic GFP, taken with the same imaging setup. For all measurements, number 1.5 
coverslips were measured for uniformity, and the correction collar of the water objective 
was optimized for this thickness using signal intensity of Alexa Fluor 488 in solution. For 
each day data were acquired, the calibration using cytosolic monomer GFP was obtained.  
Phospholipid analysis 
These analyses were performed by Avanti Polar Lipids using their standard protocols.  
Label-free mass spectrometry quantification of the NPC and associated proteins  
Raw mass spectrometry files from QconCAT Mlp1-PPX-PrA immuno-isolation 
experiments were analysed using the MaxQuant iBAQ method (63). Only peptides that 
were not isotopically labelled (that is, not QconCAT) were considered. Proteins were 
filtered to require more than three unique peptides per protein, and stoichiometries 
normalized to the absolute minimum value of the difference between label-free and the 
QconCAT stoichiometry for all the Nups (Extended Data Fig. 3c and Supplementary Table 
8). Stoichiometries were multiplied by molecular weight to obtain mass per NPC complex 
and the results summed to obtain total mass of the NPC (Fig. 8.1c and Extended Data 
Fig. 3c).  
Living mass of the NPC with charge detection mass spectrometry 
The charge detection mass spectrometry instrument has previously been described (52, 
64). In brief, the measurements are made by trapping single ions in a linear electrostatic 
ion trap. As the ions oscillate back and forth in the trap, they pass through a cylindrical 
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electrode. The charge induced on the electrode is detected by a charge sensitive 
preamplifier. The resulting signal is amplified and digitized, and then analysed using fast 
Fourier transforms. The fundamental frequency provides the m/z and the magnitude is 
proportional to the charge. The mass of each ion is then obtained by multiplying the 
charge and m/z. Each NPC sample was characterized by measuring the masses of 
several thousand ions individually and then binning the masses to yield a true mass 
spectrum (Fig. 8.1b, c).  
Chemical cross-linking and mass spectrometry analysis of the cross-linked NPC  
NPCs were immuno-purified from Mlp1-PPX-PrA, Nup82-PPX-PrA and Nup84-PPX-PrA 
S. cerevisiae strains. After native elution, 0.5 or 1.0mM disuccinimidyl suberate (DSS) 
was added and sample incubated at room temperature for 30min with gentle shaking 
(~1,000 r.p.m.). The reaction was quenched with 50mM ammonium bicarbonate or SDS-
PAGE buffer containing 100mM Tris-HCl.  
The sample was then precipitated using 90% methanol at −80°C or concentrated 
in a speed vacuum before separation by SDS electrophoresis. The sample was reduced 
by 10 mM tris-(2-carboxyethyl)-phosphine (Invitrogen) at 80°C for 15–20min, cooled to 
room temperature and alkylated by 50mM iodoacetamide for 20min in the dark to block 
the formation of disulfide bonds. After reduction and alkylation, the cross-linked 
complexes were separated by 3–8% SDS-PAGE (NuPAGE Tris-Acetate Fisher) to 
reduce the complexity of the sample. For in-gel digestion, the high-molecular-weight-
region gel bands (>460kDa, estimated by the high-molecular-weight protein markers, 
Invitrogen) corresponding to the cross-linked NPC proteins were sliced and proteolysed 
by trypsin as previously described (10, 65). In brief, gel plugs were crushed into small 
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pieces, ~5–10μg of sequencing-grade trypsin (Promega) per ~100μg protein was added 
with subsequent 6–8h incubation. This proteolysis was repeated once more to ensure 
optimal results. Peptides were extracted by formic acid and acetonitrile, desalted on C18 
cartridges (Waters) and snap-frozen before fractionation.  
To reduce the complexity of the sample, proteolysed mixtures were separated by 
an orthogonal two-step fractionation strategy. First, size exclusion chromatography (66) 
was used for size-based separation of peptides into 2–4 fractions (~2–10 kDa). Then, a 
secondary fractionation using a self-packed basic (at pH 10) C18 resins (Dr. Maisch 
GmbH) resulted in 10–12 peptide fractions, which were subsequently analysed by liquid 
chromatography–mass spectrometry.  
Each peptide fraction was dissolved in the sample loading buffer (5% MeOH and 
0.2% FA) and analysed either by an Orbitrap Q Exactive Plus mass spectrometer or a 
LTQ Velos Orbitrap Pro mass spectrometer (Thermo Fisher Scientific). The Q Exactive 
Plus instrument was directly coupled to an easy-nLC system (Thermo Fisher Scientific) 
for electrospray. The cross-linked peptides were loaded onto the Easy-Spray columns 
(15-cm prepacked columns that are filled with C18 reversephase material of 2 or 3μm 
particle size, 200Å pore size and 50μm inner diameter, Thermo Fisher Scientific) that 
were heated to 35 °C. Mobile phase A consisted of 0.1% formic acid and mobile phase B 
of 100% ACN with 0.1% formic acid. Peptides were eluted in liquid chromatography 
gradients of 120min (for example, a liquid chromatography gradient of 3–7% B, 0-6min; 
7–28% B, 6-101min; 28–100%B, 101–113min; followed by equilibration with 100% A until 
120min). Flow rates were set at ~250–275nl/min. Other instrumental parameters for 
chemical cross-linking and mass spectrometry analyses include: capillary temperature: 
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250–275 °C; target mass resolutions (at 200 Th): 70,000 for mass spectrometry and 
17,500 for tandem mass spectrometry; AGC targets: 1–3×106 (full mass) and 2×105 
(tandem mass spectrometry); mass spectrometry range of 300–1,700 Th; isolation 
window: 1.3–1.7 Th; higher-energy collisional dissociation normalized energy: 24–29; 
dynamic exclusion allowed once per 75–90s. The top 8 most abundant ions (with charge 
stage of 3–7 and intensity thresholds of 3,000–7,500 ions) were selected for 
fragmentation by higher-energy collisional dissociation. The maximum injection times 
were set at 200ms (for mass spectrometry) and 500–800ms (for tandem mass 
spectrometry). For samples that were analysed by Orbitrap Velos, the cross-linked 
peptide mixtures were pressure-loaded onto a self-packed PicoFrit column with integrated 
electrospray ionization emitter tip (360 O.D, 75 I.D with 15μm tip, New Objective). The 
column was packed with 10–15 cm reverse-phase C18 material (3μm porous silica, 200Å 
pore size, Dr. Maisch GmbH). Mobile phase A consisted of 0.5% acetic acid and mobile 
phase B of 70% ACN with 0.5% acetic acid. The peptides were eluted in a 120- or a 140-
min liquid chromatography gradient (8% B to 50% B, 0–93min, followed by 50% B to 
100% B, 93–110min and equilibrated with 100% A until 120 or 150min) using a HPLC 
system (Agilent), and analysed with a LTQ Velos Orbitrap Pro mass spectrometer using 
similar parameters to the Q Exactive Plus instrument.  
The raw data were searched by pLink (67) using a FASTA database containing 34 
NPC protein sequences. An initial MS1 search window of 5 Da was allowed to cover all 
isotopic peaks of the cross-linked peptides. The data were automatically filtered using a 
mass accuracy of MS1≤10 p.p.m. (parts per million) and MS2≤20 p.p.m. of the theoretical 
monoisotopic (A0) and other isotopic masses (A + 1, A + 2, A + 3 and A + 4) as specified 
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in the software. Other search parameters included cysteine carbamidomethyl as a fixed 
modification and methionine oxidation as a variable modification. A maximum of two 
trypsin missed-cleavage sites was allowed. The initial search results were obtained using 
a default 5% false discovery rate expected by target–decoy search strategy. All spectra 
were manually verified as previously described (9, 10, 65, 68, 69). The cross-linking data 
were analysed and plotted by an online software tool, CX-Circos (http://cx-circos.net; W.J. 
et al., manuscript in preparation) (Fig. 8.2).  
Cryo-electron tomography of whole NPCs 
We used cryo-ET and sub-tomogram averaging (Extended Data Fig. 4a) to obtain a final 
map with a global resolution of 28Å; the inner ring was solved at 20–25Å (Extended Data 
Fig. 5 and Supplementary Table 9). To create this map, NPCs were immuno-purified from 
Mlp1-PPX-PrA S. cerevisiae strain, in a final buffer of 20mM HEPES (at pH 7.5), 50mM 
Potassium Acetate, 20mM NaCl, 2mM MgCl2, 0.1% Tween 20 and 1mM DTT (see 
‘Immuno-purification of the endogenous S. cerevisiae NPC’ for details). The concentration 
was estimated by SDS-PAGE to be ~0.3–0.4mg/ ml. Freshly cleaned Quantafoil 300 
mesh copper grids with 2-μm holes in the support film were prepared with a continuous 
carbon support film that spanned the holes. Before use, the grids were glow discharged 
in air, floated on 5μl sample drops for 45min and then washed by serial transfer on 4×20μl 
drops of elution buffer without glycerol. Each grid was mounted on forceps in a Mark III 
Vitrobot (FEI) at room temperature and 100% relative humidity. Buffer on the grid was 
removed by blotting from the bottom with a tool that held a filter paper wedge, using 
access through the left-hand port. Then, 2μl of freezing buffer was added to the grid from 
the right-hand port and the grid was plunge-frozen in liquid ethane after blotting.  
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Cryo-ET data collection was done on a Titan-Krios electron microscope operating 
at 300kV, equipped with an X-FEG, a post-column energy filter set to 20 eV and a 
spherical aberration (Cs) corrector (Supplementary Table 9). Images were recorded with 
a Gatan K2 Summit direct electron detector in integration mode, with single frames taken 
at each tilt with UCSF Tomo (70), at a nominal spacing of 5.6Å per pixel. A total of 253 
tilt series were collected in steps between −60°, 0° and 60° in increments of 2.5–4° for 
different tilt series. Although the full tilt range was used for tomogram reconstruction, in 
the final sub-tomogram averaging step only data up to±45° tilt from each sub-tomogram 
were included in the final average. The dose target for each tilt series was 90–100 
electrons per Å2 and followed a cosine α dose curve with a flux of 20 electrons per pixel 
per second, and a dose of 3.5 electrons per Å2 for the zero tilt image. Extended Data Fig. 
4a presents the strategy we used to reconstruct the 3D map of the whole yeast NPC. The 
3dmod viewer in IMOD71 was used to visually screen tilts for defects with the Fourier 
transform, to gauge image motion. In total, 120 tilt series with a defocus range between 
−4.6 and −7.5 μm were kept for further processing (Supplementary Power Point 
Presentation slides 1, 2). After interactive test runs with etomo (71), we processed the tilt 
series in an automated fashion with batchtomo using 7×7 patch tracking to create aligned 
tilt series and calculated tomograms with backprojection and the simultaneous iterative 
reconstruction technique (SIRT), which were contrast transfer function (CTF)-corrected 
by phase-flipping each image in the tilt series (Supplementary Power Point Presentation 
slides 3–6). The final SIRT tomograms were binned 3× and used for interactive sub-
tomogram ‘particle’ picking with e2spt_boxer.py in the EMAN2 single particle tomography 
package (72, 73) with a low pass filter of 100Å. In total, 6,416 fully sampled unfiltered 
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sub-tomograms were extracted from the back-projection tomograms in 300×300×300 
voxel volumes.  
In the alignment and averaging process, new algorithms for high-speed 3D 
alignment with automatic missing wedge compensation and averaging (73) were used 
throughout, and were critical for processing such large sub-tomograms. An initial 
reference was prepared by averaging a small subset of sub-tomograms to produce a low-
resolution reference using the C8-symmetry of the complex (74). Owing to the large size 
and distinct shape of the particles, alignments were unambiguous. The alignment and 
averaging strategy for the final map was adapted from previously described procedures 
(72), and applied iteratively. The observed flexibility of the NPC ring initially limited the 
overall resolution to ~38Å with 5,245 sub-tomograms (data not shown); the sub-
tomograms discarded at this stage were those with the worst quality when compared to 
the average, generally owing to higher noise levels but in some cases due to particle 
damage or false positives during sub-tomogram picking. We realized that observed 
flexibility of the NPCs limited our resolution to ~38Å and therefore used a tactic to locally 
align all individual spokes (C8- symmetry units) to the reference rather than aligning whole 
rings, which could contain long-range deviations from a perfect toroid. It is important to 
note that these deviations are not large; across the entire NPC, they are on the order of 
the 38Å resolution achieved without local alignment. All previous NPC cryo-ET maps have 
been produced using the approach of dividing the NPC into subunits (6, 29, 75, 76). In 
brief, two reference volumes were prepared; (1) the entire NPC and (2) a masked volume 
in which one-fourth of the ring had been retained, centred roughly on the mass of a single 
subunit. Each NPC was rotationally and translationally aligned to the reference ring. Using 
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this initial alignment, each NPC was replicated into its eight pseudo-symmetric 
orientations, then a translation-only alignment against the masked reference was 
performed. This had the effect of bringing one asymmetric unit per replicated ring into 
register with the reference at a consistent radius. Although small per-subunit rotations 
might have occurred, this possibility was not included in the local alignment. The average 
from the eight subunits was then used to construct a symmetric ring by applying an 
azimuthal linear ramp mask centred on the mask used for alignment, which fell to zero at 
an angle of 45° in both directions, and then imposing the C8-symmetry. This interpolates 
smoothly from one side of the subunit to the other symmetry-related side, to produce a 
complete symmetrized ring. This processing dramatically reduces the blurring caused by 
local fluctuations in subunit position and the resulting 3D volume was used as a reference 
in the next cycle of iterative refinement, which was repeated until no further improvement 
was observed.  
At this stage we realized that the preferred orientation of the particles within our 
tomograms was leading to anisotropic resolution in the final structure, with 2/3 of the NPC 
rings oriented within 30° of the C8-symmetry axis (as clearly observed in our raw data). 
Producing an isotropic average required balancing the various ring orientations by 
discarding the lowest-contrast rings in the over-populated orientations to more evenly 
balance the orientation distribution (77–79). This normalizing of orientations, and not 3D 
classification, was what led to discarding a fraction of our data (Extended Data Fig. 4a). 
When doing this, we elected to discard noisier sub-tomograms. This was achieved by 
comparing the agreement of each sub-tomogram with the overall average. In each 
angular range, we then retained roughly the same number of sub-tomograms, keeping 
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those with the best quality. The discarded sub-tomograms were nearly as good, meaning 
we could equally well have used the next best subset of the sub-tomograms with virtually 
no effect on the final structure. Indeed, in the less common orientations, we were forced 
to use virtually all of the sub-tomograms irrespective of quality. Thus, in our work, a large 
fraction of the sub-tomograms were discarded not owing to their poor quality or 
conformational variability, but rather because of the preferred orientation of the particles 
within the tomogram. The final reconstruction used 1,864 (of the 6,416 initial) sub-
tomograms. These sub-tomograms were further divided randomly into two groups for 
resolution assessment. ‘Gold standard’ refinement was used for resolution testing and to 
ensure self-consistency (Supplementary Power Point Presentation slides 7, 8). Both 
global and local resolution assessments were done using a set of tiled Gaussian masks 
to estimate the local resolution and reproducibility of the structure, which is one of the 
standard methods for local resolution assessment. In brief, a 3D Gaussian shape is 
generated with a ‘full width at half maximum’ parameter of at least 2× the anticipated 
resolution, and generally even larger. This Gaussian shape is then applied as a mask to 
both maps and a Fourier shell correlation (FSC) curve is computed. This process is 
repeated in a tiled pattern throughout the volume. This provides a resolution for each 
sampled location in the volume. This procedure involves a trade-off: with smaller 
Gaussians, FSC curves are less precise, but with larger Gaussians the resolution 
estimate is less localized. The Gaussians overlap to provide better sampling of the 
volume. The resulting resolution map is similar to those produced by ResMap80, but it 
measures FSC, which is filter-independent, unlike ResMap (80) that requires unfiltered 
volumes and would not work well on sub-tomogram averages. The global resolution of 
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our cryo-ET map at the standard FSC0.143 cutoff is ~28Å and the local resolution 
distribution ranges from 20 to 38Å, with the inner ring being in the 20–25Å range 
(Extended Data Fig. 5a–d). This local resolution estimate was used to locally filter the 
density map, to produce a map with the appropriate level of detail in each area (Extended 
Data Fig. 5). The size of the Gaussian window was 140Å, indicating the smallest region 
over which the resolution is considered to vary. Although this may seem large, it is small 
compared to the size of the overall NPC (Extended Data Fig. 5). CTF phase-flipping was 
applied during tomographic reconstruction and a final approximate amplitude correction 
was applied to the averaged NPC ring. Therefore, theoretical CTF curves for the mean 
defocus values present in the tomograms were averaged assuming 10% amplitude 
contrast. The reciprocal of this curve was then applied as a filter to the final uncorrected 
map. The cryo-ET density map was refined at 5.3Å per pixel on the basis of a recalibration 
of the map with known structures.  
In parallel, and as an additional validation of our final map, we also carried out a 
tomographic analysis of the yeast NPC dataset (the same 6,416 sub-tomograms) using 
RELION 1.4, and incorporated a CTF model (81, 82). In brief, we calculated back-
projection tomograms without phase-flipping corrections for the individual tilted images, 
and binned the output sub-tomograms twofold to 10.6Å per pixel. The datasets underwent 
sequential rounds of 2D classification using Z-projections of the sub-tomograms to 
eliminate poor particles. A subsequent 2D classification identified near-top, tilted and side 
views; the latter provided an independent estimate of NPC thickness perpendicular to the 
nuclear envelope (620–640Å). A 3D reconstruction using the best sub-tomograms with 
RELION produced a map at ~35Å resolution (data not shown) with similar features to 
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those obtained with the e2spt in the EMAN2 single particle tomography package (72, 73), 
including distinct connections between each spoke and the transporter, further validating 
these features in our cryo-ET map (Fig. 8.3). Finally, Z-projections of original sub-
tomograms that were roughly aligned along the C8-symmetry axis were used for an 
additional unsupervised 2D classification, which produced classes with central 
transporters without using the C8-symmetry restraint (Extended Data Fig. 6a, b). 
Differences in the apparent resolution of the class averages in Extended Data Fig. 6a, b 
reflect different particle numbers in the classes. As mentioned above, the dataset of 
particles has a strong orientational bias, in which the NPCs tend to bind to the carbon 
support film with a range of 0–30 degrees of tilt. The class averages are based on 2D 
projections along the z axis of the original sub-tomograms, to avoid issues with the 
missing wedge, and there is therefore a disparity in particle numbers in the classes. Tilting 
in the tomographic data collection helped to fill in the missing data, but we took great care 
to ensure an equal coverage of Fourier space in the calculation of our final map, to avoid 
distortions, and also took a number of other steps to ensure that radiation damage and 
loss of data quality in later tilts was minimized by using only information in Fourier space 
at ±45° from each particle sub-tomogram when they were combined to form the final map. 
The RELION map serves as a strong validation of our final map, because if our map was 
flawed, a reconstruction with RELION would have resulted in a different map (Extended 
Data Fig. 5e). Additionally, the fact that a RELION reconstruction resulted in a ~35Å 
resolution map—virtually the same resolution as obtained in our ‘intermediate’ map 
described above (~38Å)—validates our methodology and the quality of our final map 
(Extended Data Fig. 5e). An additional point that provides prima facie evidence that our 
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cryo-ET map was calculated correctly is that local two-fold symmetry (C2-symmetry), 
which was expected in the inner ring of the NPC, emerges without any enforcement, 
whereas the overall map shows a clear asymmetry with large and distinctly different 
features on the nuclear and cytoplasmic face of the yeast NPC (which were also observed 
in the RELION map) and a slightly tapered appearance, as is shown in Fig. 8.3a and 
Extended Data Figs 4d, 5b.  
Small angle X-ray scattering. 
Small angle X-ray scattering (SAXS) measurements for 147 constructs of 18 Nups (9, 12, 
23, 83–86) (Supplementary Table 6; S.J.K. et al., manuscript in preparation; and Source 
Data) were carried out both at the Stanford Synchrotron Radiation Lightsource Beamline 
4-2 in the SLAC National Accelerator Laboratory and at the SIBYLS Beamline 12.3.1 of 
the Advanced Light Source in the Lawrence Berkeley National Laboratory. SAXS data 
were collected at concentrations ranging from 0.5 to 5.0 (or higher, depending on the 
sample) mg/ml, using the previously defined standard protocol (12, 23, 83); approximately 
20 one-second exposures were used for each sample and buffers at 15°C. Further details 
of the SAXS experiments have previously been published (9, 12, 23, 83–86). 
Phenotypic analysis by one-cell doubling evaluation by living arrays of yeast 
Yeast growth phenotypes were quantified using the one-cell doubling evaluation by living 
arrays of yeast (ODELAY) assay, as previously described14. In brief, yeast was cultured 
in YPD medium in 96-well plates overnight. Cultures were diluted to an OD600 of 0.09 
and allowed to grow for 6 h at 30°C. The cultures were then diluted again to an OD600 of 
0.02 and spotted onto YPD agarose medium. The resulting cultures were then observed 
using time-lapse microscopy for 48h with 30min intervals between images. All images 
293 
 
were collected on Leica DMI6000 microscopes with a 10× 0.3NA lens using bright field 
microscopy. MATLAB scripts using the Micro-Manager interface controlled the image 
collection process (87). Six independent experiments were performed. The population 
growth rates were scored against each other using the following equation:  
pDEFC = 1a:8! − q!r!C!  
in which di is the ith decile of doubling time of the query population, μi is the mean of the 
ith decile of the doubling time of the parent strain and σi is the standard deviation of the ith 
decile of the doubling time of the parent strain. The mean and standard deviation deciles 
were calculated from at least 4 separate populations containing at least 200–300 
individuals. All calculations were performed using MATLAB scripts. Following Z-scoring 
of the populations, an additional weight was added to the scoring for truncation strains 
that occurred in haploid versus diploid strains of yeast.  
Negative-stain electron microscopy of the native Nic96 complex 
An affinity-captured and natively eluted sample of the endogenous Nic96 complex 
(composed of Nic96, Nsp1, Nup49 and Nup57) was applied to a glow-discharged grid 
and stained with 1% uranyl formate. Images were collected on a Philips CM200 
transmission electron microscope (FEI) operating at 200 kV at 50,000× magnification and 
a defocus of ~1.5μm (2.03 pixels per Å). Images were recorded on a Gatan UltraScan 
1000 2k×2k CCD camera (Gatan). Particles were selected using Boxer from EMAN (88), 
normalized and then phase-flipped using ctfit from EMAN. In total, 34 class averages 
(selected classes shown in Extended Data Fig. 7g) were generated through ISAC (89) 
that classified ~86% of the original set of 5,458 particles.  
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Integrative structure determination of the S. cerevisiae NPC 
The structure of the S. cerevisiae NPC, including the scaffold, membrane rings, 
cytoplasmic export platform and nuclear baskets in the context of the pore membrane—
but excluding the flexible FG regions—was solved by integrative structure determination 
(see ‘Integrative structure determination of the S. cerevisiae NPC scaffold, membrane 
rings, cytoplasmic export platform and nuclear basket’). Moreover, the distributions of the 
FG regions and the cargo-bound NTFs, comprising the central transporter, were 
computed by Brownian dynamics simulation (see ‘Brownian dynamics simulation of FG 
repeats and NTFs’).  
Integrative structure determination of the S. cerevisiae NPC scaffold, membrane 
rings, cytoplasmic export platform and nuclear basket 
Integrative structure determination of the S. cerevisiae NPC proceeded through four 
stages (8, 90–92) (Extended Data Fig. 1, Supplementary Table 3 and Supplementary 
Videos 1–3): (1) gathering data, (2) representing subunits and translating data into spatial 
restraints, (3) configurational sampling to produce an ensemble of structures that satisfies 
the restraints and (4) analysing and validating the ensemble structures and data 
(Extended Data Figs 1, 7, 8 and Supplementary Tables 2–4). The integrative structure 
modelling protocol (stages 2, 3 and 4) was scripted using the Python modelling interface 
(PMI) package version 4d97507, which is a library for modelling macromolecular 
complexes based on our opensource integrative modelling platform (IMP) package (90) 
version 2.6 (https:// integrativemodeling.org). The current procedure is an updated 
version of previously described protocols (9, 10, 12, 93–96).  
Stage 1: gathering data 
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The stoichiometry of Nups in the NPC was determined using native mass 
spectrometry and biochemical quantification of the purified NPC complex (Fig. 8.1 and 
Extended Data Figs 2, 3). In total, 3,077 intra and intermolecular DSS and EDC unique 
cross-links were identified using mass spectrometry (Fig. 8.2 and Supplementary Table 
1), which informed the spatial proximities among the 32 Nups and their conformations. 
The density map of the entire NPC was determined by cryo-ET at an average resolution 
of 28Å, with the local resolution as high as ~20Å for the inner ring, which informed the 
shape of the NPC (Fig. 8.3 and Extended Data Figs 4–6). Re-interpreted immunoelectron 
microscopy data (3, 8) informed the positions of 29 Nups. Predictions of the 
transmembrane domains obtained from the Saccharomyces Genome Database (97) 
(http://yeastgenome.org) and predictions of MBMs from the HeliQuest webserver (12, 98) 
informed about their respective proximities to the pore membrane. Previous immuno-
electron microscopy measurements (99) informed the end-to-end distance for Mlp1 and 
Mlp2. Low-resolution electron microscopy images of the NPC44 informed the diameter of 
the distal basket ring formed by Mlp1 and Mlp2.  
Representations of individual Nups and some of their sub-complexes 
(Supplementary Table 2 and references therein) relied on (1) atomic structures of 21 
yeast Nup domains and 3 sub-complexes determined by X-ray crystallography or nuclear 
magnetic resonance spectroscopy; (2) our previously determined structures of Nup116, 
Nup133, Nup145N, Nup192 and Pom152, as well as the Nup82 and Nup84 sub-
complexes solved by integrative structure determination (9, 10, 12, 23, 83–86); (3) 29 
comparative models built with MODELLER 9.13 (100) on the basis of known structure(s) 
detected by HHpred (101, 102); (4) SAXS profiles for 147 constructs of 18 Nups (9, 10, 
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12, 23, 83–86);  (Supplementary Table 6; S.J.K. et al., manuscript in preparation); (5) 
secondary structure, disordered regions, and domain boundaries predicted by PSIPRED 
(103, 104), DISOPRED (105), and DomPred (106), respectively; (6) coiled-coil regions of 
Nup82, Nup159, Nsp1, Nup49, Nup57, Mlp1, and Mlp2 predicted by COILS/PCOILS 
(107) and Multicoil2 (108); (7) an atomic structure of the Nup53229–365 RRM domain from 
S. cerevisiae determined by X-ray crystallography (P. Sampathkumar et al., manuscript 
in preparation); and (8) negative-stain electron micropscopy density maps of full-length 
Nup192 (EMD-5556 (86)) and Pom152 (EMD-8543 (23)). See Supplementary Table 2 
and references therein for all above (1) to (8).  
Our previously published topological map of the NPC (3) and the 82 composites 
determined by affinity purification and overlay assay (8) were not used for computing the 
current NPC structure, but were used for validating the current NPC structure.  
Stage 2: representing subunits and translating data into spatial restraints 
Information about the modelled system (see ‘Stage 1: gathering data’) can in general be 
used for defining the system’s representation, defining the scoring function that guides 
sampling of alternative structural models, limiting sampling, filtering of good-scoring 
structures obtained by sampling and final validation of the structures. Here the NPC 
representation relies primarily on stoichiometry as well as atomic structures, integrative 
structures, comparative models and SAXS profiles of Nups and their sub-complexes 
(Supplementary Tables 2 and 6, and references therein); the scoring function relies on 
chemical cross-links, the cryo-ET density map, immuno-electron microscopy 
localizations, excluded volume, sequence connectivity, the shape of the pore membrane 
and four types of sequence-based localization relative to the membrane (below); the 
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sampling benefits from symmetry constraints (below); and the validation of the final 
structure relies in part on the SAXS profiles (Supplementary Table 6) and composites 
determined by affinity purification and overlay assays8 (below).  
To improve computational efficiency and avoid a representation that was too 
coarse, we represented the NPC in a multi-scale fashion. A rigid body consisting of 
multiple beads was defined for each X-ray structure, NMR structure, comparative model 
and integrative structure of the NPC components (Supplementary Table 2). The 
remainders of the Nup sequences not in rigid bodies (36.8% of residues, excluding FG 
repeats) were represented as flexible strings of beads. In a rigidbody, the beads have 
their relative distances constrained during configurational sampling, whereas in a flexible 
string the beads are restrained by the sequence connectivity, excluded volume and 
potentially additional restraints, such as chemical cross-links, as exemplified in previous 
publications (9, 10, 23, 93, 109).  
Rigid bodies (63.2% of residues, excluding FG repeats) were coarse-grained using 
two resolutions, in which beads represented either individual residues or segments of up 
to ten residues. The coordinates of a 1-residue bead were those of the corresponding Cα 
atom. The coordinates of a 10-residue bead were the center of mass of the ten constituent 
1-residue beads. Finally, the remaining regions without an atomic representation (that is, 
the predicted transmembrane and disordered regions) were represented by a flexible 
string of beads encompassing 25 to 100 residues each; the low-resolution representation 
of these regions is justified because their conformations are likely to be ‘decoupled’ from 
the structure of the rest of the NPC (3, 110). We used the SAXS data to confirm the rigid 
body representations of eight Nups with X-ray structures, comparative models, and 
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previously published atomic integrative structures (9, 10, 12, 23, 83–86) (Extended Data 
Fig. 7f and Supplementary Tables 2, 6). The rigid-body representation of a Nup construct 
was validated by a χ-value that quantifies the difference between the computed (from an 
atomic rigid-body representation using FoXS (111)) and experimental SAXS profiles, 
except for several constructs of Nup133 and Nup192 that were flexible during integrative 
modelling and were thus evaluated as previously described (12, 86, 112). The χ-value 
validation assumes that each Nup construct, corresponding in most cases to a single 
domain (not the whole protein), has the same conformation in solution and in complex; 
this assumption is consistent with other data (for example, the chemical cross-links and 
cryo-ET map). The SAXS validation is necessarily limited to S. cerevisiae constructs of 
Nups that exist as a rigid monomer in solution and do not contain FG repeats; rigid body 
representations of the constructs from other species, constructs that oligomerize in 
solution and constructs that include FG repeats cannot be easily used for validation, 
because of the sensitivity of a computed SAXS profile to the differences in the sequence 
and stoichiometry, as well as to potential errors in comparative modelling (especially of 
insertion and deletion).  
After producing this validated representation, we next encoded the spatial 
restraints on the basis of information gathered in Stage 1, according to the following steps 
(Supplementary Table 4; for the definition of the scoring function consisting of these 
restraints, see ‘Scoring function’):  
(1) Cross-link restraints: 1,643 of the 3,077 unique cross-links (Fig. 8.2 and 
Supplementary Table 1a) were used to restrain the distances spanned by the crosslinked 
residues, relying on a Bayesian scoring function (10). The evaluation takes into account 
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the ambiguity due to multiple copies of identical subunits and, for crosslinks involving the 
same protein type, due to the lack of knowledge of whether they are intra- or 
intermolecular (9, 93, 109); the ambiguous cross-link restraint considers all intra- and 
intermolecular assignments in multiple copies of identical subunits, with only the least 
violated distance contributing to the score. The remaining 1,434 DSS and EDC cross-
links (Fig. 8.2 and Supplementary Table 1b–f) were already used as restraints to build 
the integrative structures of the Nup84 (10) and Nup82 subcomplexes (9), represented 
here as rigid bodies. The two homo-dimer DSS crosslinks between two copies of residue 
62 of Pom152 (23) and two copies of residue 151 in Nup60 (22) were transformed into 
harmonic upper-distance bounds, enforcing the homo-dimer configuration.  
(2) Cryo-ET density restraint: the cryo-ET density restraint was applied, which 
corresponded to the cross-correlation between the Gaussian mixture model (GMM) 
representation of most Nups and the GMM representation of the cryo-ET density map 
(95, 113–115) (Fig. 8.3 and Extended Data Figs 4–6); we used a GMM representation 
for the sake of computational efficiency, necessitated by the large size of the NPC. An 
assessment of a given structure against a density map is much faster when both are 
represented with a mixture model (because the number of components in a mixture model 
is much smaller than the number of grid points covering the maps). However, these two 
scores are very strongly correlated. Thus, the structures obtained with a grid 
representation, if we had sufficient computational power, would certainly be 
indistinguishable from the current NPC structures (115).  
A 90° arc of the cryo-ET density map was approximated by the GMM, which contained 
1,750 components computed using the expectation-maximization algorithm implemented 
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in scikit-learn (http://scikit-learn.org); the cryo-ET GMM appeared to be sufficient to 
reproduce the complete features of the density map (excluding the central transporter 
region). To use a comparable number of GMM components for Nups, a Nup was 
approximated by a GMM component for each of its 100 to 500 residues. The cross-
correlation quantified the degree of overlap between the Nup GMM components and the 
cryo-ET GMM components.  
(3) Immuno-electron microscopy localization restraints: the immuno-electron microscopy 
localization restraint was used to localize the C-terminal beads of 29 of the 32 Nups, on 
the basis of previous immuno-electron microscopy data (3, 8, 116). This goal was 
achieved by imposing upper and lower harmonic bounds on the axial and radial 
coordinates of the restrained bead, reflecting the uncertainty in the immuno-electron 
microscopy data (8). The three remaining Nups (Nsp1, Sec13, and Seh1) were not 
restrained by the immuno-electron microscopy data because of their high uncertainty, 
presumably due to the positional heterogeneity of the tagged Nup in the multiple 
superposed electron microscopy images of the NPC. This heterogeneity is more likely to 
occur for Nups with multiple copies per C2- symmetry unit, which are unlikely to share the 
same radial and axial coordinates.  
(4) Excluded volume restraints: the protein excluded volume restraints were applied to 
each 10-residue bead, using the statistical relationship between the volume and the 
number of residues that it covered (8–10, 117).  
(5) Sequence connectivity restraints: we applied sequence connectivity restraints, using 
a harmonic upper bound on the distance between consecutive beads in a subunit, with a 
threshold distance equal to three times the sum of the radii of the two connected beads. 
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The bead radius was calculated from the excluded volume of the corresponding bead, 
assuming standard protein density (8–10, 117).  
(6) Membrane exclusion restraints: the membrane exclusion restraints were applied to 
beads in the non-membrane-spanning Nups or to their segments to prevent these beads 
from penetrating the pore membrane. A lower harmonic bound at 0Å was applied to the 
distance between a bead and the closest point on the pore-side membrane surface (3, 8) 
(modelled as a half-torus with the large and small radii of 390 and 150Å, respectively; 
Supplementary Table 3), for all coarse beads (10 residues or more per bead) in all Nups 
but Pom152, Ndc1, and Pom34; the restraint was also applied to all non-membrane 
coarse beads of Pom1521–110, Ndc11–28, Ndc1248–655, Pom341–63, and Pom34151–299.  
(7) Transmembrane domain restraints: the transmembrane domain restraint was used to 
localize the coarse beads in the predicted transmembrane domains (Pom152111–200, 
Ndc129–247, and Pom3464–150; Supplementary Table 2 and references therein) within the 
pore membrane, which is 45Å thick (3, 8). This aim was achieved by imposing an upper 
harmonic bound at 45Å and a lower harmonic bound at 0Å on the distance between the 
bead and the closest point on the poreside membrane surface.  
(8) Membrane surface binding restraints: the membrane surface binding restraint was 
used to localize the coarse beads in the predicted MBMs (Nup11–32, Nup6027–47, 
Nup120135–152, Nup120197–216, Nup133252–270, Nup157310–334, Nup170320–344, Nup53475 and 
Nup59528; Supplementary Table 2 and references therein), within the pore membrane up 
to 12 Å from the pore-side membrane surface (118). This aim was achieved by imposing 
an upper harmonic bound at 12 Å within the pore membrane and a lower harmonic bound 
at 0 Å on the distance between the bead and the closest point on the pore-side membrane 
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surface. For Nup120, only the best satisfied of the Nup120135–152 and Nup120197–216 
restraints were used (10, 12) (conditional restraint).  
(9) Pom152 perinuclear volume restraint: only the C-terminal region of Pom152 (residues 
201–1337) was restrained to the perinuclear lumen of the pore membrane (23). This aim 
was achieved by imposing a lower harmonic bound at 0Å on the distance between the 
Pom152 beads and the closest point on the perinuclear side of the membrane surface.  
(10) Distal basket ring restraints: the conformations of Mlp1 and Mlp2 were restrained by 
an upper harmonic bound at 350Å and a lower harmonic bound at 230Å on the distance 
between the N-terminal and C-terminal beads, on the basis of immuno-electron 
microscopy measurements (99). In addition, the radius of the distal basket ring was 
restrained by an upper harmonic bound at 170Å and a lower harmonic bound at 130Å on 
the radial coordinates of the C-terminal beads of Mlp1 and Mlp2, on the basis of low-
resolution electron microscopy images of the NPC (44). The nuclear basket was also 
informed by cross-linking restraints and the C8-symmetry constraint (see ‘Sampling 
space with symmetry constraints’).  
Stage 3: Configurational sampling 
We used the configurational sampling to produce an ensemble of structures that satisfies 
the restraints, as described below. 
Sampling space with symmetry constraints 
We aimed to maximize the efficiency of the configurational sampling: more specifically, 
we aimed to maximize the precision at which the sampling of good-scoring solutions was 
exhaustive (see ‘Stage 4: analysing and validating the ensemble structures and data’). 
Therefore, we reduced the number of independently moving parts in the NPC structure 
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by explicitly considering the C8- and C2-symmetries of the NPC, as follows. The entire 
NPC consists of 8 clones of the C8-symmetry unit, related by multiples of a 45° rotation 
around the z axis (Fig. 8.3 and Extended Data Figs 4–6). The C8-symmetry unit was 
further broken into two C2-symmetry units and non-C2-symmetric Nups (Supplementary 
Table 2a); the C2-symmetry unit contains Nups that occur equally on both the cytoplasmic 
and nucleoplasmic sides (3, 8, 116). For computational efficiency, we defined the 
coordinate system such that the C2-symmetry is imposed simply by cloning a bead in the 
C2-symmetry unit at (x, y, z) to (x, −y, −z) (equivalent to a rotation of 180° around the x 
axis). This aim was achieved by fitting both copies of Pom152 (23) into the cryo-ET 
density map, followed by moving the centre of the map to the origin of the coordinate 
system and orienting the map such that the x, −y, −z transformation applies to Pom152.  
With these symmetries in hand, we sampled only the positions of rigid-bodies and beads 
corresponding to the Nups in the C2-symmetry unit and non-C2-symmetric Nups. There 
are no Nups that occur on both the cytoplasmic and nuclear sides and are not related by 
the C2-symmetry; there are no Nups that occur with a different stoichiometry on both 
sides. In addition, the luminal domain of Pom152 was considered already well-positioned 
given its fit into the cryo-ET density map (Fig. 8.3e) and peripheral location in the NPC 
(23), and was not sampled further.  
Scoring function 
The scoring function included restraints on the sampled Nups and the Pom152 luminal 
domain as well as restraints across the interfaces with neighbouring symmetry units: (1) 
the cryo-ET density restraint and distal basket ring restraint applied to the Nups in the 
sampled C8-symmetry unit; (2) sequence connectivity, immuno-electron microscopy 
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localization, and the four types of sequence-based localizations relative to the membrane 
applied to the Nups in the sampled C2-symmetry unit and non-C2-symmetric Nups; and 
(3) cross-link and excluded volume restraints applied to the pairs of beads for Nups within 
the sampled C8-symmetry unit and across the interfaces with neighbouring symmetry 
units.  
Sampling algorithm 
The search for good-scoring structures relied on replica exchange Gibbs sampling, based 
on the Metropolis Monte Carlo algorithm (9, 10) (Supplementary Table 3). The Monte 
Carlo moves included random translation and rotation of rigid-bodies (up to 4Å and 0.04 
radians, respectively) and random translation of individual beads in the flexible segments 
(up to 4Å). As indicated above, these operations were applied only to the sampled rigid 
bodies and beads. The remaining, symmetry-constrained rigid-bodies and units were 
moved in lockstep to maintain the exact C8- and C2-symmetries at each sampling step, 
as described above. Up to 64 replicas were used, with a 1.0–5.0 temperature range. 
Forty-two independent sampling calculations were performed, each one starting with a 
random initial configuration. The coordinates were saved every 10 Gibbs sampling steps, 
each consisting of a cycle of Monte Carlo steps that moved every rigid-body and flexible 
bead once.  
To further increase the efficiency of sampling, we first applied the above Monte 
Carlo algorithm separately to the following four subsets of Nups, which are co-localized 
on the basis of previous characterizations (3, 8, 9, 23) and the current cryo-ET density 
map: (1) Nup82 and Nup84 sub-complexes, (2) Pom152, (3) inner-ring Nups (Nup157, 
Nup170, Nup188, Nup192, Pom34, Ndc1, Nup53, Nup59 and Nic96205–839), and (4) Mlp1 
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and Mlp2. Next, the best-scoring solutions from sampling each of the first three subsets 
were combined; they were already in the same reference frame, because they were all 
obtained by fitting the same cryo-ET density map and immuno-electron microscopy data. 
The rest of the Nups and the Mlp1– Mlp2 heterodimer were then added in random 
positions and orientations, followed by another application of the above Monte Carlo 
algorithm to all sampled Nups. This sampling produced a total of 100,453 modelled 
structures in 42 independent runs (the score ranges from 88,545.0 to 103,589.5, with the 
mean and standard deviation of 88,831.5 and 187.4, respectively), requiring ~10 weeks 
on a cluster of ~2,500 CPU cores. For the most detailed specification of the sampling 
procedure, see the IMP modelling script (https://salilab.org/npc2018). We considered for 
further analysis only the 5,529 modelled structures with the scores better than 88,644.1 
(1 standard deviation below the mean value); this threshold implies satisfaction of the 
input datasets within their uncertainties (Supplementary Table 4; see ‘Fit to input 
information’). These structures are already superposed because they were fit into the 
same Cryo-ET map and sampling did not move the luminal domain of Pom152 (see 
‘Sampling space with symmetry constraints’).  
Stage 4, analysing and validating the ensemble structures and data 
Input information and output structures need to be analyzed to estimate structure 
precision and accuracy, detect inconsistent and missing information, and to suggest more 
informative future experiments. We used the previously published analysis and validation 
protocol (8, 9). Assessment began with a test of the thoroughness of structural sampling, 
followed by structural clustering of the modelled structures and estimating their precision 
based on the variability in the ensemble of good-scoring structures, quantification of the 
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structure fit to the input information and structure assessment by data not used to 
compute it; structure assessment by cross-validation was not performed in this case, 
because it takes ~10 weeks on approximately 2,500 CPU cores to compute an ensemble 
of structures for a single set of input datasets. These validations are based on the nascent 
wwPDB effort (92) toward archiving, validating and disseminating integrative structures. 
We now discuss each one of these validations in turn.  
Thoroughness of the configurational sampling 
We must first estimate the precision at which sampling found the most good-scoring 
solutions (sampling precision); the sampling precision must be at least as high as the 
precision of the structure ensemble that is consistent with the input data (structure 
precision). As a proxy for testing the thoroughness of sampling, we performed four tests 
of sampling convergence (119), as follows.  
The first convergence test confirmed that the scores of refined structures do not 
continue to improve as more structures are computed, essentially independently of each 
other (Extended Data Fig. 1c).  
The second convergence test confirmed that the good-scoring structures in 
independent sampling runs 1–21 (structure sample 1; nsample1=2,359 structures) and 
22–42 (structure sample 2; nsample2=3,170 structures) satisfied the data equally well. 
The non-parametric Kolmogorov–Smirnov two-sample test (120, 121) (two-sided) 
indicates that the difference between the two score distributions is insignificant (P value 
(1.0) > 0.05). In addition, the magnitude of the difference is small, as demonstrated by 
the Kolmogorov–Smirnov two-sample test statistic, D, of 0.045 (Extended Data Fig. 1d). 
Thus, the two score distributions are effectively equal.  
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Next, we considered the 5,529 good-scoring structures themselves (not their 
scores as in the two tests described above). For stochastic sampling methods, 
thoroughness of sampling can be assessed by showing that multiple independent runs 
(for example, using random starting configurations and different random number 
generator seeds, as is the case for structure samples 1 and 2) do not result in noticeably 
different structures (8–10, 13). We tested the similarity between structure samples 1 and 
2 in the following two ways.  
The third convergence test (119) relied on the χ2-test (one-sided) for homogeneity 
of proportions (122) between structure samples 1 and 2 (Extended Data Fig. 1e, f). The 
test involves clustering structures from both samples, followed by comparing the 
proportions of structures from each sample in each cluster. No adjustment was made for 
multiple comparisons. A comparison of two NPC structures considered only the beads 
representing Nups with a single copy per C2- symmetry unit and the Nic96 complex 
(including all Nups in the inner, outer and membrane rings, but excluding Nup100, 
Nup116, Nup145N, Nup1, Nup60, Gle1, Nup42, Mlp1 and Mlp2), to avoid the 
combinatorial explosion in identification of topologically equivalent Nup copies. The 
sampling precision is defined as the largest root-mean-square deviation (r.m.s.d.) 
between a pair of NPC structures within any cluster, in the finest clustering for which each 
sample contributes structures proportionally to its size (considering both the significance 
and magnitude of the difference) and for which a sufficient proportion of all structures 
occur in sufficiently large clusters. The sampling precision for our NPC structure is 9 Å 
(Extended Data Fig. 1e).  
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Threshold-based clustering (123) results in a single dominant cluster containing 
80.3% of the good-scoring structures (Extended Data Fig. 1e, f) with a root-meansquare 
fluctuation (r.m.s.f.) of 9 Å (cluster precision). The remaining 19.7% of the structures are 
similar to those in the dominant cluster; the largest r.m.s.d. value from a structure in the 
dominant cluster is 17 Å (the mean and standard deviation of the r.m.s.d. values are 13.3 
and 1.3Å, respectively). Therefore, there is effectively a single good-scoring solution, at 
the structure precision of 9Å (equal to the cluster precision). The sampling precision of 
9Å (r.m.s.d.) is sufficiently high for computing a structure at 9 Å precision (r.m.s.f.; r.m.s.d. 
is approximately √2	 × r.m.s.f. (124)). For the remainder of our analysis, we use only the 
structures in the dominant cluster.  
The fourth convergence test relied on a comparison of two localization probability 
density maps for each Nup, obtained for dominant cluster structures in samples 1 and 2. 
A localization probability density map defines the probability of any voxel (here, 6×6×6 
Å3) being occupied by a specific protein in a set of structure densities, which in turn are 
obtained by convolving superposed structures with a Gaussian kernel (here, with a 
standard deviation of 5.4Å). The average cross-correlation coefficient between the two 
maps for each Nup is 0.90, indicating that the positions of most Nups in the two samples 
are nearly identical at the structure precision of 9Å.  
In conclusion, all four sampling tests indicate that the sampling was exhaustive at 
9Å precision (Supplementary Table 3). The caveat is that passing these tests is 
necessary but not sufficient evidence of thorough sampling; a positive outcome of the 
tests may be misleading if, for example, the landscape contains only a narrow— and thus 
difficult to find—pathway to the pronounced minimum corresponding to the correct 
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structure. Moreover, our sampling was not completely stochastic because it proceeded in 
two steps, the first of which prepared the starting configuration for the second step. As a 
result, the actual structure precision might be worse (125–128) than the estimated 9Å.  
Clustering and structure precision 
An ensemble of good-scoring structures needs to be analyzed in terms of the precision 
of its structural features (3, 8, 9). The precision of a component position can be quantified 
by its variation in an ensemble of superposed good-scoring structures. It can also be 
visualized by the localization probability density for each of the components of the NPC 
structure. As described above, integrative structure determination of the NPC resulted in 
effectively a single good-scoring solution, at the precision of ~9Å. This precision is 
sufficiently high to pinpoint the locations and orientations of the constituent Nups, 
demonstrating the quality of the input data, including the chemical crosslinks (Fig. 8.2 
and Extended Data Fig. 7a–c) and the cryo-ET density map (Fig. 8.3 and Extended Data 
Fig. 8).  
Fit to input information 
An accurate structure needs to satisfy the input information used to compute it. Because 
the sampling was exhaustive at ~9Å precision, overfitting is not a problem at this 
precision; all structures at this precision that are consistent with the data are provided in 
the ensemble.  
The dominant cluster satisfies 90% of the DSS cross-links (Extended Data Fig. 
7a–c and Supplementary Tables 1, 4); a cross-link restraint is satisfied by a cluster of 
structures if the corresponding Cα–Cα distance in any of the structures in the cluster 
(considering restraint ambiguity) is < 35Å (Extended Data Fig. 7a–c; shown in blue). 
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Therefore, the dominant cluster essentially satisfies the cross-linking data within its 
uncertainty (the false detection rate is approximately 5% to 10% (129, 130)). Most of the 
cross-link violations are small, and can be rationalized by local structural fluctuations, 
coarse-grained representations of some Nup domains, and/or finite structural sampling, 
as shown in Extended Data Fig. 7a (a histogram presenting the distribution of the cross-
linked Cα–Cα distances).  
The localization probability densities for the dominant cluster overlap well with the 
cryo-ET density map, with the cross-correlation coefficient of 0.92 (Fig. 8.3, Extended 
Data Fig. 8 and Supplementary Table 4). Additional density is present in the cryo-ET map 
for the Nup82 complex (cytoplasm) and basket attachment sites (nucleoplasm). This 
density may arise from local flexibility of these modules or may be due to the presence of 
cargo or transport factors associated with the NPC (Fig. 8.1b, c and Extended Data Fig. 
3c). For visualization, the localization probability densities are typically smoothed and 
contoured at the threshold that results in approximately twice the protein volume 
estimated from its sequence (Fig. 8.4).  
The remainder of the restraints are harmonic, with a specified standard deviation. 
The dominant cluster generally satisfied at least 95% of restraints of each type 
(Supplementary Table 4); a restraint is satisfied by a cluster of structures if the restrained 
distance in any structure in the cluster (considering restraint ambiguity) is violated by less 
than 3 standard deviations, specified for the restraint. Most of the violations are small, 
and can be rationalized by local structural fluctuations, coarse-grained representations of 
some Nup domains and/or finite structural sampling.  
Satisfaction of data and considerations that were not used to compute structures 
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The most direct test of a modelled structure is by comparing it to the data that were not 
used to compute it (a generalization of cross-validation).  
First, our current NPC structure is consistent with our previously published data 
and topological map (3, 8) (Extended Data Fig. 7d, e). Our current structure satisfies all 
82 composites determined by affinity purification and overlay assays (3, 8), even though 
these were not used in this calculation. For example, Pom152, Pom34, Ndc1, Nup157 
and Nup170 are connected with each other (left panel in Extended Data Fig. 7e), 
consistent with the composites determined in a previous publication using the affinity 
purification data (3, 8)  (right panel in Extended Data Fig. 7e). Moreover, the position of 
each Nup in the current structure is generally similar to that in the previous topological 
map (3, 8), although the current structure is determined at a precision that is an order of 
magnitude higher than in the previous map (Extended Data Fig. 7d).  
Second, the atomic structures of eight Nups are consistent with the corresponding 
SAXS profiles for their constructs (Extended Data Fig. 7f and Supplementary Tables 2, 
6), as discussed in ‘Stage 2: representing subunits and translating data into spatial 
restraints’. For example, the SAXS profile calculated from the atomic structure of 
Pom152718–1148 (red curve in Extended Data Fig. 7f) using FoXS (111) is well matched 
(χ=1.48) to the corresponding experimental SAXS profile (23) (black dots in Extended 
Data Fig. 7f; n=20 exposures). For visualization purposes, the Pom152718–1148 structure 
(represented as a ribbon) is shown along with the best fit of the ab initio shape 
(represented as a transparent envelope) computed from the experimental SAXS profile, 
in Extended Data Fig. 7f.  
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Third, the structures of the Nic96 complex (composed of Nic96, Nsp1, Nup49 and 
Nup57) in the dominant cluster can be projected well on most of the 2D class averages 
obtained for the natively isolated complex (Extended Data Fig. 7g; see ‘Negative-stain 
electron microscopy of the native Nic96 complex’). More specifically, the electron 
microscopy 2D validation fits the structure of the Nic96 complex in the whole NPC context 
to the electron microscopy class averages of the Nic96 complex, and computes a score 
that quantifies the match. The computation proceeds in three stages: (1) generation of 
alternative model projections, (2) alignment of the class average and each model 
projection, and (3) calculation of the fitting score for each projection, as follows. First, 
1,000 uniformly distributed projections of the low-pass-filtered structure of the NPC on the 
sphere (stage 1) were generated. Second, each projection was optimally aligned to each 
of the class averages in Fourier space (stage 2). Finally, a score corresponding to the 
cross-correlation coefficient was computed (stage 3). For example, the experimental 
class averages were satisfied by the structure with cross-correlation coefficients of 0.85 
and 0.80, respectively (Extended Data Fig. 7g).  
Fourth, the structure was also validated by its comparison to the core scaffold 
maps of the Homo sapiens NPC, which are based primarily on electron microscopy 
density maps (6, 7, 17, 29) (Extended Data Fig. 12). Overall, the inner-ring architecture 
is similar in both yeast and vertebrates, consistent with it being the most conserved part 
of the NPC (39).  
Finally, the structure allows us to rationalize the functional fitness (Fig. 8.5), the 
transport through the NPC (Fig. 8.6 and Extended Data Fig. 11) and the evolution 
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(Extended Data Fig. 10), therefore increasing our confidence in the structure compared 
to not being able to rationalize these aspects of the NPC (8, 131, 132).  
Brownian dynamics simulation of FG repeats and NTFs 
Distributions of the FG repeats and NTFs were computed by Brownian dynamics 
simulation (133), using our previously published protocol (34) implemented in IMP (90) 
version 2.6. The simulated system included the static NPC ring determined in this study, 
the pore membrane, disordered and flexible FG-repeat domains as well as freely diffusing 
NTFs and inert macromolecules, all enclosed within a bounding box of 
2,000×2,000×2,000Å3.  
The pore membrane was represented as a 250Å slab with a cylindrical pore of 
radius 375 Å that contains the static NPC ring (this pore membrane representation is 
simplified compared to the toroidal pore used for solving the structure of the static NPC 
ring, for reasons of computational efficiency). Each of the FG-repeat domains was 
represented as a flexible string of beads; a bead had a radius of 6Å and encompassed 
20 residues to achieve a compromise between computational efficiency and accuracy 
(34, 110, 134–136). Consecutive beads were restrained by a bond with an equilibrium 
length of 18Å and a constant force of 1.0 kcal per mol per Å, approximating the spring-
like nature of flexible polymers (137) in general and FG-repeat domains (110, 134–136, 
138–140) in particular. The freely diffusing molecules included 1,600 NTFs and 1,600 
inert macromolecules (0.33 mM each), each consisting of 8 subgroups of 200 
macromolecules, ranging in radius from 4 to 28Å in 2Å increments (10 to 75kDa, 
assuming constant protein density of 1.38 g/cm2). Excluded volume interactions were 
applied to pairs of overlapping beads and to beads penetrating the pore membrane or the 
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bounding box, using a constant repulsive force of 10.0 kcal per mol perÅ. The potential 
binding energy between a binding site on an FG motif and a binding site on an NTR was 
modelled by an anisotropic harmonic potential dependent on the distance and orientation 
between the two sites that reproduces measured apparent dissociation constants in our 
simulations (B.R. et al., manuscript in preparation).  
The Brownian dynamics of the entire system were simulated at 297.15K for 40 
microseconds with a time step of 1,047 femtoseconds, independently 400 times; the first 
10 microseconds of each trajectory were considered equilibration time and ignored in 
subsequent analysis. The distributions of the FG Nup and NTR positions were then 
computed from the total of 12 milliseconds of simulations over a cubic grid with a voxel 
size of 10×10×10Å3, at time intervals of 9.5 picoseconds, from all 400 trajectories; these 
distributions were averaged by relying on the C8-symmetry of the NPC.  
Code availability.  
Files containing integrative structure modelling scripts, as well as the input data and 
output results are available at http://salilab.org/npc2018. The source code for calibrated 
imaging is available at https://github.com/jayunruh/ Jay_Plugins.  
Data availability.  
Source Data for Fig. 1a are provided as an excel file. Original data underlying the image 
calibration data (source data for Fig. 8.1 and Extended Data Fig. 3) can be accessed 
from the Stowers Original Data Repository at http://www.stowers.org/publications/LIBPB-
1267.  
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Raw data for the chemical cross-links (source data for Fig. 8.2 and Supplementary Table 
1) are available via the Zenodo data repository, at 
http://doi.org/10.5281/zenodo.1149746.  
The cryo-ET density map (source data for Fig. 8.3) is deposited in the Electron 
Microscopy Data Bank (EMDB) with the accession code EMD-7321.  
The cryo-ET raw data (120 tilt series; source data for Extended Data Figs 4–6) are 
deposited in the Electron Microscopy Public Image Archive (EMPIAR) (https:// 
www.ebi.ac.uk/pdbe/emdb/empiar/) with the accession code EMPIAR-10155 (see 
Supplementary Power Point Presentation slides 1, 2 as examples).  
The integrative NPC structure (source data for Fig. 4) is deposited in the nascent public 
Protein Data Bank (PDB) repository, PDB-dev (https://pdb-dev.wwpdb. org/), under the 
accession codes PDBDEV_00000010, PDBDEV_00000011 and PDBDEV_00000012.  
Source data for Extended Data Fig. 2b are provided in the Supplementary Information 
(Supplementary Fig. 1). SAXS data (source data for Extended Data Fig. 7f) are deposited 
in the Small Angle Scattering Biological Data Bank (SASBDB; https://www.sasbdb.org/), 
under the accession codes SASDBV9, SASDBW9, SASDBX9, SASDBY9 and 
SASDBZ9. In addition, all SAXS data (Supplementary Table 6) are provided as source 
data with the article.  
Raw data for the negative-stain electron microscopy of the native Nic96 complex (source 
data for Extended Data Fig. 7g) are deposited in the Electron Microscopy Public Image 
Archive (EMPIAR) (https://www.ebi.ac.uk/pdbe/emdb/empiar/) with the accession code 
EMPIAR-10162. All other data are available from the corresponding author upon 
reasonable request. 
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Supplementary Information  
Supplementary Information is available in the online version of the paper.  
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Abstract 
Dynamics of three MET antibody constructs (IgG1, IgG2, and IgG4) and the IgG4-MET 
antigen complex was investigated by creating their atomic models with an integrative 
experimental and computational approach. In particular, we used two-dimensional (2D) 
Electron Microscopy (EM) images, image class averaging, homology modeling, Rapidly 
exploring Random Tree (RRT) structure sampling, and fitting of models to images, to find 
the relative orientations of antibody domains that are consistent with the EM images. We 
revealed that the conformational preferences of the constructs depend on the extent of 
the hinge flexibility. We also quantified how the MET antigen impacts on the 
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conformational dynamics of IgG4. These observations allow to create testable hypothesis 
to investigate MET biology. Our protocol may also help describe structural diversity of 
other antigen systems at approximately 5 Å precision, as quantified by Root-Mean-
Square Deviation (RMSD) among good-scoring models. 
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Introduction 
Antibodies are among the most specific biomedicines. They are important therapeutic 
agents, both as biomolecular drugs and as delivery vehicles of drugs in antibody drug 
conjugates (1). Antibodies usually contain three domains, i.e., two Fab domains and one 
Fc domain, connected by two short peptidic hinges (Fig 9.1). The 3D atomic structure of 
each full length antibody exists as an ensemble of multiple conformational states (2), 
although the three domains are almost always arranged into a Y or T-shaped 3D object 
as shown in their X-ray crystal structures (3–5). Due to the flexibility of the two hinges, 
the Cα RMSD between antibody structures could be higher than 30 Å, despite a similar 
overall arrangement of the three domains and the structural similarity among the 
individual Fab and Fc domains (Fig 9.1). This diverse structural space of antibodies 
makes the structure determination by X-ray crystallography and the application of 
structure-based design approaches extremely challenging.  
Multiple techniques have been used to study full length antibody structures, 
including X-ray crystallography that gave the structures of three full length constructs (3–
5), 3D Individual Particle Electron Tomography (IPET) (2, 6) and EM imaging (7). The 
IPET maps at 10–15 Å resolution combined with molecular dynamics simulations 
demonstrated a vast structural space represented by 120 diverse structure models (2) 
available to the mouse IgG1 construct. The model construction in the IPET study used a 
single starting structure from X-ray crystallography (3), allowing flexibility in the hinge 
region while keeping the individual domains rigid. The antibody structural space resulting 
from different arrangements of the rigid domains referred to as the “domain 
conformations” revealed by the IPET study serves as a starting point for our study. 
336 
 
To model the MET domain conformations, we used the EM2D module (8) of the 
open source Integrative Modeling Package (IMP) (9, 10) to construct the models of three 
MET isotypes (IgG1, IgG2, IgG4) from the low resolution (~20 Å, see “Stage 3: Scoring 
domain conformation” of Materials and Methods section for details) 2D class averages of 
individual particle EM images. We found that for all examined antibody constructs, every 
good quality 2D class average could be uniquely represented by a single model of domain 
conformation selected from a diverse conformational ensemble at model precision of 5 Å 
RMSD. The variability among the generated models that sufficiently satisfy the 
experimental 2D class averages is quantified by model precision, defined as the largest 
RMSD value of a model that still satisfies the 2D class average to the best scoring model 
for that 2D class average (see “Stage 4: Analysis and Assessment of the Ensemble” in 
“Materials and Methods” section for details). The determination of domain conformations 
at 5 Å RMSD precision increases our understanding of antibody structural dynamics. 
Furthermore, it allows us to relate the biological profile of constructs to the inter-domain 
interactions, location and orientation of complementarity determining regions (CDRs) as 
well as the overall shape of the antibodies. The methodology presented here can be 
applied for future exploration of dynamics of antibodies in general.  
Our modeling effort focused on MET antibody constructs. MET, the receptor for 
hepatocyte growth factor (HGF), has been implicated in driving tumor proliferation and 
metastasis. Given the critical roles of the MET/HGF pathway in tumor growth and 
development, various groups developed MET blocking antibodies (11–14). However, 
bivalent anti-MET antibodies that inhibit both HGF-dependent and HGF-independent 
activation were largely unsuccessful as these constructs tended to have agonistic rather 
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than antagonistic activity (12–14). The first reported construct with no agonistic activity 
was LY2875358 (11). LY2875358 is a humanized IgG4 antibody against the MET 
receptor, currently being evaluated in Phase II clinical trials for non-small cell lung cancer 
(NSCLC). It has high neutralization and internalization activities, resulting in inhibition of 
ligand dependent and ligand independent MET pathway inhibition. While LY2875358 
does not have agonist activity in the IgG4 format, the IgG1 version of the same MET 
antibody shows increased agonist activity. This observation suggests that the agonistic 
activity of the antibody might depend on the IgG isotypes on the top of the differences in 
the variable regions. Knowledge of the 3D structural differences between different IgG 
isotypes could help us better understand the above-mentioned functional outcomes. 
 
Figure 9.1 | The antibody structure and variability. 
(A) X-ray crystal structures of three full length antibodies: mouse IgG2 in blue (PDB code 
1IGT) (3), human IgG1 in red (1HZH) (4), and mouse IgG1 in green (1IGY) (5), 
superposed on all aligned Cα atoms from all three domains (left) for the overall shape 
comparison or only Fc domains (right) to highlight the differences in Fab domains. The 
pairwise Cα RMSD values range from 20 to 34 Å with an average of 27.6 Å. The pairwise 
Cα RMSD values of the Fab domains range from 1.1 to 3.9 Å when superposed only on 
the Fab domain residues, with an average of 2.0 Å. The pairwise Cα RMSD values of the 
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Fc domains range from 2.2 to 2.4 Å when superposed only on the Fc domain residues. 
Superposition was done using MOE 2014.09 (15). (B) An example to show the definition 
of the domain angles between every two domains measured from 3D structures as 
described by Zhang et. al. (2). The lines follow the longest axis of each domain. 
 
Results  
Isotype dependence of agonist activity 
We have previously reported (11) multiple in vitro bioassays to characterize the agonist 
properties of LY2875358, using HGF and agonist bivalent MET antibody 5D5 as positive 
controls with Phospho-AKT as the most sensitive agonist assay. Here we established that 
LY2875358 (IgG4 isotype) induced only a weak and transient phosphorylation of pan-
AKT upon binding to MET (Fig. 9.2A), and this weak phosphorylation of pan-AKT did not 
stimulate biologic activity in seven functional MET agonist assays (11). However, the 
higher levels of AKT phosphorylation induced by MET antibody 5D5 and HGF (Fig. 9.2A) 
correlated well with cell proliferation, mobility and anti-apoptosis in the same functional 
assays (11). We further compared IgG1, IgG2 and IgG4 MET antibodies in the phospho-
AKT assay, showing that IgG1 MET antibody significantly increased phospho-AKT activity 
levels by more than eight-fold, close to the levels from agonist 5D5 and HGF. In the same 
assay, the IgG2 isotype displayed a slight increase in phosphorylation of AKT as 
compared to the IgG4 isotype (Fig. 9.2B). Because these antibodies have shown 
comparable binding affinity to the MET extracellular domain (ECD) by Biacore and have 
nearly identical sequences except in the hinges (Fig. 9.2C), we hypothesized that the 
hinge flexibility of antibodies of different isotype might contribute to how antibodies 
engage MET on the cell surface, hence impacting the agonistic activity. 
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Figure 9.2 | The effect of MET antibody isotypes on pAKT in Caki-1 cells. 
(A) The humanized IgG4 MET antibody (LY2875358), hIgG4 and mIgG1 induce weak 
phosphorylation of pan-AKT as compared to the strong phosphorylation of pan-AKT by 
agonist antibody 5D5 and HGF (11). (B) Comparison of IgG1 (purple), IgG2 (blue) and 
IgG4 MET antibodies (red). (C) The sequences in the hinges. The numbering of the first 
residue is shown in each sequence. The inter-heavy-chain disulfide bonded cysteine 
residues are indicated in yellow boxes.  
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Reconstruction of 3D domain conformation models and their relative diversity 
Fig. 9.3 shows an example of EM particle images and their 2D class averages for the 
IgG1 MET antibody construct. We found that 2D class averages of antibody samples 
often had the Y/T shape, although in some cases two of the “arms” could be very close 
to each other. Therefore, we excluded the class averages with images that didn’t display 
the Y/T shape. Fig. 9.4 shows the observed good quality 2D class average, the 
corresponding best scoring simulated 2D images, together with the ribbon diagrams of 
corresponding 3D domain conformation models for all four antibody samples. Eight 
(IgG1), five (IgG2), nine (IgG4) and seven (IgG4-MET antigen complex) domain 
conformations were obtained with our protocol. The modeled conformations are quite 
different within each construct, with pairwise RMSD values ranging from 5.7 to 37.0 Å 
(Table B in S1 File and Fig. 9.5). 
  
 
Figure 9.3 | Examples of EM image thumbnails. 
An EM micrograph with a number of IgG1 particles (left) and EM 2D class average images 
(right). Not all 2D class averages contained recognizable Y/T-shaped antibody particles; 
those marked by a red “X” were not used in modeling. 
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Figure 9.4 | Observed class averages, resulting 3D models, and class averages 
computed from the models. 
Images of observed 2D class average (first row), class averages computed from the 
resulting 3D models (second row) and the ribbon views from the 3D model (light chains 
in green and magenta, heavy chains in yellow and cyan, glycoside heavy atoms in red), 
and the models (second row). (A) IgG1: image dimension 160x160 pixels, 2.0 Å/pixel. (B) 
IgG2: image dimension 160x160 pixels, 2.0 Å/pixel. (C) IgG4: image dimension 106x106 
pixels, 3.0 Å/pixel. (D) IgG4-MET antigen complex: image dimension 160x160 pixels, 3.24 
Å/pixel. 
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Figure 9.5 | Distributions of pairwise RMSD values for IgG1, IgG2, IgG4 and IgG4- 
MET complex models. 
The average values of pairwise RMSD are indicated by the gray vertical solid bars. The 
95% confidence intervals of the average are indicated by the black vertical dashed bars. 
The plots were created using TIBCO Spotfire 6.5.3 (16).  
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Figure 9.6 | EM2D scores of all conformations and their RMSD values to the 
highest scoring conformation. 
The conformations are binned into groups of 1 Å size according to the RMSD values. The 
standard error is shown as the error bar for each bin. The samples are (A) IgG1, (B) IgG2, 
(C) IgG4, and (D) IgG4 antigen complex. 
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EM2D scores (Fig. 9.6) and the visual examination (as described in Materials and 
Methods) indicated that only the best scoring conformation and its close conformational 
analogs (within 5 Å RMSD) provided satisfactory representation of the 2D class average. 
Other domain conformations (more distant than 5 Å RMSD from the best scoring one) 
had lower EM2D scores and less satisfactory matches to the 2D class average. This 
observation suggested that the 3D domain conformational models within 5 Å RMSD from 
the best scoring model were a good explanation of a given 2D class average. It further 
suggested that the model precision is approximately 5 Å RMSD. This relatively high 
“model precision” demonstrates that our modeling protocol adds significant structural 
information to the initial 2D images, which were produced at ~20 Å image resolution.  
Approximately 75% of 2D class averages were excluded from our analysis, mostly 
due to the lack of recognizable Y/T shape (see Fig. 9.3 for the examples of the excluded 
images) or because we could not find a model matching the class average (Fig. 9.4; 
Materials and Methods.) These exclusions likely stemmed from the sample preparation 
and imaging process. Our protocol, while offering model precision of 5 Å RMSD, could 
only be used to create 3D models for domain conformations that have clearly 
recognizable antibody shapes in 2D images. As a result of this process limitation, our 
comparison of domain conformations only focused on the 2D class averages that have 
recognizable stems and arms of an antibody, potentially resulting in an underestimation 
of conformational flexibility.  
The IgG1 isotype had the highest internal diversity of 3D domain conformations, 
with average pairwise RMSD of 24.8 Å (Fig. 9.5 and Table 1). The other two MET 
constructs, IgG2 and IgG4, had lower conformational diversity with average RMSD of 
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23.3 and 18.0 Å, respectively. The difference of the internal diversity between IgG1 and 
IgG4 is statistically significant at the 95% confidence level (Fig. 9.5). Both IgG1 and IgG4 
have two hinge disulfide bonds, whereas IgG2 has four disulfide bonds. The hinge length 
is 17 residues for both IgG1 and IgG2, and 15 for IgG4. Both the longer hinge length and 
lower number of disulfide bonds are expected to lead to higher conformational diversity. 
The internal conformational diversity observed in our 3D models is more consistent with 
the increased hinge length than with the number of hinge disulfide bonds.  
In contrast, the number of the modeled conformational states (as opposed to internal 
conformational diversity) increases as the number of disulfide bonds decreases. A lower 
number of disulfide bonds resulted in more 2D class averages and a higher number of 
the corresponding modeled 3D domain conformations. For example, only five unique 
conformational states were observed for the four-hinge-disulfide-bonded IgG2, while 
eight and nine conformational states were found for the two-hinge-disulfide-bonded IgG1 
and IgG4, respectively. 
The angular range of domains relative to one another (2), i.e., the angles between 
two Fab domains and the angles between the Fab and Fc domains (as defined in Fig. 
9.1B), are another commonly used characteristics of antibody flexibility. These 
parameters, together with other metrics characterizing the modeled constructs, are shown 
in Table 1 and Figure A in S1 File. Overall, IgG2 and IgG4 constructs had similar average 
values of all three domain angles (Fab-Fab and two Fab1/2-Fc) while IgG1 and IgG4 had 
a similar span of the values. The narrower span of the Fab-Fab angles from IgG2 (46 
degrees) than that for IgG1 and IgG4 (57 degrees for both) is consistent with the lower 
expected hinge flexibility of IgG2. 
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3D models for antigen bound IgG4 MET complex 
The EM images of the complex between the MET antigen and IgG4 allowed us to 
compute seven models of domain conformations. While the antigen presence did not 
change the average values of the domain angles, it led to a larger span of these angles 
and higher pairwise RMSD values (Table 1 and Fig. 9.5) than found of IgG4 on its own. 
The domain conformations of the complex were also significantly different from those of 
the isolated IgG4 with an average pairwise RMSD of 25.7 ± 4.2 Å (Table C in S1 File). 
This observation suggests that angular measurement alone is not sufficient to determine 
3D domain conformational differences. The model differences between the antigen-
bound and isolated IgG4 indicate that the conformational space of the free form might 
differ from that for the antigen bound form. 
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Table 9.1 | Flexibility of domain arrangements. 
The differences in average values of the domain angles are not statistically significant at 
95% confidence level (Figure B in S1 File). 
 IgG1 IgG2 IgG4 IgG4-MET 
Hinge 
number of residues 17 17 15 15 
number of disulfide bonds 2 4 2 2 
EM Experiments 
magnification ratio 110,000 110,000 110,000 67,000 
number of recognizable 
particles 
1,688 2,557 4,685 4,000 
number of 2D class averages 8 5 9 7 
Domain Angles from 3D Structures (°) 
average Fab1-Fab2 
(population weighted) 
114 (114) 139 (139) 138 (140) 139 (144) 
average Fab1-Fc (population 
weighted) 
113 (115) 101 (99) 95 (95) 92 (90) 
average Fab2-Fc (population 
weighted) 
130 (129) 119 (121) 122 (121) 122 (118) 
range of Fab-Fab 82–139 118–164 108–165 108–177 
span of Fab-Fab 57 46 57 69 
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 IgG1 IgG2 IgG4 IgG4-MET 
Domain Angles from 3D Structures (°) 
range of Fab1-Fc 71–135 72–142 71–127 63–127 
span of Fab1-Fc 64 70 56 64 
range of Fab2-Fc 108–163 85–138 104–163 83–154 
span of Fab2-Fc 55 53 59 71 
Pairwise RMSD of 3D Structures (Å) 
Average ± sd 24.8 ± 5.7 23.3 ± 7.3 18.0 ± 5.0 23.3 ± 5.6 
Median 26.1 24.1 18.1 25.0 
Minimum 8.3 11.4 5.7 8.0 
Maximum 33.8 34.5 27.2 32.5 
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Discussion 
It has been shown that antibodies can adopt multiple conformational states. For example, 
as many as 120 different conformations were reported for the mouse IgG1 from an IPET 
study (2). Our results support the existence of multiple conformational states for all our 
MET antibody constructs. In particular, we found that the IgG1 construct had much wider 
diversity of domain conformations (Fig. 9.5 and Table 1) and showed the smallest angle 
between the two Fab domains (Table 1). This behavior is in contrast to the other two 
isotypes (IgG2 and IgG4) that showed little or low agonist activity. It is tempting to 
speculate that the agonist activity of MET IgG1 (Fig. 9.2) is related to the extra domain 
conformational space and/or smaller Fab-Fab angles. Further structural characterization 
on additional samples with a range of biological agonist profiles will be required to 
substantiate our hypothesis about the MET antibody agonist activity. Although these 
results may not be generalizable to all antibodies, our protocol can be readily applied to 
study dynamics and/or heterogeneity of other antibody constructs.  
Our results also indicate that antigen free IgG4 MET conformations are different 
from those observed in the complex with the antigen. This observation suggests the 
conformational states required for MET antigen recognition might be different from those 
accessible to the free antibody. Therefore, the complexes rather than free antibodies are 
more suited to study structures relevant to the biological activity. Our results demonstrate 
that the conformational domain variability in our models was dependent primarily on the 
hinge length, while the number of conformational states revealed by 2D class averages 
depends on the hinge disulfide patterns. 
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It is commonly understood that negative staining may introduce artifacts, such as particle 
flattening (17). Our analysis is clearly limited by any such artifacts. However, it seems 
conceivable that staining does not significantly affect conformational variability in the 
sample, because antibody adherence to the carbon coated grid likely traps the observed 
conformations prior to application of the negative stain. Also, negative staining with uranyl 
formate was reported to fix protein samples so rapidly that the overall protein 
conformations or protein complex formation were not affected (17). Indeed, the degree of 
flexibility we observed is consistent with other studies of antibody conformation (2).  
The resolution of 2D images and the resulting class averages is lower when 
compared to the near atomic resolution from the state-of-the art single particle cryo-EM 
reconstruction (18–24). But for some applications, in particular to systems containing 
multiple functional states, the practicality of obtaining single-particle reconstructions at 
atomic resolution might be time and cost prohibitive. In such cases, our approach may 
offer a reasonable and economical start before pursuing the more involved experiments. 
In recent review articles (25, 26), it was estimated that higher resolution data comes at a 
cost of UK₤1,000/day for cryo-EM-related computing works, in addition to US$5 million 
instrument cost and half million dollars only for annual operational expenses. A number 
of studies reported the use of 2D class averages to investigate protein conformation 
flexibility(27, 28). As cryo-EM methods become more routinely applicable to particles 
smaller than 150 kDa, it will be informative to compare cryo-EM class averages of 
antibody conformations in vitreous ice with those observed by single particle and 
tomographic analyses of negative-stained samples at similar magnification on the same 
EM camera. 
351 
 
Our integrative experimental and computational approach was able to provide 
models of four MET antibody systems with 5 Å RMSD precision. It is expected to be 
applicable to the determination of low-resolution 3D models of many other antibodies and 
for testing certain structural hypothesis at a fraction of cost needed for single-particle 
reconstruction. While 2D images likely reveal only a fraction of all conformational states, 
they can serve as a good starting point to understanding a relative structural diversity of 
a particular system. Therefore, lower resolution 2D imaging and resulting class averages 
could be complementary to 3D Cryo-EM for biological systems that have multiple 
conformations differing by more than 5 Å RMSD, such as in the case demonstrated here 
for the MET antibodies.  
 
Figure 9.7 | Flowchart of integrative multi-state modeling. 
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Materials and methods 
Antibody samples and preparation 
The variable regions from LY2875358 (11) were cloned into human IgG1 and IgG2 
constant regions. The antibodies with human IgG1, IgG2 and IgG4 were expressed in 
Chinese Hamster Ovary cells and purified to greater than 95% homogeneity using Protein 
A followed by preparative Size Exclusion Chromatography. Human MET ECD containing 
a FLIS tag was expressed and purified from Chinese Hamster Ovary cells. The IgG4 
antibody in complex with human MET ECD antigen was prepared by Size Exclusion 
Chromatography. 
Samples of IgG1, IgG2, IgG4, and IgG4 MET antigen complex were diluted 1:500 
with HBS-N pH 7.4 prior to imaging. The samples were then prepared using continuous 
carbon grid method. Grids were nitrocellulose supported 400-mesh copper. The samples 
were prepared by applying 3 μL of sample suspension to a cleaned grid, blotting away 
with filter paper, and immediately staining with Uranyl Formate. 
Phosphorylation of pan-AKT assay 
Caki-1 Cells were starved overnight in serum-free medium with 0.5% BSA and then 
treated with various doses of MET antibodies for 15 minutes. Cell lysates were analyzed 
for phosphorylation of pan-AKT by MSD ELISA. HGF and agonist bivalent MET antibody 
5D5 were used as positive controls. 
EM imaging 
EM experiments were performed (29) using an FEI Tecnai T12 electron microscope, 
operating at 120 keV equipped with an FEI Eagle 4k x 4k CCD camera. Negative stain 
grids were transferred into the electron microscope using a room temperature stage. 
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Images of each grid were acquired at multiple scales to assess the overall distribution of 
the specimen. After identifying potentially suitable target areas for imaging at lower 
magnifications, high magnification images were acquired at nominal magnifications of 
110,000X (0.10 nm/pixel) or 67,000X (0.16 nm/pixel). The images were acquired at a 
nominal underfocus of -2 μm (110,000X) or -3 μm to -2 μm (67,000X), and electron doses 
of ~25–40 e/Å2. 
Integrative modeling 
Our integrative structure modeling proceeds through four stages (9, 10): (1) gathering the 
data, (2) sampling the domain conformations, (3) scoring the domain conformations, and 
(4) analyzing and assessing the domain conformations (Fig. 9.7): 
Stage 1: Gathering the data for the initial models 
EM 2D class averages 
The individual particles were identified in the high magnification images prior to the 
alignment and classification. The individual particles were then selected, boxed out, and 
individual sub-images were combined into a stack to be processed using a reference-free 
classification method (30). Individual particles in the 67,000X or 110,000X high 
magnification images were selected using automated picking protocols (31). An initial 
round of alignments was done on each sample, followed by selecting recognizable 
particles for additional rounds of alignment. Only classes with three recognizable domains 
were kept for further analysis and 3D structure modeling. Particle alignment and 
classification were carried out using a reference-free alignment strategy based on the 
XMIPP (30) processing package. Algorithms in this package aligned the selected particles 
and sorted them into self-similar groups of classes. 
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Antibody comparative modeling 
Initial comparative structure models of the antibody constructs were built by MOE 
modeling package (15) using an X-ray crystal structure (PDB code 1IGT) (3) as a 
template. In all cases, disulfide bridges were added (if not created automatically). The 
structures were then minimized using the Amber10:EHT force field (15) to avoid atomic 
clashes and resolve any strain created by disulfide addition. The glycosides were also 
grafted from the 1IGT template structure. The models were then minimized with restraints 
for non-hydrogen atoms to their original positions, and served as starting points for hinge 
flexibility exploration. The antibody-antigen complex structure for IgG4 was constructed 
by grafting the aligned MET-Fab complex (PDB code 4K3J) (32) onto the comparative 
model of MET IgG4, using the Fab domains’ backbones for superposition. In addition, the 
complete structure of the MET antigen (PDB code 2UZY) (33) was grafted to the existing 
model based on the alignment of the overlapping MET region. The final model of the 
complex was then energy minimized with backbone restraints to avoid the clashes 
produced by superposition. 
Stage 2: Sampling domain conformation 
We used the Rapidly exploring Random Tree (RRT) algorithm (34, 35) to explore the 
domain conformational space of the full length antibody, using the optimized comparative 
model as a starting conformation. A modified version of the RRT algorithm implemented 
in IMP (9, 10) was used, which sampled the dihedral angles of the protein under the 
closure constraint to keep the disulfide connections among different chains in the hinge 
region intact. During the search, two Fab domains and the Fc domain were treated as 
rigid bodies. Up to 100,000 iterations of RRT were performed, and typically about 2,000 
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diverse domain conformations were generated. The diversity of the domain conformations 
was characterized by the RMSD values of Cα atoms between every pair of generated 
models as well as the domain angles as defined in Fig. 9.1B. In depth discussion of the 
sampling exhaustiveness is present in S1 File. 
Stage 3: Scoring domain conformation 
EM2D scoring function 
The EM2D module of the IMP program (8–10) was used to compare all antibody domain 
conformation models to every experimental 2D class average. The 2D class average 
resolution was estimated to be about 20 Å based on the simulation results. Specifically, 
the EM2D score of a 3D model reaches a maximum when the model is projected to 
generate 2D images using the resolution that matches the actual resolution of the 2D 
class average. We tested a range of resolution values from 2–30 Å and found that the 
maximal EM2D scores occurred at about 20 Å, thus defining the resolution of the 2D class 
averages. For every experimental 2D class average, 1,000 different orientations of every 
domain conformation were projected onto the 2D class image plane to produce the 
simulated images. The simulated images were then optimized and scored based on the 
Gaussian-weighted cross-correlation coefficient (i.e., EM2D score) (8) between the 
observed and the simulated 2D images. For every domain conformational model, the 
score, simulated 2D image, and parameters of the best-scored orientation were recorded 
as the final solutions. The PDB file of the conformational model in the final orientation was 
generated along with the protein ribbon-view image created using a PyMOL script (36). 
A scoring function that can rank alternative models by their accuracy is an essential part 
of any structure modeling. Good scoring functions can correctly rank models over a broad 
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range of RMSD values from the native state. We examined whether or not such “scoring 
funnels” existed for EM2D scoring (37) and determined their shape for the specific 
antibody constructs. The EM2D scores of all RRT generated candidate domain 
conformations are plotted against the RMSD values from the highest scoring model 
in Fig. 9.6. When fitting to the same experimental image, differences were often observed 
from two simulated images even when the EM2D scores differed by only 0.01. We thus 
expanded the score threshold window to 0.03 (from the best scoring one) to broaden the 
pool of candidates for the visual inspection and final model refinement. 
Stage 4: Analysis and assessment of the ensemble 
For every experimental 2D class average, all domain conformational models were sorted 
in descending order by their EM2D scores (see Stage 3) and clustered by a “leader” 
algorithm (38, 39) to facilitate visual examination. In depth discussion on the EM2D 
scoring as it relates to image selection is present in S1 File. The highest scoring domain 
conformation was selected as the first leader object and removed from the list. The all-
residue Cα RMSD values of every subsequent domain conformation in the sorted list to 
the already-found leader conformation determined whether the conformation was 
designated as a new leader or a member of an existing cluster represented by a 
previously-selected leader. A new leader conformation was selected with the highest 
EM2D score and the RMSD to existing leaders exceeding the threshold value. Four 
thresholds of the RMSD values were used for the leader clustering, 5, 10, 15, and 20 Å. 
For each threshold, up to 20 top scoring leaders and several other top scoring cluster 
members were visually examined for their fit to the experimental 2D class average. 
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The visual inspection, aided by PyMOL (36) protein ribbon representation, was 
used only to select the cutoff for the EM2D score that ensures consistency between the 
2D class average, the simulated image, and the 3D model ribbon view, including the 
assignment of the Fc domain. Specifically, visual inspection of matches and mismatches 
confirmed that the EM2D score can indeed be used for ranking models based on class 
averages. However, this visual examination also suggested that some 3D models with 
slightly lower EM2D scores also match the 2D class averages well, if these models were 
within 5 Å RMSD to the best scoring model, resulting in the estimate of model precision 
of 5 Å RMSD. Visualization further revealed that the EM2D score of at least 0.83 was 
needed to ensure such consistency; otherwise, mismatches between the models and the 
class averages could occur due to similar shapes of the three domains. Therefore, we 
elected to discard the class averages without models with the EM2D score of at least 
0.83. In summary, a good fit between an experimental 2D class average and a 3D 
antibody domain conformation has two attributes: (1) EM2D score of at least 0.83; and 
(2) the observed 2D image, the simulated 2D image, and the ribbon view image are 
consistent with each other in the overall shape and Fc domain assignment. 
The final 3D structures representing the best matches to the 2D class averages 
were subsequently transferred to the MOE modelling package (15), and minimized with 
constraints for Fab and Fc domain backbone heavy atoms while allowing the hinge atoms 
to be flexible. The glycosides were attached to the glycosylation sites on the Fc domain 
heavy chains. The resulting minimized structures were transferred into Maestro15.3 (40), 
optimized with the protein preparation wizard and solvated in orthorhombic TIP3P water 
box for the NPT Molecular Dynamics (MD) local refinement with Langevin thermostat and 
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PME using Desmond package (40). The refinement protocol consisted of three steps of 
constrained minimization: 5,000 steps with heavy atom restraints, followed by 
unrestrained 50,000 steps, restrained heating at 30 ps at temperature 100 K, 200 K and 
300 K equilibration. The 5 ns MD production run for each 3D structure with backbone 
heavy atom constraints for Fab and Fc domains allowed for equilibration of side chains, 
glycosides and hinge residues. The resulting structures were then minimized with 1,000 
steps of steepest descent minimization to produce the final 3D models. 
Data Availability 
All relevant data are within the paper and its Supporting Information files. 
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The file also contains two figures and three tables. 
https://doi.org/10.1371/journal.pone.0175758.s001 
Funding 
Eli Lilly and Company provided support in the form of research materials for authors (QC, 
MV, DET, CH, WZ, JL, LL). The IMP software development was funded in part by NIH 
grants to AS, including P41 GM109824 and R01 GM083960. IEC is supported by the 
NSF Graduate Student Research Fellowship. The funders had no role in study design, 
data collection and analysis, decision to publish, or preparation of the manuscript. 
Competing interests 
The IMP software development was funded in part by NIH grants to AS, including P41 
GM109824 and R01 GM083960. IEC is supported by the NSF Graduate Student 
Research Fellowship. The affiliation of authors (QC, MV, DET, CH, WZ, JL, LL) with Eli 
359 
 
Lilly and Company does not alter our adherence to PLOS ONE policies on sharing data 
and materials. 
Acknowledgments 
The authors would like to thank Dr. Jeremy Desaphy for technical supports of protein 
structure analysis and Dr. Phil Hipskind for his help to initiate the EM studies. The authors 
would like to thank Dr. Bridget Carrager (NanoImaging Services Inc.) for helpful 
discussions on interpreting EM images. The EM data collection was performed by 
NanoImaging Services, Inc., 10835 Road to the Cure, Suite 150, San Diego, CA 92121. 
The IMP software development was funded in part by NIH grants to AS, including P41 
GM109824 and R01 GM083960. I.E.C is supported by the NSF Graduate Student 
Research Fellowship. 
Author Contributions 
Conceptualization: QC MV DET CH. Data curation: QC MV DET WZ. Formal 
analysis: QC MV WZ. Funding acquisition: DET CH AS. Investigation: DET WZ QC MV. 
Methodology: QC MV DET CH DSD IEC AS. Project administration: QC DET CH. 
Resources: DET DSD IEC WZ LL JL. Software: QC DSD IEC. Supervision: QC MV DET 
CH AS. Validation: DET IEC WZ. Visualization: QC MV WZ.Writing – original draft: QC 
MV. Writing – review & editing: CH DSD IEC AS LL JL DET. 
 
 
 
 
 
360 
 
References 
1.  J. M. Lambert, Antibody-Drug Conjugates (ADCs): Magic Bullets at Last! Mol. Pharm. 
12, 1701–1702 (2015). 
2.  X. Zhang, et al., 3D Structural Fluctuation of IgG1 Antibody Revealed by Individual 
Particle Electron Tomography. Sci Rep 5, 9803 (2015). 
3.  L. J. Harris, S. B. Larson, K. W. Hasel, A. McPherson, Refined structure of an intact 
IgG2a monoclonal antibody. Biochemistry 36, 1581–1597 (1997). 
4.  E. O. Saphire, et al., Crystal structure of a neutralizing human IGG against HIV-1: a 
template for vaccine design. Science 293, 1155–1159 (2001). 
5.  L. J. Harris, E. Skaletsky, A. McPherson, Crystallographic structure of an intact IgG1 
monoclonal antibody. J. Mol. Biol. 275, 861–872 (1998). 
6.  H. Tong, et al., Peptide-conjugation induced conformational changes in human IgG1 
observed by optimized negative-staining and individual-particle electron 
tomography. Sci Rep 3, 1089 (2013). 
7.  I. Correia, et al., The structure of dual-variable-domain immunoglobulin molecules 
alone and bound to antigen. MAbs 5, 364–372 (2013). 
8.  J. Velazquez-Muriel, et al., Assembly of macromolecular complexes by satisfaction 
of spatial restraints from electron microscopy images. Proc Natl Acad Sci U S A 109, 
18821–6 (2012). 
9.  F. Alber, B. T. Chait, M. P. Rout, A. Sali, “Integrative Structure Determination of 
Protein Assemblies by Satisfaction of Spatial Restraints” in Protein-Protein 
Interactions and Networks: Identification, Characterization and Prediction., A. 
Panchenko, T. Przytycka, Eds. (Springer-Verlag, 2008), pp. 99–114. 
361 
 
10.  D. Russel, et al., Putting the Pieces Together: Integrative Modeling Platform 
Software for Structure Determination of Macromolecular Assemblies. PLOS Biology 
10, e1001244 (2012). 
11.  L. Liu, et al., LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, 
inhibits HGF-dependent and HGF-independent MET activation and tumor growth. 
Clin. Cancer Res. 20, 6059–6070 (2014). 
12.  P. Morton, et al., In vitro and in vivo activity of fully-human monoclonal antibodies to 
c-Met protein tyrosine kinase. in (2003). 
13.  M. Prat, T. Crepaldi, S. Pennacchietti, F. Bussolino, P. M. Comoglio, Agonistic 
monoclonal antibodies against the Met receptor dissect the biological responses to 
HGF. Journal of cell science 111, 237–247 (1998). 
14.  Z. Zheng, C. Adams, B. Moffat, R. Schwall, editors, A chimeric Fab antibody serves 
as an antagonist to the HGF/SF receptor cMet. in (2003). 
15.  CCG, Molecular Operating Environment (MOE) (Chemical Computing Group Inc., 
2016). 
16.  TIBCO Software Inc., TIBCO. 
17.  D. S. Booth, A. Avila-Sakar, Y. Cheng, Visualizing proteins and macromolecular 
complexes by negative stain EM: from grid preparation to image acquisition. JoVE 
(Journal of Visualized Experiments), e3227 (2011). 
18.  A. Bartesaghi, et al., 2.2 Å resolution cryo-EM structure of β-galactosidase in 
complex with a cell-permeant inhibitor. Science 348, 1147–1151 (2015). 
362 
 
19.  M. Fischer, et al., Cryo-EM structure of fatty acid synthase (FAS) from 
Rhodosporidium toruloides provides insights into the evolutionary development of 
fungal FAS. Protein Sci. 24, 987–995 (2015). 
20.  N. Fischer, et al., Structure of the E. coli ribosome-EF-Tu complex at <3 Å resolution 
by Cs-corrected cryo-EM. Nature 520, 567–570 (2015). 
21.  L. Sun, et al., Cryo-EM structure of the bacteriophage T4 portal protein assembly at 
near-atomic resolution. Nat Commun 6, 7548 (2015). 
22.  A. Bartesaghi, D. Matthies, S. Banerjee, A. Merk, S. Subramaniam, Structure of β-
galactosidase at 3.2-Å resolution obtained by cryo-electron microscopy. Proc. Natl. 
Acad. Sci. U.S.A. 111, 11709–11714 (2014). 
23.  X. C. Bai, et al., An atomic structure of human gamma-secretase. Nature 525, 212–
7 (2015). 
24.  S. Banerjee, et al., 2.3 Å resolution cryo-EM structure of human p97 and mechanism 
of allosteric inhibition. Science 351, 871–875 (2016). 
25.  M. Eisenstein, The field that came in from the cold. Nat. Methods 13, 19–22 (2016). 
26.  R. M. Glaeser, How good can cryo-EM become? Nat Methods 13, 28–32 (2016). 
27.  E. J. Brignole, S. Smith, F. J. Asturias, Conformational flexibility of metazoan fatty 
acid synthase enables catalysis. Nat. Struct. Mol. Biol. 16, 190–197 (2009). 
28.  J. Zhang, P. Minary, M. Levitt, Multiscale natural moves refine macromolecules using 
single-particle electron microscopy projection images. Proc. Natl. Acad. Sci. U.S.A. 
109, 9845–9850 (2012). 
29. ,  NanoImaging (NanoImaging Services Inc). 
363 
 
30.  C. O. S. Sorzano, et al., XMIPP: a new generation of an open-source image 
processing package for electron microscopy. J. Struct. Biol. 148, 194–204 (2004). 
31.  G. C. Lander, et al., Appion: an integrated, database-driven pipeline to facilitate EM 
image processing. J. Struct. Biol. 166, 95–102 (2009). 
32.  M. Merchant, et al., Monovalent antibody design and mechanism of action of 
onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. Proc. 
Natl. Acad. Sci. U.S.A. 110, E2987-2996 (2013). 
33.  H. H. Niemann, et al., Structure of the human receptor tyrosine kinase met in 
complex with the Listeria invasion protein InlB. Cell 130, 235–246 (2007). 
34.  S. LaValle, “Rapidly-exploring random trees: A new tool for path planning.” 
(Computer Science Department, Iowa State University, 1998). 
35.  S. M. LaValle, J. J. Kuffner Jr, Randomized kinodynamic planning. The international 
journal of robotics research 20, 378–400 (2001). 
36.  The PyMOL Molecular Graphics System (Schrödinger, LLC.). 
37.  N. London, O. Schueler-Furman, Funnel hunting in a rough terrain: learning and 
discriminating native energy funnels. Structure 16, 269–279 (2008). 
38.  L. Hodes, Clustering a large number of compounds. 1. Establishing the method on 
an initial sample. J Chem Inf Comput Sci 29, 66–71 (1989). 
39.  L. Hodes, A. Feldman, Clustering a large number of compounds. 3. The limits of 
classification. J Chem Inf Comput Sci 31, 347–350 (1991). 
40.  Schrodinger, Schrodinger (Schrodinger LLC, 2015). 
 
 
Publishing Agreement 
 
It is the policy of the University to encourage open access and broad distribution of all 
theses, dissertations, and manuscripts. The Graduate Division will facilitate the 
distribution of UCSF theses, dissertations, and manuscripts to the UCSF Library for 
open access and distribution.  UCSF will make such theses, dissertations, and 
manuscripts accessible to the public and will take reasonable steps to preserve these 
works in perpetuity. 
  
I hereby grant the non-exclusive, perpetual right to The Regents of the University of 
California to reproduce, publicly display, distribute, preserve, and publish copies of my 
thesis, dissertation, or manuscript in any form or media, now existing or later derived, 
including access online for teaching, research, and public service purposes.  
  
 
__________________________       ________________ 
   Author Signature               Date 
 


